STUDYID,SUBJID,RAND,TREATXT,TRTCD,PCREFID,CNTNRID,PCDT,PCTM,VISIT,PCTPT,PCORRES,PCORRESU,PKACOM,PKCOML,PCSPEC,PKTERM,PCCAT,PCNAM,PCANMETH,PCMETHOD,PCLLOQ,PCLLOQU,PCSPID,ASSAYRUN,ASSAYDT
C1071013,10681001,1,PF-06863135,T,6514526668,6.51453E+11,20210209,11:30,CYCLE1_DAY1,0 H,<0.500,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 12,1RSYC,26-Oct-21
C1071013,10681001,1,PF-06863135,T,6514526668,6.51453E+11,20210209,18:45,CYCLE1_DAY1,6 H,268.9350465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 13,11RSYC,2-Nov-21
C1071013,10681001,1,PF-06863135,T,6514526671,6.51453E+11,20210216,9:12,CYCLE1_DAY8,0 H,950.2858986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 14,11RSYC,2-Nov-21
C1071013,10681001,1,PF-06863135,T,6514526671,6.51453E+11,20210216,16:30,CYCLE1_DAY8,6 H,199.0880907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 15,12RSYC,2-Nov-21
C1071013,10681001,1,PF-06863135,T,6514526673,6.51453E+11,20210223,11:20,CYCLE1_DAY15,0 H,228.9948978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 16,1RSYC,26-Oct-21
C1071013,10681001,1,PF-06863135,T,6514526675,6.51453E+11,20210302,10:08,CYCLE1_DAY22,0 H,791.2751273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 17,1RSYC,26-Oct-21
C1071013,10681001,1,PF-06863135,T,6514526676,6.51453E+11,20210309,11:00,CYCLE2_DAY1,0 H,20.50954644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 18,1RSYC,26-Oct-21
C1071013,10681001,1,PF-06863135,T,6515768046,6.51577E+11,20210406,14:04,CYCLE3_DAY1,0 H,134.9758367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 19,12RSYC,2-Nov-21
C1071013,10681001,1,PF-06863135,T,6515337610,6.51534E+11,20210504,12:00,CYCLE4_DAY1,0 H,732.9073693,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 20,12RSYC,2-Nov-21
C1071013,10681001,1,PF-06863135,T,6517472556,6.51747E+11,20210727,13:56,CYCLE7_DAY1,0 H,912.3462509,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 21,12RSYC,2-Nov-21
C1071013,10681001,1,PF-06863135,T,6517472564,6.51747E+11,20211102,11:09,CYCLE10_DAY1,0 H,10.56698722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 678,64RSYC,3-May-22
C1071013,10681001,1,PF-06863135,T,6518807395,6.51881E+11,20220111,11:36,CYCLE13_DAY1,0 H,724.3330422,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1611,97RSYC,12-May-22
C1071013,10681001,1,PF-06863135,T,6518807393,6.51881E+11,20220405,11:49,CYCLE16_DAY1,0 H,471.1091739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1921,123RSYC,29-Jul-22
C1071013,10681001,1,PF-06863135,T,6521317289,6.52132E+11,20221213,11:17,CYCLE25_DAY1,0 H,985.353709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2127,139RSYC,22-Mar-23
C1071013,10681001,1,PF-06863135,T,6521699933,6.5217E+11,20230307,10:43,CYCLE28_DAY1,0 H,169.1720319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2202,141RSYC,17-May-23
C1071013,10681001,1,PF-06863135,T,6523611270,6.52361E+11,20230810,11:51,END_OF_TRT,,195.6415532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2288,147RSYC,29-Feb-24
C1071013,10681002,2,PF-06863135,T,6514526669,6.51453E+11,20210302,11:00,CYCLE1_DAY1,0 H,290.5605009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 22,1RSYC,26-Oct-21
C1071013,10681002,2,PF-06863135,T,6514526669,6.51453E+11,20210302,18:30,CYCLE1_DAY1,6 H,3.748322998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 23,11RSYC,2-Nov-21
C1071013,10681002,2,PF-06863135,T,6514526670,6.51453E+11,20210309,9:31,CYCLE1_DAY8,0 H,70.10721739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 24,11RSYC,2-Nov-21
C1071013,10681002,2,PF-06863135,T,6514526670,6.51453E+11,20210309,17:31,CYCLE1_DAY8,6 H,688.9679603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 25,12RSYC,2-Nov-21
C1071013,10681002,2,PF-06863135,T,6514526672,6.51453E+11,20210316,9:56,CYCLE1_DAY15,0 H,520.3411206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 26,1RSYC,26-Oct-21
C1071013,10681002,2,PF-06863135,T,6515768043,6.51577E+11,20210323,10:05,CYCLE1_DAY22,0 H,484.2798346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 27,1RSYC,26-Oct-21
C1071013,10681002,2,PF-06863135,T,6515784458,6.51578E+11,20210330,10:29,CYCLE2_DAY1,0 H,271.9864044,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 28,1RSYC,26-Oct-21
C1071013,10681002,2,PF-06863135,T,6515784461,6.51578E+11,20210427,9:42,CYCLE3_DAY1,0 H,453.7809866,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 29,12RSYC,2-Nov-21
C1071013,10681002,2,PF-06863135,T,6515784462,6.51578E+11,20210601,10:06,CYCLE4_DAY1,0 H,851.682014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 30,141RSYC,17-May-23
C1071013,10031001,3,PF-06863135,T,6514857230,6.51486E+11,20210322,11:53,CYCLE1_DAY1,0 H,745.6241926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 31,119RSYC,27-Jul-22
C1071013,10031001,3,PF-06863135,T,6514857230,6.51486E+11,20210322,19:01,CYCLE1_DAY1,6 H,592.4205325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 32,122RSYC,29-Jul-22
C1071013,10031001,3,PF-06863135,T,6515792892,6.51579E+11,20210401,12:50,CYCLE1_DAY8,0 H,164.5291478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 33,11RSYC,2-Nov-21
C1071013,10031001,3,PF-06863135,T,6515792892,6.51579E+11,20210401,19:20,CYCLE1_DAY8,6 H,693.0478291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 34,12RSYC,2-Nov-21
C1071013,10031001,3,PF-06863135,T,6514020347,6.51402E+11,20210407,10:46,CYCLE1_DAY15,0 H,898.3327475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 35,2RSYC,27-Oct-21
C1071013,10031001,3,PF-06863135,T,6515792899,6.51579E+11,20210414,11:49,CYCLE1_DAY22,0 H,31.658303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 36,2RSYC,27-Oct-21
C1071013,10031001,3,PF-06863135,T,6514020351,6.51402E+11,20210421,13:10,CYCLE2_DAY1,0 H,202.9709566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 37,2RSYC,27-Oct-21
C1071013,10031001,3,PF-06863135,T,6515792911,6.51579E+11,20210616,17:56,CYCLE4_DAY1,0 H,325.834797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 38,2RSYC,27-Oct-21
C1071013,10031001,3,PF-06863135,T,6517889683,6.51789E+11,20210908,9:45,CYCLE7_DAY1,0 H,683.8950184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 174,6RSYC,29-Oct-21
C1071013,10071001,4,PF-06863135,T,6514020370,6.51402E+11,20210325,10:50,CYCLE1_DAY1,0 H,585.5404302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 39,2RSYC,27-Oct-21
C1071013,10071001,4,PF-06863135,T,6514020370,6.51402E+11,20210325,17:30,CYCLE1_DAY1,6 H,195.6762937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 40,11RSYC,2-Nov-21
C1071013,10071001,4,PF-06863135,T,6514020372,6.51402E+11,20210401,11:00,CYCLE1_DAY8,0 H,321.9784725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 41,11RSYC,2-Nov-21
C1071013,10071001,4,PF-06863135,T,6514020372,6.51402E+11,20210401,17:25,CYCLE1_DAY8,6 H,246.067863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 42,12RSYC,2-Nov-21
C1071013,10071001,4,PF-06863135,T,6514020373,6.51402E+11,20210408,10:50,CYCLE1_DAY15,0 H,847.1368444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 43,2RSYC,27-Oct-21
C1071013,10071001,4,PF-06863135,T,6514020376,6.51402E+11,20210415,14:00,CYCLE1_DAY22,0 H,199.4136129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 44,2RSYC,27-Oct-21
C1071013,10071001,4,PF-06863135,T,6514020378,6.51402E+11,20210422,14:15,CYCLE2_DAY1,0 H,361.1603868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 45,2RSYC,27-Oct-21
C1071013,10071001,4,PF-06863135,T,6515768699,6.51577E+11,20210519,13:45,CYCLE3_DAY1,0 H,455.836371,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 46,12RSYC,2-Nov-21
C1071013,10071001,4,PF-06863135,T,6515808065,6.51581E+11,20210617,14:00,CYCLE4_DAY1,0 H,479.885666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 47,2RSYC,27-Oct-21
C1071013,10071001,4,PF-06863135,T,6516303733,6.5163E+11,20210909,9:20,CYCLE7_DAY1,0 H,138.8248696,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 161,6RSYC,29-Oct-21
C1071013,10071001,4,PF-06863135,T,6518265669,6.51827E+11,20211202,11:30,CYCLE10_DAY1,0 H,857.0099844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1092,107RSYC,24-May-22
C1071013,10071001,4,PF-06863135,T,6518265671,6.51827E+11,20220224,11:30,CYCLE13_DAY1,0 H,100.826418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1885,109RSYC,25-May-22
C1071013,10071001,4,PF-06863135,T,6520930827,6.52093E+11,20220811,11:08,CYCLE19_DAY1,0 H,870.2011703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2074,129RSYC,21-Oct-22
C1071013,10071001,4,PF-06863135,T,6520930824,6.52093E+11,20221103,8:52,CYCLE22_DAY1,0 H,965.0962017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2137,139RSYC,22-Mar-23
C1071013,10071001,4,PF-06863135,T,6520930826,6.52093E+11,20230126,11:18,CYCLE25_DAY1,0 H,583.3243942,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2214,142RSYC,18-May-23
C1071013,10071001,4,PF-06863135,T,6521740467,6.52174E+11,20230420,11:18,CYCLE28_DAY1,0 H,131.788685,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2243,143RSYC,27-Nov-23
C1071013,10071001,4,PF-06863135,T,6521740464,6.52174E+11,20230713,11:32,CYCLE31_DAY1,0 H,331.6300389,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2289,145RSYC,4-Jan-24
C1071013,10071001,4,PF-06863135,T,6524291345,6.52429E+11,20231228,11:34,CYCLE37_DAY1,0 H,531.6031402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2320,148RSYC,27-Mar-24
C1071013,10071001,4,PF-06863135,T,6518265672,6.51827E+11,20220608,10:25,UNPL,9001 H,785.0695095,NG/ML,,Visit revised from C16D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2005,115RSYC,25-Jul-22
C1071013,10191002,5,PF-06863135,T,6517246477,6.51725E+11,20210712,11:20,CYCLE1_DAY1,0 H,154.4765759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 48,2RSYC,27-Oct-21
C1071013,10191002,5,PF-06863135,T,6517246477,6.51725E+11,20210712,18:35,CYCLE1_DAY1,6 H,998.93571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 49,11RSYC,2-Nov-21
C1071013,10191002,5,PF-06863135,T,6514020417,6.51402E+11,20210719,10:54,CYCLE1_DAY8,0 H,339.2251238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 50,11RSYC,2-Nov-21
C1071013,10191002,5,PF-06863135,T,6514020417,6.51402E+11,20210719,17:10,CYCLE1_DAY8,6 H,947.5687806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 51,12RSYC,2-Nov-21
C1071013,10191002,5,PF-06863135,T,6517418458,6.51742E+11,20210727,11:03,CYCLE1_DAY15,0 H,113.273081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 52,2RSYC,27-Oct-21
C1071013,10191002,5,PF-06863135,T,6517418463,6.51742E+11,20210803,11:01,CYCLE1_DAY22,0 H,453.900594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 53,2RSYC,27-Oct-21
C1071013,10191002,5,PF-06863135,T,6517418466,6.51742E+11,20210810,14:50,CYCLE2_DAY1,0 H,352.3603975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 54,2RSYC,27-Oct-21
C1071013,10191002,5,PF-06863135,T,6517418472,6.51742E+11,20210907,13:01,CYCLE3_DAY1,0 H,392.3803811,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 171,6RSYC,29-Oct-21
C1071013,10191002,5,PF-06863135,T,6517246394,6.51725E+11,20211005,11:57,CYCLE4_DAY1,0 H,256.0768025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 279,14RSYC,15-Nov-21
C1071013,10191002,5,PF-06863135,T,6517418479,6.51742E+11,20211228,9:17,CYCLE7_DAY1,0 H,320.58486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 965,65RSYC,3-May-22
C1071013,10191002,5,PF-06863135,T,6518807116,6.51881E+11,20220322,10:45,CYCLE10_DAY1,0 H,970.060685,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1890,87RSYC,13-May-22
C1071013,10191002,5,PF-06863135,T,6518807118,6.51881E+11,20220614,10:34,CYCLE13_DAY1,0 H,523.1989781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2007,115RSYC,25-Jul-22
C1071013,10191002,5,PF-06863135,T,6520491233,6.52049E+11,20220906,11:18,CYCLE16_DAY1,0 H,414.9525024,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2077,131RSYC,9-Nov-22
C1071013,10191002,5,PF-06863135,T,6520491234,6.52049E+11,20221130,10:23,CYCLE19_DAY1,0 H,773.6945501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2128,139RSYC,22-Mar-23
C1071013,10191002,5,PF-06863135,T,6521907800,6.52191E+11,20230221,10:32,CYCLE22_DAY1,0 H,135.9592459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2203,141RSYC,17-May-23
C1071013,10191002,5,PF-06863135,T,6521907798,6.52191E+11,20230518,13:22,CYCLE25_DAY1,0 H,484.9521961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2244,145RSYC,4-Jan-24
C1071013,10191002,5,PF-06863135,T,6521907801,6.52191E+11,20230718,11:56,END_OF_TRT,,215.0033179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2280,145RSYC,4-Jan-24
C1071013,10191002,5,PF-06863135,T,6517246397,6.51725E+11,20210713,12:35,CYCLE1_DAY1,24 H,846.9590523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 55,11RSYC,2-Nov-21
C1071013,10191002,5,PF-06863135,T,6517418482,6.51742E+11,20210715,10:12,CYCLE1_DAY4,0 H,201.5510776,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 56,13RSYC,15-Nov-21
C1071013,10191002,5,PF-06863135,T,6517246497,6.51725E+11,20210716,12:20,CYCLE1_DAY4,24 H,728.815543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 57,12RSYC,2-Nov-21
C1071013,10981001,6,PF-06863135,T,6517246478,6.51725E+11,20210719,10:30,CYCLE1_DAY1,0 H,570.4863639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 58,2RSYC,27-Oct-21
C1071013,10981001,6,PF-06863135,T,6517246478,6.51725E+11,20210719,20:30,CYCLE1_DAY1,6 H,591.6492849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 59,2RSYC,27-Oct-21
C1071013,10981001,6,PF-06863135,T,6516326701,6.51633E+11,20210727,9:30,CYCLE1_DAY8,0 H,809.4188346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 60,12RSYC,2-Nov-21
C1071013,10981001,6,PF-06863135,T,6516326701,6.51633E+11,20210727,16:30,CYCLE1_DAY8,6 H,220.9299311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 61,3RSYC,28-Oct-21
C1071013,10981001,6,PF-06863135,T,6517246482,6.51725E+11,20210802,11:10,CYCLE1_DAY15,0 H,511.533642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 62,3RSYC,28-Oct-21
C1071013,10981001,6,PF-06863135,T,6517769668,6.51777E+11,20210809,11:05,CYCLE1_DAY22,0 H,712.9623875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 63,3RSYC,28-Oct-21
C1071013,10981001,6,PF-06863135,T,6517769674,6.51777E+11,20210816,11:45,CYCLE2_DAY1,0 H,324.8578798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 64,3RSYC,28-Oct-21
C1071013,10981001,6,PF-06863135,T,6517769676,6.51777E+11,20210913,11:00,CYCLE3_DAY1,0 H,825.1133814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 194,7RSYC,29-Oct-21
C1071013,10981001,6,PF-06863135,T,6517768789,6.51777E+11,20211011,11:04,CYCLE4_DAY1,0 H,863.2263834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 341,16RSYC,16-Nov-21
C1071013,10981001,6,PF-06863135,T,6517246506,6.51725E+11,20210721,14:44,UNPL,9003 H,954.7726812,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 65,11RSYC,2-Nov-21
C1071013,10981001,6,PF-06863135,T,6517246494,6.51725E+11,20210720,14:30,CYCLE1_DAY1,24 H,604.0185548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 66,3RSYC,28-Oct-21
C1071013,10981001,6,PF-06863135,T,6517246496,6.51725E+11,20210722,6:25,CYCLE1_DAY4,0 H,639.0389155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 67,3RSYC,28-Oct-21
C1071013,10981001,6,PF-06863135,T,6517246498,6.51725E+11,20210724,11:00,CYCLE1_DAY4,24 H,678.3939384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 68,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6516326700,6.51633E+11,20210723,10:56,CYCLE1_DAY1,0 H,861.3684263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 69,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6516326700,6.51633E+11,20210723,19:48,CYCLE1_DAY1,6 H,965.337736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 70,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517769660,6.51777E+11,20210730,8:25,CYCLE1_DAY8,0 H,139.1096001,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 71,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517769660,6.51777E+11,20210802,18:30,CYCLE1_DAY8,6 H,357.885518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 72,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517769666,6.51777E+11,20210812,9:36,CYCLE1_DAY15,0 H,265.7720496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 73,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517246507,6.51725E+11,20210817,17:12,END_OF_TRT,,965.1440696,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 74,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517560594,6.51756E+11,20210724,11:40,CYCLE1_DAY1,24 H,522.2160923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 75,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517560596,6.51756E+11,20210726,11:57,CYCLE1_DAY4,0 H,648.8563404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 76,3RSYC,28-Oct-21
C1071013,10981002,7,PF-06863135,T,6517560598,6.51756E+11,20210727,13:43,CYCLE1_DAY4,24 H,177.5451083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 77,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6516580385,6.51658E+11,20210802,12:32,CYCLE1_DAY1,0 H,56.95089202,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 78,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6516580385,6.51658E+11,20210802,18:59,CYCLE1_DAY1,6 H,872.1047177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 79,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6517889669,6.51789E+11,20210812,10:50,CYCLE1_DAY8,0 H,464.2512435,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 80,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6517889669,6.51789E+11,20210812,17:00,CYCLE1_DAY8,6 H,996.819981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 81,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6517473942,6.51747E+11,20210803,14:10,CYCLE1_DAY1,24 H,142.6205284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 82,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6517473943,6.51747E+11,20210806,9:30,CYCLE1_DAY4,0 H,451.0243711,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 83,3RSYC,28-Oct-21
C1071013,10031005,8,PF-06863135,T,6517473952,6.51747E+11,20210807,9:35,CYCLE1_DAY4,24 H,396.4778743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 84,3RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418450,6.51742E+11,20210802,9:36,CYCLE1_DAY1,0 H,424.9633619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 85,3RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418450,6.51742E+11,20210802,17:10,CYCLE1_DAY1,6 H,883.5043118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 86,3RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418457,6.51742E+11,20210809,9:28,CYCLE1_DAY8,0 H,534.9906465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 87,12RSYC,2-Nov-21
C1071013,10191004,9,PF-06863135,T,6517418457,6.51742E+11,20210809,17:15,CYCLE1_DAY8,6 H,770.7011238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 88,3RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418459,6.51742E+11,20210816,8:40,CYCLE1_DAY15,0 H,796.1552841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 89,3RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517246387,6.51725E+11,20210823,9:10,CYCLE1_DAY22,0 H,332.370013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 172,6RSYC,29-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418467,6.51742E+11,20210830,8:50,CYCLE2_DAY1,0 H,278.0075567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 173,6RSYC,29-Oct-21
C1071013,10191004,9,PF-06863135,T,6517246393,6.51725E+11,20211025,10:19,CYCLE4_DAY1,0 H,446.6398897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 517,25RSYC,22-Apr-22
C1071013,10191004,9,PF-06863135,T,6517418481,6.51742E+11,20220117,9:30,CYCLE7_DAY1,0 H,449.9585915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1610,97RSYC,12-May-22
C1071013,10191004,9,PF-06863135,T,6518807117,6.51881E+11,20220411,9:39,CYCLE10_DAY1,0 H,600.9720549,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1922,123RSYC,29-Jul-22
C1071013,10191004,9,PF-06863135,T,6520491237,6.52049E+11,20220705,10:31,CYCLE13_DAY1,0 H,695.3429439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2027,128RSYC,21-Oct-22
C1071013,10191004,9,PF-06863135,T,6520491231,6.52049E+11,20220926,10:05,CYCLE16_DAY1,0 H,133.2284764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2107,131RSYC,9-Nov-22
C1071013,10191004,9,PF-06863135,T,6521907799,6.52191E+11,20221219,9:32,CYCLE19_DAY1,0 H,900.6232909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2171,140RSYC,22-Mar-23
C1071013,10191004,9,PF-06863135,T,6521907796,6.52191E+11,20230313,10:19,CYCLE22_DAY1,0 H,125.435447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2204,141RSYC,17-May-23
C1071013,10191004,9,PF-06863135,T,6522691980,6.52269E+11,20230605,10:30,CYCLE25_DAY1,0 H,962.7346872,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2261,144RSYC,27-Nov-23
C1071013,10191004,9,PF-06863135,T,6522691972,6.52269E+11,20230828,10:29,CYCLE28_DAY1,0 H,26.59672625,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2300,147RSYC,29-Feb-24
C1071013,10191004,9,PF-06863135,T,6517246398,6.51725E+11,20210803,11:15,CYCLE1_DAY1,24 H,275.1396996,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 90,3RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418484,6.51742E+11,20210805,8:24,CYCLE1_DAY4,0 H,218.9442736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 91,4RSYC,28-Oct-21
C1071013,10191004,9,PF-06863135,T,6517418487,6.51742E+11,20210806,11:05,CYCLE1_DAY4,24 H,567.6947434,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 92,12RSYC,2-Nov-21
C1071013,10681004,10,PF-06863135,T,6517472543,6.51747E+11,20210802,14:55,CYCLE1_DAY1,0 H,304.7831952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 93,4RSYC,28-Oct-21
C1071013,10681004,10,PF-06863135,T,6517472543,6.51747E+11,20210802,20:40,CYCLE1_DAY1,6 H,675.5312382,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 94,4RSYC,28-Oct-21
C1071013,10681004,10,PF-06863135,T,6517763953,6.51776E+11,20210812,17:25,END_OF_TRT,,146.8177737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 95,4RSYC,28-Oct-21
C1071013,10681004,10,PF-06863135,T,6517260791,6.51726E+11,20210803,14:56,CYCLE1_DAY1,24 H,464.6082049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 96,4RSYC,28-Oct-21
C1071013,10681004,10,PF-06863135,T,6517472561,6.51747E+11,20210805,8:30,CYCLE1_DAY4,0 H,427.0348011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 97,4RSYC,28-Oct-21
C1071013,10681004,10,PF-06863135,T,6517763951,6.51776E+11,20210806,11:30,CYCLE1_DAY4,24 H,292.3629557,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 98,4RSYC,28-Oct-21
C1071013,10821001,11,PF-06863135,T,6603295436,6.6033E+11,20210809,15:45,CYCLE1_DAY1,0 H,665.2817635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1,1RSYC,26-Oct-21
C1071013,10821001,11,PF-06863135,T,6603295436,6.6033E+11,20210809,22:10,CYCLE1_DAY1,6 H,102.0957138,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2,11RSYC,2-Nov-21
C1071013,10821001,11,PF-06863135,T,6603295460,6.6033E+11,20210816,19:25,UNPL,9001 H,997.9619963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 3,1RSYC,26-Oct-21
C1071013,10821001,11,PF-06863135,T,6603295452,6.6033E+11,20210810,14:30,CYCLE1_DAY1,24 H,899.1622715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 4,11RSYC,2-Nov-21
C1071013,10821001,11,PF-06863135,T,6603295454,6.6033E+11,20210812,18:20,CYCLE1_DAY4,0 H,415.3054829,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 5,11RSYC,2-Nov-21
C1071013,10821001,11,PF-06863135,T,6603295456,6.6033E+11,20210813,19:02,CYCLE1_DAY4,24 H,772.3964543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 6,11RSYC,2-Nov-21
C1071013,10771001,12,PF-06863135,T,6517246446,6.51725E+11,20210806,13:05,CYCLE1_DAY1,0 H,690.9320318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 185,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517246446,6.51725E+11,20210806,20:10,CYCLE1_DAY1,6 H,710.8753966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 184,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517246448,6.51725E+11,20210813,10:00,CYCLE1_DAY8,0 H,225.7245986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 187,12RSYC,2-Nov-21
C1071013,10771001,12,PF-06863135,T,6517246448,6.51725E+11,20210813,17:20,CYCLE1_DAY8,6 H,98.09085844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 186,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517643718,6.51764E+11,20210819,10:20,CYCLE1_DAY15,0 H,48.89216289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 192,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517246452,6.51725E+11,20210825,10:38,CYCLE1_DAY22,0 H,494.214628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 188,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517246453,6.51725E+11,20210908,10:52,CYCLE2_DAY1,0 H,452.0073274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 189,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517246455,6.51725E+11,20211006,11:34,CYCLE3_DAY1,0 H,368.6263482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 280,14RSYC,15-Nov-21
C1071013,10771001,12,PF-06863135,T,6517775846,6.51778E+11,20211103,11:50,UNPL,9001 H,731.9243596,NG/ML,,Visit revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 910,20RSYC,19-Apr-22
C1071013,10771001,12,PF-06863135,T,6517246461,6.51725E+11,20210807,14:10,CYCLE1_DAY1,24 H,402.7695524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 190,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517246464,6.51725E+11,20210809,12:20,CYCLE1_DAY4,0 H,350.3643177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 191,7RSYC,29-Oct-21
C1071013,10771001,12,PF-06863135,T,6517775855,6.51778E+11,20210810,14:55,CYCLE1_DAY4,24 H,732.6706623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 193,7RSYC,29-Oct-21
C1071013,10031004,13,PF-06863135,T,6516580382,6.51658E+11,20210809,10:50,CYCLE1_DAY1,0 H,253.8430897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 99,4RSYC,28-Oct-21
C1071013,10031004,13,PF-06863135,T,6516580382,6.51658E+11,20210809,18:15,CYCLE1_DAY1,6 H,260.5252973,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 100,4RSYC,28-Oct-21
C1071013,10031004,13,PF-06863135,T,6517751580,6.51775E+11,20211004,10:58,CYCLE3_DAY1,0 H,967.3953612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 332,16RSYC,16-Nov-21
C1071013,10031004,13,PF-06863135,T,6517751588,6.51775E+11,20211101,13:40,CYCLE4_DAY1,0 H,798.0597337,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 590,27RSYC,21-Apr-22
C1071013,10031004,13,PF-06863135,T,6517889684,6.51789E+11,20210810,12:27,CYCLE1_DAY1,24 H,661.8692272,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 102,4RSYC,28-Oct-21
C1071013,10031004,13,PF-06863135,T,6517889686,6.51789E+11,20210811,16:15,CYCLE1_DAY4,0 H,884.8392527,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 103,4RSYC,28-Oct-21
C1071013,10031004,13,PF-06863135,T,6517889689,6.51789E+11,20210812,16:57,CYCLE1_DAY4,24 H,565.6185506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 101,4RSYC,28-Oct-21
C1071013,11171001,14,PF-06863135,T,6517764044,6.51776E+11,20210809,10:23,CYCLE1_DAY1,0 H,100.8513892,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 104,4RSYC,28-Oct-21
C1071013,11171001,14,PF-06863135,T,6517764044,6.51776E+11,20210809,17:23,CYCLE1_DAY1,6 H,16.35955808,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 105,9RSYC,1-Nov-21
C1071013,11171001,14,PF-06863135,T,6517764048,6.51776E+11,20210818,9:25,CYCLE1_DAY8,0 H,241.3114319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 106,12RSYC,2-Nov-21
C1071013,11171001,14,PF-06863135,T,6517764048,6.51776E+11,20210818,17:50,CYCLE1_DAY8,6 H,158.669105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 107,4RSYC,28-Oct-21
C1071013,11171001,14,PF-06863135,T,6517433559,6.51743E+11,20210826,9:41,CYCLE1_DAY15,0 H,795.2523073,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 196,7RSYC,29-Oct-21
C1071013,11171001,14,PF-06863135,T,6517433562,6.51743E+11,20210902,9:30,CYCLE1_DAY22,0 H,909.6891531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 195,7RSYC,29-Oct-21
C1071013,11171001,14,PF-06863135,T,6517433563,6.51743E+11,20210909,13:33,CYCLE2_DAY1,0 H,258.1662294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 197,7RSYC,29-Oct-21
C1071013,11171001,14,PF-06863135,T,6518158468,6.51816E+11,20211007,9:00,CYCLE3_DAY1,0 H,782.1714983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 352,17RSYC,17-Nov-21
C1071013,11171001,14,PF-06863135,T,6518158472,6.51816E+11,20211104,10:41,CYCLE4_DAY1,0 H,968.6801443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 604,27RSYC,21-Apr-22
C1071013,11171001,14,PF-06863135,T,6517764069,6.51776E+11,20220127,9:20,CYCLE7_DAY1,0 H,277.6880376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1724,72RSYC,7-May-22
C1071013,11171001,14,PF-06863135,T,6518390144,6.51839E+11,20220421,8:04,CYCLE10_DAY1,0 H,15.65974875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1983,114RSYC,25-Jul-22
C1071013,11171001,14,PF-06863135,T,6518390143,6.51839E+11,20220714,8:45,CYCLE13_DAY1,0 H,677.2249928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2093,127RSYC,19-Oct-22
C1071013,11171001,14,PF-06863135,T,6517764086,6.51776E+11,20220912,7:30,END_OF_TRT,,25.90772879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2100,132RSYC,10-Nov-22
C1071013,11171001,14,PF-06863135,T,6517433571,6.51743E+11,20210810,11:15,CYCLE1_DAY1,24 H,414.6216695,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 108,4RSYC,28-Oct-21
C1071013,11171001,14,PF-06863135,T,6517433573,6.51743E+11,20210812,6:28,CYCLE1_DAY4,0 H,567.9668253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 109,4RSYC,28-Oct-21
C1071013,11171001,14,PF-06863135,T,6517433575,6.51743E+11,20210813,11:45,CYCLE1_DAY4,24 H,837.7648377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 110,4RSYC,28-Oct-21
C1071013,11171002,15,PF-06863135,T,6517764040,6.51776E+11,20210809,10:30,CYCLE1_DAY1,0 H,391.1902992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 111,4RSYC,28-Oct-21
C1071013,11171002,15,PF-06863135,T,6517764040,6.51776E+11,20210809,17:30,CYCLE1_DAY1,6 H,476.050611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 112,4RSYC,28-Oct-21
C1071013,11171002,15,PF-06863135,T,6517764047,6.51776E+11,20210816,8:40,CYCLE1_DAY8,0 H,862.71489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 113,12RSYC,2-Nov-21
C1071013,11171002,15,PF-06863135,T,6517764047,6.51776E+11,20210816,17:36,CYCLE1_DAY8,6 H,871.7596488,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 114,4RSYC,28-Oct-21
C1071013,11171002,15,PF-06863135,T,6517433560,6.51743E+11,20210825,9:40,CYCLE1_DAY15,0 H,986.680453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 199,7RSYC,29-Oct-21
C1071013,11171002,15,PF-06863135,T,6517433561,6.51743E+11,20210901,10:12,CYCLE1_DAY22,0 H,376.6360897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 198,7RSYC,29-Oct-21
C1071013,11171002,15,PF-06863135,T,6517764062,6.51776E+11,20210908,12:20,CYCLE2_DAY1,0 H,872.5506952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 200,7RSYC,29-Oct-21
C1071013,11171002,15,PF-06863135,T,6518158467,6.51816E+11,20211006,9:25,CYCLE3_DAY1,0 H,131.5749206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 351,17RSYC,17-Nov-21
C1071013,11171002,15,PF-06863135,T,6518158471,6.51816E+11,20211102,10:37,CYCLE4_DAY1,0 H,303.2725763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 603,27RSYC,21-Apr-22
C1071013,11171002,15,PF-06863135,T,6517764089,6.51776E+11,20211123,9:24,END_OF_TRT,,560.8423063,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 906,86RSYC,13-May-22
C1071013,11171002,15,PF-06863135,T,6517764071,6.51776E+11,20210810,11:20,CYCLE1_DAY1,24 H,655.8843078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 115,4RSYC,28-Oct-21
C1071013,11171002,15,PF-06863135,T,6517764076,6.51776E+11,20210812,6:34,CYCLE1_DAY4,0 H,176.2600839,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 116,4RSYC,28-Oct-21
C1071013,11171002,15,PF-06863135,T,6517433576,6.51743E+11,20210813,11:30,CYCLE1_DAY4,24 H,715.736598,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 117,12RSYC,2-Nov-21
C1071013,10031006,16,PF-06863135,T,6517751563,6.51775E+11,20210816,10:35,CYCLE1_DAY1,0 H,413.9082036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 118,4RSYC,28-Oct-21
C1071013,10031006,16,PF-06863135,T,6517751563,6.51775E+11,20210816,17:36,CYCLE1_DAY1,6 H,903.4615598,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 119,4RSYC,28-Oct-21
C1071013,10031006,16,PF-06863135,T,6517889668,6.51789E+11,20210825,11:20,CYCLE1_DAY8,0 H,973.5545218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 179,12RSYC,2-Nov-21
C1071013,10031006,16,PF-06863135,T,6517889668,6.51789E+11,20210825,17:02,CYCLE1_DAY8,6 H,99.84751252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 178,6RSYC,29-Oct-21
C1071013,10031006,16,PF-06863135,T,6517751571,6.51775E+11,20210901,16:35,CYCLE1_DAY15,0 H,381.0150416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 175,6RSYC,29-Oct-21
C1071013,10031006,16,PF-06863135,T,6517751572,6.51775E+11,20210908,13:16,CYCLE1_DAY22,0 H,792.2636136,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 176,6RSYC,29-Oct-21
C1071013,10031006,16,PF-06863135,T,6517751576,6.51775E+11,20210915,10:10,CYCLE2_DAY1,0 H,834.1256905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 177,6RSYC,29-Oct-21
C1071013,10031006,16,PF-06863135,T,6517751585,6.51775E+11,20211110,14:44,CYCLE4_DAY1,0 H,230.1114189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 901,20RSYC,19-Apr-22
C1071013,10031006,16,PF-06863135,T,6517260610,6.51726E+11,20210817,11:30,CYCLE1_DAY1,24 H,704.3018231,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 120,5RSYC,28-Oct-21
C1071013,10031006,16,PF-06863135,T,6517889687,6.51789E+11,20210820,14:00,CYCLE1_DAY4,0 H,804.5063192,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1086,67RSYC,8-May-22
C1071013,10031006,16,PF-06863135,T,6517889688,6.51789E+11,20210821,12:45,CYCLE1_DAY4,24 H,1.538667829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1087,87RSYC,13-May-22
C1071013,10021001,17,PF-06863135,T,6603324910,6.60332E+11,20210816,9:25,CYCLE1_DAY1,0 H,922.3144156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 7,1RSYC,26-Oct-21
C1071013,10021001,17,PF-06863135,T,6603324910,6.60332E+11,20210816,16:26,CYCLE1_DAY1,6 H,172.0873915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 8,11RSYC,2-Nov-21
C1071013,10021001,17,PF-06863135,T,6603324913,6.60332E+11,20210823,13:15,CYCLE1_DAY8,0 H,748.7466851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 132,12RSYC,2-Nov-21
C1071013,10021001,17,PF-06863135,T,6603324913,6.60332E+11,20210823,20:00,CYCLE1_DAY8,6 H,399.0100603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 133,5RSYC,28-Oct-21
C1071013,10021001,17,PF-06863135,T,6603324915,6.60332E+11,20210830,12:52,CYCLE1_DAY15,0 H,730.5308987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 134,5RSYC,28-Oct-21
C1071013,10021001,17,PF-06863135,T,6603324917,6.60332E+11,20210906,10:00,CYCLE1_DAY22,0 H,339.2766804,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 135,5RSYC,28-Oct-21
C1071013,10021001,17,PF-06863135,T,6603324919,6.60332E+11,20210913,12:50,CYCLE2_DAY1,0 H,853.0166564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 136,5RSYC,28-Oct-21
C1071013,10021001,17,PF-06863135,T,6603324921,6.60332E+11,20211013,13:40,CYCLE3_DAY1,0 H,451.6502829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 236,13RSYC,15-Nov-21
C1071013,10021001,17,PF-06863135,T,6603324923,6.60332E+11,20211110,14:40,CYCLE4_DAY1,0 H,716.9589852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 813,34RSYC,24-Apr-22
C1071013,10021001,17,PF-06863135,T,6603324924,6.60332E+11,20220202,11:35,CYCLE7_DAY1,0 H,982.7297757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1582,59RSYC,1-May-22
C1071013,10021001,17,PF-06863135,T,6603839288,6.60384E+11,20220427,12:25,CYCLE10_DAY1,0 H,550.8257366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2002,115RSYC,25-Jul-22
C1071013,10021001,17,PF-06863135,T,6603324933,6.60332E+11,20220720,12:30,CYCLE13_DAY1,0 H,826.3639329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2066,132RSYC,10-Nov-22
C1071013,10021001,17,PF-06863135,T,6604204206,6.6042E+11,20221012,12:45,CYCLE16_DAY1,0 H,581.990498,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2114,131RSYC,9-Nov-22
C1071013,10021001,17,PF-06863135,T,6604204199,6.6042E+11,20230105,11:45,CYCLE19_DAY1,0 H,245.9263076,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2185,141RSYC,17-May-23
C1071013,10021001,17,PF-06863135,T,6604204200,6.6042E+11,20230329,11:10,CYCLE22_DAY1,0 H,501.1093648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2234,143RSYC,27-Nov-23
C1071013,10021001,17,PF-06863135,T,6604608949,6.60461E+11,20230913,12:38,CYCLE28_DAY1,0 H,37.01219238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2335,148RSYC,27-Mar-24
C1071013,10021001,17,PF-06863135,T,6604777912,6.60478E+11,20231206,14:30,CYCLE31_DAY1,0 H,873.0703832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2336,148RSYC,27-Mar-24
C1071013,10021001,17,PF-06863135,T,6604777916,6.60478E+11,20240228,13:40,CYCLE34_DAY1,0 H,,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,10021001,17,PF-06863135,T,6603324937,6.60332E+11,20210820,20:18,UNPL,9002 H,782.4680012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 137,5RSYC,28-Oct-21
C1071013,10021001,17,PF-06863135,T,6603324926,6.60332E+11,20210817,9:27,CYCLE1_DAY1,24 H,245.0393315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 9,11RSYC,2-Nov-21
C1071013,10021001,17,PF-06863135,T,6603324929,6.60332E+11,20210819,9:35,CYCLE1_DAY4,0 H,133.362332,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 10,11RSYC,2-Nov-21
C1071013,10021001,17,PF-06863135,T,6603324931,6.60332E+11,20210820,9:20,CYCLE1_DAY4,24 H,939.4506232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 11,11RSYC,2-Nov-21
C1071013,11171003,18,PF-06863135,T,6517764042,6.51776E+11,20210816,10:11,CYCLE1_DAY1,0 H,533.9032218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 121,5RSYC,28-Oct-21
C1071013,11171003,18,PF-06863135,T,6517764042,6.51776E+11,20210816,17:28,CYCLE1_DAY1,6 H,523.9230985,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 122,9RSYC,1-Nov-21
C1071013,11171003,18,PF-06863135,T,6517764046,6.51776E+11,20210823,8:26,CYCLE1_DAY8,0 H,367.9981522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 123,12RSYC,2-Nov-21
C1071013,11171003,18,PF-06863135,T,6517764046,6.51776E+11,20210823,17:10,CYCLE1_DAY8,6 H,838.2192116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 124,5RSYC,28-Oct-21
C1071013,11171003,18,PF-06863135,T,6517764050,6.51776E+11,20210830,10:40,CYCLE1_DAY15,0 H,480.1440046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 201,7RSYC,29-Oct-21
C1071013,11171003,18,PF-06863135,T,6517764058,6.51776E+11,20210907,10:40,CYCLE1_DAY22,0 H,406.9366023,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 202,7RSYC,29-Oct-21
C1071013,11171003,18,PF-06863135,T,6517764063,6.51776E+11,20210915,12:22,CYCLE2_DAY1,0 H,574.7328363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 203,7RSYC,29-Oct-21
C1071013,11171003,18,PF-06863135,T,6517433565,6.51743E+11,20211015,9:10,CYCLE3_DAY1,0 H,707.0265619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 545,26RSYC,22-Apr-22
C1071013,11171003,18,PF-06863135,T,6517764068,6.51776E+11,20211110,11:57,CYCLE4_DAY1,0 H,764.7624292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 596,27RSYC,21-Apr-22
C1071013,11171003,18,PF-06863135,T,6517433570,6.51743E+11,20220202,8:24,CYCLE7_DAY1,0 H,365.4602507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1725,72RSYC,7-May-22
C1071013,11171003,18,PF-06863135,T,6517764088,6.51776E+11,20220331,13:54,END_OF_TRT,,424.6178465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1923,123RSYC,29-Jul-22
C1071013,11171003,18,PF-06863135,T,6517433572,6.51743E+11,20210817,11:02,CYCLE1_DAY1,24 H,426.6151125,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 125,5RSYC,28-Oct-21
C1071013,11171003,18,PF-06863135,T,6517764077,6.51776E+11,20210819,11:19,CYCLE1_DAY4,0 H,707.9211821,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 126,5RSYC,28-Oct-21
C1071013,11171003,18,PF-06863135,T,6517764082,6.51776E+11,20210820,11:02,CYCLE1_DAY4,24 H,790.2873986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 204,7RSYC,29-Oct-21
C1071013,11171005,19,PF-06863135,T,6517433556,6.51743E+11,20210816,10:31,CYCLE1_DAY1,0 H,10.4284169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 127,5RSYC,28-Oct-21
C1071013,11171005,19,PF-06863135,T,6517433556,6.51743E+11,20210816,17:32,CYCLE1_DAY1,6 H,160.252205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 128,9RSYC,1-Nov-21
C1071013,11171005,19,PF-06863135,T,6517764045,6.51776E+11,20210823,7:50,CYCLE1_DAY8,0 H,321.9592387,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 205,12RSYC,2-Nov-21
C1071013,11171005,19,PF-06863135,T,6517764045,6.51776E+11,20210823,18:15,CYCLE1_DAY8,6 H,845.9053513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 129,5RSYC,28-Oct-21
C1071013,11171005,19,PF-06863135,T,6517764053,6.51776E+11,20210901,10:12,CYCLE1_DAY15,0 H,209.6241902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 206,7RSYC,29-Oct-21
C1071013,11171005,19,PF-06863135,T,6517764057,6.51776E+11,20210907,10:15,CYCLE1_DAY22,0 H,751.1109146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 207,7RSYC,29-Oct-21
C1071013,11171005,19,PF-06863135,T,6518158469,6.51816E+11,20211011,8:50,CYCLE3_DAY1,0 H,50.38370531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 353,17RSYC,17-Nov-21
C1071013,11171005,19,PF-06863135,T,6517433586,6.51743E+11,20211108,11:25,END_OF_TRT,,693.2068639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 546,86RSYC,13-May-22
C1071013,11171005,19,PF-06863135,T,6517764073,6.51776E+11,20210817,10:50,CYCLE1_DAY1,24 H,934.7671265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 130,5RSYC,28-Oct-21
C1071013,11171005,19,PF-06863135,T,6517764078,6.51776E+11,20210819,11:18,CYCLE1_DAY4,0 H,214.3522783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 131,5RSYC,28-Oct-21
C1071013,11171005,19,PF-06863135,T,6517764081,6.51776E+11,20210820,11:22,CYCLE1_DAY4,24 H,117.3562753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 208,7RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472394,6.51747E+11,20210824,12:45,CYCLE1_DAY1,0 H,610.1141492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 163,6RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472394,6.51747E+11,20210824,18:50,CYCLE1_DAY1,6 H,231.5294138,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 162,9RSYC,1-Nov-21
C1071013,10071002,20,PF-06863135,T,6517472396,6.51747E+11,20210903,9:50,CYCLE1_DAY8,0 H,544.6348554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 164,6RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472396,6.51747E+11,20210903,16:31,CYCLE1_DAY8,6 H,104.5414042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 165,6RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472399,6.51747E+11,20210913,7:50,CYCLE1_DAY15,0 H,661.9659769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 166,6RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472401,6.51747E+11,20210923,8:10,CYCLE1_DAY22,0 H,55.67818234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 167,6RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472403,6.51747E+11,20210930,8:30,CYCLE2_DAY1,0 H,980.3583391,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 292,15RSYC,16-Nov-21
C1071013,10071002,20,PF-06863135,T,6517472405,6.51747E+11,20211104,8:10,CYCLE3_DAY1,0 H,320.8411414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 551,26RSYC,22-Apr-22
C1071013,10071002,20,PF-06863135,T,6517472408,6.51747E+11,20220217,8:40,CYCLE7_DAY1,0 H,237.9129743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1598,96RSYC,12-May-22
C1071013,10071002,20,PF-06863135,T,6517472417,6.51747E+11,20220520,9:43,CYCLE10_DAY1,0 H,714.9322239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1967,114RSYC,25-Jul-22
C1071013,10071002,20,PF-06863135,T,6518265670,6.51827E+11,20220812,8:40,CYCLE13_DAY1,0 H,148.3117952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2075,129RSYC,21-Oct-22
C1071013,10071002,20,PF-06863135,T,6520930829,6.52093E+11,20221104,8:01,CYCLE16_DAY1,0 H,262.0135298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2138,139RSYC,22-Mar-23
C1071013,10071002,20,PF-06863135,T,6521740462,6.52174E+11,20230127,7:52,CYCLE19_DAY1,0 H,507.6234059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2215,142RSYC,18-May-23
C1071013,10071002,20,PF-06863135,T,6521740465,6.52174E+11,20230421,7:55,CYCLE22_DAY1,0 H,400.820025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2245,143RSYC,27-Nov-23
C1071013,10071002,20,PF-06863135,T,6521740463,6.52174E+11,20230714,8:51,CYCLE25_DAY1,0 H,310.1340237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2290,145RSYC,4-Jan-24
C1071013,10071002,20,PF-06863135,T,6523543385,6.52354E+11,20231229,9:17,CYCLE31_DAY1,0 H,551.8002551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2322,148RSYC,27-Mar-24
C1071013,10071002,20,PF-06863135,T,6520344352,6.52034E+11,20211203,8:10,UNPL,9001 H,667.9669982,NG/ML,,Received as 6517472406-02,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 992,66RSYC,3-May-22
C1071013,10071002,20,PF-06863135,T,6517472411,6.51747E+11,20210825,11:45,CYCLE1_DAY1,24 H,598.2809609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 168,11RSYC,2-Nov-21
C1071013,10071002,20,PF-06863135,T,6517472412,6.51747E+11,20210830,14:00,CYCLE1_DAY4,0 H,465.4892725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 169,6RSYC,29-Oct-21
C1071013,10071002,20,PF-06863135,T,6517472415,6.51747E+11,20210831,12:25,CYCLE1_DAY4,24 H,701.4487645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 170,6RSYC,29-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349515,6.60335E+11,20210830,9:13,CYCLE1_DAY1,0 H,979.6480299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 138,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349515,6.60335E+11,20210830,17:40,CYCLE1_DAY1,6 H,402.0649329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 139,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349517,6.60335E+11,20210906,13:34,CYCLE1_DAY8,0 H,969.7805564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 140,12RSYC,2-Nov-21
C1071013,10381001,21,PF-06863135,T,6603349517,6.60335E+11,20210906,20:05,CYCLE1_DAY8,6 H,347.3759884,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 141,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349519,6.60335E+11,20210914,13:32,CYCLE1_DAY15,0 H,217.1615143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 142,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349520,6.60335E+11,20210921,13:54,CYCLE1_DAY22,0 H,110.8070023,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 143,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349525,6.60335E+11,20211026,13:10,CYCLE3_DAY1,0 H,64.7684478,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 617,90RSYC,11-May-22
C1071013,10381001,21,PF-06863135,T,6603349527,6.60335E+11,20211123,13:07,CYCLE4_DAY1,0 H,717.7069605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 814,34RSYC,24-Apr-22
C1071013,10381001,21,PF-06863135,T,6603349528,6.60335E+11,20220216,8:45,CYCLE7_DAY1,0 H,370.2629051,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1589,59RSYC,1-May-22
C1071013,10381001,21,PF-06863135,T,6603682808,6.60368E+11,20220518,10:50,CYCLE10_DAY1,0 H,566.8379089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2004,115RSYC,25-Jul-22
C1071013,10381001,21,PF-06863135,T,6604047970,6.60405E+11,20220810,11:45,CYCLE13_DAY1,0 H,603.8534991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2068,129RSYC,21-Oct-22
C1071013,10381001,21,PF-06863135,T,6603682806,6.60368E+11,20221102,12:20,CYCLE16_DAY1,0 H,994.6661019,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2150,139RSYC,22-Mar-23
C1071013,10381001,21,PF-06863135,T,6604047975,6.60405E+11,20230125,10:30,CYCLE19_DAY1,0 H,205.5774469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2187,141RSYC,17-May-23
C1071013,10381001,21,PF-06863135,T,6604254033,6.60425E+11,20230712,8:30,CYCLE25_DAY1,0 H,578.8978139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2270,144RSYC,27-Nov-23
C1071013,10381001,21,PF-06863135,T,6604594756,6.60459E+11,20231004,8:58,CYCLE28_DAY1,0 H,538.7282842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2313,147RSYC,29-Feb-24
C1071013,10381001,21,PF-06863135,T,6605017953,6.60502E+11,20240110,11:40,END_OF_TRT,,646.0435036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2337,152RSYC,9-Apr-24
C1071013,10381001,21,PF-06863135,T,6603349531,6.60335E+11,20210831,12:10,CYCLE1_DAY1,24 H,368.6795055,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 144,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349532,6.60335E+11,20210902,12:20,CYCLE1_DAY4,0 H,297.812479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 145,5RSYC,28-Oct-21
C1071013,10381001,21,PF-06863135,T,6603349534,6.60335E+11,20210903,13:30,CYCLE1_DAY4,24 H,460.744903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 146,5RSYC,28-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295435,6.6033E+11,20210906,13:40,CYCLE1_DAY1,0 H,340.5194992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 147,5RSYC,28-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295435,6.6033E+11,20210906,20:15,CYCLE1_DAY1,6 H,425.8014425,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 148,5RSYC,28-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295437,6.6033E+11,20210913,12:21,CYCLE1_DAY8,0 H,161.0889468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 149,5RSYC,28-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295437,6.6033E+11,20210913,19:50,CYCLE1_DAY8,6 H,612.9611966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 150,6RSYC,29-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295439,6.6033E+11,20210920,13:45,CYCLE1_DAY15,0 H,586.0050889,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 232,21RSYC,20-Apr-22
C1071013,10821003,22,PF-06863135,T,6603295441,6.6033E+11,20210930,13:05,CYCLE1_DAY22,0 H,332.8835634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 233,13RSYC,15-Nov-21
C1071013,10821003,22,PF-06863135,T,6603295459,6.6033E+11,20210908,18:45,UNPL,9001 H,451.040251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 151,11RSYC,2-Nov-21
C1071013,10821003,22,PF-06863135,T,6603295451,6.6033E+11,20210907,14:15,CYCLE1_DAY1,24 H,194.0438014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 152,6RSYC,29-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295453,6.6033E+11,20210910,12:20,CYCLE1_DAY4,0 H,194.1502792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 153,6RSYC,29-Oct-21
C1071013,10821003,22,PF-06863135,T,6603295455,6.6033E+11,20210911,12:50,CYCLE1_DAY4,24 H,597.0666659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 154,6RSYC,29-Oct-21
C1071013,10071003,23,PF-06863135,T,6517472395,6.51747E+11,20210930,12:10,CYCLE1_DAY1,0 H,63.69885503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 291,15RSYC,16-Nov-21
C1071013,10071003,23,PF-06863135,T,6517472395,6.51747E+11,20210930,18:20,CYCLE1_DAY1,6 H,333.6995303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 290,15RSYC,16-Nov-21
C1071013,10071003,23,PF-06863135,T,6517472397,6.51747E+11,20211019,9:15,CYCLE1_DAY8,0 H,559.7069546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 548,26RSYC,22-Apr-22
C1071013,10071003,23,PF-06863135,T,6517472397,6.51747E+11,20211019,15:55,CYCLE1_DAY8,6 H,913.4542079,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 547,26RSYC,22-Apr-22
C1071013,10071003,23,PF-06863135,T,6517472398,6.51747E+11,20211025,11:05,CYCLE1_DAY15,0 H,834.3194429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 549,26RSYC,22-Apr-22
C1071013,10071003,23,PF-06863135,T,6517472402,6.51747E+11,20211101,8:40,CYCLE2_DAY1,0 H,98.43233311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 550,26RSYC,22-Apr-22
C1071013,10071003,23,PF-06863135,T,6517472404,6.51747E+11,20211129,8:25,CYCLE3_DAY1,0 H,121.7946157,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 991,66RSYC,3-May-22
C1071013,10071003,23,PF-06863135,T,6517472407,6.51747E+11,20211227,9:00,CYCLE4_DAY1,0 H,295.2035242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 993,66RSYC,3-May-22
C1071013,10071003,23,PF-06863135,T,6517472425,6.51747E+11,20220124,8:25,END_OF_TRT,,956.7618227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1599,110RSYC,25-May-22
C1071013,10071003,23,PF-06863135,T,6517472410,6.51747E+11,20211001,12:15,CYCLE1_DAY1,24 H,391.4654658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 293,15RSYC,16-Nov-21
C1071013,10071003,23,PF-06863135,T,6517472413,6.51747E+11,20211015,11:00,CYCLE1_DAY4,0 H,690.4009077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 294,15RSYC,16-Nov-21
C1071013,10071003,23,PF-06863135,T,6517472414,6.51747E+11,20211016,10:30,CYCLE1_DAY4,24 H,151.9708022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 295,15RSYC,16-Nov-21
C1071013,11211001,24,PF-06863135,T,6801650268,6.80165E+11,20210913,9:04,CYCLE1_DAY1,0 H,367.775265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 209,7RSYC,29-Oct-21
C1071013,11211001,24,PF-06863135,T,6801650268,6.80165E+11,20210913,18:40,CYCLE1_DAY1,6 H,61.476972,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 210,8RSYC,29-Oct-21
C1071013,11211001,24,PF-06863135,T,6801650270,6.80165E+11,20210921,8:55,CYCLE1_DAY8,0 H,435.780208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 211,12RSYC,2-Nov-21
C1071013,11211001,24,PF-06863135,T,6801650271,6.80165E+11,20211013,9:00,CYCLE2_DAY1,0 H,139.7926168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 650,110RSYC,25-May-22
C1071013,11211001,24,PF-06863135,T,6801703038,6.8017E+11,20211111,9:25,CYCLE3_DAY1,0 H,575.9739851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 670,30RSYC,22-Apr-22
C1071013,11211001,24,PF-06863135,T,6801703039,6.8017E+11,20211209,9:15,CYCLE4_DAY1,0 H,619.267507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 959,65RSYC,3-May-22
C1071013,11211001,24,PF-06863135,T,6801793351,6.80179E+11,20220303,11:30,CYCLE7_DAY1,0 H,795.8987033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1874,80RSYC,4-May-22
C1071013,11211001,24,PF-06863135,T,6801697216,6.8017E+11,20220525,10:20,CYCLE10_DAY1,0 H,132.1191858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1963,114RSYC,25-Jul-22
C1071013,11211001,24,PF-06863135,T,6802000328,6.802E+11,20220818,9:50,CYCLE13_DAY1,0 H,502.6905382,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2073,129RSYC,21-Oct-22
C1071013,11211001,24,PF-06863135,T,6802000329,6.802E+11,20221110,8:45,CYCLE16_DAY1,0 H,720.8654047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2159,140RSYC,22-Mar-23
C1071013,11211001,24,PF-06863135,T,6802110620,6.80211E+11,20230202,9:10,CYCLE19_DAY1,0 H,,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,11211001,24,PF-06863135,T,6802110621,6.80211E+11,20230427,10:45,CYCLE22_DAY1,0 H,814.664113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2254,145RSYC,4-Jan-24
C1071013,11211001,24,PF-06863135,T,6802330963,6.80233E+11,20230720,10:10,CYCLE25_DAY1,0 H,27.58202734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2271,145RSYC,4-Jan-24
C1071013,11211001,24,PF-06863135,T,6802351832,6.80235E+11,20231012,9:00,CYCLE28_DAY1,0 H,77.36170485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2314,147RSYC,29-Feb-24
C1071013,11211001,24,PF-06863135,T,6801650286,6.80165E+11,20210915,10:40,UNPL,9001 H,912.8887673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 212,8RSYC,29-Oct-21
C1071013,11211001,24,PF-06863135,T,6802024260,6.80202E+11,20211013,17:40,UNPL,9002 H,559.7054354,NG/ML,9,Received as 6801650271-05,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,11211001,24,PF-06863135,T,6801650280,6.80165E+11,20210914,11:25,CYCLE1_DAY1,24 H,505.9328714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 213,8RSYC,29-Oct-21
C1071013,11211001,24,PF-06863135,T,6801650282,6.80165E+11,20210916,8:35,CYCLE1_DAY4,0 H,517.4607923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 214,8RSYC,29-Oct-21
C1071013,11211001,24,PF-06863135,T,6801650284,6.80165E+11,20210917,12:00,CYCLE1_DAY4,24 H,925.197211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 215,8RSYC,29-Oct-21
C1071013,10031007,25,PF-06863135,T,6517889667,6.51789E+11,20210914,11:27,CYCLE1_DAY1,0 H,909.1691603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1084,41RSYC,26-Apr-22
C1071013,10031007,25,PF-06863135,T,6517889667,6.51789E+11,20210914,18:00,CYCLE1_DAY1,6 H,959.633601,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1083,41RSYC,26-Apr-22
C1071013,10031007,25,PF-06863135,T,6517751566,6.51775E+11,20210921,10:55,CYCLE1_DAY8,0 H,65.34267667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 182,12RSYC,2-Nov-21
C1071013,10031007,25,PF-06863135,T,6517751566,6.51775E+11,20210921,16:27,CYCLE1_DAY8,6 H,967.5290357,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 181,7RSYC,29-Oct-21
C1071013,10031007,25,PF-06863135,T,6517751569,6.51775E+11,20210928,12:43,CYCLE1_DAY15,0 H,970.0717324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 331,16RSYC,16-Nov-21
C1071013,10031007,25,PF-06863135,T,6517751583,6.51775E+11,20211109,11:43,CYCLE3_DAY1,0 H,284.0579575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 589,27RSYC,21-Apr-22
C1071013,10031007,25,PF-06863135,T,6515337624,6.51534E+11,20211207,10:45,CYCLE4_DAY1,0 H,976.5906418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1924,123RSYC,29-Jul-22
C1071013,10031007,25,PF-06863135,T,6519134606,6.51913E+11,20221108,12:55,END_OF_TRT,,472.3989008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2139,139RSYC,22-Mar-23
C1071013,10031007,25,PF-06863135,T,6517260611,6.51726E+11,20210916,12:15,CYCLE1_DAY4,0 H,242.1988657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 962,65RSYC,3-May-22
C1071013,10031007,25,PF-06863135,T,6517473951,6.51747E+11,20210917,13:40,CYCLE1_DAY4,24 H,547.2535386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 180,7RSYC,29-Oct-21
C1071013,11081002,26,PF-06863135,T,6801650151,6.80165E+11,20210914,10:10,CYCLE1_DAY1,0 H,20.59003736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 216,8RSYC,29-Oct-21
C1071013,11081002,26,PF-06863135,T,6801650151,6.80165E+11,20210914,19:12,CYCLE1_DAY1,6 H,342.3675628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 217,9RSYC,1-Nov-21
C1071013,11081002,26,PF-06863135,T,6801650153,6.80165E+11,20210921,10:50,CYCLE1_DAY8,0 H,548.0036039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 218,12RSYC,2-Nov-21
C1071013,11081002,26,PF-06863135,T,6801650153,6.80165E+11,20210921,19:55,CYCLE1_DAY8,6 H,945.3606005,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 219,8RSYC,29-Oct-21
C1071013,11081002,26,PF-06863135,T,6801650155,6.80165E+11,20210928,9:05,CYCLE1_DAY15,0 H,322.0718922,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 220,8RSYC,29-Oct-21
C1071013,11081002,26,PF-06863135,T,6801650157,6.80165E+11,20211005,10:15,CYCLE1_DAY22,0 H,925.2037668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 247,13RSYC,15-Nov-21
C1071013,11081002,26,PF-06863135,T,6801650159,6.80165E+11,20211012,11:56,CYCLE2_DAY1,0 H,161.9725878,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 248,13RSYC,15-Nov-21
C1071013,11081002,26,PF-06863135,T,6801701817,6.8017E+11,20211109,11:25,CYCLE3_DAY1,0 H,252.64581,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 669,30RSYC,22-Apr-22
C1071013,11081002,26,PF-06863135,T,6801701819,6.8017E+11,20211207,10:40,CYCLE4_DAY1,0 H,430.9613216,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 950,65RSYC,3-May-22
C1071013,11081002,26,PF-06863135,T,6801790622,6.80179E+11,20220301,11:00,CYCLE7_DAY1,0 H,599.0403688,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1590,110RSYC,25-May-22
C1071013,11081002,26,PF-06863135,T,6801701821,6.8017E+11,20220524,11:08,CYCLE10_DAY1,0 H,495.7902634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1960,114RSYC,25-Jul-22
C1071013,11081002,26,PF-06863135,T,6801893000,6.80189E+11,20220816,10:42,CYCLE13_DAY1,0 H,417.2171347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2069,129RSYC,21-Oct-22
C1071013,11081002,26,PF-06863135,T,6801958743,6.80196E+11,20221108,10:56,CYCLE16_DAY1,0 H,955.0691542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2151,139RSYC,22-Mar-23
C1071013,11081002,26,PF-06863135,T,6802068779,6.80207E+11,20230131,10:49,CYCLE19_DAY1,0 H,852.9063218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2201,141RSYC,17-May-23
C1071013,11081002,26,PF-06863135,T,6802135340,6.80214E+11,20230425,10:40,CYCLE22_DAY1,0 H,600.3621806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2253,143RSYC,27-Nov-23
C1071013,11081002,26,PF-06863135,T,6802256363,6.80226E+11,20230718,10:52,CYCLE25_DAY1,0 H,314.8407709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2272,144RSYC,27-Nov-23
C1071013,11081002,26,PF-06863135,T,6802256365,6.80226E+11,20231010,10:47,CYCLE28_DAY1,0 H,272.4534214,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2315,147RSYC,29-Feb-24
C1071013,11081002,26,PF-06863135,T,6802408401,6.80241E+11,20240109,11:00,CYCLE31_DAY1,0 H,864.8702504,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2338,148RSYC,27-Mar-24
C1071013,11081002,26,PF-06863135,T,6801650169,6.80165E+11,20210916,9:50,UNPL,9001 H,4.276669515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 221,11RSYC,2-Nov-21
C1071013,11081002,26,PF-06863135,T,6801650163,6.80165E+11,20210915,13:07,CYCLE1_DAY1,24 H,820.8643438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 222,8RSYC,29-Oct-21
C1071013,11081002,26,PF-06863135,T,6801650165,6.80165E+11,20210917,10:39,CYCLE1_DAY4,0 H,82.07786307,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 223,8RSYC,29-Oct-21
C1071013,11081002,26,PF-06863135,T,6801650167,6.80165E+11,20210918,13:20,CYCLE1_DAY4,24 H,402.3104432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 224,13RSYC,15-Nov-21
C1071013,10821005,27,PF-06863135,T,6603459530,6.60346E+11,20210920,16:40,CYCLE1_DAY1,0 H,466.5110345,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 155,6RSYC,29-Oct-21
C1071013,10821005,27,PF-06863135,T,6603459530,6.60346E+11,20210920,22:40,CYCLE1_DAY1,6 H,512.7109367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 156,6RSYC,29-Oct-21
C1071013,10821005,27,PF-06863135,T,6603459541,6.60346E+11,20210921,16:45,CYCLE1_DAY1,24 H,38.0180596,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 240,13RSYC,15-Nov-21
C1071013,10821005,27,PF-06863135,T,6603459544,6.60346E+11,20210923,15:40,CYCLE1_DAY4,0 H,756.8688516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 241,13RSYC,15-Nov-21
C1071013,10821005,27,PF-06863135,T,6603459547,6.60346E+11,20210924,16:57,CYCLE1_DAY4,24 H,722.8381017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 242,13RSYC,15-Nov-21
C1071013,10031008,28,PF-06863135,T,6517889666,6.51789E+11,20210920,11:20,CYCLE1_DAY1,0 H,579.3424798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 183,7RSYC,29-Oct-21
C1071013,10031008,28,PF-06863135,T,6517751567,6.51775E+11,20210929,11:40,CYCLE1_DAY8,0 H,577.3081719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 330,16RSYC,16-Nov-21
C1071013,10031008,28,PF-06863135,T,6517751567,6.51775E+11,20210929,17:30,CYCLE1_DAY8,6 H,319.6996669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 329,16RSYC,16-Nov-21
C1071013,10031008,28,PF-06863135,T,6517889671,6.51789E+11,20211006,12:55,CYCLE1_DAY15,0 H,879.1090538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 346,16RSYC,16-Nov-21
C1071013,10031008,28,PF-06863135,T,6516580398,6.51658E+11,20211013,13:00,CYCLE1_DAY22,0 H,645.6707975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 278,14RSYC,15-Nov-21
C1071013,10031008,28,PF-06863135,T,6517889674,6.51789E+11,20211020,15:50,CYCLE2_DAY1,0 H,109.2638745,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 347,16RSYC,16-Nov-21
C1071013,10031008,28,PF-06863135,T,6517889678,6.51789E+11,20211117,10:45,CYCLE3_DAY1,0 H,765.1228262,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 911,20RSYC,19-Apr-22
C1071013,10031008,28,PF-06863135,T,6518620858,6.51862E+11,20211215,17:30,CYCLE4_DAY1,0 H,608.1019003,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1925,123RSYC,29-Jul-22
C1071013,10031008,28,PF-06863135,T,6516580425,6.51658E+11,20220309,15:20,CYCLE7_DAY1,0 H,388.455678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2009,115RSYC,25-Jul-22
C1071013,10031008,28,PF-06863135,T,6519134616,6.51913E+11,20220601,18:00,CYCLE10_DAY1,0 H,300.5688134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2010,115RSYC,25-Jul-22
C1071013,10031008,28,PF-06863135,T,6519134614,6.51913E+11,20221116,16:17,CYCLE16_DAY1,0 H,427.00681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2140,139RSYC,22-Mar-23
C1071013,10031008,28,PF-06863135,T,6521762368,6.52176E+11,20230206,15:10,CYCLE19_DAY1,0 H,918.2838882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2217,142RSYC,18-May-23
C1071013,10031008,28,PF-06863135,T,6522244541,6.52224E+11,20230503,15:36,CYCLE22_DAY1,0 H,744.9507958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2281,144RSYC,27-Nov-23
C1071013,10031008,28,PF-06863135,T,6524705277,6.52471E+11,,,,,969.4728593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2323,148RSYC,27-Mar-24
C1071013,10031008,28,PF-06863135,T,6517473947,6.51747E+11,20210923,10:56,CYCLE1_DAY4,0 H,676.7673207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 296,15RSYC,16-Nov-21
C1071013,10031008,28,PF-06863135,T,6517260614,6.51726E+11,20210924,10:37,CYCLE1_DAY4,24 H,700.7695719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 964,65RSYC,3-May-22
C1071013,10101002,29,PF-06863135,T,6517559654,6.51756E+11,20210928,10:44,CYCLE1_DAY1,0 H,630.0803378,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 303,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6517559654,6.51756E+11,20210928,17:37,CYCLE1_DAY1,6 H,867.8978278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 302,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6517559655,6.51756E+11,20211006,8:16,CYCLE1_DAY8,0 H,266.6295438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 305,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6517559655,6.51756E+11,20211006,15:02,CYCLE1_DAY8,6 H,425.5521043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 304,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6517559658,6.51756E+11,20211013,8:22,CYCLE1_DAY15,0 H,367.9158661,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 309,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6518459660,6.51846E+11,20211124,10:50,CYCLE3_DAY1,0 H,761.8875543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 679,30RSYC,22-Apr-22
C1071013,10101002,29,PF-06863135,T,6518877338,6.51888E+11,20211220,11:45,CYCLE4_DAY1,0 H,635.7208456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1167,104RSYC,22-May-22
C1071013,10101002,29,PF-06863135,T,6519690726,6.51969E+11,20220316,9:20,CYCLE7_DAY1,0 H,257.9484757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1891,87RSYC,13-May-22
C1071013,10101002,29,PF-06863135,T,6517559676,6.51756E+11,20220608,10:51,CYCLE10_DAY1,0 H,444.8314417,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2008,115RSYC,25-Jul-22
C1071013,10101002,29,PF-06863135,T,6520726026,6.52073E+11,20220831,0:00,CYCLE13_DAY1,0 H,270.5818311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2078,129RSYC,21-Oct-22
C1071013,10101002,29,PF-06863135,T,6520726028,6.52073E+11,20221123,0:00,CYCLE16_DAY1,0 H,616.8997207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2129,139RSYC,22-Mar-23
C1071013,10101002,29,PF-06863135,T,6521315623,6.52132E+11,20230215,9:51,CYCLE19_DAY1,0 H,653.3033863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2190,141RSYC,17-May-23
C1071013,10101002,29,PF-06863135,T,6521315621,6.52132E+11,20230508,12:20,CYCLE22_DAY1,0 H,841.3106926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2246,143RSYC,27-Nov-23
C1071013,10101002,29,PF-06863135,T,6524471823,6.52447E+11,20240117,10:16,CYCLE31_DAY1,0 H,275.3471472,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2354,148RSYC,27-Mar-24
C1071013,10101002,29,PF-06863135,T,6521205060,6.52121E+11,20211110,11:16,UNPL,9001 H,839.1048941,NG/ML,,Received as 6517559662-07,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 563,26RSYC,22-Apr-22
C1071013,10101002,29,PF-06863135,T,6517559670,6.51756E+11,20210929,11:30,CYCLE1_DAY1,24 H,135.5063334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 312,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6517559672,6.51756E+11,20211001,10:50,CYCLE1_DAY4,0 H,696.4805478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 314,15RSYC,16-Nov-21
C1071013,10101002,29,PF-06863135,T,6517559673,6.51756E+11,20211002,10:50,CYCLE1_DAY4,24 H,440.1221593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 315,15RSYC,16-Nov-21
C1071013,10541001,30,PF-06863135,T,6216170878,6.21617E+11,20210921,10:10,CYCLE1_DAY1,0 H,776.4698617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 157,6RSYC,29-Oct-21
C1071013,10541001,30,PF-06863135,T,6216170880,6.21617E+11,20210927,10:19,CYCLE1_DAY8,0 H,405.4717869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 158,6RSYC,29-Oct-21
C1071013,10541001,30,PF-06863135,T,6216170882,6.21617E+11,20211004,9:20,CYCLE1_DAY15,0 H,392.0815622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 365,17RSYC,17-Nov-21
C1071013,10541001,30,PF-06863135,T,6216170885,6.21617E+11,20211011,7:50,CYCLE1_DAY22,0 H,288.5938883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 366,17RSYC,17-Nov-21
C1071013,10541001,30,PF-06863135,T,6216170886,6.21617E+11,20211018,8:30,CYCLE2_DAY1,0 H,855.7613291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 367,17RSYC,17-Nov-21
C1071013,10541001,30,PF-06863135,T,6216170888,6.21617E+11,20211115,8:30,CYCLE3_DAY1,0 H,635.0365021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 698,31RSYC,23-Apr-22
C1071013,10541001,30,PF-06863135,T,6216170890,6.21617E+11,20211213,8:40,CYCLE4_DAY1,0 H,725.9915254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1275,89RSYC,11-May-22
C1071013,10541001,30,PF-06863135,T,6216170909,6.21617E+11,20220217,10:50,END_OF_TRT,,507.8314702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1771,87RSYC,13-May-22
C1071013,10541001,30,PF-06863135,T,6216170895,6.21617E+11,20210922,11:25,CYCLE1_DAY1,24 H,881.9065715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 159,6RSYC,29-Oct-21
C1071013,10541001,30,PF-06863135,T,6216170896,6.21617E+11,20210923,12:05,CYCLE1_DAY4,0 H,916.9016925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 160,6RSYC,29-Oct-21
C1071013,10541001,30,PF-06863135,T,6216170898,6.21617E+11,20210924,12:30,CYCLE1_DAY4,24 H,575.4485411,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1770,71RSYC,7-May-22
C1071013,10101001,31,PF-06863135,T,6518332217,6.51833E+11,20210927,10:32,CYCLE1_DAY1,0 H,810.9644033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 361,17RSYC,17-Nov-21
C1071013,10101001,31,PF-06863135,T,6518332217,6.51833E+11,20210927,16:00,CYCLE1_DAY1,6 H,354.7109517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 360,17RSYC,17-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559656,6.51756E+11,20211005,8:32,CYCLE1_DAY8,0 H,673.1585103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 307,15RSYC,16-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559656,6.51756E+11,20211005,17:47,CYCLE1_DAY8,6 H,146.5517517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 306,15RSYC,16-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559657,6.51756E+11,20211012,8:26,CYCLE1_DAY15,0 H,732.9397719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 308,15RSYC,16-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559660,6.51756E+11,20211019,7:54,CYCLE1_DAY22,0 H,542.6767103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 310,15RSYC,16-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559661,6.51756E+11,20211025,8:26,CYCLE2_DAY1,0 H,779.2141971,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 562,26RSYC,22-Apr-22
C1071013,10101001,31,PF-06863135,T,6517559664,6.51756E+11,20211122,8:53,CYCLE3_DAY1,0 H,88.5986563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 879,19RSYC,19-Apr-22
C1071013,10101001,31,PF-06863135,T,6518877339,6.51888E+11,20211220,8:30,CYCLE4_DAY1,0 H,631.527602,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1168,104RSYC,22-May-22
C1071013,10101001,31,PF-06863135,T,6519690725,6.51969E+11,20220314,8:48,CYCLE7_DAY1,0 H,8.548317821,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1892,81RSYC,4-May-22
C1071013,10101001,31,PF-06863135,T,6517559675,6.51756E+11,20220829,0:00,CYCLE13_DAY1,0 H,530.3256591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2079,129RSYC,21-Oct-22
C1071013,10101001,31,PF-06863135,T,6518806985,6.51881E+11,20221121,8:42,CYCLE16_DAY1,0 H,562.7826553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2169,140RSYC,22-Mar-23
C1071013,10101001,31,PF-06863135,T,6520726024,6.52073E+11,20230215,9:25,CYCLE19_DAY1,0 H,236.6252134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2191,141RSYC,17-May-23
C1071013,10101001,31,PF-06863135,T,6522542260,6.52254E+11,20230508,8:45,CYCLE22_DAY1,0 H,935.3202361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2247,143RSYC,27-Nov-23
C1071013,10101001,31,PF-06863135,T,6522542261,6.52254E+11,20230731,8:26,CYCLE25_DAY1,0 H,940.7236898,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2291,145RSYC,4-Jan-24
C1071013,10101001,31,PF-06863135,T,6524145854,6.52415E+11,20240115,7:57,CYCLE31_DAY1,0 H,18.83018311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2355,148RSYC,27-Mar-24
C1071013,10101001,31,PF-06863135,T,6522365006,6.52237E+11,20221219,8:51,UNPL,9001 H,567.7614923,NG/ML,,Received as 6520726027-02,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2192,141RSYC,17-May-23
C1071013,10101001,31,PF-06863135,T,6517559669,6.51756E+11,20210928,10:17,CYCLE1_DAY1,24 H,520.4815075,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 311,15RSYC,16-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559671,6.51756E+11,20211001,9:55,CYCLE1_DAY4,0 H,557.8595677,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 313,15RSYC,16-Nov-21
C1071013,10101001,31,PF-06863135,T,6517559674,6.51756E+11,20211002,10:16,CYCLE1_DAY4,24 H,718.6740166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 316,15RSYC,16-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650368,6.80165E+11,20210927,9:50,CYCLE1_DAY1,0 H,98.89918396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 270,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650368,6.80165E+11,20210927,19:01,CYCLE1_DAY1,6 H,103.075461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 271,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650369,6.80165E+11,20211005,9:00,CYCLE1_DAY8,0 H,394.6835334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 273,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650369,6.80165E+11,20211005,18:00,CYCLE1_DAY8,6 H,460.6869191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 272,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650371,6.80165E+11,20211012,9:15,CYCLE1_DAY15,0 H,885.6804736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 274,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650373,6.80165E+11,20211018,10:37,CYCLE1_DAY22,0 H,790.7324234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 275,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650388,6.80165E+11,20211027,9:45,END_OF_TRT,,800.0965275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 668,64RSYC,3-May-22
C1071013,11111002,32,PF-06863135,T,6801650379,6.80165E+11,20210928,13:05,CYCLE1_DAY1,24 H,101.1775643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 225,8RSYC,29-Oct-21
C1071013,11111002,32,PF-06863135,T,6801650399,6.80165E+11,20211001,8:35,CYCLE1_DAY4,0 H,173.3436046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 277,14RSYC,15-Nov-21
C1071013,11111002,32,PF-06863135,T,6801650383,6.80165E+11,20211002,11:40,CYCLE1_DAY4,24 H,202.3664336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 276,14RSYC,15-Nov-21
C1071013,11091001,33,PF-06863135,T,6801650191,6.80165E+11,20210927,9:45,CYCLE1_DAY1,0 H,255.6344522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 226,21RSYC,20-Apr-22
C1071013,11091001,33,PF-06863135,T,6801650191,6.80165E+11,20210927,20:58,CYCLE1_DAY1,6 H,796.6362731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 227,8RSYC,29-Oct-21
C1071013,11091001,33,PF-06863135,T,6801650192,6.80165E+11,20211004,10:05,CYCLE1_DAY8,0 H,723.7934354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 253,13RSYC,15-Nov-21
C1071013,11091001,33,PF-06863135,T,6801650192,6.80165E+11,20211005,21:30,CYCLE1_DAY8,6 H,293.2314043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 252,13RSYC,15-Nov-21
C1071013,11091001,33,PF-06863135,T,6801650194,6.80165E+11,20211012,8:50,CYCLE1_DAY15,0 H,187.429806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 256,13RSYC,15-Nov-21
C1071013,11091001,33,PF-06863135,T,6801650196,6.80165E+11,20211019,13:10,CYCLE1_DAY22,0 H,472.8583048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 258,13RSYC,15-Nov-21
C1071013,11091001,33,PF-06863135,T,6801650198,6.80165E+11,20211026,12:50,CYCLE2_DAY1,0 H,551.4025912,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 637,29RSYC,22-Apr-22
C1071013,11091001,33,PF-06863135,T,6801709454,6.80171E+11,20211124,11:22,CYCLE3_DAY1,0 H,562.5603174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 838,35RSYC,25-Apr-22
C1071013,11091001,33,PF-06863135,T,6801709455,6.80171E+11,20211221,11:25,CYCLE4_DAY1,0 H,663.4637497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 954,65RSYC,3-May-22
C1071013,11091001,33,PF-06863135,T,6801812297,6.80181E+11,20220315,11:00,CYCLE7_DAY1,0 H,441.9503703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1873,80RSYC,4-May-22
C1071013,11091001,33,PF-06863135,T,6801893157,6.80189E+11,20220607,10:55,CYCLE10_DAY1,0 H,810.925611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2016,115RSYC,25-Jul-22
C1071013,11091001,33,PF-06863135,T,6801962917,6.80196E+11,20220830,10:54,CYCLE13_DAY1,0 H,159.8045723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2071,129RSYC,21-Oct-22
C1071013,11091001,33,PF-06863135,T,6802045271,6.80205E+11,20221122,10:55,CYCLE16_DAY1,0 H,644.4462438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2152,139RSYC,22-Mar-23
C1071013,11091001,33,PF-06863135,T,6801962918,6.80196E+11,20221208,11:20,END_OF_TRT,,983.2718694,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2160,140RSYC,22-Mar-23
C1071013,11091001,33,PF-06863135,T,6801650208,6.80165E+11,20210929,8:40,UNPL,9001 H,502.143277,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 228,8RSYC,29-Oct-21
C1071013,11091001,33,PF-06863135,T,6801650202,6.80165E+11,20210928,15:15,CYCLE1_DAY1,24 H,753.1245545,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 229,8RSYC,29-Oct-21
C1071013,11091001,33,PF-06863135,T,6801650204,6.80165E+11,20210930,9:53,CYCLE1_DAY4,0 H,135.6353054,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 230,8RSYC,29-Oct-21
C1071013,11091001,33,PF-06863135,T,6801650206,6.80165E+11,20211001,15:15,CYCLE1_DAY4,24 H,559.5401376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 261,14RSYC,15-Nov-21
C1071013,10791001,34,PF-06863135,T,6216170981,6.21617E+11,20210927,14:15,CYCLE1_DAY1,0 H,369.3677377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 371,17RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216170981,6.21617E+11,20210927,20:55,CYCLE1_DAY1,6 H,484.124278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 370,17RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216170982,6.21617E+11,20211004,14:24,CYCLE1_DAY8,0 H,430.954085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 372,17RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216170985,6.21617E+11,20211011,15:07,CYCLE1_DAY15,0 H,239.9442513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 375,17RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216843014,6.21684E+11,20211018,14:27,CYCLE1_DAY22,0 H,841.5706345,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 396,18RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216170988,6.21617E+11,20211025,17:30,CYCLE2_DAY1,0 H,741.0809356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 416,21RSYC,20-Apr-22
C1071013,10791001,34,PF-06863135,T,6217031634,6.21703E+11,20211124,17:24,CYCLE3_DAY1,0 H,821.4091991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 767,33RSYC,24-Apr-22
C1071013,10791001,34,PF-06863135,T,6217184137,6.21718E+11,20211223,14:18,CYCLE4_DAY1,0 H,819.8222021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1521,97RSYC,12-May-22
C1071013,10791001,34,PF-06863135,T,6216170994,6.21617E+11,20220315,12:48,CYCLE7_DAY1,0 H,640.8836944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1879,80RSYC,4-May-22
C1071013,10791001,34,PF-06863135,T,6216171003,6.21617E+11,20220615,14:57,CYCLE10_DAY1,0 H,792.8972433,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2041,128RSYC,21-Oct-22
C1071013,10791001,34,PF-06863135,T,6217178487,6.21718E+11,20220914,13:21,CYCLE13_DAY1,0 H,942.4397274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2102,132RSYC,10-Nov-22
C1071013,10791001,34,PF-06863135,T,6219244642,6.21924E+11,20221209,17:50,CYCLE16_DAY1,0 H,73.76729874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2182,141RSYC,17-May-23
C1071013,10791001,34,PF-06863135,T,6219947540,6.21995E+11,20230302,14:20,CYCLE19_DAY1,0 H,175.3857119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2212,143RSYC,27-Nov-23
C1071013,10791001,34,PF-06863135,T,6219947539,6.21995E+11,20230525,13:20,CYCLE22_DAY1,0 H,712.4034588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2256,144RSYC,27-Nov-23
C1071013,10791001,34,PF-06863135,T,6219947542,6.21995E+11,20230824,13:15,CYCLE25_DAY1,0 H,531.8457254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2294,145RSYC,4-Jan-24
C1071013,10791001,34,PF-06863135,T,6219244645,6.21924E+11,20240229,14:49,CYCLE31_DAY1,0 H,154.7441373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2366,152RSYC,9-Apr-24
C1071013,10791001,34,PF-06863135,T,6216170997,6.21617E+11,20210928,13:57,CYCLE1_DAY1,24 H,846.6451542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 377,17RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216170999,6.21617E+11,20210930,14:33,CYCLE1_DAY4,0 H,678.3276269,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 379,17RSYC,17-Nov-21
C1071013,10791001,34,PF-06863135,T,6216171001,6.21617E+11,20211001,14:44,CYCLE1_DAY4,24 H,934.4928541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 381,18RSYC,17-Nov-21
C1071013,10071005,35,PF-06863135,T,6518157745,6.51816E+11,20211005,12:10,CYCLE1_DAY1,0 H,805.4318414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 349,16RSYC,16-Nov-21
C1071013,10071005,35,PF-06863135,T,6518157745,6.51816E+11,20211005,18:15,CYCLE1_DAY1,6 H,607.3043497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 348,16RSYC,16-Nov-21
C1071013,10071005,35,PF-06863135,T,6518265654,6.51827E+11,20211015,10:45,CYCLE1_DAY8,0 H,528.6562188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 355,17RSYC,17-Nov-21
C1071013,10071005,35,PF-06863135,T,6518265654,6.51827E+11,20211015,17:30,CYCLE1_DAY8,6 H,985.2484507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 354,17RSYC,17-Nov-21
C1071013,10071005,35,PF-06863135,T,6518418506,6.51842E+11,20211021,9:00,CYCLE1_DAY15,0 H,917.0562291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 609,90RSYC,11-May-22
C1071013,10071005,35,PF-06863135,T,6518418507,6.51842E+11,20211027,11:10,CYCLE1_DAY22,0 H,535.3879359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 610,90RSYC,11-May-22
C1071013,10071005,35,PF-06863135,T,6518157746,6.51816E+11,20211105,9:50,CYCLE2_DAY1,0 H,207.415076,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 602,27RSYC,21-Apr-22
C1071013,10071005,35,PF-06863135,T,6518265659,6.51827E+11,20211203,11:45,CYCLE3_DAY1,0 H,200.2527225,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1091,67RSYC,8-May-22
C1071013,10071005,35,PF-06863135,T,6518265662,6.51827E+11,20211230,10:22,CYCLE4_DAY1,0 H,973.7763305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1600,96RSYC,12-May-22
C1071013,10071005,35,PF-06863135,T,6518265664,6.51827E+11,20220324,10:12,CYCLE7_DAY1,0 H,168.5548059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1926,123RSYC,29-Jul-22
C1071013,10071005,35,PF-06863135,T,6517472416,6.51747E+11,20220616,10:00,CYCLE10_DAY1,0 H,935.9827397,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2006,115RSYC,25-Jul-22
C1071013,10071005,35,PF-06863135,T,6520930825,6.52093E+11,20220908,9:50,CYCLE13_DAY1,0 H,984.5266514,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2076,129RSYC,21-Oct-22
C1071013,10071005,35,PF-06863135,T,6520930828,6.52093E+11,20221201,10:00,CYCLE16_DAY1,0 H,260.7037587,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2130,139RSYC,22-Mar-23
C1071013,10071005,35,PF-06863135,T,6521240600,6.52124E+11,20230106,10:02,END_OF_TRT,,672.1298276,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2168,140RSYC,22-Mar-23
C1071013,10071005,35,PF-06863135,T,6518157753,6.51816E+11,20211006,13:03,CYCLE1_DAY1,24 H,968.9378011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 350,17RSYC,17-Nov-21
C1071013,10071005,35,PF-06863135,T,6518265665,6.51827E+11,20211011,12:00,CYCLE1_DAY4,0 H,223.0634039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 356,17RSYC,17-Nov-21
C1071013,10071005,35,PF-06863135,T,6518265668,6.51827E+11,20211012,11:45,CYCLE1_DAY4,24 H,237.5155095,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 357,17RSYC,17-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650190,6.80165E+11,20210930,9:50,CYCLE1_DAY1,0 H,916.3985131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 231,8RSYC,29-Oct-21
C1071013,11091002,36,PF-06863135,T,6801650190,6.80165E+11,20210930,17:40,CYCLE1_DAY1,6 H,131.2555472,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 251,18RSYC,17-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650193,6.80165E+11,20211007,10:25,CYCLE1_DAY8,0 H,948.9780157,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 255,13RSYC,15-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650193,6.80165E+11,20211007,17:35,CYCLE1_DAY8,6 H,749.1204785,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 254,13RSYC,15-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650195,6.80165E+11,20211014,10:10,END_OF_TRT,,397.5734261,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 257,13RSYC,15-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650203,6.80165E+11,20211001,11:23,CYCLE1_DAY1,24 H,980.2793476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 259,13RSYC,15-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650205,6.80165E+11,20211004,6:55,CYCLE1_DAY4,0 H,498.6002111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 260,14RSYC,15-Nov-21
C1071013,11091002,36,PF-06863135,T,6801650207,6.80165E+11,20211005,11:34,CYCLE1_DAY4,24 H,326.2839178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 262,14RSYC,15-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650307,6.80165E+11,20211004,10:08,CYCLE1_DAY1,0 H,635.3877248,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 263,14RSYC,15-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650307,6.80165E+11,20211004,16:39,CYCLE1_DAY1,6 H,149.3554916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 264,18RSYC,17-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650309,6.80165E+11,20211011,11:12,CYCLE1_DAY8,0 H,799.6382389,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 266,14RSYC,15-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650309,6.80165E+11,20211011,17:55,CYCLE1_DAY8,6 H,885.1259179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 265,14RSYC,15-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650313,6.80165E+11,20211025,10:10,CYCLE1_DAY22,0 H,97.55975149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 656,29RSYC,22-Apr-22
C1071013,11241001,37,PF-06863135,T,6801650328,6.80165E+11,20211101,11:05,END_OF_TRT,,704.9799243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 661,86RSYC,13-May-22
C1071013,11241001,37,PF-06863135,T,6801650319,6.80165E+11,20211005,10:10,CYCLE1_DAY1,24 H,450.5015699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 267,14RSYC,15-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650321,6.80165E+11,20211007,10:39,CYCLE1_DAY4,0 H,600.8771373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 268,14RSYC,15-Nov-21
C1071013,11241001,37,PF-06863135,T,6801650323,6.80165E+11,20211008,11:32,CYCLE1_DAY4,24 H,595.8702501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 269,18RSYC,17-Nov-21
C1071013,10981003,38,PF-06863135,T,6517769657,6.51777E+11,20211004,10:20,CYCLE1_DAY1,0 H,501.9235404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 343,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517769657,6.51777E+11,20211004,21:15,CYCLE1_DAY1,6 H,555.1707417,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 342,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517769662,6.51777E+11,20211011,8:50,CYCLE1_DAY8,0 H,694.4806213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 345,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517769662,6.51777E+11,20211011,13:56,CYCLE1_DAY8,6 H,373.1091437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 344,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517768773,6.51777E+11,20211020,9:20,CYCLE1_DAY15,0 H,710.3856085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 340,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517768774,6.51777E+11,20211027,8:33,CYCLE1_DAY22,0 H,286.5942589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 597,27RSYC,21-Apr-22
C1071013,10981003,38,PF-06863135,T,6517769672,6.51777E+11,20211103,8:50,CYCLE2_DAY1,0 H,656.5299126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 600,27RSYC,21-Apr-22
C1071013,10981003,38,PF-06863135,T,6517769678,6.51777E+11,20211130,8:50,CYCLE3_DAY1,0 H,408.5731115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1082,41RSYC,26-Apr-22
C1071013,10981003,38,PF-06863135,T,6517769686,6.51777E+11,20211229,9:35,CYCLE4_DAY1,0 H,977.1892383,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1717,72RSYC,7-May-22
C1071013,10981003,38,PF-06863135,T,6517769690,6.51777E+11,20220324,9:00,CYCLE7_DAY1,0 H,687.4755505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1927,123RSYC,29-Jul-22
C1071013,10981003,38,PF-06863135,T,6518807318,6.51881E+11,20220615,9:28,CYCLE10_DAY1,0 H,932.6732456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2034,128RSYC,21-Oct-22
C1071013,10981003,38,PF-06863135,T,6520972522,6.52097E+11,20220923,9:20,CYCLE13_DAY1,0 H,140.9182757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2111,131RSYC,9-Nov-22
C1071013,10981003,38,PF-06863135,T,6521653169,6.52165E+11,20221228,8:20,CYCLE16_DAY1,0 H,854.3451325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2173,140RSYC,22-Mar-23
C1071013,10981003,38,PF-06863135,T,6520972524,6.52097E+11,20230324,9:10,CYCLE19_DAY1,0 H,986.6655553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2222,142RSYC,18-May-23
C1071013,10981003,38,PF-06863135,T,6522845154,6.52285E+11,20230613,8:41,CYCLE22_DAY1,0 H,831.9392084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2262,144RSYC,27-Nov-23
C1071013,10981003,38,PF-06863135,T,6524724652,6.52472E+11,20240103,9:25,CYCLE28_DAY1,0 H,868.471766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2324,148RSYC,27-Mar-24
C1071013,10981003,38,PF-06863135,T,6517755820,6.51776E+11,20211005,15:25,CYCLE1_DAY1,24 H,818.7289358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 333,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517755822,6.51776E+11,20211007,12:05,CYCLE1_DAY4,0 H,184.9397475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 334,16RSYC,16-Nov-21
C1071013,10981003,38,PF-06863135,T,6517755828,6.51776E+11,20211008,11:00,CYCLE1_DAY4,24 H,423.6746766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 335,16RSYC,16-Nov-21
C1071013,10671003,39,PF-06863135,T,6517433455,6.51743E+11,20211004,11:45,CYCLE1_DAY1,0 H,907.617844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 283,14RSYC,15-Nov-21
C1071013,10671003,39,PF-06863135,T,6517433455,6.51743E+11,20211004,18:35,CYCLE1_DAY1,6 H,367.4398016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 282,18RSYC,17-Nov-21
C1071013,10671003,39,PF-06863135,T,6517433457,6.51743E+11,20211011,9:25,CYCLE1_DAY8,0 H,917.5637817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 284,14RSYC,15-Nov-21
C1071013,10671003,39,PF-06863135,T,6517433457,6.51743E+11,20211011,17:07,CYCLE1_DAY8,6 H,900.0031945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 531,25RSYC,22-Apr-22
C1071013,10671003,39,PF-06863135,T,6517433460,6.51743E+11,20211018,11:00,CYCLE1_DAY15,0 H,251.8503345,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 285,14RSYC,15-Nov-21
C1071013,10671003,39,PF-06863135,T,6518354391,6.51835E+11,20211025,9:11,CYCLE1_DAY22,0 H,176.3899702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 607,90RSYC,11-May-22
C1071013,10671003,39,PF-06863135,T,6518354392,6.51835E+11,20211101,10:21,CYCLE2_DAY1,0 H,329.0712636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 608,90RSYC,11-May-22
C1071013,10671003,39,PF-06863135,T,6517433465,6.51743E+11,20211129,10:33,CYCLE3_DAY1,0 H,956.4932571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 967,65RSYC,3-May-22
C1071013,10671003,39,PF-06863135,T,6517433472,6.51743E+11,20211005,12:35,CYCLE1_DAY1,24 H,874.4744248,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 286,14RSYC,15-Nov-21
C1071013,10671003,39,PF-06863135,T,6517433474,6.51743E+11,20211007,11:43,CYCLE1_DAY4,0 H,191.9047356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 287,14RSYC,15-Nov-21
C1071013,10671003,39,PF-06863135,T,6517433476,6.51743E+11,20211008,13:05,CYCLE1_DAY4,24 H,988.2623717,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 288,14RSYC,15-Nov-21
C1071013,10351001,40,PF-06863135,T,6216407870,6.21641E+11,20211015,9:15,CYCLE1_DAY1,0 H,499.1406758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 383,18RSYC,17-Nov-21
C1071013,10351001,40,PF-06863135,T,6216407870,6.21641E+11,20211015,16:15,CYCLE1_DAY1,6 H,424.8327848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 382,18RSYC,17-Nov-21
C1071013,10351001,40,PF-06863135,T,6215033391,6.21503E+11,20211025,10:30,CYCLE1_DAY8,0 H,728.3715827,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 402,21RSYC,20-Apr-22
C1071013,10351001,40,PF-06863135,T,6215033391,6.21503E+11,20211025,16:30,CYCLE1_DAY8,6 H,404.7283756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 401,21RSYC,20-Apr-22
C1071013,10351001,40,PF-06863135,T,6216407874,6.21641E+11,20211101,8:15,CYCLE1_DAY15,0 H,842.0959732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 428,88RSYC,11-May-22
C1071013,10351001,40,PF-06863135,T,6217091593,6.21709E+11,20211108,10:24,CYCLE1_DAY22,0 H,15.41205285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 507,24RSYC,20-Apr-22
C1071013,10351001,40,PF-06863135,T,6216407878,6.21641E+11,20211115,10:06,CYCLE2_DAY1,0 H,670.8444797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 429,88RSYC,11-May-22
C1071013,10351001,40,PF-06863135,T,6216407885,6.21641E+11,20211016,10:15,CYCLE1_DAY1,24 H,698.9649957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 384,18RSYC,17-Nov-21
C1071013,10351001,40,PF-06863135,T,6216407888,6.21641E+11,20211018,9:28,CYCLE1_DAY4,0 H,294.0515847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 385,18RSYC,17-Nov-21
C1071013,10351001,40,PF-06863135,T,6216407890,6.21641E+11,20211019,10:37,CYCLE1_DAY4,24 H,741.0446895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 386,18RSYC,17-Nov-21
C1071013,10771002,41,PF-06863135,T,6517643711,6.51764E+11,20211005,13:00,CYCLE1_DAY1,0 H,116.6553017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 326,16RSYC,16-Nov-21
C1071013,10771002,41,PF-06863135,T,6517643711,6.51764E+11,20211005,20:30,CYCLE1_DAY1,6 H,484.2215033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 325,16RSYC,16-Nov-21
C1071013,10771002,41,PF-06863135,T,6517643714,6.51764E+11,20211015,2:53,CYCLE1_DAY8,0 H,738.6261545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 892,19RSYC,19-Apr-22
C1071013,10771002,41,PF-06863135,T,6517643714,6.51764E+11,20211015,19:45,CYCLE1_DAY8,6 H,91.95902672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 891,19RSYC,19-Apr-22
C1071013,10771002,41,PF-06863135,T,6517246450,6.51725E+11,20211021,7:55,CYCLE1_DAY15,0 H,733.8512639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 842,35RSYC,25-Apr-22
C1071013,10771002,41,PF-06863135,T,6517529121,6.51753E+11,20211027,8:40,CYCLE1_DAY22,0 H,605.5607634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 872,19RSYC,19-Apr-22
C1071013,10771002,41,PF-06863135,T,6517775835,6.51778E+11,20211101,11:34,CYCLE2_DAY1,0 H,389.6010033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 909,20RSYC,19-Apr-22
C1071013,10771002,41,PF-06863135,T,6517246469,6.51725E+11,20211012,13:40,UNPL,9001 H,856.5643431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 281,14RSYC,15-Nov-21
C1071013,10771002,41,PF-06863135,T,6517643721,6.51764E+11,20211006,14:35,CYCLE1_DAY1,24 H,449.0493831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 327,16RSYC,16-Nov-21
C1071013,10771002,41,PF-06863135,T,6517643725,6.51764E+11,20211009,8:15,CYCLE1_DAY4,0 H,149.7452009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2126,137RSYC,18-Nov-22
C1071013,10771002,41,PF-06863135,T,6517756053,6.51776E+11,20211010,9:30,CYCLE1_DAY4,24 H,461.1223769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 336,16RSYC,16-Nov-21
C1071013,10151001,42,PF-06863135,T,6517560122,6.51756E+11,20211013,8:25,CYCLE1_DAY1,0 H,912.5589452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 317,15RSYC,16-Nov-21
C1071013,10151001,42,PF-06863135,T,6517560124,6.51756E+11,20211020,9:45,CYCLE1_DAY8,0 H,359.8740056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 320,16RSYC,16-Nov-21
C1071013,10151001,42,PF-06863135,T,6517560124,6.51756E+11,20211020,16:35,CYCLE1_DAY8,6 H,855.8340312,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 319,15RSYC,16-Nov-21
C1071013,10151001,42,PF-06863135,T,6517560126,6.51756E+11,20211027,10:20,CYCLE1_DAY15,0 H,691.0867422,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 578,27RSYC,21-Apr-22
C1071013,10151001,42,PF-06863135,T,6517560128,6.51756E+11,20211103,10:20,CYCLE1_DAY22,0 H,113.2524499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 580,27RSYC,21-Apr-22
C1071013,10151001,42,PF-06863135,T,6517560130,6.51756E+11,20211110,10:30,CYCLE2_DAY1,0 H,904.8446775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 582,27RSYC,21-Apr-22
C1071013,10151001,42,PF-06863135,T,6517560133,6.51756E+11,20211208,13:02,CYCLE3_DAY1,0 H,336.2269768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1050,40RSYC,26-Apr-22
C1071013,10151001,42,PF-06863135,T,6517560135,6.51756E+11,20220105,11:01,CYCLE4_DAY1,0 H,590.228356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1660,100RSYC,23-May-22
C1071013,10151001,42,PF-06863135,T,6517560137,6.51756E+11,20220330,11:00,CYCLE7_DAY1,0 H,127.6295158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1928,123RSYC,29-Jul-22
C1071013,10151001,42,PF-06863135,T,6523756324,6.52376E+11,20230828,11:50,UNPL,9001 H,833.1859464,NG/ML,,Visit revised from C25D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2303,147RSYC,29-Feb-24
C1071013,10151001,42,PF-06863135,T,6517560139,6.51756E+11,20211014,17:00,CYCLE1_DAY1,24 H,126.3712827,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 321,16RSYC,16-Nov-21
C1071013,10151001,42,PF-06863135,T,6517560141,6.51756E+11,20211015,16:30,CYCLE1_DAY4,0 H,965.6739814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 323,16RSYC,16-Nov-21
C1071013,10111001,43,PF-06863135,T,6517559759,6.51756E+11,20211014,11:50,CYCLE1_DAY1,0 H,947.6728067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 568,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559759,6.51756E+11,20211014,19:57,CYCLE1_DAY1,6 H,797.0399704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 567,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559760,6.51756E+11,20211022,8:50,CYCLE1_DAY8,0 H,806.2823782,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 570,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559760,6.51756E+11,20211022,18:15,CYCLE1_DAY8,6 H,70.33904669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 569,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559762,6.51756E+11,20211028,9:20,CYCLE1_DAY15,0 H,141.4811948,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 571,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559764,6.51756E+11,20211103,8:30,CYCLE1_DAY22,0 H,627.161837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 572,86RSYC,13-May-22
C1071013,10111001,43,PF-06863135,T,6514526586,6.51453E+11,20211109,8:33,CYCLE2_DAY1,0 H,593.6019778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 839,64RSYC,3-May-22
C1071013,10111001,43,PF-06863135,T,6517559769,6.51756E+11,20211206,11:00,CYCLE3_DAY1,0 H,947.3480279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1031,40RSYC,26-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559774,6.51756E+11,20211015,12:50,CYCLE1_DAY1,24 H,559.1782973,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 573,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559776,6.51756E+11,20211018,9:45,CYCLE1_DAY4,0 H,155.2858814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 574,26RSYC,22-Apr-22
C1071013,10111001,43,PF-06863135,T,6517559779,6.51756E+11,20211019,12:55,CYCLE1_DAY4,24 H,667.8706471,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 575,86RSYC,13-May-22
C1071013,10101003,44,PF-06863135,T,6518332216,6.51833E+11,20211012,11:30,CYCLE1_DAY1,0 H,616.0331404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 359,17RSYC,17-Nov-21
C1071013,10101003,44,PF-06863135,T,6518332216,6.51833E+11,20211012,18:00,CYCLE1_DAY1,6 H,114.7840094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 358,17RSYC,17-Nov-21
C1071013,10101003,44,PF-06863135,T,6517559677,6.51756E+11,20211022,8:00,CYCLE1_DAY8,0 H,854.806102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 564,26RSYC,22-Apr-22
C1071013,10101003,44,PF-06863135,T,6517559677,6.51756E+11,20211022,16:15,CYCLE1_DAY8,6 H,287.4365659,NG/ML,,Received as 6517559679-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 565,86RSYC,13-May-22
C1071013,10101003,44,PF-06863135,T,6518558183,6.51856E+11,20211105,9:04,CYCLE1_DAY22,0 H,275.0356361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 611,90RSYC,11-May-22
C1071013,10101003,44,PF-06863135,T,6518706283,6.51871E+11,20211112,12:50,CYCLE2_DAY1,0 H,323.2388925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 935,36RSYC,25-Apr-22
C1071013,10101003,44,PF-06863135,T,6518877335,6.51888E+11,20211210,8:33,CYCLE3_DAY1,0 H,792.0335508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1166,104RSYC,22-May-22
C1071013,10101003,44,PF-06863135,T,6518877340,6.51888E+11,20220107,8:19,CYCLE4_DAY1,0 H,615.1431597,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1612,97RSYC,12-May-22
C1071013,10101003,44,PF-06863135,T,6519690724,6.51969E+11,20220401,8:13,CYCLE7_DAY1,0 H,321.3031232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1929,122RSYC,29-Jul-22
C1071013,10101003,44,PF-06863135,T,6518806983,6.51881E+11,20220624,8:20,CYCLE10_DAY1,0 H,827.7155149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2028,131RSYC,9-Nov-22
C1071013,10101003,44,PF-06863135,T,6520726025,6.52073E+11,20220916,0:00,CYCLE13_DAY1,0 H,224.8167669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2098,132RSYC,10-Nov-22
C1071013,10101003,44,PF-06863135,T,6520726030,6.52073E+11,20221216,10:14,UNPL,9001 H,925.0661725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2131,139RSYC,22-Mar-23
C1071013,10101003,44,PF-06863135,T,6518459661,6.51846E+11,20211013,12:00,CYCLE1_DAY1,24 H,761.0510079,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 362,17RSYC,17-Nov-21
C1071013,10101003,44,PF-06863135,T,6518499635,6.5185E+11,20211015,10:35,CYCLE1_DAY4,0 H,579.7880638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 363,17RSYC,17-Nov-21
C1071013,10101003,44,PF-06863135,T,6518499636,6.5185E+11,20211016,12:22,CYCLE1_DAY4,24 H,17.13414071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 364,17RSYC,17-Nov-21
C1071013,10021002,45,PF-06863135,T,6603324911,6.60332E+11,20211011,9:09,CYCLE1_DAY1,0 H,807.1022835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 234,18RSYC,17-Nov-21
C1071013,10021002,45,PF-06863135,T,6603324911,6.60332E+11,20211011,16:09,CYCLE1_DAY1,6 H,117.123379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 235,13RSYC,15-Nov-21
C1071013,10021002,45,PF-06863135,T,6603529935,6.60353E+11,20211018,9:25,CYCLE1_DAY8,0 H,692.8301364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 244,13RSYC,15-Nov-21
C1071013,10021002,45,PF-06863135,T,6603529935,6.60353E+11,20211018,15:09,CYCLE1_DAY8,6 H,307.9025933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 243,13RSYC,15-Nov-21
C1071013,10021002,45,PF-06863135,T,6603529938,6.60353E+11,20211025,9:10,CYCLE1_DAY15,0 H,147.8608895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 629,64RSYC,3-May-22
C1071013,10021002,45,PF-06863135,T,6603529940,6.60353E+11,20211101,9:10,CYCLE1_DAY22,0 H,283.0095986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 630,64RSYC,3-May-22
C1071013,10021002,45,PF-06863135,T,6603563110,6.60356E+11,20211108,11:00,CYCLE2_DAY1,0 H,94.13529687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 820,35RSYC,25-Apr-22
C1071013,10021002,45,PF-06863135,T,6603529946,6.60353E+11,20211206,10:10,CYCLE3_DAY1,0 H,652.5001367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 942,65RSYC,3-May-22
C1071013,10021002,45,PF-06863135,T,6603529947,6.60353E+11,20220105,9:49,CYCLE4_DAY1,0 H,861.1826924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1583,59RSYC,1-May-22
C1071013,10021002,45,PF-06863135,T,6603529950,6.60353E+11,20220330,9:45,CYCLE7_DAY1,0 H,155.4532172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1917,122RSYC,29-Jul-22
C1071013,10021002,45,PF-06863135,T,6603578688,6.60358E+11,20220620,8:55,CYCLE10_DAY1,0 H,123.1551449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2024,132RSYC,10-Nov-22
C1071013,10021002,45,PF-06863135,T,6603839290,6.60384E+11,20220912,10:25,CYCLE13_DAY1,0 H,147.9267441,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2115,131RSYC,9-Nov-22
C1071013,10021002,45,PF-06863135,T,6604204202,6.6042E+11,20221205,9:00,CYCLE16_DAY1,0 H,373.5543342,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2161,140RSYC,22-Mar-23
C1071013,10021002,45,PF-06863135,T,6604204197,6.6042E+11,20230227,10:45,CYCLE19_DAY1,0 H,529.6625613,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2208,142RSYC,18-May-23
C1071013,10021002,45,PF-06863135,T,6604608948,6.60461E+11,20230522,10:50,CYCLE22_DAY1,0 H,295.1531017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2252,143RSYC,27-Nov-23
C1071013,10021002,45,PF-06863135,T,6604608946,6.60461E+11,20230828,10:35,CYCLE25_DAY1,0 H,660.2418209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2339,149RSYC,27-Mar-24
C1071013,10021002,45,PF-06863135,T,6604608947,6.60461E+11,20231120,12:00,CYCLE28_DAY1,0 H,420.0467408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2340,148RSYC,27-Mar-24
C1071013,10021002,45,PF-06863135,T,6604777913,6.60478E+11,20240212,10:25,CYCLE31_DAY1,0 H,613.5876423,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2359,152RSYC,9-Apr-24
C1071013,10021002,45,PF-06863135,T,6603324927,6.60332E+11,20211012,9:25,CYCLE1_DAY1,24 H,794.3680957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 237,13RSYC,15-Nov-21
C1071013,10021002,45,PF-06863135,T,6603324928,6.60332E+11,20211014,9:55,CYCLE1_DAY4,0 H,433.7714346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 238,13RSYC,15-Nov-21
C1071013,10021002,45,PF-06863135,T,6603324930,6.60332E+11,20211015,9:35,CYCLE1_DAY4,24 H,636.7754532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 239,13RSYC,15-Nov-21
C1071013,10481001,46,PF-06863135,T,6216407971,6.21641E+11,20211012,17:10,CYCLE1_DAY1,0 H,569.3921496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 434,76RSYC,4-May-22
C1071013,10481001,46,PF-06863135,T,6216407971,6.21641E+11,20211012,23:10,CYCLE1_DAY1,6 H,993.4593473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 433,88RSYC,11-May-22
C1071013,10481001,46,PF-06863135,T,6216407973,6.21641E+11,20211019,10:05,CYCLE1_DAY8,0 H,153.9402667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 438,88RSYC,11-May-22
C1071013,10481001,46,PF-06863135,T,6216407973,6.21641E+11,20211019,16:00,CYCLE1_DAY8,6 H,348.6945197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 437,88RSYC,11-May-22
C1071013,10481001,46,PF-06863135,T,6216407976,6.21641E+11,20211026,9:30,CYCLE1_DAY15,0 H,445.6455958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 439,88RSYC,11-May-22
C1071013,10481001,46,PF-06863135,T,6216856431,6.21686E+11,20211102,9:00,CYCLE1_DAY22,0 H,749.0472776,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 477,23RSYC,20-Apr-22
C1071013,10481001,46,PF-06863135,T,6216408001,6.21641E+11,20211111,10:55,END_OF_TRT,,892.3464183,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 710,64RSYC,3-May-22
C1071013,10481001,46,PF-06863135,T,6216407987,6.21641E+11,20211013,17:10,CYCLE1_DAY1,24 H,15.89132679,NG/ML,9; Tube received empty,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 440,,
C1071013,10481001,46,PF-06863135,T,6216407989,6.21641E+11,20211015,11:55,CYCLE1_DAY4,0 H,902.7478178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 442,88RSYC,11-May-22
C1071013,10481001,46,PF-06863135,T,6216407991,6.21641E+11,20211016,12:00,CYCLE1_DAY4,24 H,977.049449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 443,88RSYC,11-May-22
C1071013,10031009,47,PF-06863135,T,6517751561,6.51775E+11,20211012,11:27,CYCLE1_DAY1,0 H,798.5544691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1068,41RSYC,26-Apr-22
C1071013,10031009,47,PF-06863135,T,6517751561,6.51775E+11,20211012,18:00,CYCLE1_DAY1,6 H,612.5971221,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1067,41RSYC,26-Apr-22
C1071013,10031009,47,PF-06863135,T,6517751564,6.51775E+11,20211020,10:35,CYCLE1_DAY8,0 H,890.8307088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 588,27RSYC,21-Apr-22
C1071013,10031009,47,PF-06863135,T,6517751564,6.51775E+11,20211020,17:30,CYCLE1_DAY8,6 H,477.834369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 587,27RSYC,21-Apr-22
C1071013,10031009,47,PF-06863135,T,6517472379,6.51747E+11,20211013,10:35,CYCLE1_DAY1,24 H,90.87177779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 988,66RSYC,3-May-22
C1071013,10031009,47,PF-06863135,T,6517260612,6.51726E+11,20211014,12:35,CYCLE1_DAY4,0 H,944.0390206,NG/ML,,Visit revised from C1D8 and Time Point updated; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2011,126RSYC,1-Aug-22
C1071013,10031009,47,PF-06863135,T,6517260613,6.51726E+11,20211015,12:30,CYCLE1_DAY4,24 H,873.80796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 963,65RSYC,3-May-22
C1071013,11041001,48,PF-06863135,T,6216725274,6.21673E+11,20211013,12:00,CYCLE1_DAY1,0 H,464.1243403,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 451,76RSYC,4-May-22
C1071013,11041001,48,PF-06863135,T,6216725274,6.21673E+11,20211013,22:00,CYCLE1_DAY1,6 H,217.3841048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 450,88RSYC,11-May-22
C1071013,11041001,48,PF-06863135,T,6216923991,6.21692E+11,20211021,15:10,CYCLE1_DAY8,0 H,977.0148473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 484,23RSYC,20-Apr-22
C1071013,11041001,48,PF-06863135,T,6216923991,6.21692E+11,20211022,1:20,CYCLE1_DAY8,6 H,562.8442363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 483,23RSYC,20-Apr-22
C1071013,11041001,48,PF-06863135,T,6216923998,6.21692E+11,20211029,13:00,CYCLE1_DAY15,0 H,922.2288091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1418,57RSYC,30-Apr-22
C1071013,11041001,48,PF-06863135,T,6216924001,6.21692E+11,20211108,12:00,CYCLE1_DAY22,0 H,737.6083069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 746,32RSYC,23-Apr-22
C1071013,11041001,48,PF-06863135,T,6216924046,6.21692E+11,20211116,15:40,END_OF_TRT,,830.4979949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1425,108RSYC,24-May-22
C1071013,11041001,48,PF-06863135,T,6216725290,6.21673E+11,20211014,16:00,CYCLE1_DAY1,24 H,253.6111188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 452,89RSYC,11-May-22
C1071013,11041001,48,PF-06863135,T,6216725293,6.21673E+11,20211018,14:00,CYCLE1_DAY4,0 H,280.9684105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 454,89RSYC,11-May-22
C1071013,11041001,48,PF-06863135,T,6216725294,6.21673E+11,20211019,16:20,CYCLE1_DAY4,24 H,721.9274081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 387,18RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216170980,6.21617E+11,20211013,12:18,CYCLE1_DAY1,0 H,503.5102126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 369,17RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216170980,6.21617E+11,20211013,19:21,CYCLE1_DAY1,6 H,12.72384044,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 368,17RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216170983,6.21617E+11,20211019,14:48,CYCLE1_DAY8,0 H,833.0916467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 374,17RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216170983,6.21617E+11,20211019,21:07,CYCLE1_DAY8,6 H,422.3420287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 373,17RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216843012,6.21684E+11,20211028,16:18,CYCLE1_DAY15,0 H,369.5643688,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 473,23RSYC,20-Apr-22
C1071013,10791002,49,PF-06863135,T,6216170996,6.21617E+11,20211014,14:12,CYCLE1_DAY1,24 H,400.3488939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 376,17RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216170998,6.21617E+11,20211015,14:15,CYCLE1_DAY4,0 H,272.3603165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 378,17RSYC,17-Nov-21
C1071013,10791002,49,PF-06863135,T,6216171000,6.21617E+11,20211016,14:34,CYCLE1_DAY4,24 H,116.2710218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 380,18RSYC,17-Nov-21
C1071013,10151002,50,PF-06863135,T,6517560123,6.51756E+11,20211015,16:30,CYCLE1_DAY1,0 H,906.2233638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 318,15RSYC,16-Nov-21
C1071013,10151002,50,PF-06863135,T,6517560125,6.51756E+11,20211022,9:30,CYCLE1_DAY8,0 H,953.6302475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 577,27RSYC,21-Apr-22
C1071013,10151002,50,PF-06863135,T,6517560125,6.51756E+11,20211022,15:24,CYCLE1_DAY8,6 H,296.4076558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 576,27RSYC,21-Apr-22
C1071013,10151002,50,PF-06863135,T,6517560127,6.51756E+11,20211029,10:50,CYCLE1_DAY15,0 H,98.08861043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 579,27RSYC,21-Apr-22
C1071013,10151002,50,PF-06863135,T,6517560129,6.51756E+11,20211105,10:25,CYCLE1_DAY22,0 H,986.7436583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 581,27RSYC,21-Apr-22
C1071013,10151002,50,PF-06863135,T,6517560131,6.51756E+11,20211112,10:09,CYCLE2_DAY1,0 H,413.5371648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 886,19RSYC,19-Apr-22
C1071013,10151002,50,PF-06863135,T,6517560132,6.51756E+11,20211210,10:38,CYCLE3_DAY1,0 H,447.3956654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1049,40RSYC,26-Apr-22
C1071013,10151002,50,PF-06863135,T,6519170849,6.51917E+11,20220107,10:30,CYCLE4_DAY1,0 H,387.4810525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1661,100RSYC,23-May-22
C1071013,10151002,50,PF-06863135,T,6520320365,6.52032E+11,20220623,10:34,CYCLE10_DAY1,0 H,948.5099966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2033,128RSYC,21-Oct-22
C1071013,10151002,50,PF-06863135,T,6517560152,6.51756E+11,20220707,11:00,END_OF_TRT,,179.4745679,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2032,128RSYC,21-Oct-22
C1071013,10151002,50,PF-06863135,T,6517560140,6.51756E+11,20211018,13:15,CYCLE1_DAY4,0 H,857.9534137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 322,16RSYC,16-Nov-21
C1071013,10151002,50,PF-06863135,T,6517560142,6.51756E+11,20211019,14:05,CYCLE1_DAY4,24 H,637.1348813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 324,16RSYC,16-Nov-21
C1071013,10791004,51,PF-06863135,T,6216840408,6.21684E+11,20211014,13:28,CYCLE1_DAY1,0 H,481.5983605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 467,23RSYC,20-Apr-22
C1071013,10791004,51,PF-06863135,T,6216840408,6.21684E+11,20211014,20:08,CYCLE1_DAY1,6 H,954.8264493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 466,23RSYC,20-Apr-22
C1071013,10791004,51,PF-06863135,T,6216843010,6.21684E+11,20211021,13:33,CYCLE1_DAY8,0 H,956.7782743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 472,23RSYC,20-Apr-22
C1071013,10791004,51,PF-06863135,T,6216843010,6.21684E+11,20211021,19:23,CYCLE1_DAY8,6 H,175.7458817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 471,23RSYC,20-Apr-22
C1071013,10791004,51,PF-06863135,T,6216170984,6.21617E+11,20211028,14:30,CYCLE1_DAY15,0 H,561.1864619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 415,21RSYC,20-Apr-22
C1071013,10791004,51,PF-06863135,T,6216843015,6.21684E+11,20211104,13:22,CYCLE1_DAY22,0 H,434.361219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 474,23RSYC,20-Apr-22
C1071013,10791004,51,PF-06863135,T,6216170989,6.21617E+11,20211111,14:00,CYCLE2_DAY1,0 H,592.8515881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 702,64RSYC,3-May-22
C1071013,10791004,51,PF-06863135,T,6217142537,6.21714E+11,20211216,13:20,CYCLE3_DAY1,0 H,629.4225255,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1467,54RSYC,30-Apr-22
C1071013,10791004,51,PF-06863135,T,6217031636,6.21703E+11,20220113,13:35,CYCLE4_DAY1,0 H,365.6022291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1811,92RSYC,12-May-22
C1071013,10791004,51,PF-06863135,T,6217031638,6.21703E+11,20220407,13:19,CYCLE7_DAY1,0 H,7.94544826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1912,123RSYC,29-Jul-22
C1071013,10791004,51,PF-06863135,T,6219244643,6.21924E+11,20221222,14:21,CYCLE16_DAY1,0 H,388.21231,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2183,141RSYC,17-May-23
C1071013,10791004,51,PF-06863135,T,6219244641,6.21924E+11,20230316,15:45,CYCLE19_DAY1,0 H,287.1021355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2213,142RSYC,18-May-23
C1071013,10791004,51,PF-06863135,T,6219244644,6.21924E+11,20230608,9:53,CYCLE22_DAY1,0 H,440.0777738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2257,144RSYC,27-Nov-23
C1071013,10791004,51,PF-06863135,T,6219947541,6.21995E+11,20230829,14:00,CYCLE25_DAY1,0 H,400.3449205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2311,147RSYC,29-Feb-24
C1071013,10791004,51,PF-06863135,T,6219947543,6.21995E+11,20240222,13:38,CYCLE31_DAY1,0 H,885.1433157,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2367,153RSYC,10-Apr-24
C1071013,10791004,51,PF-06863135,T,6216840412,6.21684E+11,20211015,14:07,CYCLE1_DAY1,24 H,12.04150547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 394,18RSYC,17-Nov-21
C1071013,10791004,51,PF-06863135,T,6216840413,6.21684E+11,20211018,14:00,CYCLE1_DAY4,0 H,329.3792211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 395,18RSYC,17-Nov-21
C1071013,10791004,51,PF-06863135,T,6216840410,6.21684E+11,20211019,14:00,CYCLE1_DAY4,24 H,216.0833102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 393,18RSYC,17-Nov-21
C1071013,11171006,52,PF-06863135,T,6517764043,6.51776E+11,20211018,11:25,CYCLE1_DAY1,0 H,955.287987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 338,16RSYC,16-Nov-21
C1071013,11171006,52,PF-06863135,T,6517764043,6.51776E+11,20211018,17:32,CYCLE1_DAY1,6 H,364.0656084,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 337,16RSYC,16-Nov-21
C1071013,11171006,52,PF-06863135,T,6517433558,6.51743E+11,20211025,10:50,CYCLE1_DAY8,0 H,831.3549719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 544,25RSYC,22-Apr-22
C1071013,11171006,52,PF-06863135,T,6517433558,6.51743E+11,20211025,16:47,CYCLE1_DAY8,6 H,862.5420017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 543,25RSYC,22-Apr-22
C1071013,11171006,52,PF-06863135,T,6517764054,6.51776E+11,20211102,9:42,CYCLE1_DAY15,0 H,735.1964995,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 594,27RSYC,21-Apr-22
C1071013,11171006,52,PF-06863135,T,6517764059,6.51776E+11,20211108,9:03,CYCLE1_DAY22,0 H,938.4568714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 595,27RSYC,21-Apr-22
C1071013,11171006,52,PF-06863135,T,6517764064,6.51776E+11,20211115,12:05,CYCLE2_DAY1,0 H,504.8303777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 903,20RSYC,19-Apr-22
C1071013,11171006,52,PF-06863135,T,6517433585,6.51743E+11,20211122,8:32,END_OF_TRT,,390.0069375,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 848,107RSYC,24-May-22
C1071013,11171006,52,PF-06863135,T,6517764070,6.51776E+11,20211019,10:30,CYCLE1_DAY1,24 H,988.2672132,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 339,16RSYC,16-Nov-21
C1071013,11171006,52,PF-06863135,T,6517433574,6.51743E+11,20211021,9:42,CYCLE1_DAY4,0 H,360.427037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 289,14RSYC,15-Nov-21
C1071013,11171006,52,PF-06863135,T,6518011622,6.51801E+11,20211022,9:20,CYCLE1_DAY4,24 H,333.7963215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 601,27RSYC,21-Apr-22
C1071013,10321001,53,PF-06863135,T,6517509070,6.51751E+11,20211015,11:52,CYCLE1_DAY1,0 H,38.77133159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 298,15RSYC,16-Nov-21
C1071013,10321001,53,PF-06863135,T,6517509070,6.51751E+11,20211015,19:24,CYCLE1_DAY1,6 H,27.50530341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 297,15RSYC,16-Nov-21
C1071013,10321001,53,PF-06863135,T,6517509073,6.51751E+11,20211022,11:41,CYCLE1_DAY8,0 H,779.7530193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 557,26RSYC,22-Apr-22
C1071013,10321001,53,PF-06863135,T,6517509073,6.51751E+11,20211022,17:46,CYCLE1_DAY8,6 H,582.5576253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 556,26RSYC,22-Apr-22
C1071013,10321001,53,PF-06863135,T,6517509074,6.51751E+11,20211028,14:41,CYCLE1_DAY15,0 H,344.2595379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 558,26RSYC,22-Apr-22
C1071013,10321001,53,PF-06863135,T,6517509077,6.51751E+11,20211104,8:33,CYCLE1_DAY22,0 H,558.3894454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 559,26RSYC,22-Apr-22
C1071013,10321001,53,PF-06863135,T,6517509078,6.51751E+11,20211110,11:25,CYCLE2_DAY1,0 H,250.9039775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 869,19RSYC,19-Apr-22
C1071013,10321001,53,PF-06863135,T,6518150043,6.51815E+11,20211209,11:55,CYCLE3_DAY1,0 H,357.2312142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1090,67RSYC,8-May-22
C1071013,10321001,53,PF-06863135,T,6518150044,6.51815E+11,20220106,11:56,CYCLE4_DAY1,0 H,265.8456109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1630,85RSYC,10-May-22
C1071013,10321001,53,PF-06863135,T,6517559966,6.51756E+11,20220331,14:24,CYCLE7_DAY1,0 H,488.5180869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1930,123RSYC,29-Jul-22
C1071013,10321001,53,PF-06863135,T,6517559974,6.51756E+11,20220627,12:55,CYCLE10_DAY1,0 H,790.2312691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2030,128RSYC,21-Oct-22
C1071013,10321001,53,PF-06863135,T,6518807506,6.51881E+11,20220919,9:21,CYCLE13_DAY1,0 H,448.2003956,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2099,132RSYC,10-Nov-22
C1071013,10321001,53,PF-06863135,T,6519136799,6.51914E+11,20221128,11:33,END_OF_TRT,,995.7578393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2132,139RSYC,22-Mar-23
C1071013,10321001,53,PF-06863135,T,6517509082,6.51751E+11,20211016,13:35,CYCLE1_DAY1,24 H,623.254005,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 299,15RSYC,16-Nov-21
C1071013,10321001,53,PF-06863135,T,6517509084,6.51751E+11,20211018,12:51,CYCLE1_DAY4,0 H,459.402719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 300,15RSYC,16-Nov-21
C1071013,10321001,53,PF-06863135,T,6517509086,6.51751E+11,20211019,13:41,CYCLE1_DAY4,24 H,303.1138652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 301,15RSYC,16-Nov-21
C1071013,11021001,54,PF-06863135,T,6216756800,6.21676E+11,20211018,14:05,CYCLE1_DAY1,0 H,331.4634454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 390,18RSYC,17-Nov-21
C1071013,11021001,54,PF-06863135,T,6216756800,6.21676E+11,20211018,20:00,CYCLE1_DAY1,6 H,172.5546384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1384,100RSYC,23-May-22
C1071013,11021001,54,PF-06863135,T,6217023832,6.21702E+11,20211102,19:10,CYCLE1_DAY15,0 H,598.7925421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 505,24RSYC,20-Apr-22
C1071013,11021001,54,PF-06863135,T,6217136144,6.21714E+11,20211108,15:50,CYCLE1_DAY22,0 H,926.6971648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 509,24RSYC,20-Apr-22
C1071013,11021001,54,PF-06863135,T,6217023837,6.21702E+11,20211115,17:00,CYCLE2_DAY1,0 H,645.6426095,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 757,33RSYC,24-Apr-22
C1071013,11021001,54,PF-06863135,T,6217142695,6.21714E+11,20211216,15:00,END_OF_TRT,,118.4758877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1469,109RSYC,25-May-22
C1071013,11021001,54,PF-06863135,T,6216756811,6.21676E+11,20211019,14:27,CYCLE1_DAY1,24 H,532.3664916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 391,18RSYC,17-Nov-21
C1071013,11021001,54,PF-06863135,T,6216756814,6.21676E+11,20211021,14:45,CYCLE1_DAY4,0 H,37.16441518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 461,23RSYC,20-Apr-22
C1071013,11021001,54,PF-06863135,T,6216756816,6.21676E+11,20211022,16:05,CYCLE1_DAY4,24 H,596.2803287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 463,23RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216923990,6.21692E+11,20211018,11:00,CYCLE1_DAY1,0 H,535.9536924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 482,23RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216923990,6.21692E+11,20211019,0:30,CYCLE1_DAY1,6 H,262.3908914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 481,23RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216923994,6.21692E+11,20211025,10:30,CYCLE1_DAY8,0 H,552.3765559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 486,24RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216923994,6.21692E+11,20211025,17:45,CYCLE1_DAY8,6 H,117.3702554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 485,24RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216923995,6.21692E+11,20211102,11:45,CYCLE1_DAY15,0 H,887.5437659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 487,24RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216924002,6.21692E+11,20211108,12:40,CYCLE1_DAY22,0 H,565.2542092,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 488,24RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216725284,6.21673E+11,20211214,10:42,CYCLE3_DAY1,0 H,124.2537172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1377,84RSYC,10-May-22
C1071013,11041002,55,PF-06863135,T,6216725304,6.21673E+11,20220113,12:45,END_OF_TRT,,240.6689421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1756,109RSYC,25-May-22
C1071013,11041002,55,PF-06863135,T,6216725291,6.21673E+11,20211019,18:30,CYCLE1_DAY1,24 H,388.9695474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 453,89RSYC,11-May-22
C1071013,11041002,55,PF-06863135,T,6216924029,6.21692E+11,20211021,6:00,CYCLE1_DAY4,0 H,839.759278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 490,24RSYC,20-Apr-22
C1071013,11041002,55,PF-06863135,T,6216924033,6.21692E+11,20211022,13:45,CYCLE1_DAY4,24 H,350.4301112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 493,24RSYC,20-Apr-22
C1071013,10121001,56,PF-06863135,T,6517433306,6.51743E+11,20211019,8:58,CYCLE1_DAY1,0 H,241.0536568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 522,25RSYC,22-Apr-22
C1071013,10121001,56,PF-06863135,T,6517433306,6.51743E+11,20211019,16:12,CYCLE1_DAY1,6 H,299.0726246,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 521,25RSYC,22-Apr-22
C1071013,10121001,56,PF-06863135,T,6517433308,6.51743E+11,20211026,9:55,CYCLE1_DAY8,0 H,755.4248194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 524,25RSYC,22-Apr-22
C1071013,10121001,56,PF-06863135,T,6517433308,6.51743E+11,20211026,15:55,CYCLE1_DAY8,6 H,928.6520087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 523,25RSYC,22-Apr-22
C1071013,10121001,56,PF-06863135,T,6518019676,6.51802E+11,20220426,11:32,END_OF_TRT,,282.9035485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1982,114RSYC,25-Jul-22
C1071013,10121001,56,PF-06863135,T,6517433322,6.51743E+11,20211020,11:35,CYCLE1_DAY1,24 H,247.8172635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 526,107RSYC,24-May-22
C1071013,10121001,56,PF-06863135,T,6517433323,6.51743E+11,20211021,12:10,CYCLE1_DAY4,0 H,701.6689725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 527,109RSYC,25-May-22
C1071013,10121001,56,PF-06863135,T,6517433326,6.51743E+11,20211022,11:25,CYCLE1_DAY4,24 H,237.0773081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 530,25RSYC,22-Apr-22
C1071013,11081003,57,PF-06863135,T,6801650152,6.80165E+11,20211019,9:55,CYCLE1_DAY1,0 H,936.9087701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 245,13RSYC,15-Nov-21
C1071013,11081003,57,PF-06863135,T,6801650152,6.80165E+11,20211019,20:10,CYCLE1_DAY1,6 H,15.88334947,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 246,13RSYC,15-Nov-21
C1071013,11081003,57,PF-06863135,T,6801650154,6.80165E+11,20211026,10:00,CYCLE1_DAY8,0 H,166.6687786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 632,64RSYC,3-May-22
C1071013,11081003,57,PF-06863135,T,6801650154,6.80165E+11,20211026,19:35,CYCLE1_DAY8,6 H,600.6594763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 631,64RSYC,3-May-22
C1071013,11081003,57,PF-06863135,T,6801650156,6.80165E+11,20211102,8:40,CYCLE1_DAY15,0 H,64.77337862,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 633,64RSYC,3-May-22
C1071013,11081003,57,PF-06863135,T,6801650158,6.80165E+11,20211109,9:35,CYCLE1_DAY22,0 H,852.6595123,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 634,64RSYC,3-May-22
C1071013,11081003,57,PF-06863135,T,6801650160,6.80165E+11,20211116,9:45,CYCLE2_DAY1,0 H,257.1211678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 635,29RSYC,22-Apr-22
C1071013,11081003,57,PF-06863135,T,6801650172,6.80165E+11,20211210,11:20,END_OF_TRT,,474.972189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 951,86RSYC,13-May-22
C1071013,11081003,57,PF-06863135,T,6801650164,6.80165E+11,20211020,14:35,CYCLE1_DAY1,24 H,392.7548796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 249,13RSYC,15-Nov-21
C1071013,11081003,57,PF-06863135,T,6801650166,6.80165E+11,20211022,8:40,CYCLE1_DAY4,0 H,510.0523432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 250,13RSYC,15-Nov-21
C1071013,11081003,57,PF-06863135,T,6801650168,6.80165E+11,20211023,12:58,CYCLE1_DAY4,24 H,312.3152406,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 636,29RSYC,22-Apr-22
C1071013,11021002,58,PF-06863135,T,6216756799,6.21676E+11,20211020,13:05,CYCLE1_DAY1,0 H,93.37985401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 389,18RSYC,17-Nov-21
C1071013,11021002,58,PF-06863135,T,6216756799,6.21676E+11,20211020,19:00,CYCLE1_DAY1,6 H,452.2006268,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 388,18RSYC,17-Nov-21
C1071013,11021002,58,PF-06863135,T,6216756801,6.21676E+11,20211027,17:20,CYCLE1_DAY8,0 H,81.51875626,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 459,23RSYC,20-Apr-22
C1071013,11021002,58,PF-06863135,T,6216756801,6.21676E+11,20211027,23:20,CYCLE1_DAY8,6 H,537.8459111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 458,23RSYC,20-Apr-22
C1071013,11021002,58,PF-06863135,T,6217023831,6.21702E+11,20211103,16:30,CYCLE1_DAY15,0 H,810.7544222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 504,24RSYC,20-Apr-22
C1071013,11021002,58,PF-06863135,T,6217118740,6.21712E+11,20211110,12:10,CYCLE1_DAY22,0 H,632.4820919,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1452,54RSYC,30-Apr-22
C1071013,11021002,58,PF-06863135,T,6217170460,6.21717E+11,20211117,15:10,CYCLE2_DAY1,0 H,984.7849874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 795,34RSYC,24-Apr-22
C1071013,11021002,58,PF-06863135,T,6217136148,6.21714E+11,20211215,15:35,CYCLE3_DAY1,0 H,179.0343923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1465,54RSYC,30-Apr-22
C1071013,11021002,58,PF-06863135,T,6217142692,6.21714E+11,20220105,13:50,END_OF_TRT,,573.4521826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1834,86RSYC,13-May-22
C1071013,11021002,58,PF-06863135,T,6216756812,6.21676E+11,20211021,13:15,CYCLE1_DAY1,24 H,107.1069062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 392,18RSYC,17-Nov-21
C1071013,11021002,58,PF-06863135,T,6216756813,6.21676E+11,20211022,15:35,CYCLE1_DAY4,0 H,324.202815,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 460,23RSYC,20-Apr-22
C1071013,10171001,60,PF-06863135,T,6215033337,6.21503E+11,20211021,14:57,CYCLE1_DAY1,0 H,19.88177221,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 398,21RSYC,20-Apr-22
C1071013,10171001,60,PF-06863135,T,6215033337,6.21503E+11,20211021,22:00,CYCLE1_DAY1,6 H,333.9450447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 397,21RSYC,20-Apr-22
C1071013,10171001,60,PF-06863135,T,6216407831,6.21641E+11,20211109,11:30,END_OF_TRT,,812.7796413,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 705,64RSYC,3-May-22
C1071013,10171001,60,PF-06863135,T,6216407817,6.21641E+11,20211022,16:00,CYCLE1_DAY1,24 H,941.6305528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 419,21RSYC,20-Apr-22
C1071013,10171001,60,PF-06863135,T,6216407820,6.21641E+11,20211027,12:00,CYCLE1_DAY4,0 H,702.2037718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 422,21RSYC,20-Apr-22
C1071013,10171001,60,PF-06863135,T,6216407821,6.21641E+11,20211028,15:03,CYCLE1_DAY4,24 H,777.2800067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 423,21RSYC,20-Apr-22
C1071013,10791005,61,PF-06863135,T,6216840407,6.21684E+11,20211021,17:45,CYCLE1_DAY1,0 H,158.6512325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 465,23RSYC,20-Apr-22
C1071013,10791005,61,PF-06863135,T,6216840407,6.21684E+11,20211021,23:48,CYCLE1_DAY1,6 H,354.833174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 464,23RSYC,20-Apr-22
C1071013,10791005,61,PF-06863135,T,6216170987,6.21617E+11,20211111,13:49,CYCLE1_DAY22,0 H,743.538566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 701,31RSYC,23-Apr-22
C1071013,10791005,61,PF-06863135,T,6216843016,6.21684E+11,20211118,14:14,CYCLE2_DAY1,0 H,709.7796027,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 737,32RSYC,23-Apr-22
C1071013,10791005,61,PF-06863135,T,6216171011,6.21617E+11,20211210,12:17,END_OF_TRT,,743.4127524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1291,108RSYC,24-May-22
C1071013,10791005,61,PF-06863135,T,6216840409,6.21684E+11,20211022,16:00,CYCLE1_DAY1,24 H,672.8816918,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 468,23RSYC,20-Apr-22
C1071013,10791005,61,PF-06863135,T,6216840415,6.21684E+11,20211025,17:09,CYCLE1_DAY4,0 H,944.2492624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 469,23RSYC,20-Apr-22
C1071013,10791005,61,PF-06863135,T,6216840418,6.21684E+11,20211026,17:21,CYCLE1_DAY4,24 H,313.5803223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 470,23RSYC,20-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433521,6.51743E+11,20211025,14:35,CYCLE1_DAY1,0 H,725.8695477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 536,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433521,6.51743E+11,20211025,21:35,CYCLE1_DAY1,6 H,571.7499116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 535,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433523,6.51743E+11,20211101,16:15,CYCLE1_DAY8,0 H,254.5024396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 538,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433523,6.51743E+11,20211101,22:32,CYCLE1_DAY8,6 H,346.5633284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 537,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433526,6.51743E+11,20211108,14:58,CYCLE1_DAY15,0 H,26.65849659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 539,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433538,6.51743E+11,20211026,15:54,CYCLE1_DAY1,24 H,931.1514021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 540,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433539,6.51743E+11,20211028,12:18,CYCLE1_DAY4,0 H,804.6751738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 541,25RSYC,22-Apr-22
C1071013,10901001,62,PF-06863135,T,6517433541,6.51743E+11,20211029,15:30,CYCLE1_DAY4,24 H,527.677212,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 542,86RSYC,13-May-22
C1071013,10031010,63,PF-06863135,T,6516580384,6.51658E+11,20211025,10:35,CYCLE1_DAY1,0 H,367.7545527,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 512,24RSYC,20-Apr-22
C1071013,10031010,63,PF-06863135,T,6516580384,6.51658E+11,20211025,17:45,CYCLE1_DAY1,6 H,488.6413289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 511,24RSYC,20-Apr-22
C1071013,10031010,63,PF-06863135,T,6516580386,6.51658E+11,20211103,11:50,CYCLE1_DAY8,0 H,898.4215223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 514,24RSYC,20-Apr-22
C1071013,10031010,63,PF-06863135,T,6516580386,6.51658E+11,20211103,17:30,CYCLE1_DAY8,6 H,409.0060376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 513,24RSYC,20-Apr-22
C1071013,10031010,63,PF-06863135,T,6517751570,6.51775E+11,20211110,17:12,CYCLE1_DAY15,0 H,259.2824284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1069,41RSYC,26-Apr-22
C1071013,10031010,63,PF-06863135,T,6518620863,6.51862E+11,20211026,10:40,CYCLE1_DAY1,24 H,672.1717239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 615,90RSYC,11-May-22
C1071013,10031010,63,PF-06863135,T,6518620865,6.51862E+11,20211027,10:43,CYCLE1_DAY4,0 H,72.7441495,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1123,94RSYC,12-May-22
C1071013,10031010,63,PF-06863135,T,6517473948,6.51747E+11,20211028,10:51,CYCLE1_DAY4,24 H,193.3287964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1008,39RSYC,26-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650308,6.80165E+11,20211025,10:29,CYCLE1_DAY1,0 H,893.5021874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 651,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650308,6.80165E+11,20211025,16:53,CYCLE1_DAY1,6 H,189.9878777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 652,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650310,6.80165E+11,20211101,10:13,CYCLE1_DAY8,0 H,225.9676815,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 654,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650310,6.80165E+11,20211101,16:31,CYCLE1_DAY8,6 H,882.8664806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 653,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650312,6.80165E+11,20211110,14:15,CYCLE1_DAY15,0 H,266.1721737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 655,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801700252,6.8017E+11,20211116,14:32,CYCLE1_DAY22,0 H,99.38267183,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 831,64RSYC,3-May-22
C1071013,11241002,64,PF-06863135,T,6801650316,6.80165E+11,20211124,14:39,CYCLE2_DAY1,0 H,511.7991339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 829,35RSYC,25-Apr-22
C1071013,11241002,64,PF-06863135,T,6801700259,6.8017E+11,20211221,12:49,CYCLE3_DAY1,0 H,148.8309608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 960,65RSYC,3-May-22
C1071013,11241002,64,PF-06863135,T,6801700262,6.8017E+11,20220118,14:47,CYCLE4_DAY1,0 H,44.68807017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1597,96RSYC,12-May-22
C1071013,11241002,64,PF-06863135,T,6801805147,6.80181E+11,20220412,14:50,CYCLE7_DAY1,0 H,356.9469879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1918,122RSYC,29-Jul-22
C1071013,11241002,64,PF-06863135,T,6801913233,6.80191E+11,20220705,14:24,CYCLE10_DAY1,0 H,563.5697341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2026,131RSYC,9-Nov-22
C1071013,11241002,64,PF-06863135,T,6801913234,6.80191E+11,20220927,14:08,CYCLE13_DAY1,0 H,86.81307094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2120,134RSYC,11-Nov-22
C1071013,11241002,64,PF-06863135,T,6802054682,6.80205E+11,20221220,15:07,CYCLE16_DAY1,0 H,831.4274974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2162,143RSYC,27-Nov-23
C1071013,11241002,64,PF-06863135,T,6802054683,6.80205E+11,20230315,14:18,CYCLE19_DAY1,0 H,926.8998377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2209,142RSYC,18-May-23
C1071013,11241002,64,PF-06863135,T,6802232421,6.80223E+11,20230606,14:45,CYCLE22_DAY1,0 H,8.914952829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2273,144RSYC,27-Nov-23
C1071013,11241002,64,PF-06863135,T,6802232422,6.80223E+11,20230829,13:55,CYCLE25_DAY1,0 H,20.02308504,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2299,147RSYC,29-Feb-24
C1071013,11241002,64,PF-06863135,T,6802432310,6.80243E+11,20231121,13:25,CYCLE28_DAY1,0 H,396.8400235,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2341,148RSYC,27-Mar-24
C1071013,11241002,64,PF-06863135,T,6802432311,6.80243E+11,20240213,14:40,CYCLE31_DAY1,0 H,774.1501234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2360,153RSYC,10-Apr-24
C1071013,11241002,64,PF-06863135,T,6801650325,6.80165E+11,20211027,11:35,UNPL,9001 H,363.2275191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 660,64RSYC,3-May-22
C1071013,11241002,64,PF-06863135,T,6801650320,6.80165E+11,20211026,11:22,CYCLE1_DAY1,24 H,313.7749484,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 657,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650322,6.80165E+11,20211029,10:22,CYCLE1_DAY4,0 H,831.6336175,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 658,29RSYC,22-Apr-22
C1071013,11241002,64,PF-06863135,T,6801650324,6.80165E+11,20211030,11:20,CYCLE1_DAY4,24 H,31.48808619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 659,29RSYC,22-Apr-22
C1071013,10961001,65,PF-06863135,T,6215349420,6.21535E+11,20211025,11:00,CYCLE1_DAY1,0 H,646.7670119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 404,21RSYC,20-Apr-22
C1071013,10961001,65,PF-06863135,T,6215349420,6.21535E+11,20211025,20:15,CYCLE1_DAY1,6 H,107.2926292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 403,21RSYC,20-Apr-22
C1071013,10961001,65,PF-06863135,T,6216170914,6.21617E+11,20211104,16:00,CYCLE1_DAY8,0 H,894.9705944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 700,31RSYC,23-Apr-22
C1071013,10961001,65,PF-06863135,T,6216170914,6.21617E+11,20211104,22:15,CYCLE1_DAY8,6 H,707.8453604,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 699,31RSYC,23-Apr-22
C1071013,10961001,65,PF-06863135,T,6215349424,6.21535E+11,20211112,15:25,CYCLE1_DAY15,0 H,215.8195296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 694,30RSYC,22-Apr-22
C1071013,10961001,65,PF-06863135,T,6215349426,6.21535E+11,20211122,14:00,CYCLE1_DAY22,0 H,661.1709749,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 695,30RSYC,22-Apr-22
C1071013,10961001,65,PF-06863135,T,6216170920,6.21617E+11,20211201,13:58,CYCLE2_DAY1,0 H,113.2556543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1276,89RSYC,11-May-22
C1071013,10961001,65,PF-06863135,T,6216170922,6.21617E+11,20211227,10:20,CYCLE3_DAY1,0 H,117.6041392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1783,71RSYC,7-May-22
C1071013,10961001,65,PF-06863135,T,6216170924,6.21617E+11,20220124,9:40,CYCLE4_DAY1,0 H,413.4860827,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1784,71RSYC,7-May-22
C1071013,10961001,65,PF-06863135,T,6218290587,6.21829E+11,20220419,12:00,CYCLE7_DAY1,0 H,178.5761667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1913,123RSYC,29-Jul-22
C1071013,10961001,65,PF-06863135,T,6217142393,6.21714E+11,20220711,11:00,CYCLE10_DAY1,0 H,214.0661122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2040,128RSYC,21-Oct-22
C1071013,10961001,65,PF-06863135,T,6216170943,6.21617E+11,20220725,9:00,END_OF_TRT,,844.2772881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2053,132RSYC,10-Nov-22
C1071013,10961001,65,PF-06863135,T,6216170928,6.21617E+11,20211026,14:15,CYCLE1_DAY1,24 H,891.391691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 412,107RSYC,24-May-22
C1071013,10961001,65,PF-06863135,T,6216170930,6.21617E+11,20211028,14:00,CYCLE1_DAY4,0 H,316.619187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 413,21RSYC,20-Apr-22
C1071013,10961001,65,PF-06863135,T,6216170933,6.21617E+11,20211029,14:15,CYCLE1_DAY4,24 H,614.0548851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 414,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6215033338,6.21503E+11,20211025,12:38,CYCLE1_DAY1,0 H,799.0512292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 400,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6215033338,6.21503E+11,20211025,19:44,CYCLE1_DAY1,6 H,80.93434104,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 399,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407803,6.21641E+11,20211108,13:05,CYCLE1_DAY8,0 H,804.8874398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 418,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407803,6.21641E+11,20211108,19:20,CYCLE1_DAY8,6 H,527.8453639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 417,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407806,6.21641E+11,20211115,12:00,CYCLE1_DAY15,0 H,942.3744148,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 703,31RSYC,23-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407807,6.21641E+11,20211122,11:17,CYCLE1_DAY22,0 H,8.398670863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 704,31RSYC,23-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407816,6.21641E+11,20220420,11:01,CYCLE7_DAY1,0 H,546.4873753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1990,114RSYC,25-Jul-22
C1071013,10171002,66,PF-06863135,T,6217142268,6.21714E+11,20220711,10:10,CYCLE10_DAY1,0 H,792.1398631,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2038,128RSYC,21-Oct-22
C1071013,10171002,66,PF-06863135,T,6219335461,6.21934E+11,20221004,16:11,CYCLE13_DAY1,0 H,80.91374807,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2122,131RSYC,9-Nov-22
C1071013,10171002,66,PF-06863135,T,6221257540,6.22126E+11,20231128,8:25,CYCLE28_DAY1,0 H,282.74524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2346,151RSYC,8-Apr-24
C1071013,10171002,66,PF-06863135,T,6222063119,6.22206E+11,20240219,8:24,CYCLE31_DAY1,0 H,318.4724879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2363,152RSYC,9-Apr-24
C1071013,10171002,66,PF-06863135,T,6216407809,6.21641E+11,20211221,14:50,UNPL,9001 H,218.0108998,NG/ML,,Visit revised from C2D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1292,84RSYC,10-May-22
C1071013,10171002,66,PF-06863135,T,6219335460,6.21934E+11,20230327,11:30,UNPL,9002 H,749.7767933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2227,145RSYC,4-Jan-24
C1071013,10171002,66,PF-06863135,T,6216407818,6.21641E+11,20211026,14:10,CYCLE1_DAY1,24 H,936.1067644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 420,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407819,6.21641E+11,20211103,15:08,CYCLE1_DAY4,0 H,15.08500825,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 421,21RSYC,20-Apr-22
C1071013,10171002,66,PF-06863135,T,6216407822,6.21641E+11,20211104,14:00,CYCLE1_DAY4,24 H,964.8624884,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 424,21RSYC,20-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756763,6.21676E+11,20211109,9:45,CYCLE1_DAY1,0 H,275.6724758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 456,23RSYC,20-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756763,6.21676E+11,20211109,18:00,CYCLE1_DAY1,6 H,420.2333835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 455,23RSYC,20-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756764,6.21676E+11,20211118,10:40,CYCLE1_DAY8,0 H,94.20405991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 731,32RSYC,23-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756764,6.21676E+11,20211118,19:00,CYCLE1_DAY8,6 H,518.6624146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 730,32RSYC,23-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756767,6.21676E+11,20211124,10:50,CYCLE1_DAY15,0 H,755.2556207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1380,84RSYC,10-May-22
C1071013,10461001,67,PF-06863135,T,6216756769,6.21676E+11,20211201,10:50,CYCLE1_DAY22,0 H,912.1040253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1382,84RSYC,10-May-22
C1071013,10461001,67,PF-06863135,T,6217283546,6.21728E+11,20211208,9:30,CYCLE2_DAY1,0 H,184.4965618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1565,58RSYC,1-May-22
C1071013,10461001,67,PF-06863135,T,6217233434,6.21723E+11,20220105,6:00,CYCLE3_DAY1,0 H,4.654069483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1812,92RSYC,12-May-22
C1071013,10461001,67,PF-06863135,T,6217233437,6.21723E+11,20220202,10:47,CYCLE4_DAY1,0 H,351.0640864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1813,92RSYC,12-May-22
C1071013,10461001,67,PF-06863135,T,6217647292,6.21765E+11,20220504,10:20,CYCLE7_DAY1,0 H,956.5060067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2001,115RSYC,25-Jul-22
C1071013,10461001,67,PF-06863135,T,6217647302,6.21765E+11,20220727,9:50,CYCLE10_DAY1,0 H,425.8077365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2058,132RSYC,10-Nov-22
C1071013,10461001,67,PF-06863135,T,6219611638,6.21961E+11,20230118,10:45,CYCLE16_DAY1,0 H,288.7910025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2200,141RSYC,17-May-23
C1071013,10461001,67,PF-06863135,T,6219611636,6.21961E+11,20230712,9:45,CYCLE22_DAY1,0 H,952.647589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2276,144RSYC,27-Nov-23
C1071013,10461001,67,PF-06863135,T,6220331901,6.22033E+11,20231004,11:35,CYCLE25_DAY1,0 H,968.4182736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2316,147RSYC,29-Feb-24
C1071013,10461001,67,PF-06863135,T,6220331903,6.22033E+11,20231227,9:55,CYCLE28_DAY1,0 H,491.0551186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2368,152RSYC,9-Apr-24
C1071013,10461001,67,PF-06863135,T,6216756774,6.21676E+11,20211110,11:10,CYCLE1_DAY1,24 H,849.0388289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 457,23RSYC,20-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756776,6.21676E+11,20211115,13:00,CYCLE1_DAY4,0 H,905.6466929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 733,32RSYC,23-Apr-22
C1071013,10461001,67,PF-06863135,T,6216756779,6.21676E+11,20211116,15:10,CYCLE1_DAY4,24 H,913.618777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 736,32RSYC,23-Apr-22
C1071013,10561001,68,PF-06863135,T,6216408039,6.21641E+11,20211025,13:00,CYCLE1_DAY1,0 H,317.7116859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 446,76RSYC,4-May-22
C1071013,10561001,68,PF-06863135,T,6216408039,6.21641E+11,20211025,20:15,CYCLE1_DAY1,6 H,726.5744094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 445,88RSYC,11-May-22
C1071013,10561001,68,PF-06863135,T,6216898572,6.2169E+11,20211103,9:40,CYCLE1_DAY8,0 H,686.0148341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 480,23RSYC,20-Apr-22
C1071013,10561001,68,PF-06863135,T,6216898572,6.2169E+11,20211103,20:50,CYCLE1_DAY8,6 H,904.0268542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 479,23RSYC,20-Apr-22
C1071013,10561001,68,PF-06863135,T,6217026143,6.21703E+11,20211116,10:00,CYCLE1_DAY22,0 H,404.2313513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 766,33RSYC,24-Apr-22
C1071013,10561001,68,PF-06863135,T,6216408048,6.21641E+11,20211125,9:15,CYCLE2_DAY1,0 H,406.8395185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 713,31RSYC,23-Apr-22
C1071013,10561001,68,PF-06863135,T,6217026165,6.21703E+11,20211223,14:05,CYCLE3_DAY1,0 H,517.3930849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1432,57RSYC,30-Apr-22
C1071013,10561001,68,PF-06863135,T,6216898587,6.2169E+11,20220119,13:00,CYCLE4_DAY1,0 H,454.3000859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1773,71RSYC,7-May-22
C1071013,10561001,68,PF-06863135,T,6216408053,6.21641E+11,20220414,10:40,CYCLE7_DAY1,0 H,170.7066416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1914,123RSYC,29-Jul-22
C1071013,10561001,68,PF-06863135,T,6218590825,6.21859E+11,20220706,10:50,CYCLE10_DAY1,0 H,146.8329033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2039,128RSYC,21-Oct-22
C1071013,10561001,68,PF-06863135,T,6219498866,6.2195E+11,20230316,10:50,CYCLE19_DAY1,0 H,516.3264016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2210,142RSYC,18-May-23
C1071013,10561001,68,PF-06863135,T,6220036098,6.22004E+11,20230608,9:40,CYCLE22_DAY1,0 H,168.4074553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2258,147RSYC,29-Feb-24
C1071013,10561001,68,PF-06863135,T,6220036108,6.22004E+11,20230831,12:30,CYCLE25_DAY1,0 H,326.1608775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2308,148RSYC,27-Mar-24
C1071013,10561001,68,PF-06863135,T,6222181789,6.22218E+11,20240215,9:15,CYCLE31_DAY1,0 H,693.5922501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2361,152RSYC,9-Apr-24
C1071013,10561001,68,PF-06863135,T,6219498868,6.2195E+11,20230105,9:40,UNPL,9001 H,551.3001378,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2178,140RSYC,22-Mar-23
C1071013,10561001,68,PF-06863135,T,6216408056,6.21641E+11,20211026,14:15,CYCLE1_DAY1,24 H,815.7609791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 447,88RSYC,11-May-22
C1071013,10561001,68,PF-06863135,T,6216408058,6.21641E+11,20211028,13:30,CYCLE1_DAY4,0 H,392.7091709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 448,88RSYC,11-May-22
C1071013,10561001,68,PF-06863135,T,6216408060,6.21641E+11,20211029,14:30,CYCLE1_DAY4,24 H,531.5609356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 449,88RSYC,11-May-22
C1071013,10981004,69,PF-06863135,T,6516326699,6.51633E+11,20211025,9:17,CYCLE1_DAY1,0 H,828.1166962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 841,35RSYC,25-Apr-22
C1071013,10981004,69,PF-06863135,T,6516326699,6.51633E+11,20211025,18:07,CYCLE1_DAY1,6 H,28.57049102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 840,35RSYC,25-Apr-22
C1071013,10981004,69,PF-06863135,T,6517769661,6.51777E+11,20211102,9:25,CYCLE1_DAY8,0 H,507.0018753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 599,27RSYC,21-Apr-22
C1071013,10981004,69,PF-06863135,T,6517769661,6.51777E+11,20211102,17:35,CYCLE1_DAY8,6 H,261.7460116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 598,27RSYC,21-Apr-22
C1071013,10981004,69,PF-06863135,T,6517769663,6.51777E+11,20211109,9:42,CYCLE1_DAY15,0 H,65.92139433,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 907,20RSYC,19-Apr-22
C1071013,10981004,69,PF-06863135,T,6517769670,6.51777E+11,20211118,8:45,CYCLE1_DAY22,0 H,362.2062062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 908,20RSYC,19-Apr-22
C1071013,10981004,69,PF-06863135,T,6517768779,6.51777E+11,20211124,9:37,CYCLE2_DAY1,0 H,469.292174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1075,41RSYC,26-Apr-22
C1071013,10981004,69,PF-06863135,T,6517768782,6.51777E+11,20211223,9:50,CYCLE3_DAY1,0 H,958.8939075,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1076,41RSYC,26-Apr-22
C1071013,10981004,69,PF-06863135,T,6517768786,6.51777E+11,20220120,9:09,CYCLE4_DAY1,0 H,388.0348376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1718,72RSYC,7-May-22
C1071013,10981004,69,PF-06863135,T,6517769688,6.51777E+11,20220412,9:14,CYCLE7_DAY1,0 H,882.853431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1931,122RSYC,29-Jul-22
C1071013,10981004,69,PF-06863135,T,6518807319,6.51881E+11,20220706,9:25,CYCLE10_DAY1,0 H,76.02601218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2035,128RSYC,21-Oct-22
C1071013,10981004,69,PF-06863135,T,6520972525,6.52097E+11,20220928,10:54,CYCLE13_DAY1,0 H,70.96807656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2112,131RSYC,9-Nov-22
C1071013,10981004,69,PF-06863135,T,6521653170,6.52165E+11,20221227,11:10,CYCLE16_DAY1,0 H,49.83592062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2174,140RSYC,22-Mar-23
C1071013,10981004,69,PF-06863135,T,6521653171,6.52165E+11,20230322,10:44,CYCLE19_DAY1,0 H,71.40167422,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2223,142RSYC,18-May-23
C1071013,10981004,69,PF-06863135,T,6522845153,6.52285E+11,20230614,12:00,CYCLE22_DAY1,0 H,68.51719851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2263,144RSYC,27-Nov-23
C1071013,10981004,69,PF-06863135,T,6524724651,6.52472E+11,20231218,12:10,CYCLE28_DAY1,0 H,802.5178627,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2325,148RSYC,27-Mar-24
C1071013,10981004,69,PF-06863135,T,6517755819,6.51776E+11,20211026,10:35,CYCLE1_DAY1,24 H,354.8201852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 591,27RSYC,21-Apr-22
C1071013,10981004,69,PF-06863135,T,6517755824,6.51776E+11,20211029,6:19,CYCLE1_DAY4,0 H,429.7460494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 592,27RSYC,21-Apr-22
C1071013,10981004,69,PF-06863135,T,6517755826,6.51776E+11,20211030,13:00,CYCLE1_DAY4,24 H,25.02418398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 593,27RSYC,21-Apr-22
C1071013,10401001,70,PF-06863135,T,6518161422,6.51816E+11,20211026,10:25,CYCLE1_DAY1,0 H,826.6835243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 606,63RSYC,2-May-22
C1071013,10401001,70,PF-06863135,T,6518161422,6.51816E+11,20211026,16:22,CYCLE1_DAY1,6 H,709.7018213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 605,89RSYC,11-May-22
C1071013,10401001,70,PF-06863135,T,6517560297,6.51756E+11,20211105,8:46,CYCLE1_DAY8,0 H,539.1434531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 888,19RSYC,19-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560297,6.51756E+11,20211105,15:16,CYCLE1_DAY8,6 H,14.6540349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 887,19RSYC,19-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560298,6.51756E+11,20211112,10:57,CYCLE1_DAY15,0 H,19.05546358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 889,19RSYC,19-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560300,6.51756E+11,20211119,12:10,CYCLE1_DAY22,0 H,835.4955428,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 890,19RSYC,19-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560303,6.51756E+11,20211125,11:47,CYCLE2_DAY1,0 H,423.7692284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1051,40RSYC,26-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560305,6.51756E+11,20211223,11:10,CYCLE3_DAY1,0 H,183.2180577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1052,40RSYC,26-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560307,6.51756E+11,20220121,9:08,CYCLE4_DAY1,0 H,21.39049429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1721,72RSYC,7-May-22
C1071013,10401001,70,PF-06863135,T,6517560308,6.51756E+11,20220414,11:00,CYCLE7_DAY1,0 H,996.4691105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1932,123RSYC,29-Jul-22
C1071013,10401001,70,PF-06863135,T,6517560317,6.51756E+11,20220706,10:05,CYCLE10_DAY1,0 H,921.3134847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2036,131RSYC,9-Nov-22
C1071013,10401001,70,PF-06863135,T,6520956318,6.52096E+11,20221005,13:00,CYCLE13_DAY1,0 H,259.0855307,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2113,134RSYC,11-Nov-22
C1071013,10401001,70,PF-06863135,T,6523034191,6.52303E+11,20230614,8:28,CYCLE22_DAY1,0 H,982.5232689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2264,144RSYC,27-Nov-23
C1071013,10401001,70,PF-06863135,T,6521647797,6.52165E+11,20230907,9:29,CYCLE25_DAY1,0 H,349.427118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2305,147RSYC,29-Feb-24
C1071013,10401001,70,PF-06863135,T,6524124731,6.52412E+11,20231130,12:29,CYCLE28_DAY1,0 H,361.0443446,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2326,148RSYC,27-Mar-24
C1071013,10401001,70,PF-06863135,T,6524124733,6.52412E+11,20240306,12:14,CYCLE31_DAY1,0 H,896.9866875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2372,152RSYC,9-Apr-24
C1071013,10401001,70,PF-06863135,T,6517560319,6.51756E+11,20211029,10:48,UNPL,9001 H,905.0260796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 586,27RSYC,21-Apr-22
C1071013,10401001,70,PF-06863135,T,6521647796,6.52165E+11,20230125,10:29,UNPL,9002 H,998.7858153,NG/ML,,Visit revised from C16D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2205,141RSYC,17-May-23
C1071013,10401001,70,PF-06863135,T,6517560311,6.51756E+11,20211027,10:20,CYCLE1_DAY1,24 H,773.5667911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 583,27RSYC,21-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560312,6.51756E+11,20211101,10:40,CYCLE1_DAY4,0 H,913.9653291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 584,27RSYC,21-Apr-22
C1071013,10401001,70,PF-06863135,T,6517560315,6.51756E+11,20211102,11:58,CYCLE1_DAY4,24 H,198.2556384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 585,86RSYC,13-May-22
C1071013,10191007,71,PF-06863135,T,6517246381,6.51725E+11,20211026,8:59,CYCLE1_DAY1,0 H,67.25193401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 516,25RSYC,22-Apr-22
C1071013,10191007,71,PF-06863135,T,6517246381,6.51725E+11,20211026,19:30,CYCLE1_DAY1,6 H,763.9575883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 515,25RSYC,22-Apr-22
C1071013,10191007,71,PF-06863135,T,6517246493,6.51725E+11,20211027,13:30,CYCLE1_DAY1,24 H,759.7711345,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 518,63RSYC,2-May-22
C1071013,10481005,72,PF-06863135,T,6216407972,6.21641E+11,20211029,11:00,CYCLE1_DAY1,0 H,594.9548412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 436,76RSYC,4-May-22
C1071013,10481005,72,PF-06863135,T,6216407972,6.21641E+11,20211029,17:00,CYCLE1_DAY1,6 H,57.35876203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 435,88RSYC,11-May-22
C1071013,10481005,72,PF-06863135,T,6216856419,6.21686E+11,20211105,9:00,CYCLE1_DAY8,0 H,776.2494736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 476,23RSYC,20-Apr-22
C1071013,10481005,72,PF-06863135,T,6216856419,6.21686E+11,20211105,15:20,CYCLE1_DAY8,6 H,611.5700875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 475,23RSYC,20-Apr-22
C1071013,10481005,72,PF-06863135,T,6216856423,6.21686E+11,20211112,8:55,CYCLE1_DAY15,0 H,30.97233777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 738,32RSYC,23-Apr-22
C1071013,10481005,72,PF-06863135,T,6216407977,6.21641E+11,20211119,9:25,CYCLE1_DAY22,0 H,190.2164764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1306,49RSYC,29-Apr-22
C1071013,10481005,72,PF-06863135,T,6216856440,6.21686E+11,20211126,11:15,CYCLE2_DAY1,0 H,796.3255266,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1400,95RSYC,13-May-22
C1071013,10481005,72,PF-06863135,T,6216856453,6.21686E+11,20211223,10:00,CYCLE3_DAY1,0 H,993.7437675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1401,95RSYC,13-May-22
C1071013,10481005,72,PF-06863135,T,6217184393,6.21718E+11,20220120,8:30,CYCLE4_DAY1,0 H,345.1205409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1749,91RSYC,11-May-22
C1071013,10481005,72,PF-06863135,T,6217142723,6.21714E+11,20220707,9:00,CYCLE10_DAY1,0 H,347.4270308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2037,128RSYC,21-Oct-22
C1071013,10481005,72,PF-06863135,T,6217142722,6.21714E+11,20220929,10:40,CYCLE13_DAY1,0 H,883.0908296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2121,131RSYC,9-Nov-22
C1071013,10481005,72,PF-06863135,T,6219283083,6.21928E+11,20221222,9:30,CYCLE16_DAY1,0 H,290.6373451,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2177,140RSYC,22-Mar-23
C1071013,10481005,72,PF-06863135,T,6219283082,6.21928E+11,20230316,9:30,CYCLE19_DAY1,0 H,643.4910384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2226,142RSYC,18-May-23
C1071013,10481005,72,PF-06863135,T,6219283081,6.21928E+11,20230608,9:00,CYCLE22_DAY1,0 H,184.1453375,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2259,144RSYC,27-Nov-23
C1071013,10481005,72,PF-06863135,T,6220027062,6.22003E+11,20230831,8:57,CYCLE25_DAY1,0 H,163.9318216,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2307,147RSYC,29-Feb-24
C1071013,10481005,72,PF-06863135,T,6220027063,6.22003E+11,20231123,12:21,CYCLE28_DAY1,0 H,671.4935587,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2347,148RSYC,27-Mar-24
C1071013,10481005,72,PF-06863135,T,6221581756,6.22158E+11,20240214,9:15,CYCLE31_DAY1,0 H,169.8706984,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2364,152RSYC,9-Apr-24
C1071013,10481005,72,PF-06863135,T,6222579039,6.22258E+11,20240228,8:05,END_OF_TRT,,405.0508345,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2369,152RSYC,9-Apr-24
C1071013,10481005,72,PF-06863135,T,6218548367,6.21855E+11,20220428,9:30,UNPL,9001 H,723.0930745,NG/ML,,Received as 6216407986-09,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2163,141RSYC,17-May-23
C1071013,10481005,72,PF-06863135,T,6216407988,6.21641E+11,20211030,11:00,CYCLE1_DAY1,24 H,737.6778577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 441,88RSYC,11-May-22
C1071013,10481005,72,PF-06863135,T,6216856467,6.21686E+11,20211101,12:20,CYCLE1_DAY4,0 H,943.142471,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 478,23RSYC,20-Apr-22
C1071013,10481005,72,PF-06863135,T,6216407992,6.21641E+11,20211102,12:20,CYCLE1_DAY4,24 H,98.3575836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 444,88RSYC,11-May-22
C1071013,10101004,73,PF-06863135,T,6517559653,6.51756E+11,20211029,10:57,CYCLE1_DAY1,0 H,308.9153668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 561,26RSYC,22-Apr-22
C1071013,10101004,73,PF-06863135,T,6517559653,6.51756E+11,20211029,18:17,CYCLE1_DAY1,6 H,877.8758642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 560,26RSYC,22-Apr-22
C1071013,10101004,73,PF-06863135,T,6518706277,6.51871E+11,20211106,13:59,CYCLE1_DAY8,0 H,394.8768575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 616,90RSYC,11-May-22
C1071013,10101004,73,PF-06863135,T,6518558181,6.51856E+11,20211112,10:43,CYCLE1_DAY15,0 H,638.8924505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 915,20RSYC,19-Apr-22
C1071013,10101004,73,PF-06863135,T,6517559659,6.51756E+11,20211119,10:00,CYCLE1_DAY22,0 H,320.7272139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 878,19RSYC,19-Apr-22
C1071013,10101004,73,PF-06863135,T,6518922660,6.51892E+11,20211126,10:16,CYCLE2_DAY1,0 H,468.7353689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 680,30RSYC,22-Apr-22
C1071013,10101004,73,PF-06863135,T,6517559680,6.51756E+11,20211030,12:07,CYCLE1_DAY1,24 H,234.9882162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 566,26RSYC,22-Apr-22
C1071013,10101004,73,PF-06863135,T,6518558186,6.51856E+11,20211101,10:45,CYCLE1_DAY4,0 H,900.0530034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 612,90RSYC,11-May-22
C1071013,10101004,73,PF-06863135,T,6518558188,6.51856E+11,20211102,14:20,CYCLE1_DAY4,24 H,175.9669209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 613,90RSYC,11-May-22
C1071013,10121002,74,PF-06863135,T,6517433305,6.51743E+11,20211101,8:20,CYCLE1_DAY1,0 H,909.8755504,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 520,25RSYC,22-Apr-22
C1071013,10121002,74,PF-06863135,T,6517433305,6.51743E+11,20211101,16:00,CYCLE1_DAY1,6 H,860.8428923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 519,25RSYC,22-Apr-22
C1071013,10121002,74,PF-06863135,T,6517433307,6.51743E+11,20211109,10:35,CYCLE1_DAY8,0 H,538.52183,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 844,35RSYC,25-Apr-22
C1071013,10121002,74,PF-06863135,T,6517433307,6.51743E+11,20211109,16:35,CYCLE1_DAY8,6 H,474.7122914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 843,35RSYC,25-Apr-22
C1071013,10121002,74,PF-06863135,T,6517433310,6.51743E+11,20211116,8:10,CYCLE1_DAY15,0 H,768.8329738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 845,35RSYC,25-Apr-22
C1071013,10121002,74,PF-06863135,T,6517433311,6.51743E+11,20211123,10:03,CYCLE1_DAY22,0 H,291.1419091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 966,65RSYC,3-May-22
C1071013,10121002,74,PF-06863135,T,6518019666,6.51802E+11,20211130,10:15,CYCLE2_DAY1,0 H,836.9084778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1088,67RSYC,8-May-22
C1071013,10121002,74,PF-06863135,T,6517433316,6.51743E+11,20211229,9:00,CYCLE3_DAY1,0 H,863.5521869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1628,85RSYC,10-May-22
C1071013,10121002,74,PF-06863135,T,6517433318,6.51743E+11,20220127,9:25,CYCLE4_DAY1,0 H,306.2953918,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1629,85RSYC,10-May-22
C1071013,10121002,74,PF-06863135,T,6518019671,6.51802E+11,20220420,11:20,CYCLE7_DAY1,0 H,99.09885816,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1933,123RSYC,29-Jul-22
C1071013,10121002,74,PF-06863135,T,6517433328,6.51743E+11,20220714,10:30,CYCLE10_DAY1,0 H,390.1974602,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2029,131RSYC,9-Nov-22
C1071013,10121002,74,PF-06863135,T,6520915406,6.52092E+11,20221007,10:15,CYCLE13_DAY1,0 H,764.1692364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2108,134RSYC,11-Nov-22
C1071013,10121002,74,PF-06863135,T,6520915405,6.52092E+11,20221229,9:25,CYCLE16_DAY1,0 H,949.7333196,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2170,140RSYC,22-Mar-23
C1071013,10121002,74,PF-06863135,T,6520915407,6.52092E+11,20230321,10:00,CYCLE19_DAY1,0 H,35.01138176,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2219,142RSYC,18-May-23
C1071013,10121002,74,PF-06863135,T,6523311141,6.52331E+11,20230615,9:45,CYCLE22_DAY1,0 H,189.6505464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2265,144RSYC,27-Nov-23
C1071013,10121002,74,PF-06863135,T,6523311142,6.52331E+11,20230907,10:20,CYCLE25_DAY1,0 H,427.5712383,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2301,147RSYC,29-Feb-24
C1071013,10121002,74,PF-06863135,T,6523737982,6.52374E+11,20231130,10:15,CYCLE28_DAY1,0 H,727.6940521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2327,148RSYC,27-Mar-24
C1071013,10121002,74,PF-06863135,T,6523737988,6.52374E+11,20231212,8:20,END_OF_TRT,,481.1364838,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2328,149RSYC,27-Mar-24
C1071013,10121002,74,PF-06863135,T,6517433321,6.51743E+11,20211102,10:30,CYCLE1_DAY1,24 H,910.8157569,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 525,107RSYC,24-May-22
C1071013,10121002,74,PF-06863135,T,6517433324,6.51743E+11,20211104,13:15,CYCLE1_DAY4,0 H,593.1864291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 528,25RSYC,22-Apr-22
C1071013,10121002,74,PF-06863135,T,6517433325,6.51743E+11,20211105,11:50,CYCLE1_DAY4,24 H,478.5733162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 529,25RSYC,22-Apr-22
C1071013,11021003,75,PF-06863135,T,6217023822,6.21702E+11,20211028,19:15,CYCLE1_DAY1,0 H,66.74375477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 499,24RSYC,20-Apr-22
C1071013,11021003,75,PF-06863135,T,6217023822,6.21702E+11,20211029,0:30,CYCLE1_DAY1,6 H,723.4504471,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 498,24RSYC,20-Apr-22
C1071013,11021003,75,PF-06863135,T,6217023825,6.21702E+11,20211109,20:30,CYCLE1_DAY8,0 H,592.3329748,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 503,24RSYC,20-Apr-22
C1071013,11021003,75,PF-06863135,T,6217023825,6.21702E+11,20211110,2:50,CYCLE1_DAY8,6 H,674.025169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 502,24RSYC,20-Apr-22
C1071013,11021003,75,PF-06863135,T,6217170434,6.21717E+11,20211116,14:00,CYCLE1_DAY15,0 H,307.7983011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 790,34RSYC,24-Apr-22
C1071013,11021003,75,PF-06863135,T,6217170449,6.21717E+11,20211123,12:30,CYCLE1_DAY22,0 H,798.7556343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 794,34RSYC,24-Apr-22
C1071013,11021003,75,PF-06863135,T,6217170457,6.21717E+11,20211130,10:30,CYCLE2_DAY1,0 H,842.53741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1507,56RSYC,30-Apr-22
C1071013,11021003,75,PF-06863135,T,6217023844,6.21702E+11,20211228,11:40,CYCLE3_DAY1,0 H,506.3856319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1835,93RSYC,12-May-22
C1071013,11021003,75,PF-06863135,T,6217417531,6.21742E+11,20220125,11:30,CYCLE4_DAY1,0 H,530.4972358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1836,93RSYC,12-May-22
C1071013,11021003,75,PF-06863135,T,6217170495,6.21717E+11,20220419,12:15,CYCLE7_DAY1,0 H,274.8190443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1915,123RSYC,29-Jul-22
C1071013,11021003,75,PF-06863135,T,6218223703,6.21822E+11,20220601,12:30,END_OF_TRT,,461.3646909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2019,115RSYC,25-Jul-22
C1071013,11021003,75,PF-06863135,T,6217023853,6.21702E+11,20211102,14:00,CYCLE1_DAY4,0 H,871.8342879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 506,24RSYC,20-Apr-22
C1071013,11021003,75,PF-06863135,T,6216756815,6.21676E+11,20211103,14:10,CYCLE1_DAY4,24 H,721.7655923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 462,23RSYC,20-Apr-22
C1071013,11021004,76,PF-06863135,T,6217023821,6.21702E+11,20211108,17:00,CYCLE1_DAY1,0 H,152.6998951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 497,24RSYC,20-Apr-22
C1071013,11021004,76,PF-06863135,T,6217023821,6.21702E+11,20211108,23:00,CYCLE1_DAY1,6 H,965.3264623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 496,24RSYC,20-Apr-22
C1071013,11021004,76,PF-06863135,T,6217184362,6.21718E+11,20211115,15:50,CYCLE1_DAY8,0 H,521.0467962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 802,34RSYC,24-Apr-22
C1071013,11021004,76,PF-06863135,T,6217184362,6.21718E+11,20211115,22:00,CYCLE1_DAY8,6 H,151.8089556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 801,34RSYC,24-Apr-22
C1071013,11021004,76,PF-06863135,T,6217170435,6.21717E+11,20211122,15:00,CYCLE1_DAY15,0 H,506.3229548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 791,34RSYC,24-Apr-22
C1071013,11021004,76,PF-06863135,T,6217170446,6.21717E+11,20211129,13:00,CYCLE1_DAY22,0 H,310.4109049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1501,55RSYC,30-Apr-22
C1071013,11021004,76,PF-06863135,T,6217170459,6.21717E+11,20211206,13:30,CYCLE2_DAY1,0 H,594.4928153,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1508,56RSYC,30-Apr-22
C1071013,11021004,76,PF-06863135,T,6217023846,6.21702E+11,20220103,14:30,CYCLE3_DAY1,0 H,227.3165392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1837,93RSYC,12-May-22
C1071013,11021004,76,PF-06863135,T,6217170486,6.21717E+11,20220131,16:25,CYCLE4_DAY1,0 H,143.1583964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1838,93RSYC,12-May-22
C1071013,11021004,76,PF-06863135,T,6217170501,6.21717E+11,20220425,14:58,CYCLE7_DAY1,0 H,885.0597331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1997,115RSYC,25-Jul-22
C1071013,11021004,76,PF-06863135,T,6218384029,6.21838E+11,20220719,14:50,CYCLE10_DAY1,0 H,24.92839666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2103,132RSYC,10-Nov-22
C1071013,11021004,76,PF-06863135,T,6218384031,6.21838E+11,20221010,14:40,CYCLE13_DAY1,0 H,112.3021193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2124,131RSYC,9-Nov-22
C1071013,11021004,76,PF-06863135,T,6217136150,6.21714E+11,20211109,17:00,CYCLE1_DAY1,24 H,177.7105372,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 510,24RSYC,20-Apr-22
C1071013,11021004,76,PF-06863135,T,6217023851,6.21702E+11,20211110,16:15,CYCLE1_DAY4,0 H,283.5368946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 759,33RSYC,24-Apr-22
C1071013,11021005,77,PF-06863135,T,6217023823,6.21702E+11,20211108,18:10,CYCLE1_DAY1,0 H,125.4381645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 501,24RSYC,20-Apr-22
C1071013,11021005,77,PF-06863135,T,6217023823,6.21702E+11,20211109,0:30,CYCLE1_DAY1,6 H,213.6870382,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 500,24RSYC,20-Apr-22
C1071013,11021005,77,PF-06863135,T,6217023826,6.21702E+11,20211115,16:50,CYCLE1_DAY8,0 H,681.0648082,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 752,32RSYC,23-Apr-22
C1071013,11021005,77,PF-06863135,T,6217170433,6.21717E+11,20211122,15:30,CYCLE1_DAY15,0 H,787.7249641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 789,34RSYC,24-Apr-22
C1071013,11021005,77,PF-06863135,T,6217170443,6.21717E+11,20211129,15:10,CYCLE1_DAY22,0 H,730.2899066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1500,55RSYC,30-Apr-22
C1071013,11021005,77,PF-06863135,T,6217170456,6.21717E+11,20211206,15:30,CYCLE2_DAY1,0 H,596.3707866,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1506,56RSYC,30-Apr-22
C1071013,11021005,77,PF-06863135,T,6217142696,6.21714E+11,20220103,14:10,END_OF_TRT,,782.4600966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1839,86RSYC,13-May-22
C1071013,11021005,77,PF-06863135,T,6217118743,6.21712E+11,20211109,18:25,CYCLE1_DAY1,24 H,231.6725581,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 508,24RSYC,20-Apr-22
C1071013,11021005,77,PF-06863135,T,6217023850,6.21702E+11,20211110,13:45,CYCLE1_DAY4,0 H,189.1114595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 758,33RSYC,24-Apr-22
C1071013,11021006,78,PF-06863135,T,6217023820,6.21702E+11,20211109,17:10,CYCLE1_DAY1,0 H,163.9747224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 495,24RSYC,20-Apr-22
C1071013,11021006,78,PF-06863135,T,6217023820,6.21702E+11,20211109,23:15,CYCLE1_DAY1,6 H,723.9356518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 494,24RSYC,20-Apr-22
C1071013,11021006,78,PF-06863135,T,6217023827,6.21702E+11,20211116,17:50,CYCLE1_DAY8,0 H,457.0639621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 754,32RSYC,23-Apr-22
C1071013,11021006,78,PF-06863135,T,6217023827,6.21702E+11,20211117,0:00,CYCLE1_DAY8,6 H,603.9090247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 753,32RSYC,23-Apr-22
C1071013,11021006,78,PF-06863135,T,6217170440,6.21717E+11,20211123,12:30,CYCLE1_DAY15,0 H,179.2210668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 793,34RSYC,24-Apr-22
C1071013,11021006,78,PF-06863135,T,6217170448,6.21717E+11,20211130,13:30,CYCLE1_DAY22,0 H,847.5440167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1502,55RSYC,30-Apr-22
C1071013,11021006,78,PF-06863135,T,6217170461,6.21717E+11,20211207,12:30,CYCLE2_DAY1,0 H,719.3797423,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1509,56RSYC,30-Apr-22
C1071013,11021006,78,PF-06863135,T,6217170478,6.21717E+11,20220104,9:50,CYCLE3_DAY1,0 H,644.3121166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1840,93RSYC,12-May-22
C1071013,11021006,78,PF-06863135,T,6217170492,6.21717E+11,20220201,10:55,CYCLE4_DAY1,0 H,687.2670638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1841,93RSYC,12-May-22
C1071013,11021006,78,PF-06863135,T,6217170502,6.21717E+11,20220426,10:50,CYCLE7_DAY1,0 H,340.7040243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1998,115RSYC,25-Jul-22
C1071013,11021006,78,PF-06863135,T,6217142672,6.21714E+11,20220719,14:55,CYCLE10_DAY1,0 H,383.3018734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2064,132RSYC,10-Nov-22
C1071013,11021006,78,PF-06863135,T,6218384030,6.21838E+11,20221011,10:45,CYCLE13_DAY1,0 H,54.10885614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2125,131RSYC,9-Nov-22
C1071013,11021006,78,PF-06863135,T,6217136153,6.21714E+11,20211110,17:15,CYCLE1_DAY1,24 H,196.6933541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 786,34RSYC,24-Apr-22
C1071013,11021006,78,PF-06863135,T,6217184363,6.21718E+11,20211112,17:50,CYCLE1_DAY4,0 H,906.5259111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 803,34RSYC,24-Apr-22
C1071013,11021006,78,PF-06863135,T,6217136154,6.21714E+11,20211113,18:15,CYCLE1_DAY4,24 H,299.7397137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 787,34RSYC,24-Apr-22
C1071013,11021007,79,PF-06863135,T,6217184361,6.21718E+11,20211115,13:30,CYCLE1_DAY1,0 H,222.2184464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 800,34RSYC,24-Apr-22
C1071013,11021007,79,PF-06863135,T,6217184361,6.21718E+11,20211115,20:10,CYCLE1_DAY1,6 H,296.3794093,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 799,34RSYC,24-Apr-22
C1071013,11021007,79,PF-06863135,T,6217233479,6.21723E+11,20211122,16:30,CYCLE1_DAY8,0 H,406.2236997,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 810,64RSYC,3-May-22
C1071013,11021007,79,PF-06863135,T,6217233479,6.21723E+11,20211122,23:00,CYCLE1_DAY8,6 H,301.173991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 809,34RSYC,24-Apr-22
C1071013,11021007,79,PF-06863135,T,6217170436,6.21717E+11,20211129,15:30,CYCLE1_DAY15,0 H,468.5512513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1496,55RSYC,30-Apr-22
C1071013,11021007,79,PF-06863135,T,6217170512,6.21717E+11,20211116,13:00,CYCLE1_DAY1,24 H,643.1891138,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1515,56RSYC,30-Apr-22
C1071013,11021007,79,PF-06863135,T,6217233481,6.21723E+11,20211118,15:00,CYCLE1_DAY4,0 H,643.7220914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1545,58RSYC,1-May-22
C1071013,11021007,79,PF-06863135,T,6217184366,6.21718E+11,20211119,15:30,CYCLE1_DAY4,24 H,81.62186414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1523,56RSYC,30-Apr-22
C1071013,10821007,80,PF-06863135,T,6603459531,6.60346E+11,20211101,12:55,CYCLE1_DAY1,0 H,780.6038405,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 619,63RSYC,2-May-22
C1071013,10821007,80,PF-06863135,T,6603459531,6.60346E+11,20211101,19:40,CYCLE1_DAY1,6 H,26.71036666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 620,90RSYC,11-May-22
C1071013,10821007,80,PF-06863135,T,6603491873,6.60349E+11,20211108,9:40,CYCLE1_DAY8,0 H,658.8266077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 625,64RSYC,3-May-22
C1071013,10821007,80,PF-06863135,T,6603491873,6.60349E+11,20211108,16:20,CYCLE1_DAY8,6 H,479.6405054,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 624,64RSYC,3-May-22
C1071013,10821007,80,PF-06863135,T,6603459535,6.60346E+11,20211115,11:20,CYCLE1_DAY15,0 H,425.2665465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 621,90RSYC,11-May-22
C1071013,10821007,80,PF-06863135,T,6603541506,6.60354E+11,20211122,12:10,END_OF_TRT,,428.9093054,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 818,107RSYC,24-May-22
C1071013,10821007,80,PF-06863135,T,6603505731,6.60351E+11,20211103,2:10,UNPL,9001 H,217.5278209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 627,107RSYC,24-May-22
C1071013,10821007,80,PF-06863135,T,6603491879,6.60349E+11,20211103,17:30,UNPL,9002 H,774.4044678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 626,107RSYC,24-May-22
C1071013,10821007,80,PF-06863135,T,6603505732,6.60351E+11,20211105,15:25,UNPL,9003 H,360.8698363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 628,107RSYC,24-May-22
C1071013,10821007,80,PF-06863135,T,6603459540,6.60346E+11,20211102,13:45,CYCLE1_DAY1,24 H,977.7746752,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 622,64RSYC,3-May-22
C1071013,10821007,80,PF-06863135,T,6603451262,6.60345E+11,20211104,15:20,CYCLE1_DAY4,0 H,973.1558719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 618,90RSYC,11-May-22
C1071013,10821007,80,PF-06863135,T,6603459546,6.60346E+11,20211105,16:50,CYCLE1_DAY4,24 H,112.2271629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 623,64RSYC,3-May-22
C1071013,11111003,81,PF-06863135,T,6801708299,6.80171E+11,20211101,10:30,CYCLE1_DAY1,0 H,930.6290343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 672,30RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801708299,6.80171E+11,20211101,20:38,CYCLE1_DAY1,6 H,171.7155737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 673,30RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650370,6.80165E+11,20211108,9:15,CYCLE1_DAY8,0 H,396.2922131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 663,29RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650370,6.80165E+11,20211108,18:30,CYCLE1_DAY8,6 H,942.3476919,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 662,29RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650372,6.80165E+11,20211115,10:00,CYCLE1_DAY15,0 H,69.92688478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 664,29RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650374,6.80165E+11,20211122,9:55,CYCLE1_DAY22,0 H,564.7616064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 830,35RSYC,25-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650376,6.80165E+11,20211129,10:25,CYCLE2_DAY1,0 H,345.7034049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 940,65RSYC,3-May-22
C1071013,11111003,81,PF-06863135,T,6801697214,6.8017E+11,20211227,11:30,CYCLE3_DAY1,0 H,929.4167933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 958,65RSYC,3-May-22
C1071013,11111003,81,PF-06863135,T,6801697215,6.8017E+11,20220124,10:55,CYCLE4_DAY1,0 H,173.7142533,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1596,96RSYC,12-May-22
C1071013,11111003,81,PF-06863135,T,6801828108,6.80183E+11,20220418,9:50,CYCLE7_DAY1,0 H,841.1352614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1919,123RSYC,29-Jul-22
C1071013,11111003,81,PF-06863135,T,6801891347,6.80189E+11,20220711,9:25,CYCLE10_DAY1,0 H,459.2952068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2025,132RSYC,10-Nov-22
C1071013,11111003,81,PF-06863135,T,6801944848,6.80194E+11,20221003,9:40,END_OF_TRT,,595.3136669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2119,131RSYC,9-Nov-22
C1071013,11111003,81,PF-06863135,T,6801650380,6.80165E+11,20211102,14:38,CYCLE1_DAY1,24 H,892.9728293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 665,29RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650382,6.80165E+11,20211104,9:05,CYCLE1_DAY4,0 H,180.7368983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 666,30RSYC,22-Apr-22
C1071013,11111003,81,PF-06863135,T,6801650384,6.80165E+11,20211105,12:40,CYCLE1_DAY4,24 H,384.5773134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 667,30RSYC,22-Apr-22
C1071013,10351002,82,PF-06863135,T,6216407869,6.21641E+11,20211101,11:38,CYCLE1_DAY1,0 H,560.505546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 426,76RSYC,4-May-22
C1071013,10351002,82,PF-06863135,T,6216407869,6.21641E+11,20211101,21:30,CYCLE1_DAY1,6 H,997.1494006,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 425,88RSYC,11-May-22
C1071013,10351002,82,PF-06863135,T,6216407872,6.21641E+11,20211111,8:32,CYCLE1_DAY8,0 H,323.4225194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 427,88RSYC,11-May-22
C1071013,10351002,82,PF-06863135,T,6216407873,6.21641E+11,20211118,8:50,CYCLE1_DAY15,0 H,736.6083307,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 706,31RSYC,23-Apr-22
C1071013,10351002,82,PF-06863135,T,6217091592,6.21709E+11,20211124,9:15,CYCLE1_DAY22,0 H,903.5680994,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 783,33RSYC,24-Apr-22
C1071013,10351002,82,PF-06863135,T,6216407877,6.21641E+11,20211201,9:25,CYCLE2_DAY1,0 H,93.76001271,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1297,49RSYC,29-Apr-22
C1071013,10351002,82,PF-06863135,T,6216407899,6.21641E+11,20211208,12:10,END_OF_TRT,,137.9744275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1298,108RSYC,24-May-22
C1071013,10351002,82,PF-06863135,T,6216407886,6.21641E+11,20211102,13:35,CYCLE1_DAY1,24 H,440.695394,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 430,88RSYC,11-May-22
C1071013,10351002,82,PF-06863135,T,6216407887,6.21641E+11,20211104,8:15,CYCLE1_DAY4,0 H,775.3069015,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 431,88RSYC,11-May-22
C1071013,10351002,82,PF-06863135,T,6216407889,6.21641E+11,20211105,9:45,CYCLE1_DAY4,24 H,811.9156692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 432,88RSYC,11-May-22
C1071013,10931001,83,PF-06863135,T,6517472607,6.51747E+11,20211101,15:37,CYCLE1_DAY1,0 H,715.063323,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 553,26RSYC,22-Apr-22
C1071013,10931001,83,PF-06863135,T,6517472607,6.51747E+11,20211101,22:45,CYCLE1_DAY1,6 H,882.8451678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 552,26RSYC,22-Apr-22
C1071013,10931001,83,PF-06863135,T,6517472609,6.51747E+11,20211108,14:35,CYCLE1_DAY8,0 H,958.5883796,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 857,36RSYC,25-Apr-22
C1071013,10931001,83,PF-06863135,T,6517472609,6.51747E+11,20211108,20:01,CYCLE1_DAY8,6 H,628.0641854,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 856,36RSYC,25-Apr-22
C1071013,10931001,83,PF-06863135,T,6517472610,6.51747E+11,20211115,9:23,CYCLE1_DAY15,0 H,101.4272466,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 858,36RSYC,25-Apr-22
C1071013,10931001,83,PF-06863135,T,6518778274,6.51878E+11,20211201,14:30,CYCLE2_DAY1,0 H,209.9213558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1147,107RSYC,24-May-22
C1071013,10931001,83,PF-06863135,T,6518934245,6.51893E+11,20220126,13:35,CYCLE4_DAY1,0 H,194.5978277,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1708,72RSYC,7-May-22
C1071013,10931001,83,PF-06863135,T,6517472623,6.51747E+11,20211102,16:45,CYCLE1_DAY1,24 H,425.0500852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 554,26RSYC,22-Apr-22
C1071013,10931001,83,PF-06863135,T,6517472625,6.51747E+11,20211104,11:50,CYCLE1_DAY4,0 H,930.656008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 555,26RSYC,22-Apr-22
C1071013,10931001,83,PF-06863135,T,6517472626,6.51747E+11,20211105,11:50,CYCLE1_DAY4,24 H,956.4405645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 861,36RSYC,25-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170879,6.21617E+11,20211102,10:00,CYCLE1_DAY1,0 H,518.5836784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 406,21RSYC,20-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170879,6.21617E+11,20211102,18:30,CYCLE1_DAY1,6 H,928.695002,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 405,21RSYC,20-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170881,6.21617E+11,20211108,9:00,CYCLE1_DAY8,0 H,581.6472129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 408,21RSYC,20-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170881,6.21617E+11,20211108,17:50,CYCLE1_DAY8,6 H,101.5445823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 407,21RSYC,20-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170883,6.21617E+11,20211115,9:21,CYCLE1_DAY15,0 H,812.4153573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 696,31RSYC,23-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170884,6.21617E+11,20211122,9:10,CYCLE1_DAY22,0 H,194.6877599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 697,31RSYC,23-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170887,6.21617E+11,20211129,9:40,CYCLE2_DAY1,0 H,269.6622883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1274,89RSYC,11-May-22
C1071013,10541002,84,PF-06863135,T,6216170889,6.21617E+11,20211227,9:20,END_OF_TRT,,983.1262551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1772,71RSYC,7-May-22
C1071013,10541002,84,PF-06863135,T,6216170894,6.21617E+11,20211103,12:30,CYCLE1_DAY1,24 H,381.4712219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 409,21RSYC,20-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170897,6.21617E+11,20211104,9:40,CYCLE1_DAY4,0 H,467.4397456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 410,21RSYC,20-Apr-22
C1071013,10541002,84,PF-06863135,T,6216170899,6.21617E+11,20211105,12:30,CYCLE1_DAY4,24 H,501.4007971,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 411,21RSYC,20-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650229,6.80165E+11,20211104,10:25,CYCLE1_DAY1,0 H,374.828707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 638,29RSYC,22-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650229,6.80165E+11,20211104,16:08,CYCLE1_DAY1,6 H,898.4121308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 639,29RSYC,22-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650231,6.80165E+11,20211111,10:12,CYCLE1_DAY8,0 H,724.0035948,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 643,29RSYC,22-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650231,6.80165E+11,20211111,15:50,CYCLE1_DAY8,6 H,55.64554832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 642,29RSYC,22-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650233,6.80165E+11,20211117,15:45,CYCLE1_DAY15,0 H,735.4620924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 826,35RSYC,25-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650235,6.80165E+11,20211124,13:25,CYCLE1_DAY22,0 H,526.9686896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 828,35RSYC,25-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650237,6.80165E+11,20211201,13:15,CYCLE2_DAY1,0 H,40.2499899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 956,65RSYC,3-May-22
C1071013,11101003,85,PF-06863135,T,6801747726,6.80175E+11,20211228,11:00,CYCLE3_DAY1,0 H,251.688593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 957,65RSYC,3-May-22
C1071013,11101003,85,PF-06863135,T,6801747727,6.80175E+11,20220126,11:36,CYCLE4_DAY1,0 H,616.3638623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1595,59RSYC,1-May-22
C1071013,11101003,85,PF-06863135,T,6801650250,6.80165E+11,20220401,11:35,END_OF_TRT,,38.7767902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1920,123RSYC,29-Jul-22
C1071013,11101003,85,PF-06863135,T,6801650241,6.80165E+11,20211105,10:05,CYCLE1_DAY1,24 H,210.2743821,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 644,29RSYC,22-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650243,6.80165E+11,20211108,15:18,CYCLE1_DAY4,0 H,271.4339769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 646,29RSYC,22-Apr-22
C1071013,11101003,85,PF-06863135,T,6801650245,6.80165E+11,20211109,14:10,CYCLE1_DAY4,24 H,952.9108211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 648,29RSYC,22-Apr-22
C1071013,11041003,86,PF-06863135,T,6216923989,6.21692E+11,20211104,12:30,CYCLE1_DAY1,0 H,390.1628729,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1758,91RSYC,11-May-22
C1071013,11041003,86,PF-06863135,T,6216923993,6.21692E+11,20211115,16:30,CYCLE1_DAY8,0 H,83.40339626,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 744,32RSYC,23-Apr-22
C1071013,11041003,86,PF-06863135,T,6216923993,6.21692E+11,20211115,23:35,CYCLE1_DAY8,6 H,64.04760319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 743,32RSYC,23-Apr-22
C1071013,11041003,86,PF-06863135,T,6216725279,6.21673E+11,20211123,8:50,CYCLE1_DAY15,0 H,540.6492072,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 725,31RSYC,23-Apr-22
C1071013,11041003,86,PF-06863135,T,6216725280,6.21673E+11,20211129,15:00,CYCLE1_DAY22,0 H,281.8428977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1376,84RSYC,10-May-22
C1071013,11041003,86,PF-06863135,T,6216924003,6.21692E+11,20211206,11:00,CYCLE2_DAY1,0 H,514.9067202,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1420,57RSYC,30-Apr-22
C1071013,11041003,86,PF-06863135,T,6216725285,6.21673E+11,20220104,12:15,CYCLE3_DAY1,0 H,140.6030916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1757,91RSYC,11-May-22
C1071013,11041003,86,PF-06863135,T,6216924045,6.21692E+11,20220111,11:47,END_OF_TRT,,666.8909223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1759,109RSYC,25-May-22
C1071013,11041003,86,PF-06863135,T,6216924028,6.21692E+11,20211105,18:20,CYCLE1_DAY1,24 H,711.1006037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 748,32RSYC,23-Apr-22
C1071013,11041003,86,PF-06863135,T,6216924032,6.21692E+11,20211108,12:00,CYCLE1_DAY4,0 H,990.5880806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 492,24RSYC,20-Apr-22
C1071013,11041003,86,PF-06863135,T,6216924034,6.21692E+11,20211109,16:15,CYCLE1_DAY4,24 H,163.2971637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 749,32RSYC,23-Apr-22
C1071013,10151003,87,PF-06863135,T,6518602938,6.5186E+11,20211110,13:50,CYCLE1_DAY1,0 H,620.7398452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 614,63RSYC,2-May-22
C1071013,10151003,87,PF-06863135,T,6518842175,6.51884E+11,20211118,9:20,CYCLE1_DAY8,0 H,257.271012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 938,65RSYC,3-May-22
C1071013,10151003,87,PF-06863135,T,6518842175,6.51884E+11,20211118,16:05,CYCLE1_DAY8,6 H,118.8857905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 937,64RSYC,3-May-22
C1071013,10151003,87,PF-06863135,T,6518842176,6.51884E+11,20211124,9:30,CYCLE1_DAY15,0 H,778.0124573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1164,104RSYC,22-May-22
C1071013,10151003,87,PF-06863135,T,6518602944,6.5186E+11,20211201,9:29,CYCLE1_DAY22,0 H,737.9515772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1114,67RSYC,8-May-22
C1071013,10151003,87,PF-06863135,T,6517560136,6.51756E+11,20220426,11:45,CYCLE7_DAY1,0 H,643.8665268,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1980,114RSYC,25-Jul-22
C1071013,10151003,87,PF-06863135,T,6521544923,6.52154E+11,20230321,11:08,CYCLE19_DAY1,0 H,572.2418521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2206,145RSYC,4-Jan-24
C1071013,10151003,87,PF-06863135,T,6521544920,6.52154E+11,20230615,11:05,CYCLE22_DAY1,0 H,944.6243914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2266,147RSYC,29-Feb-24
C1071013,10151003,87,PF-06863135,T,6518602952,6.5186E+11,20211111,15:00,CYCLE1_DAY1,24 H,274.3184946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 923,20RSYC,19-Apr-22
C1071013,10151003,87,PF-06863135,T,6518602955,6.5186E+11,20211112,13:00,CYCLE1_DAY4,0 H,580.1741522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 924,20RSYC,19-Apr-22
C1071013,11041004,88,PF-06863135,T,6216923987,6.21692E+11,20211105,15:00,CYCLE1_DAY1,0 H,240.6684015,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1413,96RSYC,12-May-22
C1071013,11041004,88,PF-06863135,T,6216923987,6.21692E+11,20211105,22:30,CYCLE1_DAY1,6 H,671.4788047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1412,108RSYC,24-May-22
C1071013,11041004,88,PF-06863135,T,6216725277,6.21673E+11,20211112,12:50,CYCLE1_DAY8,0 H,916.6295738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 724,31RSYC,23-Apr-22
C1071013,11041004,88,PF-06863135,T,6216725277,6.21673E+11,20211113,0:45,CYCLE1_DAY8,6 H,146.7762587,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 723,31RSYC,23-Apr-22
C1071013,11041004,88,PF-06863135,T,6216923997,6.21692E+11,20211118,15:20,CYCLE1_DAY15,0 H,998.8306907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 745,32RSYC,23-Apr-22
C1071013,11041004,88,PF-06863135,T,6216924048,6.21692E+11,20211124,19:30,END_OF_TRT,,67.95780952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1760,109RSYC,25-May-22
C1071013,11041004,88,PF-06863135,T,6216924027,6.21692E+11,20211106,16:30,CYCLE1_DAY1,24 H,427.3805664,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 489,24RSYC,20-Apr-22
C1071013,11041004,88,PF-06863135,T,6216924031,6.21692E+11,20211108,11:40,CYCLE1_DAY4,0 H,789.036063,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 491,24RSYC,20-Apr-22
C1071013,11041004,88,PF-06863135,T,6216924036,6.21692E+11,20211109,14:00,CYCLE1_DAY4,24 H,431.1841765,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 750,32RSYC,23-Apr-22
C1071013,10741001,89,PF-06863135,T,6518693890,6.51869E+11,20211109,13:26,CYCLE1_DAY1,0 H,825.7356716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 930,36RSYC,25-Apr-22
C1071013,10741001,89,PF-06863135,T,6518693890,6.51869E+11,20211109,20:05,CYCLE1_DAY1,6 H,379.8552597,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 929,36RSYC,25-Apr-22
C1071013,10741001,89,PF-06863135,T,6518693891,6.51869E+11,20211119,11:40,CYCLE1_DAY8,0 H,975.5782508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 932,36RSYC,25-Apr-22
C1071013,10741001,89,PF-06863135,T,6518693891,6.51869E+11,20211119,22:45,CYCLE1_DAY8,6 H,308.2964012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 931,36RSYC,25-Apr-22
C1071013,10741001,89,PF-06863135,T,6517472579,6.51747E+11,20211129,9:35,CYCLE1_DAY15,0 H,668.3773732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 997,39RSYC,26-Apr-22
C1071013,10741001,89,PF-06863135,T,6517472581,6.51747E+11,20211208,15:10,CYCLE1_DAY22,0 H,884.7904548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1968,122RSYC,29-Jul-22
C1071013,10741001,89,PF-06863135,T,6517472583,6.51747E+11,20211215,12:00,CYCLE2_DAY1,0 H,557.9229237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 998,39RSYC,26-Apr-22
C1071013,10741001,89,PF-06863135,T,6519029238,6.51903E+11,20220113,15:00,CYCLE3_DAY1,0 H,470.0585182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1654,100RSYC,23-May-22
C1071013,10741001,89,PF-06863135,T,6517472604,6.51747E+11,20220119,13:24,END_OF_TRT,,566.3560588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1653,100RSYC,23-May-22
C1071013,10741001,89,PF-06863135,T,6518693897,6.51869E+11,20211110,14:41,CYCLE1_DAY1,24 H,163.2992247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1131,94RSYC,12-May-22
C1071013,10741001,89,PF-06863135,T,6518693899,6.51869E+11,20211112,8:30,CYCLE1_DAY4,0 H,542.899788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 933,36RSYC,25-Apr-22
C1071013,10741001,89,PF-06863135,T,6518693902,6.51869E+11,20211113,10:30,CYCLE1_DAY4,24 H,486.8270449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 934,36RSYC,25-Apr-22
C1071013,10801001,90,PF-06863135,T,6517433488,6.51743E+11,20211108,10:59,CYCLE1_DAY1,0 H,66.87735637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 533,25RSYC,22-Apr-22
C1071013,10801001,90,PF-06863135,T,6517433488,6.51743E+11,20211108,16:47,CYCLE1_DAY1,6 H,816.464382,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 532,25RSYC,22-Apr-22
C1071013,10801001,90,PF-06863135,T,6517433490,6.51743E+11,20211115,9:58,CYCLE1_DAY8,0 H,761.890887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 973,66RSYC,3-May-22
C1071013,10801001,90,PF-06863135,T,6517433490,6.51743E+11,20211115,16:09,CYCLE1_DAY8,6 H,765.5075258,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 972,66RSYC,3-May-22
C1071013,10801001,90,PF-06863135,T,6518789963,6.51879E+11,20211122,13:36,CYCLE1_DAY15,0 H,853.6034321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 936,64RSYC,3-May-22
C1071013,10801001,90,PF-06863135,T,6517433494,6.51743E+11,20211129,13:16,CYCLE1_DAY22,0 H,281.0376526,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 975,66RSYC,3-May-22
C1071013,10801001,90,PF-06863135,T,6517433495,6.51743E+11,20211207,10:13,CYCLE2_DAY1,0 H,799.8776412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 976,66RSYC,3-May-22
C1071013,10801001,90,PF-06863135,T,6517433518,6.51743E+11,20220104,11:35,END_OF_TRT,,760.1799864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1649,100RSYC,23-May-22
C1071013,10801001,90,PF-06863135,T,6517433504,6.51743E+11,20211109,9:00,CYCLE1_DAY1,24 H,492.2392863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 534,107RSYC,24-May-22
C1071013,10801001,90,PF-06863135,T,6517433505,6.51743E+11,20211111,15:25,CYCLE1_DAY4,0 H,851.3963023,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 846,36RSYC,25-Apr-22
C1071013,10801001,90,PF-06863135,T,6517433508,6.51743E+11,20211112,14:25,CYCLE1_DAY4,24 H,724.232541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 847,36RSYC,25-Apr-22
C1071013,10021003,91,PF-06863135,T,6603529933,6.60353E+11,20211108,8:40,CYCLE1_DAY1,0 H,577.5491487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 815,34RSYC,24-Apr-22
C1071013,10021003,91,PF-06863135,T,6603529933,6.60353E+11,20211108,19:07,CYCLE1_DAY1,6 H,454.1274053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 816,35RSYC,25-Apr-22
C1071013,10021003,91,PF-06863135,T,6603529936,6.60353E+11,20211115,13:38,CYCLE1_DAY8,0 H,986.6411842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 817,35RSYC,25-Apr-22
C1071013,10021003,91,PF-06863135,T,6603551414,6.60355E+11,20211122,13:20,CYCLE1_DAY15,0 H,659.9273475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 819,35RSYC,25-Apr-22
C1071013,10021003,91,PF-06863135,T,6603529939,6.60353E+11,20211129,13:43,CYCLE1_DAY22,0 H,342.473897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 943,65RSYC,3-May-22
C1071013,10021003,91,PF-06863135,T,6603546714,6.60355E+11,20211206,10:55,CYCLE2_DAY1,0 H,145.9201659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 944,65RSYC,3-May-22
C1071013,10021003,91,PF-06863135,T,6603529945,6.60353E+11,20220105,14:15,CYCLE3_DAY1,0 H,37.80820903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1584,59RSYC,1-May-22
C1071013,10021003,91,PF-06863135,T,6603529948,6.60353E+11,20220201,14:17,CYCLE4_DAY1,0 H,422.8581089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1585,59RSYC,1-May-22
C1071013,10021003,91,PF-06863135,T,6603324925,6.60332E+11,20220426,14:09,CYCLE7_DAY1,0 H,145.5940753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2003,122RSYC,29-Jul-22
C1071013,10021003,91,PF-06863135,T,6603839289,6.60384E+11,20220719,13:56,CYCLE10_DAY1,0 H,880.378813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2067,129RSYC,21-Oct-22
C1071013,10021003,91,PF-06863135,T,6603578700,6.60358E+11,20221011,14:16,CYCLE13_DAY1,0 H,331.1116742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2116,131RSYC,9-Nov-22
C1071013,10021003,91,PF-06863135,T,6604204198,6.6042E+11,20230103,13:22,CYCLE16_DAY1,0 H,594.1984792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2186,141RSYC,17-May-23
C1071013,10021003,91,PF-06863135,T,6604204201,6.6042E+11,20230328,12:50,CYCLE19_DAY1,0 H,15.16262793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2235,142RSYC,18-May-23
C1071013,10021003,91,PF-06863135,T,6604204203,6.6042E+11,20230621,13:00,CYCLE22_DAY1,0 H,990.2028155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2255,143RSYC,27-Nov-23
C1071013,10021003,91,PF-06863135,T,6604608950,6.60461E+11,20230912,13:05,CYCLE25_DAY1,0 H,260.4516805,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,10021003,91,PF-06863135,T,6604608951,6.60461E+11,20231205,12:20,CYCLE28_DAY1,0 H,111.2594563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2342,148RSYC,27-Mar-24
C1071013,10021003,91,PF-06863135,T,6604777914,6.60478E+11,20240227,13:01,CYCLE31_DAY1,0 H,74.32868264,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,10021003,91,PF-06863135,T,6603563111,6.60356E+11,20211109,11:00,CYCLE1_DAY1,24 H,204.5022212,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 821,35RSYC,25-Apr-22
C1071013,10021003,91,PF-06863135,T,6603563112,6.60356E+11,20211111,10:10,CYCLE1_DAY4,0 H,962.2960999,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 822,35RSYC,25-Apr-22
C1071013,10021003,91,PF-06863135,T,6603563113,6.60356E+11,20211112,13:06,CYCLE1_DAY4,24 H,76.81348194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 823,35RSYC,25-Apr-22
C1071013,10561002,92,PF-06863135,T,6216408040,6.21641E+11,20211108,13:30,CYCLE1_DAY1,0 H,494.1750692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 712,31RSYC,23-Apr-22
C1071013,10561002,92,PF-06863135,T,6216408040,6.21641E+11,20211109,0:30,CYCLE1_DAY1,6 H,946.4360194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 711,31RSYC,23-Apr-22
C1071013,10561002,92,PF-06863135,T,6216898573,6.2169E+11,20211115,14:20,CYCLE1_DAY8,0 H,27.55325466,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 739,32RSYC,23-Apr-22
C1071013,10561002,92,PF-06863135,T,6216898575,6.2169E+11,20211122,9:45,CYCLE1_DAY15,0 H,310.1984069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 740,32RSYC,23-Apr-22
C1071013,10561002,92,PF-06863135,T,6216898580,6.2169E+11,20211206,10:45,CYCLE2_DAY1,0 H,861.1897591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1406,96RSYC,12-May-22
C1071013,10561002,92,PF-06863135,T,6217026166,6.21703E+11,20220104,11:00,CYCLE3_DAY1,0 H,824.9927188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1775,71RSYC,7-May-22
C1071013,10561002,92,PF-06863135,T,6216898588,6.2169E+11,20220201,10:00,CYCLE4_DAY1,0 H,614.777179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1774,71RSYC,7-May-22
C1071013,10561002,92,PF-06863135,T,6216898591,6.2169E+11,20220426,11:30,CYCLE7_DAY1,0 H,263.947496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1995,115RSYC,25-Jul-22
C1071013,10561002,92,PF-06863135,T,6216408062,6.21641E+11,20220719,10:35,CYCLE10_DAY1,0 H,239.9873692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2049,132RSYC,10-Nov-22
C1071013,10561002,92,PF-06863135,T,6218590819,6.21859E+11,20221013,15:30,CYCLE13_DAY1,0 H,928.6234605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2123,131RSYC,9-Nov-22
C1071013,10561002,92,PF-06863135,T,6219498865,6.2195E+11,20230103,8:40,CYCLE16_DAY1,0 H,744.5026931,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2179,140RSYC,22-Mar-23
C1071013,10561002,92,PF-06863135,T,6220036109,6.22004E+11,20230328,9:40,CYCLE19_DAY1,0 H,852.4661906,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2228,142RSYC,18-May-23
C1071013,10561002,92,PF-06863135,T,6220036106,6.22004E+11,20230620,10:00,CYCLE22_DAY1,0 H,447.6481022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2260,144RSYC,27-Nov-23
C1071013,10561002,92,PF-06863135,T,6220036105,6.22004E+11,20230911,10:55,CYCLE25_DAY1,0 H,7.499609944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2309,147RSYC,29-Feb-24
C1071013,10561002,92,PF-06863135,T,6221375068,6.22138E+11,20231207,10:30,CYCLE28_DAY1,0 H,68.73763762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2348,148RSYC,27-Mar-24
C1071013,10561002,92,PF-06863135,T,6221375069,6.22138E+11,20240229,10:15,CYCLE31_DAY1,0 H,576.6815441,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2370,152RSYC,9-Apr-24
C1071013,10561002,92,PF-06863135,T,6216898596,6.2169E+11,20211112,13:00,CYCLE1_DAY4,0 H,997.0601293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 741,32RSYC,23-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472606,6.51747E+11,20211108,14:15,CYCLE1_DAY1,0 H,189.1846068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 853,36RSYC,25-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472606,6.51747E+11,20211108,21:17,CYCLE1_DAY1,6 H,933.9540752,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 852,36RSYC,25-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472608,6.51747E+11,20211115,12:23,CYCLE1_DAY8,0 H,354.4501742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 855,36RSYC,25-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472608,6.51747E+11,20211115,19:15,CYCLE1_DAY8,6 H,902.197702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 854,36RSYC,25-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472611,6.51747E+11,20211122,16:00,CYCLE1_DAY15,0 H,761.8034796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 689,30RSYC,22-Apr-22
C1071013,10931002,93,PF-06863135,T,6518778272,6.51878E+11,20211129,16:39,CYCLE1_DAY22,0 H,978.8056167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1146,107RSYC,24-May-22
C1071013,10931002,93,PF-06863135,T,6518778276,6.51878E+11,20211207,10:31,CYCLE2_DAY1,0 H,475.1696645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1148,107RSYC,24-May-22
C1071013,10931002,93,PF-06863135,T,6518934242,6.51893E+11,20220103,16:45,CYCLE3_DAY1,0 H,841.8217125,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1709,72RSYC,7-May-22
C1071013,10931002,93,PF-06863135,T,6519290787,6.51929E+11,20220131,17:03,CYCLE4_DAY1,0 H,403.8105708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1710,72RSYC,7-May-22
C1071013,10931002,93,PF-06863135,T,6519290794,6.51929E+11,20220425,16:00,CYCLE7_DAY1,0 H,964.1225544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1989,114RSYC,25-Jul-22
C1071013,10931002,93,PF-06863135,T,6519290796,6.51929E+11,20220718,16:30,CYCLE10_DAY1,0 H,46.11797975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2089,129RSYC,21-Oct-22
C1071013,10931002,93,PF-06863135,T,6519290799,6.51929E+11,20221010,17:10,CYCLE13_DAY1,0 H,301.320654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2110,131RSYC,9-Nov-22
C1071013,10931002,93,PF-06863135,T,6521929818,6.52193E+11,20230103,17:56,CYCLE16_DAY1,0 H,866.7376016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2172,140RSYC,22-Mar-23
C1071013,10931002,93,PF-06863135,T,6522161150,6.52216E+11,20230327,15:06,CYCLE19_DAY1,0 H,701.8060134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2221,142RSYC,18-May-23
C1071013,10931002,93,PF-06863135,T,6521929816,6.52193E+11,20230619,14:23,CYCLE22_DAY1,0 H,34.07802277,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2267,144RSYC,27-Nov-23
C1071013,10931002,93,PF-06863135,T,6521929819,6.52193E+11,20230913,17:05,CYCLE25_DAY1,0 H,81.85472749,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2304,147RSYC,29-Feb-24
C1071013,10931002,93,PF-06863135,T,6524397935,6.5244E+11,20231204,15:21,CYCLE28_DAY1,0 H,473.979907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2329,148RSYC,27-Mar-24
C1071013,10931002,93,PF-06863135,T,6524397936,6.5244E+11,,,CYCLE31_DAY1,0 H,348.0393903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2373,152RSYC,9-Apr-24
C1071013,10931002,93,PF-06863135,T,6517472622,6.51747E+11,20211109,15:16,CYCLE1_DAY1,24 H,642.7775756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 859,36RSYC,25-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472624,6.51747E+11,20211111,10:45,CYCLE1_DAY4,0 H,284.9545029,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 860,36RSYC,25-Apr-22
C1071013,10931002,93,PF-06863135,T,6517472627,6.51747E+11,20211112,11:36,CYCLE1_DAY4,24 H,550.9504716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 862,36RSYC,25-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559758,6.51756E+11,20211109,12:40,CYCLE1_DAY1,0 H,81.85247031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 881,19RSYC,19-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559758,6.51756E+11,20211109,19:20,CYCLE1_DAY1,6 H,313.5778034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 880,19RSYC,19-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559761,6.51756E+11,20211116,8:15,CYCLE1_DAY8,0 H,736.098233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 882,19RSYC,19-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559763,6.51756E+11,20211123,9:30,CYCLE1_DAY15,0 H,266.4159531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1028,40RSYC,26-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559765,6.51756E+11,20211130,9:30,CYCLE1_DAY22,0 H,814.0128154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1029,40RSYC,26-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559767,6.51756E+11,20211207,9:30,CYCLE2_DAY1,0 H,325.4432541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1030,40RSYC,26-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559768,6.51756E+11,20220104,8:55,CYCLE3_DAY1,0 H,358.2107845,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1617,97RSYC,12-May-22
C1071013,10111002,94,PF-06863135,T,6517559770,6.51756E+11,20220201,10:30,CYCLE4_DAY1,0 H,816.9627982,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1618,85RSYC,10-May-22
C1071013,10111002,94,PF-06863135,T,6517559772,6.51756E+11,20220426,10:00,CYCLE7_DAY1,0 H,304.2090035,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1978,114RSYC,25-Jul-22
C1071013,10111002,94,PF-06863135,T,6517559775,6.51756E+11,20211110,13:15,CYCLE1_DAY1,24 H,368.8941717,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 883,19RSYC,19-Apr-22
C1071013,10111002,94,PF-06863135,T,6517559777,6.51756E+11,20211112,10:40,CYCLE1_DAY4,0 H,992.6841963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 884,19RSYC,19-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650230,6.80165E+11,20211110,10:10,CYCLE1_DAY1,0 H,146.567896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 640,29RSYC,22-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650230,6.80165E+11,20211110,16:15,CYCLE1_DAY1,6 H,653.2370644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 641,29RSYC,22-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650232,6.80165E+11,20211118,10:44,CYCLE1_DAY8,0 H,444.2095043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 825,35RSYC,25-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650232,6.80165E+11,20211118,16:54,CYCLE1_DAY8,6 H,983.7318192,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 824,35RSYC,25-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650234,6.80165E+11,20211124,11:21,CYCLE1_DAY15,0 H,427.4634879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 827,35RSYC,25-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650236,6.80165E+11,20211201,11:35,CYCLE1_DAY22,0 H,816.4899397,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 939,65RSYC,3-May-22
C1071013,11101002,95,PF-06863135,T,6801650238,6.80165E+11,20211208,11:20,CYCLE2_DAY1,0 H,135.2211235,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 955,65RSYC,3-May-22
C1071013,11101002,95,PF-06863135,T,6801741157,6.80174E+11,20220105,11:33,CYCLE3_DAY1,0 H,827.6376135,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1593,59RSYC,1-May-22
C1071013,11101002,95,PF-06863135,T,6801741158,6.80174E+11,20220202,12:08,CYCLE4_DAY1,0 H,781.1358215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1594,59RSYC,1-May-22
C1071013,11101002,95,PF-06863135,T,6801830279,6.80183E+11,20220427,12:35,CYCLE7_DAY1,0 H,443.2466915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1962,114RSYC,25-Jul-22
C1071013,11101002,95,PF-06863135,T,6801721367,6.80172E+11,20220720,12:32,CYCLE10_DAY1,0 H,745.2495384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2072,129RSYC,21-Oct-22
C1071013,11101002,95,PF-06863135,T,6802027132,6.80203E+11,20221012,10:43,CYCLE13_DAY1,0 H,962.9816388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2118,131RSYC,9-Nov-22
C1071013,11101002,95,PF-06863135,T,6802027133,6.80203E+11,20230104,11:25,CYCLE16_DAY1,0 H,263.4589175,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2189,141RSYC,17-May-23
C1071013,11101002,95,PF-06863135,T,6802065578,6.80207E+11,20230329,11:15,CYCLE19_DAY1,0 H,602.1548169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2237,145RSYC,4-Jan-24
C1071013,11101002,95,PF-06863135,T,6802065579,6.80207E+11,20230621,10:45,CYCLE22_DAY1,0 H,246.9543742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2274,147RSYC,29-Feb-24
C1071013,11101002,95,PF-06863135,T,6802302903,6.8023E+11,20230913,10:27,CYCLE25_DAY1,0 H,538.5948676,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2298,147RSYC,29-Feb-24
C1071013,11101002,95,PF-06863135,T,6802400458,6.8024E+11,20231206,10:40,CYCLE28_DAY1,0 H,274.1264311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2343,148RSYC,27-Mar-24
C1071013,11101002,95,PF-06863135,T,6802400459,6.8024E+11,20240228,10:38,CYCLE31_DAY1,0 H,128.3343186,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,11101002,95,PF-06863135,T,6801650242,6.80165E+11,20211111,9:15,CYCLE1_DAY1,24 H,121.5364786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 645,29RSYC,22-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650244,6.80165E+11,20211115,11:28,CYCLE1_DAY4,0 H,128.1853485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 647,29RSYC,22-Apr-22
C1071013,11101002,95,PF-06863135,T,6801650246,6.80165E+11,20211116,10:17,CYCLE1_DAY4,24 H,270.8322353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 649,29RSYC,22-Apr-22
C1071013,10461002,96,PF-06863135,T,6216756762,6.21676E+11,20211116,10:30,CYCLE1_DAY1,0 H,475.1897716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 729,32RSYC,23-Apr-22
C1071013,10461002,96,PF-06863135,T,6216756762,6.21676E+11,20211116,18:30,CYCLE1_DAY1,6 H,91.12018113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 728,32RSYC,23-Apr-22
C1071013,10461002,96,PF-06863135,T,6217039131,6.21704E+11,20211123,10:27,CYCLE1_DAY8,0 H,971.4112334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1436,57RSYC,30-Apr-22
C1071013,10461002,96,PF-06863135,T,6217039131,6.21704E+11,20211123,17:30,CYCLE1_DAY8,6 H,703.7640913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 772,33RSYC,24-Apr-22
C1071013,10461002,96,PF-06863135,T,6217233419,6.21723E+11,20211201,11:35,CYCLE1_DAY15,0 H,715.6618828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1538,58RSYC,1-May-22
C1071013,10461002,96,PF-06863135,T,6216756768,6.21676E+11,20211208,11:05,CYCLE1_DAY22,0 H,521.3559978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1381,84RSYC,10-May-22
C1071013,10461002,96,PF-06863135,T,6217142651,6.21714E+11,20220114,15:00,END_OF_TRT,,384.8641481,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1814,86RSYC,13-May-22
C1071013,10461002,96,PF-06863135,T,6218478267,6.21848E+11,20211222,11:00,UNPL,9001 H,375.7419404,NG/ML,,Received as 6217340169-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1815,92RSYC,12-May-22
C1071013,10461002,96,PF-06863135,T,6216756775,6.21676E+11,20211117,13:00,CYCLE1_DAY1,24 H,352.004941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 732,32RSYC,23-Apr-22
C1071013,10461002,96,PF-06863135,T,6216756777,6.21676E+11,20211118,10:25,CYCLE1_DAY4,0 H,288.9463208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 734,32RSYC,23-Apr-22
C1071013,10461002,96,PF-06863135,T,6216756778,6.21676E+11,20211119,12:15,CYCLE1_DAY4,24 H,275.8514522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 735,32RSYC,23-Apr-22
C1071013,10461003,97,PF-06863135,T,6217039129,6.21704E+11,20211123,10:37,CYCLE1_DAY1,0 H,307.2912109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 771,33RSYC,24-Apr-22
C1071013,10461003,97,PF-06863135,T,6217039129,6.21704E+11,20211123,17:30,CYCLE1_DAY1,6 H,967.9299706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 770,33RSYC,24-Apr-22
C1071013,10461003,97,PF-06863135,T,6217039133,6.21704E+11,20211202,11:30,CYCLE1_DAY8,0 H,55.91262528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1440,96RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6217039133,6.21704E+11,20211202,19:00,CYCLE1_DAY8,6 H,496.6206607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1439,96RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6217368116,6.21737E+11,20211210,10:45,CYCLE1_DAY15,0 H,894.0171101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1822,92RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6217368121,6.21737E+11,20211216,10:20,CYCLE1_DAY22,0 H,826.5129783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1823,92RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6216756770,6.21676E+11,20211222,10:10,CYCLE2_DAY1,0 H,961.0750751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1819,92RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6217233436,6.21723E+11,20220119,10:50,CYCLE3_DAY1,0 H,772.1608668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1820,92RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6217340180,6.21734E+11,20220216,9:30,CYCLE4_DAY1,0 H,743.5047123,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1821,92RSYC,12-May-22
C1071013,10461003,97,PF-06863135,T,6217647296,6.21765E+11,20220511,9:45,CYCLE7_DAY1,0 H,578.5755593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2062,132RSYC,10-Nov-22
C1071013,10461003,97,PF-06863135,T,6217647301,6.21765E+11,20220808,6:00,CYCLE10_DAY1,0 H,706.1766497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2063,132RSYC,10-Nov-22
C1071013,10461003,97,PF-06863135,T,6216756783,6.21676E+11,20220818,12:29,END_OF_TRT,,110.2862164,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2061,132RSYC,10-Nov-22
C1071013,10461003,97,PF-06863135,T,6216756782,6.21676E+11,20211208,9:30,UNPL,9001 H,793.1763305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1383,86RSYC,13-May-22
C1071013,10461003,97,PF-06863135,T,6217039135,6.21704E+11,20211124,12:00,CYCLE1_DAY1,24 H,276.2293925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 774,33RSYC,24-Apr-22
C1071013,10461003,97,PF-06863135,T,6217283551,6.21728E+11,20211129,10:29,CYCLE1_DAY4,0 H,81.9019849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1566,59RSYC,1-May-22
C1071013,10461003,97,PF-06863135,T,6217039142,6.21704E+11,20211130,12:10,CYCLE1_DAY4,24 H,280.7665586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1443,96RSYC,12-May-22
C1071013,10461004,98,PF-06863135,T,6217039128,6.21704E+11,20211118,10:15,CYCLE1_DAY1,0 H,890.9430283,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 769,33RSYC,24-Apr-22
C1071013,10461004,98,PF-06863135,T,6217039128,6.21704E+11,20211118,18:48,CYCLE1_DAY1,6 H,609.6759645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 768,33RSYC,24-Apr-22
C1071013,10461004,98,PF-06863135,T,6217233416,6.21723E+11,20211125,10:15,CYCLE1_DAY8,0 H,551.511373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 805,34RSYC,24-Apr-22
C1071013,10461004,98,PF-06863135,T,6217233416,6.21723E+11,20211125,17:56,CYCLE1_DAY8,6 H,469.994508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 804,34RSYC,24-Apr-22
C1071013,10461004,98,PF-06863135,T,6217233417,6.21723E+11,20211203,8:00,CYCLE1_DAY15,0 H,196.5236426,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1537,58RSYC,1-May-22
C1071013,10461004,98,PF-06863135,T,6217233423,6.21723E+11,20211209,10:50,CYCLE1_DAY22,0 H,974.8244817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1825,92RSYC,12-May-22
C1071013,10461004,98,PF-06863135,T,6217340170,6.21734E+11,20211216,10:20,CYCLE2_DAY1,0 H,743.2529451,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1826,92RSYC,12-May-22
C1071013,10461004,98,PF-06863135,T,6217142650,6.21714E+11,20220114,10:50,END_OF_TRT,,859.8726665,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1824,86RSYC,13-May-22
C1071013,10461004,98,PF-06863135,T,6217039134,6.21704E+11,20211119,12:05,CYCLE1_DAY1,24 H,130.548687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 773,33RSYC,24-Apr-22
C1071013,10461004,98,PF-06863135,T,6217039139,6.21704E+11,20211122,10:30,CYCLE1_DAY4,0 H,978.3667139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 776,33RSYC,24-Apr-22
C1071013,10461004,98,PF-06863135,T,6217039140,6.21704E+11,20211123,11:40,CYCLE1_DAY4,24 H,373.9652456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 777,33RSYC,24-Apr-22
C1071013,10461005,99,PF-06863135,T,6217233415,6.21723E+11,20211125,11:08,CYCLE1_DAY1,0 H,712.8564672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1536,58RSYC,1-May-22
C1071013,10461005,99,PF-06863135,T,6217233415,6.21723E+11,20211125,18:03,CYCLE1_DAY1,6 H,909.7618113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1535,56RSYC,30-Apr-22
C1071013,10461005,99,PF-06863135,T,6216756765,6.21676E+11,20211202,12:00,CYCLE1_DAY8,0 H,871.573368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1379,84RSYC,10-May-22
C1071013,10461005,99,PF-06863135,T,6216756765,6.21676E+11,20211202,18:55,CYCLE1_DAY8,6 H,399.8940787,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1378,84RSYC,10-May-22
C1071013,10461005,99,PF-06863135,T,6217368120,6.21737E+11,20211214,6:00,CYCLE1_DAY22,0 H,843.8408119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1818,92RSYC,12-May-22
C1071013,10461005,99,PF-06863135,T,6217233426,6.21723E+11,20211221,9:40,CYCLE2_DAY1,0 H,658.2189904,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1816,92RSYC,12-May-22
C1071013,10461005,99,PF-06863135,T,6217283548,6.21728E+11,20220118,9:50,CYCLE3_DAY1,0 H,64.58950148,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1817,92RSYC,12-May-22
C1071013,10461005,99,PF-06863135,T,6217647291,6.21765E+11,20220510,11:20,CYCLE7_DAY1,0 H,502.483429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2000,115RSYC,25-Jul-22
C1071013,10461005,99,PF-06863135,T,6217647299,6.21765E+11,20220802,14:30,CYCLE10_DAY1,0 H,857.7998668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2059,132RSYC,10-Nov-22
C1071013,10461005,99,PF-06863135,T,6218022369,6.21802E+11,20220901,12:30,END_OF_TRT,,757.5994839,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2060,132RSYC,10-Nov-22
C1071013,10461005,99,PF-06863135,T,6217039136,6.21704E+11,20211126,10:55,CYCLE1_DAY1,24 H,775.2433071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1441,96RSYC,12-May-22
C1071013,10461005,99,PF-06863135,T,6217233439,6.21723E+11,20211129,10:15,CYCLE1_DAY4,0 H,867.3351178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 806,34RSYC,24-Apr-22
C1071013,10461005,99,PF-06863135,T,6217233440,6.21723E+11,20211130,11:50,CYCLE1_DAY4,24 H,375.017427,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1540,58RSYC,1-May-22
C1071013,10321002,100,PF-06863135,T,6517509071,6.51751E+11,20211110,11:50,CYCLE1_DAY1,0 H,994.9131747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 866,36RSYC,25-Apr-22
C1071013,10321002,100,PF-06863135,T,6517509071,6.51751E+11,20211110,19:30,CYCLE1_DAY1,6 H,868.4104911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 865,36RSYC,25-Apr-22
C1071013,10321002,100,PF-06863135,T,6517509072,6.51751E+11,20211117,8:56,CYCLE1_DAY8,0 H,228.9159286,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 868,19RSYC,19-Apr-22
C1071013,10321002,100,PF-06863135,T,6517509072,6.51751E+11,20211117,17:10,CYCLE1_DAY8,6 H,502.4937117,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 867,36RSYC,25-Apr-22
C1071013,10321002,100,PF-06863135,T,6517559955,6.51756E+11,20211124,15:38,CYCLE1_DAY15,0 H,44.98567473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1040,40RSYC,26-Apr-22
C1071013,10321002,100,PF-06863135,T,6517559957,6.51756E+11,20211202,15:31,CYCLE1_DAY22,0 H,945.4643696,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1042,40RSYC,26-Apr-22
C1071013,10321002,100,PF-06863135,T,6517559960,6.51756E+11,20211209,15:36,CYCLE2_DAY1,0 H,810.1659568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1043,40RSYC,26-Apr-22
C1071013,10321002,100,PF-06863135,T,6517559961,6.51756E+11,20220106,14:47,CYCLE3_DAY1,0 H,43.01186154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1631,85RSYC,10-May-22
C1071013,10321002,100,PF-06863135,T,6517559982,6.51756E+11,20220113,12:21,END_OF_TRT,,511.8987397,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1632,100RSYC,23-May-22
C1071013,10321002,100,PF-06863135,T,6517509083,6.51751E+11,20211111,14:21,CYCLE1_DAY1,24 H,17.97337844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 870,19RSYC,19-Apr-22
C1071013,10321002,100,PF-06863135,T,6517559969,6.51756E+11,20211113,9:13,CYCLE1_DAY4,0 H,31.91347763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 885,19RSYC,19-Apr-22
C1071013,10321002,100,PF-06863135,T,6517509087,6.51751E+11,20211114,9:59,CYCLE1_DAY4,24 H,523.8082293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 871,19RSYC,19-Apr-22
C1071013,11061001,101,PF-06863135,T,6216408243,6.21641E+11,20211110,12:30,CYCLE1_DAY1,0 H,799.183228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1328,50RSYC,29-Apr-22
C1071013,11061001,101,PF-06863135,T,6216408243,6.21641E+11,20211110,20:05,CYCLE1_DAY1,6 H,392.962839,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1327,50RSYC,29-Apr-22
C1071013,11061001,101,PF-06863135,T,6216408246,6.21641E+11,20211115,14:01,CYCLE1_DAY8,0 H,918.9544653,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1330,50RSYC,29-Apr-22
C1071013,11061001,101,PF-06863135,T,6216408246,6.21641E+11,20211115,21:30,CYCLE1_DAY8,6 H,125.1360893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1329,50RSYC,29-Apr-22
C1071013,11061001,101,PF-06863135,T,6217165073,6.21717E+11,20211123,9:00,CYCLE1_DAY15,0 H,480.0278188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1489,55RSYC,30-Apr-22
C1071013,11061001,101,PF-06863135,T,6217193496,6.21719E+11,20211130,10:00,CYCLE1_DAY22,0 H,828.5231981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1526,56RSYC,30-Apr-22
C1071013,11061001,101,PF-06863135,T,6217193503,6.21719E+11,20211207,9:00,CYCLE2_DAY1,0 H,121.5898554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1528,56RSYC,30-Apr-22
C1071013,11061001,101,PF-06863135,T,6216408260,6.21641E+11,20211111,14:05,CYCLE1_DAY1,24 H,729.8484109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1331,50RSYC,29-Apr-22
C1071013,11061001,101,PF-06863135,T,6216408261,6.21641E+11,20211112,11:00,CYCLE1_DAY4,0 H,61.0848273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1332,50RSYC,29-Apr-22
C1071013,11021010,102,PF-06863135,T,6217023819,6.21702E+11,20211110,13:30,CYCLE1_DAY1,0 H,719.8341606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 751,32RSYC,23-Apr-22
C1071013,11021010,102,PF-06863135,T,6217023828,6.21702E+11,20211116,14:00,CYCLE1_DAY8,0 H,480.1797089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 756,33RSYC,24-Apr-22
C1071013,11021010,102,PF-06863135,T,6217023828,6.21702E+11,20211116,20:05,CYCLE1_DAY8,6 H,168.581155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 755,32RSYC,23-Apr-22
C1071013,11021010,102,PF-06863135,T,6217170439,6.21717E+11,20211124,13:30,CYCLE1_DAY15,0 H,371.9863728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 792,34RSYC,24-Apr-22
C1071013,11021010,102,PF-06863135,T,6217170450,6.21717E+11,20211202,17:30,CYCLE1_DAY22,0 H,481.8668896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1503,55RSYC,30-Apr-22
C1071013,11021010,102,PF-06863135,T,6217142693,6.21714E+11,20211208,10:00,END_OF_TRT,,621.5207418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1468,109RSYC,25-May-22
C1071013,11021010,102,PF-06863135,T,6217023849,6.21702E+11,20211112,14:50,CYCLE1_DAY4,0 H,782.0674194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1428,57RSYC,30-Apr-22
C1071013,11021010,102,PF-06863135,T,6217136155,6.21714E+11,20211113,15:00,CYCLE1_DAY4,24 H,547.1059051,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 788,34RSYC,24-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408006,6.21641E+11,20211129,13:50,CYCLE1_DAY1,0 H,713.4168888,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1308,76RSYC,4-May-22
C1071013,10511001,103,PF-06863135,T,6216408006,6.21641E+11,20211129,19:00,CYCLE1_DAY1,6 H,729.5901949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1307,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408008,6.21641E+11,20211206,12:43,CYCLE1_DAY8,0 H,253.6866393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1310,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408008,6.21641E+11,20211206,19:40,CYCLE1_DAY8,6 H,277.7401681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1309,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408010,6.21641E+11,20211213,18:15,CYCLE1_DAY15,0 H,615.2753027,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1311,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408029,6.21641E+11,20211201,12:44,UNPL,9001 H,258.1501517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1315,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408021,6.21641E+11,20211130,14:20,CYCLE1_DAY1,24 H,980.367852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1312,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408023,6.21641E+11,20211202,13:30,CYCLE1_DAY4,0 H,391.8858582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1313,49RSYC,29-Apr-22
C1071013,10511001,103,PF-06863135,T,6216408026,6.21641E+11,20211203,14:25,CYCLE1_DAY4,24 H,564.233846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1314,49RSYC,29-Apr-22
C1071013,10031012,104,PF-06863135,T,6517751562,6.51775E+11,20211115,9:26,CYCLE1_DAY1,0 H,463.924195,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 900,20RSYC,19-Apr-22
C1071013,10031012,104,PF-06863135,T,6517751562,6.51775E+11,20211115,18:01,CYCLE1_DAY1,6 H,381.1105997,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 899,20RSYC,19-Apr-22
C1071013,10031012,104,PF-06863135,T,6518620843,6.51862E+11,20211130,14:20,CYCLE1_DAY15,0 H,152.8293064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1119,94RSYC,12-May-22
C1071013,10031012,104,PF-06863135,T,6516580433,6.51658E+11,20220114,15:25,END_OF_TRT,,935.3832139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1934,123RSYC,29-Jul-22
C1071013,10031012,104,PF-06863135,T,6518620862,6.51862E+11,20211116,10:35,CYCLE1_DAY1,24 H,407.9966455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1122,94RSYC,12-May-22
C1071013,10031012,104,PF-06863135,T,6518620866,6.51862E+11,20211117,11:48,CYCLE1_DAY4,0 H,187.5271316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 928,36RSYC,25-Apr-22
C1071013,10031012,104,PF-06863135,T,6518620869,6.51862E+11,20211118,12:52,CYCLE1_DAY4,24 H,769.2101081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1125,94RSYC,12-May-22
C1071013,11041005,105,PF-06863135,T,6216725275,6.21673E+11,20211115,14:00,CYCLE1_DAY1,0 H,244.8129702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 720,31RSYC,23-Apr-22
C1071013,11041005,105,PF-06863135,T,6216725275,6.21673E+11,20211115,23:50,CYCLE1_DAY1,6 H,942.4866061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 719,31RSYC,23-Apr-22
C1071013,11041005,105,PF-06863135,T,6216725276,6.21673E+11,20211122,10:00,CYCLE1_DAY8,0 H,918.6669408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 722,31RSYC,23-Apr-22
C1071013,11041005,105,PF-06863135,T,6216725276,6.21673E+11,20211122,19:00,CYCLE1_DAY8,6 H,24.27173508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 721,31RSYC,23-Apr-22
C1071013,11041005,105,PF-06863135,T,6217133150,6.21713E+11,20211129,8:50,CYCLE1_DAY15,0 H,827.0726834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1459,54RSYC,30-Apr-22
C1071013,11041005,105,PF-06863135,T,6216923999,6.21692E+11,20211206,8:30,CYCLE1_DAY22,0 H,291.6332848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1419,57RSYC,30-Apr-22
C1071013,11041005,105,PF-06863135,T,6216924004,6.21692E+11,20211213,10:40,CYCLE2_DAY1,0 H,673.7225837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1421,57RSYC,30-Apr-22
C1071013,11041005,105,PF-06863135,T,6217133164,6.21713E+11,20220110,10:40,CYCLE3_DAY1,0 H,177.102111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1761,91RSYC,11-May-22
C1071013,11041005,105,PF-06863135,T,6216924044,6.21692E+11,20220207,10:50,END_OF_TRT,,382.5115012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1877,86RSYC,13-May-22
C1071013,11041005,105,PF-06863135,T,6216924026,6.21692E+11,20211116,17:50,CYCLE1_DAY1,24 H,783.6912927,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 747,32RSYC,23-Apr-22
C1071013,11041005,105,PF-06863135,T,6216725292,6.21673E+11,20211117,18:30,CYCLE1_DAY4,0 H,392.5171913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 726,32RSYC,23-Apr-22
C1071013,11041005,105,PF-06863135,T,6216725295,6.21673E+11,20211118,18:35,CYCLE1_DAY4,24 H,313.0405933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 727,32RSYC,23-Apr-22
C1071013,11061002,106,PF-06863135,T,6217165069,6.21717E+11,20211122,10:00,CYCLE1_DAY8,0 H,322.7175832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1485,55RSYC,30-Apr-22
C1071013,11061002,106,PF-06863135,T,6217165077,6.21717E+11,20211201,10:00,CYCLE1_DAY15,0 H,836.7312289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1492,55RSYC,30-Apr-22
C1071013,11061002,106,PF-06863135,T,6217193495,6.21719E+11,20211207,9:00,CYCLE1_DAY22,0 H,10.87394965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1525,56RSYC,30-Apr-22
C1071013,11061002,106,PF-06863135,T,6217165080,6.21717E+11,20211214,9:00,CYCLE2_DAY1,0 H,924.2834669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1493,55RSYC,30-Apr-22
C1071013,11061002,106,PF-06863135,T,6217193513,6.21719E+11,20220118,10:00,CYCLE3_DAY1,0 H,184.844715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1802,91RSYC,11-May-22
C1071013,11061002,106,PF-06863135,T,6217193522,6.21719E+11,20220215,9:00,CYCLE4_DAY1,0 H,648.2978573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1803,92RSYC,12-May-22
C1071013,11061002,106,PF-06863135,T,6217193530,6.21719E+11,20220503,10:00,CYCLE7_DAY1,0 H,878.5260567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1999,115RSYC,25-Jul-22
C1071013,11061002,106,PF-06863135,T,6217193529,6.21719E+11,20220802,9:00,CYCLE10_DAY1,0 H,884.8805367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2057,132RSYC,10-Nov-22
C1071013,11061002,106,PF-06863135,T,6219811032,6.21981E+11,20230117,9:00,CYCLE16_DAY1,0 H,496.6489657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2184,141RSYC,17-May-23
C1071013,11061002,106,PF-06863135,T,6219811031,6.21981E+11,20230418,9:00,CYCLE19_DAY1,0 H,405.1302699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2239,143RSYC,27-Nov-23
C1071013,11061002,106,PF-06863135,T,6219804830,6.2198E+11,20231031,9:00,CYCLE25_DAY1,0 H,959.2517108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2349,149RSYC,27-Mar-24
C1071013,11061002,106,PF-06863135,T,6219804831,6.2198E+11,,,END_OF_TRT,,86.07163715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2350,149RSYC,27-Mar-24
C1071013,11061002,106,PF-06863135,T,6217165092,6.21717E+11,20211118,14:00,CYCLE1_DAY4,0 H,204.3806222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1801,91RSYC,11-May-22
C1071013,11061002,106,PF-06863135,T,6217193544,6.21719E+11,20211119,10:00,CYCLE1_DAY4,24 H,121.8506544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1531,56RSYC,30-Apr-22
C1071013,10921002,107,PF-06863135,T,6217039323,6.21704E+11,20211115,11:36,CYCLE1_DAY1,0 H,738.5155813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 779,33RSYC,24-Apr-22
C1071013,10921002,107,PF-06863135,T,6217039323,6.21704E+11,20211115,19:46,CYCLE1_DAY1,6 H,229.0657548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 778,33RSYC,24-Apr-22
C1071013,10921002,107,PF-06863135,T,6216725230,6.21673E+11,20211122,10:56,CYCLE1_DAY8,0 H,576.9876503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 717,31RSYC,23-Apr-22
C1071013,10921002,107,PF-06863135,T,6216725230,6.21673E+11,20211122,19:00,CYCLE1_DAY8,6 H,28.96887816,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 716,31RSYC,23-Apr-22
C1071013,10921002,107,PF-06863135,T,6216725232,6.21673E+11,20211129,13:44,CYCLE1_DAY15,0 H,134.1302251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 718,31RSYC,23-Apr-22
C1071013,10921002,107,PF-06863135,T,6216725234,6.21673E+11,20211206,11:45,CYCLE1_DAY22,0 H,960.5583873,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1370,84RSYC,10-May-22
C1071013,10921002,107,PF-06863135,T,6217039356,6.21704E+11,20211116,11:50,CYCLE1_DAY1,24 H,852.3751716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 780,33RSYC,24-Apr-22
C1071013,10921002,107,PF-06863135,T,6217039362,6.21704E+11,20211118,14:02,CYCLE1_DAY4,0 H,868.551318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 781,33RSYC,24-Apr-22
C1071013,10921002,107,PF-06863135,T,6217039366,6.21704E+11,20211119,16:00,CYCLE1_DAY4,24 H,385.6720981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 782,33RSYC,24-Apr-22
C1071013,10081001,108,PF-06863135,T,6518075544,6.51808E+11,20211115,10:36,CYCLE1_DAY1,0 H,344.0256241,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 675,30RSYC,22-Apr-22
C1071013,10081001,108,PF-06863135,T,6518075544,6.51808E+11,20211115,23:03,CYCLE1_DAY1,6 H,260.4922263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 674,30RSYC,22-Apr-22
C1071013,10081001,108,PF-06863135,T,6518075565,6.51808E+11,20211124,12:35,END_OF_TRT,,82.22711083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1089,87RSYC,13-May-22
C1071013,10081001,108,PF-06863135,T,6518075557,6.51808E+11,20211116,17:03,CYCLE1_DAY1,24 H,474.9393638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 676,30RSYC,22-Apr-22
C1071013,10561006,109,PF-06863135,T,6217026118,6.21703E+11,20211115,14:45,CYCLE1_DAY1,0 H,972.5179203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 763,33RSYC,24-Apr-22
C1071013,10561006,109,PF-06863135,T,6217026118,6.21703E+11,20211115,22:30,CYCLE1_DAY1,6 H,77.93289813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 762,33RSYC,24-Apr-22
C1071013,10561006,109,PF-06863135,T,6217026120,6.21703E+11,20211123,10:30,CYCLE1_DAY8,0 H,160.0354684,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 765,33RSYC,24-Apr-22
C1071013,10561006,109,PF-06863135,T,6217026120,6.21703E+11,20211123,18:10,CYCLE1_DAY8,6 H,937.5657049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 764,33RSYC,24-Apr-22
C1071013,10561006,109,PF-06863135,T,6216408045,6.21641E+11,20211206,13:30,CYCLE1_DAY22,0 H,743.0842121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1318,49RSYC,29-Apr-22
C1071013,10561006,109,PF-06863135,T,6216898581,6.2169E+11,20211220,10:30,CYCLE2_DAY1,0 H,877.4140123,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1407,96RSYC,12-May-22
C1071013,10561006,109,PF-06863135,T,6216408049,6.21641E+11,20220110,10:50,CYCLE3_DAY1,0 H,280.6935431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1778,71RSYC,7-May-22
C1071013,10561006,109,PF-06863135,T,6216408051,6.21641E+11,20220208,11:20,CYCLE4_DAY1,0 H,604.5155349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1779,71RSYC,7-May-22
C1071013,10561006,109,PF-06863135,T,6216898592,6.2169E+11,20220502,10:45,CYCLE7_DAY1,0 H,949.1211301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1996,115RSYC,25-Jul-22
C1071013,10561006,109,PF-06863135,T,6218590823,6.21859E+11,20220727,11:15,CYCLE10_DAY1,0 H,218.3889525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2051,132RSYC,10-Nov-22
C1071013,10561006,109,PF-06863135,T,6219498869,6.2195E+11,20230109,9:45,CYCLE16_DAY1,0 H,214.309668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2181,141RSYC,17-May-23
C1071013,10561006,109,PF-06863135,T,6220036104,6.22004E+11,20230403,13:20,CYCLE19_DAY1,0 H,373.7065755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2230,142RSYC,18-May-23
C1071013,10561006,109,PF-06863135,T,6220036099,6.22004E+11,20230627,11:30,CYCLE22_DAY1,0 H,910.0856261,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2277,144RSYC,27-Nov-23
C1071013,10561006,109,PF-06863135,T,6220036107,6.22004E+11,20230919,10:36,CYCLE25_DAY1,0 H,437.4757654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2310,147RSYC,29-Feb-24
C1071013,10561006,109,PF-06863135,T,6221375071,6.22138E+11,20240305,9:40,CYCLE31_DAY1,0 H,92.35821163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2371,153RSYC,10-Apr-24
C1071013,10561006,109,PF-06863135,T,6216408057,6.21641E+11,20211119,11:05,CYCLE1_DAY4,0 H,243.616147,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 715,31RSYC,23-Apr-22
C1071013,10561006,109,PF-06863135,T,6216898600,6.2169E+11,20211120,12:00,CYCLE1_DAY4,24 H,401.8121124,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 742,32RSYC,23-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697441,6.5177E+11,20211115,10:06,CYCLE1_DAY1,0 H,747.0110584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 894,19RSYC,19-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697441,6.5177E+11,20211115,16:58,CYCLE1_DAY1,6 H,845.5474308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 893,19RSYC,19-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697443,6.5177E+11,20211122,8:35,CYCLE1_DAY8,0 H,422.8308568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 677,30RSYC,22-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697443,6.5177E+11,20211122,15:07,CYCLE1_DAY8,6 H,514.3423231,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 895,19RSYC,19-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697446,6.5177E+11,20211129,8:44,CYCLE1_DAY15,0 H,672.0318742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1057,41RSYC,26-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697447,6.5177E+11,20211206,8:27,CYCLE1_DAY22,0 H,216.9355771,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1058,41RSYC,26-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697449,6.5177E+11,20211213,8:48,CYCLE2_DAY1,0 H,58.78688782,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1060,41RSYC,26-Apr-22
C1071013,10161001,110,PF-06863135,T,6519057405,6.51906E+11,20220110,8:26,CYCLE3_DAY1,0 H,778.9449747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1602,97RSYC,12-May-22
C1071013,10161001,110,PF-06863135,T,6517697453,6.5177E+11,20220207,9:02,CYCLE4_DAY1,0 H,147.3209516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1601,97RSYC,12-May-22
C1071013,10161001,110,PF-06863135,T,6520019566,6.52002E+11,20220308,8:51,END_OF_TRT,,92.1819596,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1886,86RSYC,13-May-22
C1071013,10161001,110,PF-06863135,T,6517697458,6.5177E+11,20211116,10:00,CYCLE1_DAY1,24 H,92.20942967,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 896,19RSYC,19-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697460,6.5177E+11,20211118,9:59,CYCLE1_DAY4,0 H,820.7252976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 897,19RSYC,19-Apr-22
C1071013,10161001,110,PF-06863135,T,6517697461,6.5177E+11,20211119,11:09,CYCLE1_DAY4,24 H,612.702999,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 898,20RSYC,19-Apr-22
C1071013,11171007,111,PF-06863135,T,6518011605,6.51801E+11,20211115,10:00,CYCLE1_DAY1,0 H,648.7165709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 913,20RSYC,19-Apr-22
C1071013,11171007,111,PF-06863135,T,6518011605,6.51801E+11,20211115,17:15,CYCLE1_DAY1,6 H,216.5715463,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 912,63RSYC,2-May-22
C1071013,11171007,111,PF-06863135,T,6517764049,6.51776E+11,20211122,10:59,CYCLE1_DAY8,0 H,730.0501416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 693,30RSYC,22-Apr-22
C1071013,11171007,111,PF-06863135,T,6517764049,6.51776E+11,20211122,17:01,CYCLE1_DAY8,6 H,930.8020953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 902,20RSYC,19-Apr-22
C1071013,11171007,111,PF-06863135,T,6517764052,6.51776E+11,20211130,10:09,CYCLE1_DAY15,0 H,511.7274909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1073,41RSYC,26-Apr-22
C1071013,11171007,111,PF-06863135,T,6517764056,6.51776E+11,20211207,7:39,CYCLE1_DAY22,0 H,861.9289837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1074,41RSYC,26-Apr-22
C1071013,11171007,111,PF-06863135,T,6517433564,6.51743E+11,20211214,12:19,CYCLE2_DAY1,0 H,955.9179107,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 987,66RSYC,3-May-22
C1071013,11171007,111,PF-06863135,T,6517764065,6.51776E+11,20220111,8:00,CYCLE3_DAY1,0 H,645.3437084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1727,72RSYC,7-May-22
C1071013,11171007,111,PF-06863135,T,6517433566,6.51743E+11,20220208,11:09,CYCLE4_DAY1,0 H,657.9318272,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1726,72RSYC,7-May-22
C1071013,11171007,111,PF-06863135,T,6517433569,6.51743E+11,20220503,9:00,CYCLE7_DAY1,0 H,509.1864501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1965,114RSYC,25-Jul-22
C1071013,11171007,111,PF-06863135,T,6520894174,6.52089E+11,20220726,8:46,CYCLE10_DAY1,0 H,460.3694422,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2094,127RSYC,19-Oct-22
C1071013,11171007,111,PF-06863135,T,6521348641,6.52135E+11,20221018,7:15,CYCLE13_DAY1,0 H,252.3682448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2141,139RSYC,22-Mar-23
C1071013,11171007,111,PF-06863135,T,6520894175,6.52089E+11,20230113,13:00,CYCLE16_DAY1,0 H,275.2533773,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2175,140RSYC,22-Mar-23
C1071013,11171007,111,PF-06863135,T,6521348643,6.52135E+11,20230628,7:15,CYCLE22_DAY1,0 H,689.2652026,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2282,145RSYC,4-Jan-24
C1071013,11171007,111,PF-06863135,T,6517764085,6.51776E+11,20230725,7:15,END_OF_TRT,,174.7846145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2292,145RSYC,4-Jan-24
C1071013,11171007,111,PF-06863135,T,6518011607,6.51801E+11,20211116,12:18,CYCLE1_DAY1,24 H,128.1646499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 914,20RSYC,19-Apr-22
C1071013,11171007,111,PF-06863135,T,6517764075,6.51776E+11,20211118,8:00,CYCLE1_DAY4,0 H,773.8991064,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 904,20RSYC,19-Apr-22
C1071013,11171007,111,PF-06863135,T,6517764083,6.51776E+11,20211119,10:15,CYCLE1_DAY4,24 H,615.6674618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 905,20RSYC,19-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559619,6.51756E+11,20211115,11:00,CYCLE1_DAY1,0 H,507.4313957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 873,19RSYC,19-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559622,6.51756E+11,20211122,12:20,CYCLE1_DAY8,0 H,336.2364636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 874,19RSYC,19-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559623,6.51756E+11,20211129,8:30,CYCLE1_DAY15,0 H,345.0718059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1014,39RSYC,26-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559626,6.51756E+11,20211206,10:45,CYCLE1_DAY22,0 H,822.7621862,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1016,39RSYC,26-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559627,6.51756E+11,20211213,10:30,CYCLE2_DAY1,0 H,943.2137044,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1017,39RSYC,26-Apr-22
C1071013,10251001,112,PF-06863135,T,6519204945,6.5192E+11,20220111,10:20,CYCLE3_DAY1,0 H,936.6725141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1668,101RSYC,13-May-22
C1071013,10251001,112,PF-06863135,T,6517559631,6.51756E+11,20220208,12:25,CYCLE4_DAY1,0 H,957.645538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1667,101RSYC,13-May-22
C1071013,10251001,112,PF-06863135,T,6517559634,6.51756E+11,20220503,12:10,CYCLE7_DAY1,0 H,422.1102926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1972,114RSYC,25-Jul-22
C1071013,10251001,112,PF-06863135,T,6517559650,6.51756E+11,20220524,13:10,END_OF_TRT,,225.474812,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1973,122RSYC,29-Jul-22
C1071013,10251001,112,PF-06863135,T,6517559636,6.51756E+11,20211116,16:43,CYCLE1_DAY1,24 H,531.9598606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 875,19RSYC,19-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559637,6.51756E+11,20211118,12:10,CYCLE1_DAY4,0 H,28.66177486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 876,19RSYC,19-Apr-22
C1071013,10251001,112,PF-06863135,T,6517559639,6.51756E+11,20211119,12:10,CYCLE1_DAY4,24 H,519.4356844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 877,64RSYC,3-May-22
C1071013,10151004,113,PF-06863135,T,6518602939,6.5186E+11,20211117,6:00,CYCLE1_DAY1,0 H,105.9639993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 918,20RSYC,19-Apr-22
C1071013,10151004,113,PF-06863135,T,6518602939,6.5186E+11,20211117,18:20,CYCLE1_DAY1,6 H,702.5566794,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 917,20RSYC,19-Apr-22
C1071013,10151004,113,PF-06863135,T,6518602941,6.5186E+11,20211124,9:30,CYCLE1_DAY8,0 H,755.512159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1111,67RSYC,8-May-22
C1071013,10151004,113,PF-06863135,T,6518602941,6.5186E+11,20211124,15:19,CYCLE1_DAY8,6 H,913.7732131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1110,67RSYC,8-May-22
C1071013,10151004,113,PF-06863135,T,6518602942,6.5186E+11,20211201,12:13,CYCLE1_DAY15,0 H,896.3911132,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1112,67RSYC,8-May-22
C1071013,10151004,113,PF-06863135,T,6518602945,6.5186E+11,20211208,11:36,CYCLE1_DAY22,0 H,41.55161696,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1115,97RSYC,12-May-22
C1071013,10151004,113,PF-06863135,T,6518957157,6.51896E+11,20211215,11:20,CYCLE2_DAY1,0 H,316.655623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1251,87RSYC,13-May-22
C1071013,10151004,113,PF-06863135,T,6518602951,6.5186E+11,20211118,12:20,CYCLE1_DAY1,24 H,308.2471315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 922,20RSYC,19-Apr-22
C1071013,10151004,113,PF-06863135,T,6518602957,6.5186E+11,20211119,13:30,CYCLE1_DAY4,0 H,543.1511384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 926,20RSYC,19-Apr-22
C1071013,10151007,114,PF-06863135,T,6518602936,6.5186E+11,20211116,15:43,CYCLE1_DAY1,0 H,444.0879439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 916,20RSYC,19-Apr-22
C1071013,10151007,114,PF-06863135,T,6518602940,6.5186E+11,20211123,9:30,CYCLE1_DAY8,0 H,690.7540433,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 920,20RSYC,19-Apr-22
C1071013,10151007,114,PF-06863135,T,6518602940,6.5186E+11,20211123,16:40,CYCLE1_DAY8,6 H,630.558638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 919,20RSYC,19-Apr-22
C1071013,10151007,114,PF-06863135,T,6518602943,6.5186E+11,20211201,13:10,CYCLE1_DAY15,0 H,851.7568644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1113,67RSYC,8-May-22
C1071013,10151007,114,PF-06863135,T,6518842177,6.51884E+11,20211208,12:47,CYCLE1_DAY22,0 H,533.526156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1165,104RSYC,22-May-22
C1071013,10151007,114,PF-06863135,T,6518957158,6.51896E+11,20211215,12:35,CYCLE2_DAY1,0 H,604.8810634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1252,47RSYC,28-Apr-22
C1071013,10151007,114,PF-06863135,T,6518602950,6.5186E+11,20211117,14:45,CYCLE1_DAY1,24 H,858.496788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 921,20RSYC,19-Apr-22
C1071013,10151007,114,PF-06863135,T,6518602956,6.5186E+11,20211119,13:35,CYCLE1_DAY4,0 H,478.434351,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 925,20RSYC,19-Apr-22
C1071013,10031011,115,PF-06863135,T,6517473904,6.51747E+11,20211116,13:45,CYCLE1_DAY1,0 H,689.9391542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 864,36RSYC,25-Apr-22
C1071013,10031011,115,PF-06863135,T,6517473904,6.51747E+11,20211116,21:49,CYCLE1_DAY1,6 H,680.7241394,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 863,36RSYC,25-Apr-22
C1071013,10031011,115,PF-06863135,T,6518620839,6.51862E+11,20211129,9:55,CYCLE1_DAY8,0 H,143.1122826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1118,94RSYC,12-May-22
C1071013,10031011,115,PF-06863135,T,6518620839,6.51862E+11,20211129,15:54,CYCLE1_DAY8,6 H,264.1614687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1117,94RSYC,12-May-22
C1071013,10031011,115,PF-06863135,T,6517889670,6.51789E+11,20211209,13:40,CYCLE1_DAY15,0 H,88.35313292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1085,41RSYC,26-Apr-22
C1071013,10031011,115,PF-06863135,T,6518620844,6.51862E+11,20211216,14:20,CYCLE1_DAY22,0 H,665.9684822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1120,94RSYC,12-May-22
C1071013,10031011,115,PF-06863135,T,6519134610,6.51913E+11,20220120,15:40,CYCLE3_DAY1,0 H,677.8178449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1622,85RSYC,10-May-22
C1071013,10031011,115,PF-06863135,T,6516580419,6.51658E+11,20220217,12:12,CYCLE4_DAY1,0 H,778.7564551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1621,85RSYC,10-May-22
C1071013,10031011,115,PF-06863135,T,6519134613,6.51913E+11,20220512,12:28,CYCLE7_DAY1,0 H,347.4169251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1987,114RSYC,25-Jul-22
C1071013,10031011,115,PF-06863135,T,6518620873,6.51862E+11,20221027,10:10,CYCLE13_DAY1,0 H,346.8521603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2142,139RSYC,22-Mar-23
C1071013,10031011,115,PF-06863135,T,6519134605,6.51913E+11,20230119,13:43,CYCLE16_DAY1,0 H,556.5396161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2193,141RSYC,17-May-23
C1071013,10031011,115,PF-06863135,T,6523047504,6.52305E+11,20230413,10:57,CYCLE19_DAY1,0 H,280.8652957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2218,142RSYC,18-May-23
C1071013,10031011,115,PF-06863135,T,6521762365,6.52176E+11,20230710,13:46,CYCLE22_DAY1,0 H,606.4032339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2330,149RSYC,27-Mar-24
C1071013,10031011,115,PF-06863135,T,6522244539,6.52224E+11,20231002,12:49,CYCLE25_DAY1,0 H,71.67649039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2331,149RSYC,27-Mar-24
C1071013,10031011,115,PF-06863135,T,6523132945,6.52313E+11,,,CYCLE31_DAY1,0 H,794.8455179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2376,152RSYC,9-Apr-24
C1071013,10031011,115,PF-06863135,T,6518620864,6.51862E+11,20211117,13:55,CYCLE1_DAY1,24 H,253.5653087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 927,20RSYC,19-Apr-22
C1071013,10031011,115,PF-06863135,T,6517472381,6.51747E+11,20211122,10:14,CYCLE1_DAY4,0 H,826.8000249,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 989,66RSYC,3-May-22
C1071013,10031011,115,PF-06863135,T,6518620868,6.51862E+11,20211123,11:47,CYCLE1_DAY4,24 H,731.6543139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1124,94RSYC,12-May-22
C1071013,11081005,116,PF-06863135,T,6801707956,6.80171E+11,20211116,11:00,CYCLE1_DAY1,0 H,39.61848311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 671,30RSYC,22-Apr-22
C1071013,11081005,116,PF-06863135,T,6801707956,6.80171E+11,20211116,20:40,CYCLE1_DAY1,6 H,84.52083294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 832,35RSYC,25-Apr-22
C1071013,11081005,116,PF-06863135,T,6801707958,6.80171E+11,20211124,10:00,CYCLE1_DAY8,0 H,512.1168366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 834,35RSYC,25-Apr-22
C1071013,11081005,116,PF-06863135,T,6801707958,6.80171E+11,20211124,19:45,CYCLE1_DAY8,6 H,888.3627867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 833,35RSYC,25-Apr-22
C1071013,11081005,116,PF-06863135,T,6801707960,6.80171E+11,20211130,10:42,CYCLE1_DAY15,0 H,627.1461923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 941,65RSYC,3-May-22
C1071013,11081005,116,PF-06863135,T,6801707962,6.80171E+11,20211207,8:45,CYCLE1_DAY22,0 H,865.0143419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 952,65RSYC,3-May-22
C1071013,11081005,116,PF-06863135,T,6801734181,6.80173E+11,20211214,9:30,CYCLE2_DAY1,0 H,124.328396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 953,65RSYC,3-May-22
C1071013,11081005,116,PF-06863135,T,6801701818,6.8017E+11,20220111,9:26,CYCLE3_DAY1,0 H,389.6408182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1591,59RSYC,1-May-22
C1071013,11081005,116,PF-06863135,T,6801701820,6.8017E+11,20220208,9:50,CYCLE4_DAY1,0 H,563.8867318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1592,59RSYC,1-May-22
C1071013,11081005,116,PF-06863135,T,6801811838,6.80181E+11,20220509,10:16,CYCLE7_DAY1,0 H,419.8253849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1961,114RSYC,25-Jul-22
C1071013,11081005,116,PF-06863135,T,6801892999,6.80189E+11,20220725,10:02,CYCLE10_DAY1,0 H,541.6054566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2070,129RSYC,21-Oct-22
C1071013,11081005,116,PF-06863135,T,6801958742,6.80196E+11,20221017,9:53,CYCLE13_DAY1,0 H,182.732308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2117,131RSYC,9-Nov-22
C1071013,11081005,116,PF-06863135,T,6802068778,6.80207E+11,20230110,9:43,CYCLE16_DAY1,0 H,799.3107713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2188,141RSYC,17-May-23
C1071013,11081005,116,PF-06863135,T,6802135339,6.80214E+11,20230403,10:05,CYCLE19_DAY1,0 H,164.7509836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2236,143RSYC,27-Nov-23
C1071013,11081005,116,PF-06863135,T,6802256362,6.80226E+11,20230626,9:43,CYCLE22_DAY1,0 H,366.9322889,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2275,144RSYC,27-Nov-23
C1071013,11081005,116,PF-06863135,T,6802256364,6.80226E+11,20230919,10:16,CYCLE25_DAY1,0 H,534.3902225,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2297,154RSYC,11-Apr-24
C1071013,11081005,116,PF-06863135,T,6802408400,6.80241E+11,20231213,10:37,CYCLE28_DAY1,0 H,674.8290527,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2344,148RSYC,27-Mar-24
C1071013,11081005,116,PF-06863135,T,6802408402,6.80241E+11,20240110,10:50,END_OF_TRT,,16.59078576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2345,149RSYC,27-Mar-24
C1071013,11081005,116,PF-06863135,T,6801707964,6.80171E+11,20211117,14:50,CYCLE1_DAY1,24 H,818.3773797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 835,35RSYC,25-Apr-22
C1071013,11081005,116,PF-06863135,T,6801707966,6.80171E+11,20211119,8:50,CYCLE1_DAY4,0 H,631.9753866,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 836,35RSYC,25-Apr-22
C1071013,11081005,116,PF-06863135,T,6801707968,6.80171E+11,20211120,13:50,CYCLE1_DAY4,24 H,916.8895585,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 837,35RSYC,25-Apr-22
C1071013,11021009,117,PF-06863135,T,6217184360,6.21718E+11,20211116,14:10,CYCLE1_DAY1,0 H,348.9643885,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 798,34RSYC,24-Apr-22
C1071013,11021009,117,PF-06863135,T,6217184360,6.21718E+11,20211116,20:25,CYCLE1_DAY1,6 H,237.3557841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 797,34RSYC,24-Apr-22
C1071013,11021009,117,PF-06863135,T,6217233478,6.21723E+11,20211126,15:30,CYCLE1_DAY8,0 H,523.3845446,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1544,58RSYC,1-May-22
C1071013,11021009,117,PF-06863135,T,6217233478,6.21723E+11,20211126,22:00,CYCLE1_DAY8,6 H,35.78300241,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1543,58RSYC,1-May-22
C1071013,11021009,117,PF-06863135,T,6217170441,6.21717E+11,20211203,13:30,CYCLE1_DAY15,0 H,743.4964463,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1499,55RSYC,30-Apr-22
C1071013,11021009,117,PF-06863135,T,6217170452,6.21717E+11,20211210,13:40,CYCLE1_DAY22,0 H,824.0720189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1504,55RSYC,30-Apr-22
C1071013,11021009,117,PF-06863135,T,6217170453,6.21717E+11,20211217,13:35,CYCLE2_DAY1,0 H,693.3751377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1505,55RSYC,30-Apr-22
C1071013,11021009,117,PF-06863135,T,6217170477,6.21717E+11,20220114,13:00,CYCLE3_DAY1,0 H,28.10991203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1842,93RSYC,12-May-22
C1071013,11021009,117,PF-06863135,T,6217656226,6.21766E+11,20220308,10:30,END_OF_TRT,,857.373916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1880,86RSYC,13-May-22
C1071013,11021009,117,PF-06863135,T,6217136152,6.21714E+11,20211117,14:20,CYCLE1_DAY1,24 H,248.2838021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 785,33RSYC,24-Apr-22
C1071013,11021009,117,PF-06863135,T,6217233480,6.21723E+11,20211122,16:00,CYCLE1_DAY4,0 H,723.0223568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 811,34RSYC,24-Apr-22
C1071013,11021009,117,PF-06863135,T,6217118744,6.21712E+11,20211123,16:30,CYCLE1_DAY4,24 H,324.4290667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 784,33RSYC,24-Apr-22
C1071013,10151005,118,PF-06863135,T,6518602937,6.5186E+11,20211123,10:05,CYCLE1_DAY1,0 H,480.1248437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1109,67RSYC,8-May-22
C1071013,10151005,118,PF-06863135,T,6518911702,6.51891E+11,20211129,10:00,CYCLE1_DAY8,0 H,296.3040155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1187,104RSYC,22-May-22
C1071013,10151005,118,PF-06863135,T,6518911702,6.51891E+11,20211129,15:44,CYCLE1_DAY8,6 H,42.93245191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1186,104RSYC,22-May-22
C1071013,10151005,118,PF-06863135,T,6518957153,6.51896E+11,20211206,10:50,CYCLE1_DAY15,0 H,294.1423174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1247,47RSYC,28-Apr-22
C1071013,10151005,118,PF-06863135,T,6518957155,6.51896E+11,20211213,10:10,CYCLE1_DAY22,0 H,771.765555,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1249,47RSYC,28-Apr-22
C1071013,10151005,118,PF-06863135,T,6518602953,6.5186E+11,20211124,13:00,CYCLE1_DAY1,24 H,925.6389618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1116,94RSYC,12-May-22
C1071013,11061005,119,PF-06863135,T,6217165063,6.21717E+11,20211119,16:05,CYCLE1_DAY1,0 H,828.4601019,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1482,55RSYC,30-Apr-22
C1071013,11061005,119,PF-06863135,T,6217165072,6.21717E+11,20211126,12:30,CYCLE1_DAY8,0 H,611.6703003,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1488,105RSYC,22-May-22
C1071013,11061005,119,PF-06863135,T,6217165074,6.21717E+11,20211202,11:30,CYCLE1_DAY15,0 H,957.7125599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1490,55RSYC,30-Apr-22
C1071013,11061005,119,PF-06863135,T,6217193498,6.21719E+11,20211209,11:10,CYCLE1_DAY22,0 H,13.22335843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1527,56RSYC,30-Apr-22
C1071013,11061005,119,PF-06863135,T,6217165088,6.21717E+11,20211123,15:00,CYCLE1_DAY4,0 H,341.2527739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1494,55RSYC,30-Apr-22
C1071013,11061005,119,PF-06863135,T,6217193548,6.21719E+11,20211124,16:10,CYCLE1_DAY4,24 H,519.6908493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1532,56RSYC,30-Apr-22
C1071013,10741004,120,PF-06863135,T,6517472574,6.51747E+11,20211119,13:45,CYCLE1_DAY1,0 H,571.5356859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 850,36RSYC,25-Apr-22
C1071013,10741004,120,PF-06863135,T,6517472574,6.51747E+11,20211119,23:45,CYCLE1_DAY1,6 H,699.8678574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 849,36RSYC,25-Apr-22
C1071013,10741004,120,PF-06863135,T,6517472577,6.51747E+11,20211130,8:45,CYCLE1_DAY8,0 H,582.5298928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 995,88RSYC,11-May-22
C1071013,10741004,120,PF-06863135,T,6517472577,6.51747E+11,20211130,18:35,CYCLE1_DAY8,6 H,795.2324633,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 994,66RSYC,3-May-22
C1071013,10741004,120,PF-06863135,T,6518693893,6.51869E+11,20211207,12:45,CYCLE1_DAY15,0 H,54.10810968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1128,94RSYC,12-May-22
C1071013,10741004,120,PF-06863135,T,6519029235,6.51903E+11,20211213,8:57,CYCLE1_DAY22,0 H,185.6233512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1263,47RSYC,28-Apr-22
C1071013,10741004,120,PF-06863135,T,6519029237,6.51903E+11,20211221,8:23,CYCLE2_DAY1,0 H,98.93178456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1265,47RSYC,28-Apr-22
C1071013,10741004,120,PF-06863135,T,6518988296,6.51899E+11,20220118,11:26,CYCLE3_DAY1,0 H,74.85636978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1655,100RSYC,23-May-22
C1071013,10741004,120,PF-06863135,T,6519158559,6.51916E+11,20220215,12:04,CYCLE4_DAY1,0 H,304.4680321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1656,100RSYC,23-May-22
C1071013,10741004,120,PF-06863135,T,6517472588,6.51747E+11,20220510,12:15,CYCLE7_DAY1,0 H,444.6229263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1969,114RSYC,25-Jul-22
C1071013,10741004,120,PF-06863135,T,6518807210,6.51881E+11,20220804,11:13,CYCLE10_DAY1,0 H,288.1761475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2083,129RSYC,21-Oct-22
C1071013,10741004,120,PF-06863135,T,6520917899,6.52092E+11,20221026,10:18,CYCLE13_DAY1,0 H,263.0130881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2143,139RSYC,22-Mar-23
C1071013,10741004,120,PF-06863135,T,6521628791,6.52163E+11,20221207,12:47,END_OF_TRT,,608.6429506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2133,139RSYC,22-Mar-23
C1071013,10741004,120,PF-06863135,T,6517472591,6.51747E+11,20211120,17:40,CYCLE1_DAY1,24 H,940.6759961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 851,36RSYC,25-Apr-22
C1071013,10741004,120,PF-06863135,T,6517472593,6.51747E+11,20211122,10:10,CYCLE1_DAY4,0 H,994.9866652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1001,39RSYC,26-Apr-22
C1071013,10741004,120,PF-06863135,T,6518693901,6.51869E+11,20211123,15:27,CYCLE1_DAY4,24 H,710.4738476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1133,94RSYC,12-May-22
C1071013,10031013,121,PF-06863135,T,6517751560,6.51775E+11,20211122,11:54,CYCLE1_DAY1,0 H,482.3924225,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1066,41RSYC,26-Apr-22
C1071013,10031013,121,PF-06863135,T,6517751560,6.51775E+11,20211122,18:35,CYCLE1_DAY1,6 H,846.5638825,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1065,41RSYC,26-Apr-22
C1071013,10031013,121,PF-06863135,T,6518620838,6.51862E+11,20211202,11:20,CYCLE1_DAY8,0 H,160.5526385,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1935,120RSYC,28-Jul-22
C1071013,10031013,121,PF-06863135,T,6518620838,6.51862E+11,20211202,16:55,CYCLE1_DAY8,6 H,292.7824763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1936,123RSYC,29-Jul-22
C1071013,10031013,121,PF-06863135,T,6516580394,6.51658E+11,20211210,16:45,CYCLE1_DAY15,0 H,272.8369975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1937,123RSYC,29-Jul-22
C1071013,10031013,121,PF-06863135,T,6518620845,6.51862E+11,20211217,14:15,CYCLE1_DAY22,0 H,582.9688204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1121,94RSYC,12-May-22
C1071013,10031013,121,PF-06863135,T,6518620848,6.51862E+11,20211222,15:33,CYCLE2_DAY1,0 H,799.9666702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1938,124RSYC,29-Jul-22
C1071013,10031013,121,PF-06863135,T,6517751582,6.51775E+11,20220121,15:42,CYCLE3_DAY1,0 H,916.7289875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1623,85RSYC,10-May-22
C1071013,10031013,121,PF-06863135,T,6517473941,6.51747E+11,20211123,12:32,CYCLE1_DAY1,24 H,824.1073805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1006,39RSYC,26-Apr-22
C1071013,10031013,121,PF-06863135,T,6517473946,6.51747E+11,20211124,12:30,CYCLE1_DAY4,0 H,742.9555008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1007,39RSYC,26-Apr-22
C1071013,10031013,121,PF-06863135,T,6518620870,6.51862E+11,20211125,11:45,CYCLE1_DAY4,24 H,769.5568281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1126,94RSYC,12-May-22
C1071013,11281001,122,PF-06863135,T,6518343087,6.51834E+11,20211119,15:05,CYCLE1_DAY1,0 H,96.32109544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1094,67RSYC,8-May-22
C1071013,11281001,122,PF-06863135,T,6518343087,6.51834E+11,20211120,0:20,CYCLE1_DAY1,6 H,273.0713663,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1093,67RSYC,8-May-22
C1071013,11281001,122,PF-06863135,T,6518343089,6.51834E+11,20211126,13:13,CYCLE1_DAY8,0 H,710.128418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1096,67RSYC,8-May-22
C1071013,11281001,122,PF-06863135,T,6518343089,6.51834E+11,20211126,17:00,CYCLE1_DAY8,6 H,622.3215263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1095,87RSYC,13-May-22
C1071013,11281001,122,PF-06863135,T,6518343091,6.51834E+11,20211203,11:06,CYCLE1_DAY15,0 H,84.87182799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1097,67RSYC,8-May-22
C1071013,11281001,122,PF-06863135,T,6518343107,6.51834E+11,20211210,17:35,END_OF_TRT,,68.63742738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1101,107RSYC,24-May-22
C1071013,11281001,122,PF-06863135,T,6518343099,6.51834E+11,20211120,16:05,CYCLE1_DAY1,24 H,429.5010046,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1098,67RSYC,8-May-22
C1071013,11281001,122,PF-06863135,T,6518343100,6.51834E+11,20211122,11:45,CYCLE1_DAY4,0 H,787.8765594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1099,67RSYC,8-May-22
C1071013,11281001,122,PF-06863135,T,6518343103,6.51834E+11,20211123,14:25,CYCLE1_DAY4,24 H,88.82109342,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1100,67RSYC,8-May-22
C1071013,10561004,123,PF-06863135,T,6217026113,6.21703E+11,20211122,13:20,CYCLE1_DAY1,0 H,959.0180314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 761,33RSYC,24-Apr-22
C1071013,10561004,123,PF-06863135,T,6217026113,6.21703E+11,20211122,21:00,CYCLE1_DAY1,6 H,366.3638822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 760,64RSYC,3-May-22
C1071013,10561004,123,PF-06863135,T,6216898571,6.2169E+11,20211129,14:00,CYCLE1_DAY8,0 H,881.1416797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1403,95RSYC,13-May-22
C1071013,10561004,123,PF-06863135,T,6216898571,6.2169E+11,20211129,22:20,CYCLE1_DAY8,6 H,197.361361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1402,95RSYC,13-May-22
C1071013,10561004,123,PF-06863135,T,6216898576,6.2169E+11,20211206,14:30,CYCLE1_DAY15,0 H,126.8540305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1405,96RSYC,12-May-22
C1071013,10561004,123,PF-06863135,T,6216408046,6.21641E+11,20211213,11:05,CYCLE1_DAY22,0 H,942.4094829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1319,49RSYC,29-Apr-22
C1071013,10561004,123,PF-06863135,T,6216898582,6.2169E+11,20211221,10:45,CYCLE2_DAY1,0 H,787.0547852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1408,96RSYC,12-May-22
C1071013,10561004,123,PF-06863135,T,6216408050,6.21641E+11,20220117,13:20,CYCLE3_DAY1,0 H,527.0070398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1776,71RSYC,7-May-22
C1071013,10561004,123,PF-06863135,T,6216408052,6.21641E+11,20220216,12:35,CYCLE4_DAY1,0 H,262.2600068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1777,71RSYC,7-May-22
C1071013,10561004,123,PF-06863135,T,6216408054,6.21641E+11,20220512,10:00,CYCLE7_DAY1,0 H,567.9348977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1992,115RSYC,25-Jul-22
C1071013,10561004,123,PF-06863135,T,6216898603,6.2169E+11,20220803,12:00,CYCLE10_DAY1,0 H,324.9896987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2050,132RSYC,10-Nov-22
C1071013,10561004,123,PF-06863135,T,6218590830,6.21859E+11,20221025,11:15,CYCLE13_DAY1,0 H,108.1821833,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2153,139RSYC,22-Mar-23
C1071013,10561004,123,PF-06863135,T,6219498867,6.2195E+11,20230116,13:30,CYCLE16_DAY1,0 H,205.1643365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2180,140RSYC,22-Mar-23
C1071013,10561004,123,PF-06863135,T,6220036100,6.22004E+11,20230412,12:40,CYCLE19_DAY1,0 H,743.8148835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2229,142RSYC,18-May-23
C1071013,10561004,123,PF-06863135,T,6220036101,6.22004E+11,20230719,10:20,CYCLE22_DAY1,0 H,381.2958022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2278,147RSYC,29-Feb-24
C1071013,10561004,123,PF-06863135,T,6220036103,6.22004E+11,20231019,15:25,CYCLE25_DAY1,0 H,905.6812086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2317,147RSYC,29-Feb-24
C1071013,10561004,123,PF-06863135,T,6222181788,6.22218E+11,20240111,12:15,CYCLE28_DAY1,0 H,674.3595134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2351,152RSYC,9-Apr-24
C1071013,10561004,123,PF-06863135,T,6216408055,6.21641E+11,20211123,15:00,CYCLE1_DAY1,24 H,913.7753523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 714,31RSYC,23-Apr-22
C1071013,10561004,123,PF-06863135,T,6217026189,6.21703E+11,20211126,14:00,CYCLE1_DAY4,24 H,335.4230868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1433,57RSYC,30-Apr-22
C1071013,10291001,125,PF-06863135,T,6217232417,6.21723E+11,20211122,14:10,CYCLE1_DAY1,0 H,110.7905683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1534,56RSYC,30-Apr-22
C1071013,10291001,125,PF-06863135,T,6217232417,6.21723E+11,20211122,20:51,CYCLE1_DAY1,6 H,253.4794182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1533,56RSYC,30-Apr-22
C1071013,10291001,125,PF-06863135,T,6216407838,6.21641E+11,20211129,10:13,CYCLE1_DAY8,0 H,261.9008965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1294,84RSYC,10-May-22
C1071013,10291001,125,PF-06863135,T,6216407838,6.21641E+11,20211129,19:40,CYCLE1_DAY8,6 H,422.9373767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1293,84RSYC,10-May-22
C1071013,10291001,125,PF-06863135,T,6216407840,6.21641E+11,20211206,8:10,CYCLE1_DAY15,0 H,447.0217987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1295,84RSYC,10-May-22
C1071013,10291001,125,PF-06863135,T,6217232422,6.21723E+11,20211213,13:12,CYCLE1_DAY22,0 H,395.950205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1748,90RSYC,11-May-22
C1071013,10291001,125,PF-06863135,T,6216407844,6.21641E+11,20211220,8:46,CYCLE2_DAY1,0 H,742.694674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1746,90RSYC,11-May-22
C1071013,10291001,125,PF-06863135,T,6216407846,6.21641E+11,20220117,8:20,CYCLE3_DAY1,0 H,161.8248632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1747,90RSYC,11-May-22
C1071013,10291001,125,PF-06863135,T,6217230872,6.21723E+11,20220214,8:38,CYCLE4_DAY1,0 H,857.8492729,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1876,80RSYC,4-May-22
C1071013,10291001,125,PF-06863135,T,6218182028,6.21818E+11,20220331,10:30,END_OF_TRT,,743.1666479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1916,123RSYC,29-Jul-22
C1071013,10291001,125,PF-06863135,T,6217183327,6.21718E+11,20211123,15:40,UNPL,9001 H,598.1522651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1516,56RSYC,30-Apr-22
C1071013,10291001,125,PF-06863135,T,6217183332,6.21718E+11,20211124,16:30,UNPL,9002 H,846.5555788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1517,56RSYC,30-Apr-22
C1071013,10291001,125,PF-06863135,T,6216407851,6.21641E+11,20211123,15:40,CYCLE1_DAY1,24 H,243.8714348,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1296,49RSYC,29-Apr-22
C1071013,10291001,125,PF-06863135,T,6217262392,6.21726E+11,20211125,8:20,CYCLE1_DAY4,0 H,867.7108437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1548,58RSYC,1-May-22
C1071013,10291001,125,PF-06863135,T,6217262394,6.21726E+11,20211126,13:14,CYCLE1_DAY4,24 H,114.849541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1549,58RSYC,1-May-22
C1071013,11021008,126,PF-06863135,T,6217233477,6.21723E+11,20211122,17:15,CYCLE1_DAY1,0 H,925.227939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 808,34RSYC,24-Apr-22
C1071013,11021008,126,PF-06863135,T,6217233477,6.21723E+11,20211122,23:30,CYCLE1_DAY1,6 H,479.2075625,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 807,34RSYC,24-Apr-22
C1071013,11021008,126,PF-06863135,T,6217023824,6.21702E+11,20211202,15:55,CYCLE1_DAY8,0 H,8.50007842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1427,57RSYC,30-Apr-22
C1071013,11021008,126,PF-06863135,T,6217023824,6.21702E+11,20211202,23:45,CYCLE1_DAY8,6 H,787.8545952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1426,57RSYC,30-Apr-22
C1071013,11021008,126,PF-06863135,T,6217170438,6.21717E+11,20211208,13:30,CYCLE1_DAY15,0 H,412.989476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1498,110RSYC,25-May-22
C1071013,11021008,126,PF-06863135,T,6216756805,6.21676E+11,20211215,15:35,CYCLE1_DAY22,0 H,777.8193645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1385,81RSYC,4-May-22
C1071013,11021008,126,PF-06863135,T,6217023838,6.21702E+11,20211222,17:00,CYCLE2_DAY1,0 H,697.5781771,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1843,93RSYC,12-May-22
C1071013,11021008,126,PF-06863135,T,6216756820,6.21676E+11,20220224,10:35,END_OF_TRT,,563.2674064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1881,109RSYC,25-May-22
C1071013,11021008,126,PF-06863135,T,6217170509,6.21717E+11,20211123,17:30,CYCLE1_DAY1,24 H,654.0834003,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 796,34RSYC,24-Apr-22
C1071013,11021008,126,PF-06863135,T,6217136156,6.21714E+11,20211126,18:30,CYCLE1_DAY4,24 H,44.55022896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1466,54RSYC,30-Apr-22
C1071013,10401002,127,PF-06863135,T,6518727314,6.51873E+11,20211123,9:26,CYCLE1_DAY1,0 H,369.0967185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 692,30RSYC,22-Apr-22
C1071013,10401002,127,PF-06863135,T,6518727314,6.51873E+11,20211123,16:48,CYCLE1_DAY1,6 H,56.53167368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 691,30RSYC,22-Apr-22
C1071013,10401002,127,PF-06863135,T,6518727316,6.51873E+11,20211130,8:42,CYCLE1_DAY8,0 H,246.9530654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1139,94RSYC,12-May-22
C1071013,10401002,127,PF-06863135,T,6518727316,6.51873E+11,20211130,15:15,CYCLE1_DAY8,6 H,136.8952554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1138,94RSYC,12-May-22
C1071013,10401002,127,PF-06863135,T,6518926328,6.51893E+11,20211214,9:30,CYCLE1_DAY22,0 H,387.5046428,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1196,105RSYC,22-May-22
C1071013,10401002,127,PF-06863135,T,6518926331,6.51893E+11,20211222,16:01,CYCLE2_DAY1,0 H,679.0575798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1197,105RSYC,22-May-22
C1071013,10401002,127,PF-06863135,T,6519180202,6.51918E+11,20220119,10:50,CYCLE3_DAY1,0 H,108.9842216,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1723,72RSYC,7-May-22
C1071013,10401002,127,PF-06863135,T,6517560306,6.51756E+11,20220216,8:19,CYCLE4_DAY1,0 H,631.4911567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1722,72RSYC,7-May-22
C1071013,10401002,127,PF-06863135,T,6517560309,6.51756E+11,20220511,12:12,CYCLE7_DAY1,0 H,697.3786996,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1981,114RSYC,25-Jul-22
C1071013,10401002,127,PF-06863135,T,6518806949,6.51881E+11,20220817,7:35,CYCLE10_DAY1,0 H,783.3383328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2092,127RSYC,19-Oct-22
C1071013,10401002,127,PF-06863135,T,6520956319,6.52096E+11,20221109,8:04,CYCLE13_DAY1,0 H,100.3947056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2144,139RSYC,22-Mar-23
C1071013,10401002,127,PF-06863135,T,6521647793,6.52165E+11,20230201,7:44,CYCLE16_DAY1,0 H,269.7920548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2194,141RSYC,17-May-23
C1071013,10401002,127,PF-06863135,T,6521647794,6.52165E+11,20230426,11:23,CYCLE19_DAY1,0 H,889.9188616,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2248,143RSYC,27-Nov-23
C1071013,10401002,127,PF-06863135,T,6523034190,6.52303E+11,20230719,10:12,CYCLE22_DAY1,0 H,564.8222616,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2283,145RSYC,4-Jan-24
C1071013,10401002,127,PF-06863135,T,6524124734,6.52412E+11,20231025,7:42,CYCLE25_DAY1,0 H,294.3400265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2332,149RSYC,27-Mar-24
C1071013,10401002,127,PF-06863135,T,6524124735,6.52412E+11,20240117,8:50,CYCLE28_DAY1,0 H,22.34887314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2356,148RSYC,27-Mar-24
C1071013,10401002,127,PF-06863135,T,6518712782,6.51871E+11,20211124,9:20,CYCLE1_DAY1,24 H,882.2816909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1137,94RSYC,12-May-22
C1071013,10401002,127,PF-06863135,T,6518712786,6.51871E+11,20211126,10:40,CYCLE1_DAY4,0 H,833.5814675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 690,30RSYC,22-Apr-22
C1071013,10401002,127,PF-06863135,T,6517560314,6.51756E+11,20211127,11:30,CYCLE1_DAY4,24 H,512.8841717,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1053,40RSYC,26-Apr-22
C1071013,10101006,128,PF-06863135,T,6518706273,6.51871E+11,20211123,10:40,CYCLE1_DAY1,0 H,922.9305077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 685,30RSYC,22-Apr-22
C1071013,10101006,128,PF-06863135,T,6518706273,6.51871E+11,20211123,17:55,CYCLE1_DAY1,6 H,416.345727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 686,30RSYC,22-Apr-22
C1071013,10101006,128,PF-06863135,T,6518558179,6.51856E+11,20211130,8:33,CYCLE1_DAY8,0 H,496.8936603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1108,67RSYC,8-May-22
C1071013,10101006,128,PF-06863135,T,6518706279,6.51871E+11,20211207,9:35,CYCLE1_DAY15,0 H,105.8182589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1134,94RSYC,12-May-22
C1071013,10101006,128,PF-06863135,T,6518447644,6.51845E+11,20211215,10:32,CYCLE1_DAY22,0 H,943.6260974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1103,67RSYC,8-May-22
C1071013,10101006,128,PF-06863135,T,6518447645,6.51845E+11,20211221,13:00,CYCLE2_DAY1,0 H,396.0649999,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1104,67RSYC,8-May-22
C1071013,10101006,128,PF-06863135,T,6517559663,6.51756E+11,20220119,9:56,CYCLE3_DAY1,0 H,555.4538516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1615,97RSYC,12-May-22
C1071013,10101006,128,PF-06863135,T,6517559666,6.51756E+11,20220216,10:44,CYCLE4_DAY1,0 H,212.3719541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1616,97RSYC,12-May-22
C1071013,10101006,128,PF-06863135,T,6517559668,6.51756E+11,20220511,9:18,CYCLE7_DAY1,0 H,387.941782,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1975,114RSYC,25-Jul-22
C1071013,10101006,128,PF-06863135,T,6521315622,6.52132E+11,20221026,13:00,CYCLE13_DAY1,0 H,628.1178175,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2145,143RSYC,27-Nov-23
C1071013,10101006,128,PF-06863135,T,6521315620,6.52132E+11,20230412,11:55,CYCLE19_DAY1,0 H,770.5219565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2216,142RSYC,18-May-23
C1071013,10101006,128,PF-06863135,T,6522542259,6.52254E+11,20230705,10:36,CYCLE22_DAY1,0 H,835.2561843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2284,145RSYC,4-Jan-24
C1071013,10101006,128,PF-06863135,T,6524996224,6.525E+11,,,CYCLE31_DAY1,0 H,91.38910079,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2374,152RSYC,9-Apr-24
C1071013,10101006,128,PF-06863135,T,6526011931,6.52601E+11,20240124,11:54,UNPL,9001 H,849.5041536,NG/ML,,Received as 6524145852-02; visit revised from C28D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2357,148RSYC,27-Mar-24
C1071013,10101006,128,PF-06863135,T,6518558185,6.51856E+11,20211124,11:56,CYCLE1_DAY1,24 H,397.1925319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 684,30RSYC,22-Apr-22
C1071013,10101006,128,PF-06863135,T,6518706291,6.51871E+11,20211126,10:50,CYCLE1_DAY4,0 H,602.18057,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 687,30RSYC,22-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559687,6.51756E+11,20211123,13:56,CYCLE1_DAY1,0 H,742.7692867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1022,39RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559687,6.51756E+11,20211123,20:05,CYCLE1_DAY1,6 H,619.8881946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1021,39RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559690,6.51756E+11,20211130,12:35,CYCLE1_DAY8,0 H,349.4769328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1024,39RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559690,6.51756E+11,20211130,18:49,CYCLE1_DAY8,6 H,39.2026547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1023,39RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559692,6.51756E+11,20211206,8:54,CYCLE1_DAY15,0 H,96.549241,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1025,39RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559693,6.51756E+11,20211213,8:12,CYCLE1_DAY22,0 H,1.413961211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1026,40RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559695,6.51756E+11,20211220,8:07,CYCLE2_DAY1,0 H,4.406288829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1027,40RSYC,26-Apr-22
C1071013,10131001,129,PF-06863135,T,6517559697,6.51756E+11,20220117,7:59,CYCLE3_DAY1,0 H,979.0152828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1619,85RSYC,10-May-22
C1071013,10131001,129,PF-06863135,T,6517559700,6.51756E+11,20220215,9:39,CYCLE4_DAY1,0 H,886.648446,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1620,85RSYC,10-May-22
C1071013,10131001,129,PF-06863135,T,6517559701,6.51756E+11,20220509,8:05,CYCLE7_DAY1,0 H,346.042858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1977,114RSYC,25-Jul-22
C1071013,10131001,129,PF-06863135,T,6520266800,6.52027E+11,20220801,8:26,CYCLE10_DAY1,0 H,255.8043285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2080,129RSYC,21-Oct-22
C1071013,10131001,129,PF-06863135,T,6517559703,6.51756E+11,20211124,13:51,CYCLE1_DAY1,24 H,245.6119194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 688,30RSYC,22-Apr-22
C1071013,10801002,130,PF-06863135,T,6517433487,6.51743E+11,20211129,11:26,CYCLE1_DAY1,0 H,915.3876838,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 969,66RSYC,3-May-22
C1071013,10801002,130,PF-06863135,T,6517433487,6.51743E+11,20211129,17:41,CYCLE1_DAY1,6 H,67.26645935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 968,65RSYC,3-May-22
C1071013,10801002,130,PF-06863135,T,6518789961,6.51879E+11,20211206,10:09,CYCLE1_DAY8,0 H,708.7252546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1152,107RSYC,24-May-22
C1071013,10801002,130,PF-06863135,T,6518789961,6.51879E+11,20211206,16:13,CYCLE1_DAY8,6 H,94.91199862,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1151,107RSYC,24-May-22
C1071013,10801002,130,PF-06863135,T,6517433492,6.51743E+11,20211213,9:22,CYCLE1_DAY15,0 H,878.8435493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 974,66RSYC,3-May-22
C1071013,10801002,130,PF-06863135,T,6518918013,6.51892E+11,20211220,10:26,CYCLE1_DAY22,0 H,943.2373888,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1190,105RSYC,22-May-22
C1071013,10801002,130,PF-06863135,T,6518918015,6.51892E+11,20211227,10:19,CYCLE2_DAY1,0 H,800.2445106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1191,105RSYC,22-May-22
C1071013,10801002,130,PF-06863135,T,6517433517,6.51743E+11,20220110,14:10,END_OF_TRT,,921.9155654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1650,100RSYC,23-May-22
C1071013,10801002,130,PF-06863135,T,6517433503,6.51743E+11,20211130,11:40,CYCLE1_DAY1,24 H,207.128252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 977,66RSYC,3-May-22
C1071013,10801002,130,PF-06863135,T,6517433506,6.51743E+11,20211202,11:43,CYCLE1_DAY4,0 H,704.2767499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 978,66RSYC,3-May-22
C1071013,10801002,130,PF-06863135,T,6517433507,6.51743E+11,20211203,11:00,CYCLE1_DAY4,24 H,966.7036048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 979,66RSYC,3-May-22
C1071013,11001001,131,PF-06863135,T,6216170946,6.21617E+11,20211123,11:15,CYCLE1_DAY1,0 H,281.0034903,NG/ML,,Received as 6216170971-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1289,76RSYC,4-May-22
C1071013,11001001,131,PF-06863135,T,6216170946,6.21617E+11,20211123,18:01,CYCLE1_DAY1,6 H,254.0006809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1277,89RSYC,11-May-22
C1071013,11001001,131,PF-06863135,T,6217163742,6.21716E+11,20211203,12:15,CYCLE1_DAY8,0 H,413.7206337,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1477,55RSYC,30-Apr-22
C1071013,11001001,131,PF-06863135,T,6217163742,6.21716E+11,20211203,17:45,CYCLE1_DAY8,6 H,383.3142916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1476,110RSYC,25-May-22
C1071013,11001001,131,PF-06863135,T,6217163744,6.21716E+11,20211210,16:20,CYCLE1_DAY15,0 H,117.25201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1478,55RSYC,30-Apr-22
C1071013,11001001,131,PF-06863135,T,6216170952,6.21617E+11,20211217,14:00,CYCLE1_DAY22,0 H,877.3715475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1785,71RSYC,7-May-22
C1071013,11001001,131,PF-06863135,T,6217163751,6.21716E+11,20211224,11:50,CYCLE2_DAY1,0 H,873.6445713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1786,71RSYC,7-May-22
C1071013,11001001,131,PF-06863135,T,6216170962,6.21617E+11,20211124,12:20,CYCLE1_DAY1,24 H,105.7938247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1284,89RSYC,11-May-22
C1071013,11001001,131,PF-06863135,T,6216170965,6.21617E+11,20211129,10:01,CYCLE1_DAY4,0 H,702.3774951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1287,89RSYC,11-May-22
C1071013,11001001,131,PF-06863135,T,6217183920,6.21718E+11,20211130,15:00,CYCLE1_DAY4,24 H,89.89426935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1519,56RSYC,30-Apr-22
C1071013,11001002,132,PF-06863135,T,6216170947,6.21617E+11,20211123,11:45,CYCLE1_DAY1,0 H,31.85705288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1279,76RSYC,4-May-22
C1071013,11001002,132,PF-06863135,T,6216170947,6.21617E+11,20211123,18:15,CYCLE1_DAY1,6 H,346.3713288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1278,89RSYC,11-May-22
C1071013,11001002,132,PF-06863135,T,6216170949,6.21617E+11,20211130,11:30,CYCLE1_DAY8,0 H,960.6030129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1281,89RSYC,11-May-22
C1071013,11001002,132,PF-06863135,T,6216170949,6.21617E+11,20211130,17:15,CYCLE1_DAY8,6 H,590.1817981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1280,89RSYC,11-May-22
C1071013,11001002,132,PF-06863135,T,6217163745,6.21716E+11,20211207,13:00,CYCLE1_DAY15,0 H,221.5204346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1479,55RSYC,30-Apr-22
C1071013,11001002,132,PF-06863135,T,6217163748,6.21716E+11,20211214,10:30,CYCLE1_DAY22,0 H,377.7443163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1480,55RSYC,30-Apr-22
C1071013,11001002,132,PF-06863135,T,6216170954,6.21617E+11,20211221,12:15,CYCLE2_DAY1,0 H,785.4587339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1787,71RSYC,7-May-22
C1071013,11001002,132,PF-06863135,T,6217468784,6.21747E+11,20220120,13:00,CYCLE3_DAY1,0 H,340.6101658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1788,71RSYC,7-May-22
C1071013,11001002,132,PF-06863135,T,6216170963,6.21617E+11,20211124,12:20,CYCLE1_DAY1,24 H,536.4185421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1285,89RSYC,11-May-22
C1071013,11001002,132,PF-06863135,T,6216170964,6.21617E+11,20211125,11:01,CYCLE1_DAY4,0 H,902.8393158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1286,89RSYC,11-May-22
C1071013,11001002,132,PF-06863135,T,6217183957,6.21718E+11,20211126,12:15,CYCLE1_DAY4,24 H,997.2480817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1520,56RSYC,30-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407903,6.21641E+11,20211123,11:45,CYCLE1_DAY1,0 H,33.40180358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 708,31RSYC,23-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407903,6.21641E+11,20211123,19:04,CYCLE1_DAY1,6 H,629.491719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 707,31RSYC,23-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407905,6.21641E+11,20211130,12:35,CYCLE1_DAY8,0 H,284.9026025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1300,49RSYC,29-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407905,6.21641E+11,20211130,18:45,CYCLE1_DAY8,6 H,456.0347943,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1299,49RSYC,29-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407908,6.21641E+11,20211207,13:00,CYCLE1_DAY15,0 H,43.22491168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1301,49RSYC,29-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407910,6.21641E+11,20211214,13:30,CYCLE1_DAY22,0 H,485.7814529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1302,49RSYC,29-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407912,6.21641E+11,20211227,12:55,CYCLE2_DAY1,0 H,687.5837218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1303,49RSYC,29-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407914,6.21641E+11,20220117,13:25,CYCLE3_DAY1,0 H,722.4348823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1798,91RSYC,11-May-22
C1071013,10371002,133,PF-06863135,T,6216407916,6.21641E+11,20220214,8:55,CYCLE4_DAY1,0 H,914.284946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1799,91RSYC,11-May-22
C1071013,10371002,133,PF-06863135,T,6216407918,6.21641E+11,20220509,11:55,CYCLE7_DAY1,0 H,470.23168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1991,114RSYC,25-Jul-22
C1071013,10371002,133,PF-06863135,T,6216407926,6.21641E+11,20220801,13:15,CYCLE10_DAY1,0 H,884.1562087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2056,132RSYC,10-Nov-22
C1071013,10371002,133,PF-06863135,T,6219054603,6.21905E+11,20221024,12:55,CYCLE13_DAY1,0 H,790.13895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2154,140RSYC,22-Mar-23
C1071013,10371002,133,PF-06863135,T,6219054602,6.21905E+11,20230116,13:25,CYCLE16_DAY1,0 H,694.3052437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2176,140RSYC,22-Mar-23
C1071013,10371002,133,PF-06863135,T,6219054604,6.21905E+11,20230412,12:00,CYCLE19_DAY1,0 H,492.329177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2232,142RSYC,18-May-23
C1071013,10371002,133,PF-06863135,T,6220666023,6.22067E+11,20230710,9:10,CYCLE22_DAY1,0 H,802.8005955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2279,144RSYC,27-Nov-23
C1071013,10371002,133,PF-06863135,T,6220666022,6.22067E+11,20231002,13:20,CYCLE25_DAY1,0 H,846.8761912,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2318,147RSYC,29-Feb-24
C1071013,10371002,133,PF-06863135,T,6220666026,6.22067E+11,20231227,13:30,CYCLE28_DAY1,0 H,668.7613767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2352,148RSYC,27-Mar-24
C1071013,10371002,133,PF-06863135,T,6222511475,6.22251E+11,,,CYCLE31_DAY1,0 H,719.6224984,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,10371002,133,PF-06863135,T,6216407919,6.21641E+11,20211124,13:05,CYCLE1_DAY1,24 H,424.3812457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 709,31RSYC,23-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407922,6.21641E+11,20211126,12:50,CYCLE1_DAY4,0 H,766.4592974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1304,49RSYC,29-Apr-22
C1071013,10371002,133,PF-06863135,T,6216407923,6.21641E+11,20211127,12:55,CYCLE1_DAY4,24 H,821.1343454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1305,49RSYC,29-Apr-22
C1071013,11061004,134,PF-06863135,T,6217193486,6.21719E+11,20211122,15:00,CYCLE1_DAY1,0 H,401.8106688,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1524,56RSYC,30-Apr-22
C1071013,11061004,134,PF-06863135,T,6217165070,6.21717E+11,20211129,10:00,CYCLE1_DAY8,0 H,537.388213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1487,55RSYC,30-Apr-22
C1071013,11061004,134,PF-06863135,T,6217165070,6.21717E+11,20211129,20:00,CYCLE1_DAY8,6 H,707.1878879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1486,55RSYC,30-Apr-22
C1071013,11061004,134,PF-06863135,T,6217165076,6.21717E+11,20211207,10:30,CYCLE1_DAY15,0 H,111.9949851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1491,55RSYC,30-Apr-22
C1071013,11061004,134,PF-06863135,T,6217193504,6.21719E+11,20211220,9:00,CYCLE2_DAY1,0 H,877.434464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1800,91RSYC,11-May-22
C1071013,11061004,134,PF-06863135,T,6217193533,6.21719E+11,20211124,17:00,CYCLE1_DAY1,24 H,560.5136656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1529,56RSYC,30-Apr-22
C1071013,11061004,134,PF-06863135,T,6217165091,6.21717E+11,20211125,13:00,CYCLE1_DAY4,0 H,605.5475243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1495,55RSYC,30-Apr-22
C1071013,10101005,135,PF-06863135,T,6518706272,6.51871E+11,20211124,10:25,CYCLE1_DAY1,0 H,876.8035512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 683,30RSYC,22-Apr-22
C1071013,10101005,135,PF-06863135,T,6518706272,6.51871E+11,20211124,20:10,CYCLE1_DAY1,6 H,710.1871603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 682,30RSYC,22-Apr-22
C1071013,10101005,135,PF-06863135,T,6518558178,6.51856E+11,20211201,8:00,CYCLE1_DAY8,0 H,580.4052997,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1107,67RSYC,8-May-22
C1071013,10101005,135,PF-06863135,T,6518558178,6.51856E+11,20211201,16:20,CYCLE1_DAY8,6 H,167.3412772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1106,67RSYC,8-May-22
C1071013,10101005,135,PF-06863135,T,6518447643,6.51845E+11,20211208,8:00,CYCLE1_DAY15,0 H,545.4445302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1102,67RSYC,8-May-22
C1071013,10101005,135,PF-06863135,T,6518706281,6.51871E+11,20211215,11:05,CYCLE1_DAY22,0 H,224.764259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1135,94RSYC,12-May-22
C1071013,10101005,135,PF-06863135,T,6518922661,6.51892E+11,20211221,12:32,CYCLE2_DAY1,0 H,782.7597605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1195,105RSYC,22-May-22
C1071013,10101005,135,PF-06863135,T,6518877336,6.51888E+11,20220119,8:50,CYCLE3_DAY1,0 H,198.4750214,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1614,97RSYC,12-May-22
C1071013,10101005,135,PF-06863135,T,6517559665,6.51756E+11,20220214,8:05,CYCLE4_DAY1,0 H,505.484013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1613,97RSYC,12-May-22
C1071013,10101005,135,PF-06863135,T,6517559667,6.51756E+11,20220510,9:13,CYCLE7_DAY1,0 H,600.9450434,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1974,114RSYC,25-Jul-22
C1071013,10101005,135,PF-06863135,T,6517559684,6.51756E+11,20220524,13:40,END_OF_TRT,,493.0651069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1976,114RSYC,25-Jul-22
C1071013,10101005,135,PF-06863135,T,6518558184,6.51856E+11,20211125,12:25,CYCLE1_DAY1,24 H,258.6802049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 681,30RSYC,22-Apr-22
C1071013,10101005,135,PF-06863135,T,6518706293,6.51871E+11,20211128,13:20,CYCLE1_DAY4,0 H,848.8322697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1136,94RSYC,12-May-22
C1071013,10101005,135,PF-06863135,T,6518447648,6.51845E+11,20211129,12:30,CYCLE1_DAY4,24 H,651.2974711,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1105,87RSYC,13-May-22
C1071013,10461006,136,PF-06863135,T,6217039130,6.21704E+11,20211124,9:45,CYCLE1_DAY1,0 H,526.6144149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1435,57RSYC,30-Apr-22
C1071013,10461006,136,PF-06863135,T,6217039130,6.21704E+11,20211124,18:20,CYCLE1_DAY1,6 H,706.9578592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1434,57RSYC,30-Apr-22
C1071013,10461006,136,PF-06863135,T,6217039132,6.21704E+11,20211202,11:30,CYCLE1_DAY8,0 H,322.9300917,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1438,57RSYC,30-Apr-22
C1071013,10461006,136,PF-06863135,T,6217039132,6.21704E+11,20211202,18:40,CYCLE1_DAY8,6 H,271.8435709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1437,57RSYC,30-Apr-22
C1071013,10461006,136,PF-06863135,T,6217283550,6.21728E+11,20211125,12:20,CYCLE1_DAY1,24 H,381.1715775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 812,34RSYC,24-Apr-22
C1071013,10461006,136,PF-06863135,T,6217039138,6.21704E+11,20211129,10:23,CYCLE1_DAY4,0 H,919.3379189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 775,33RSYC,24-Apr-22
C1071013,10461006,136,PF-06863135,T,6217039141,6.21704E+11,20211130,15:00,CYCLE1_DAY4,24 H,335.9977679,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1442,108RSYC,24-May-22
C1071013,10161004,137,PF-06863135,T,6518935555,6.51894E+11,20211124,9:25,CYCLE1_DAY1,0 H,507.6189181,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1226,87RSYC,13-May-22
C1071013,10161004,137,PF-06863135,T,6518935555,6.51894E+11,20211124,16:38,CYCLE1_DAY1,6 H,677.0376884,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1225,46RSYC,28-Apr-22
C1071013,10161004,137,PF-06863135,T,6517697444,6.5177E+11,20211202,10:21,CYCLE1_DAY8,0 H,125.5063344,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1055,40RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6517697444,6.5177E+11,20211202,16:58,CYCLE1_DAY8,6 H,225.0547906,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1054,40RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6517697445,6.5177E+11,20211208,10:20,CYCLE1_DAY15,0 H,675.2726532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1056,41RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6517697448,6.5177E+11,20211216,10:03,CYCLE1_DAY22,0 H,687.1575343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1059,41RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6517697450,6.5177E+11,20211222,10:19,CYCLE2_DAY1,0 H,496.8491869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1061,41RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6519082806,6.51908E+11,20220118,10:54,CYCLE3_DAY1,0 H,77.84695563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1605,97RSYC,12-May-22
C1071013,10161004,137,PF-06863135,T,6517697471,6.5177E+11,20220225,8:47,END_OF_TRT,,899.1875498,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1888,87RSYC,13-May-22
C1071013,10161004,137,PF-06863135,T,6517697457,6.5177E+11,20211125,10:55,CYCLE1_DAY1,24 H,497.0782561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1062,41RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6517697459,6.5177E+11,20211127,11:03,CYCLE1_DAY4,0 H,312.7256755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1063,41RSYC,26-Apr-22
C1071013,10161004,137,PF-06863135,T,6518935578,6.51894E+11,20211128,10:06,CYCLE1_DAY4,24 H,164.7198889,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1241,47RSYC,28-Apr-22
C1071013,10251004,138,PF-06863135,T,6519212001,6.51921E+11,20211217,12:30,CYCLE1_DAY1,0 H,420.4426478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1272,76RSYC,4-May-22
C1071013,10251004,138,PF-06863135,T,6519212001,6.51921E+11,20211217,18:30,CYCLE1_DAY1,6 H,615.5185936,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1675,101RSYC,13-May-22
C1071013,10251004,138,PF-06863135,T,6519158571,6.51916E+11,20211227,7:33,CYCLE1_DAY8,0 H,966.2782337,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1269,89RSYC,11-May-22
C1071013,10251004,138,PF-06863135,T,6519158571,6.51916E+11,20211227,17:09,CYCLE1_DAY8,6 H,546.1196028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1268,89RSYC,11-May-22
C1071013,10251004,138,PF-06863135,T,6517559624,6.51756E+11,20220104,8:00,CYCLE1_DAY15,0 H,290.2008629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1672,101RSYC,13-May-22
C1071013,10251004,138,PF-06863135,T,6519138066,6.51914E+11,20220111,9:30,CYCLE1_DAY22,0 H,279.1719692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1673,101RSYC,13-May-22
C1071013,10251004,138,PF-06863135,T,6519158572,6.51916E+11,20220118,11:50,CYCLE2_DAY1,0 H,322.1253796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1674,109RSYC,25-May-22
C1071013,10251004,138,PF-06863135,T,6517559630,6.51756E+11,20220215,13:30,CYCLE3_DAY1,0 H,52.23664594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1671,101RSYC,13-May-22
C1071013,10251004,138,PF-06863135,T,6519204946,6.5192E+11,20220315,13:25,CYCLE4_DAY1,0 H,153.8955594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1901,81RSYC,4-May-22
C1071013,10251004,138,PF-06863135,T,6519204948,6.5192E+11,20220906,10:11,CYCLE10_DAY1,0 H,744.5401835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2086,129RSYC,21-Oct-22
C1071013,10251004,138,PF-06863135,T,6517559649,6.51756E+11,20230207,11:50,END_OF_TRT,,528.3582361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2195,141RSYC,17-May-23
C1071013,10251004,138,PF-06863135,T,6520939733,6.52094E+11,20220621,12:35,UNPL,9001 H,817.7581421,NG/ML,,Received as 6517559633-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2268,145RSYC,4-Jan-24
C1071013,10251004,138,PF-06863135,T,6519211968,6.51921E+11,20211218,12:35,CYCLE1_DAY1,24 H,536.0615894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1271,89RSYC,11-May-22
C1071013,10251004,138,PF-06863135,T,6519206322,6.51921E+11,20211220,11:14,CYCLE1_DAY4,0 H,548.0188003,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1270,89RSYC,11-May-22
C1071013,10251004,138,PF-06863135,T,6519219388,6.51922E+11,20211221,8:40,CYCLE1_DAY4,24 H,964.4915721,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1273,89RSYC,11-May-22
C1071013,10161002,139,PF-06863135,T,6518935553,6.51894E+11,20211129,10:34,CYCLE1_DAY1,0 H,373.8877492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1222,87RSYC,13-May-22
C1071013,10161002,139,PF-06863135,T,6518935553,6.51894E+11,20211129,17:11,CYCLE1_DAY1,6 H,765.293961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1221,46RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6518935558,6.51894E+11,20211206,8:49,CYCLE1_DAY8,0 H,375.9628895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1230,46RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6518935558,6.51894E+11,20211206,15:54,CYCLE1_DAY8,6 H,617.3875225,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1229,46RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6518935563,6.51894E+11,20211213,8:21,CYCLE1_DAY15,0 H,94.3478129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1234,46RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6518935571,6.51894E+11,20211220,8:02,CYCLE1_DAY22,0 H,883.4260232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1236,47RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6519057401,6.51906E+11,20211229,9:27,CYCLE2_DAY1,0 H,317.9218893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1267,89RSYC,11-May-22
C1071013,10161002,139,PF-06863135,T,6519057403,6.51906E+11,20220126,8:30,CYCLE3_DAY1,0 H,873.3173122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1603,97RSYC,12-May-22
C1071013,10161002,139,PF-06863135,T,6517697472,6.5177E+11,20220228,10:57,END_OF_TRT,,307.283574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1887,87RSYC,13-May-22
C1071013,10161002,139,PF-06863135,T,6518935574,6.51894E+11,20211130,11:48,CYCLE1_DAY1,24 H,740.1649588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1238,47RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6518981611,6.51898E+11,20211202,10:31,CYCLE1_DAY4,0 H,513.8095644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1259,47RSYC,28-Apr-22
C1071013,10161002,139,PF-06863135,T,6517697462,6.5177E+11,20211203,10:02,CYCLE1_DAY4,24 H,194.89032,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1064,41RSYC,26-Apr-22
C1071013,10711001,140,PF-06863135,T,6216408107,6.21641E+11,20211130,10:40,CYCLE1_DAY1,0 H,46.51154086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1321,76RSYC,4-May-22
C1071013,10711001,140,PF-06863135,T,6216408107,6.21641E+11,20211130,16:40,CYCLE1_DAY1,6 H,749.9421295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1320,49RSYC,29-Apr-22
C1071013,10711001,140,PF-06863135,T,6216408110,6.21641E+11,20211210,9:00,CYCLE1_DAY8,0 H,977.3636926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1323,49RSYC,29-Apr-22
C1071013,10711001,140,PF-06863135,T,6216408110,6.21641E+11,20211210,18:00,CYCLE1_DAY8,6 H,77.47525432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1322,49RSYC,29-Apr-22
C1071013,10711001,140,PF-06863135,T,6216408138,6.21641E+11,20211222,12:30,END_OF_TRT,,787.7747596,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1326,108RSYC,24-May-22
C1071013,10711001,140,PF-06863135,T,6216408124,6.21641E+11,20211201,10:40,CYCLE1_DAY1,24 H,362.5877577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1324,49RSYC,29-Apr-22
C1071013,10711001,140,PF-06863135,T,6216408126,6.21641E+11,20211203,12:50,CYCLE1_DAY4,0 H,871.4727779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1325,49RSYC,29-Apr-22
C1071013,10031014,141,PF-06863135,T,6517473908,6.51747E+11,20211206,10:18,CYCLE1_DAY1,0 H,940.4561469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1005,39RSYC,26-Apr-22
C1071013,10031014,141,PF-06863135,T,6517473908,6.51747E+11,20211206,16:40,CYCLE1_DAY1,6 H,426.5978561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1004,39RSYC,26-Apr-22
C1071013,10031014,141,PF-06863135,T,6516580387,6.51658E+11,20211223,9:43,CYCLE1_DAY8,0 H,114.2535399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1939,123RSYC,29-Jul-22
C1071013,10031014,141,PF-06863135,T,6516580387,6.51658E+11,20211223,16:12,CYCLE1_DAY8,6 H,544.7684505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1940,123RSYC,29-Jul-22
C1071013,10031014,141,PF-06863135,T,6518620842,6.51862E+11,20211229,11:57,CYCLE1_DAY15,0 H,3.372289271,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1941,123RSYC,29-Jul-22
C1071013,10031014,141,PF-06863135,T,6517751574,6.51775E+11,20220105,11:08,CYCLE1_DAY22,0 H,665.4795637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1942,123RSYC,29-Jul-22
C1071013,10031014,141,PF-06863135,T,6517751579,6.51775E+11,20220113,10:20,CYCLE2_DAY1,0 H,383.6566294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1943,124RSYC,29-Jul-22
C1071013,10031014,141,PF-06863135,T,6516580412,6.51658E+11,20220209,12:05,CYCLE3_DAY1,0 H,105.9869975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1624,85RSYC,10-May-22
C1071013,10031014,141,PF-06863135,T,6518620856,6.51862E+11,20220309,12:32,CYCLE4_DAY1,0 H,467.155752,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1893,81RSYC,4-May-22
C1071013,10031014,141,PF-06863135,T,6517751595,6.51775E+11,20220601,10:20,CYCLE7_DAY1,0 H,362.0562442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2012,122RSYC,29-Jul-22
C1071013,10031014,141,PF-06863135,T,6517751598,6.51775E+11,20220825,9:53,CYCLE10_DAY1,0 H,998.6858849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2081,131RSYC,9-Nov-22
C1071013,10031014,141,PF-06863135,T,6517472383,6.51747E+11,20211207,9:13,CYCLE1_DAY1,24 H,795.3316418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 990,86RSYC,13-May-22
C1071013,10031014,141,PF-06863135,T,6517472382,6.51747E+11,20211214,11:50,CYCLE1_DAY4,0 H,36.76909672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1966,126RSYC,1-Aug-22
C1071013,10031014,141,PF-06863135,T,6517473939,6.51747E+11,20211215,12:38,CYCLE1_DAY4,24 H,294.3754832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1971,114RSYC,25-Jul-22
C1071013,10931003,142,PF-06863135,T,6518778264,6.51878E+11,20211129,15:10,CYCLE1_DAY1,0 H,507.7372236,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1143,95RSYC,13-May-22
C1071013,10931003,142,PF-06863135,T,6518778264,6.51878E+11,20211129,21:17,CYCLE1_DAY1,6 H,790.6028548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1142,95RSYC,13-May-22
C1071013,10931003,142,PF-06863135,T,6518778267,6.51878E+11,20211206,13:22,CYCLE1_DAY8,0 H,312.7629298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1145,95RSYC,13-May-22
C1071013,10931003,142,PF-06863135,T,6518778267,6.51878E+11,20211206,19:15,CYCLE1_DAY8,6 H,520.1932317,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1144,95RSYC,13-May-22
C1071013,10931003,142,PF-06863135,T,6518934232,6.51893E+11,20211213,13:47,CYCLE1_DAY15,0 H,686.2680159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1208,46RSYC,28-Apr-22
C1071013,10931003,142,PF-06863135,T,6518934233,6.51893E+11,20211220,12:18,CYCLE1_DAY22,0 H,60.69373193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1209,46RSYC,28-Apr-22
C1071013,10931003,142,PF-06863135,T,6518934238,6.51893E+11,20211227,14:16,CYCLE2_DAY1,0 H,118.4802367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1712,72RSYC,7-May-22
C1071013,10931003,142,PF-06863135,T,6518934244,6.51893E+11,20220126,13:23,CYCLE3_DAY1,0 H,764.7741573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1713,72RSYC,7-May-22
C1071013,10931003,142,PF-06863135,T,6519290804,6.51929E+11,20220216,9:59,END_OF_TRT,,7.777813903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1714,122RSYC,29-Jul-22
C1071013,10931003,142,PF-06863135,T,6518934248,6.51893E+11,20211130,15:17,CYCLE1_DAY1,24 H,779.7107579,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1210,46RSYC,28-Apr-22
C1071013,10931003,142,PF-06863135,T,6518934251,6.51893E+11,20211202,14:15,CYCLE1_DAY4,0 H,311.9508173,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1213,46RSYC,28-Apr-22
C1071013,10931003,142,PF-06863135,T,6518934254,6.51893E+11,20211203,14:30,CYCLE1_DAY4,24 H,548.6129187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1216,87RSYC,13-May-22
C1071013,10801003,143,PF-06863135,T,6518789960,6.51879E+11,20211206,11:15,CYCLE1_DAY1,0 H,466.1391091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1150,107RSYC,24-May-22
C1071013,10801003,143,PF-06863135,T,6518789960,6.51879E+11,20211206,17:45,CYCLE1_DAY1,6 H,562.3664831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1149,87RSYC,13-May-22
C1071013,10801003,143,PF-06863135,T,6517433489,6.51743E+11,20211213,10:40,CYCLE1_DAY8,0 H,990.6771259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 971,66RSYC,3-May-22
C1071013,10801003,143,PF-06863135,T,6517433489,6.51743E+11,20211213,17:10,CYCLE1_DAY8,6 H,653.3069141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 970,66RSYC,3-May-22
C1071013,10801003,143,PF-06863135,T,6518918011,6.51892E+11,20211220,10:10,CYCLE1_DAY15,0 H,120.6642525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1189,105RSYC,22-May-22
C1071013,10801003,143,PF-06863135,T,6518789966,6.51879E+11,20211227,8:40,CYCLE1_DAY22,0 H,342.051158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1153,107RSYC,24-May-22
C1071013,10801003,143,PF-06863135,T,6518789967,6.51879E+11,20220103,9:40,CYCLE2_DAY1,0 H,406.8634438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1651,100RSYC,23-May-22
C1071013,10801003,143,PF-06863135,T,6519494494,6.51949E+11,20220215,8:18,END_OF_TRT,,991.4482791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1652,100RSYC,23-May-22
C1071013,10801003,143,PF-06863135,T,6518918024,6.51892E+11,20211207,12:00,CYCLE1_DAY1,24 H,760.6301917,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1192,105RSYC,22-May-22
C1071013,10801003,143,PF-06863135,T,6518918028,6.51892E+11,20211209,13:17,CYCLE1_DAY4,0 H,897.618403,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1193,105RSYC,22-May-22
C1071013,10801003,143,PF-06863135,T,6518918029,6.51892E+11,20211210,13:32,CYCLE1_DAY4,24 H,825.4399871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1194,105RSYC,22-May-22
C1071013,10741002,144,PF-06863135,T,6518931447,6.51893E+11,20211130,10:45,CYCLE1_DAY1,0 H,228.445105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1199,105RSYC,22-May-22
C1071013,10741002,144,PF-06863135,T,6518931447,6.51893E+11,20211130,18:19,CYCLE1_DAY1,6 H,137.6463211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1198,105RSYC,22-May-22
C1071013,10741002,144,PF-06863135,T,6518935637,6.51894E+11,20211208,9:05,CYCLE1_DAY8,0 H,700.1118048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1244,47RSYC,28-Apr-22
C1071013,10741002,144,PF-06863135,T,6518935637,6.51894E+11,20211208,17:40,CYCLE1_DAY8,6 H,521.0283936,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1243,47RSYC,28-Apr-22
C1071013,10741002,144,PF-06863135,T,6517472578,6.51747E+11,20211214,9:58,CYCLE1_DAY15,0 H,847.4818961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 996,39RSYC,26-Apr-22
C1071013,10741002,144,PF-06863135,T,6518693896,6.51869E+11,20211222,9:27,CYCLE1_DAY22,0 H,412.8058808,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1130,94RSYC,12-May-22
C1071013,10741002,144,PF-06863135,T,6519029236,6.51903E+11,20211229,10:47,CYCLE2_DAY1,0 H,569.6494811,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1264,47RSYC,28-Apr-22
C1071013,10741002,144,PF-06863135,T,6517472605,6.51747E+11,20220126,10:05,END_OF_TRT,,102.3107334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1657,100RSYC,23-May-22
C1071013,10741002,144,PF-06863135,T,6517472590,6.51747E+11,20211201,12:28,CYCLE1_DAY1,24 H,646.5033923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 999,39RSYC,26-Apr-22
C1071013,10741002,144,PF-06863135,T,6518693900,6.51869E+11,20211203,9:32,CYCLE1_DAY4,0 H,58.53828127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1132,94RSYC,12-May-22
C1071013,10741002,144,PF-06863135,T,6517472594,6.51747E+11,20211204,12:23,CYCLE1_DAY4,24 H,378.2039427,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1002,39RSYC,26-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725161,6.21673E+11,20211130,11:04,CYCLE1_DAY1,0 H,167.934252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1344,50RSYC,29-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725161,6.21673E+11,20211130,17:40,CYCLE1_DAY1,6 H,459.8821346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1343,87RSYC,13-May-22
C1071013,10051001,145,PF-06863135,T,6216725163,6.21673E+11,20211207,10:30,CYCLE1_DAY8,0 H,545.9222962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1347,50RSYC,29-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725163,6.21673E+11,20211207,17:15,CYCLE1_DAY8,6 H,637.0143219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1346,50RSYC,29-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725165,6.21673E+11,20211215,10:30,CYCLE1_DAY15,0 H,910.2198674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1349,50RSYC,29-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725169,6.21673E+11,20211229,11:30,CYCLE2_DAY1,0 H,731.260143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1740,90RSYC,11-May-22
C1071013,10051001,145,PF-06863135,T,6216725170,6.21673E+11,20220128,11:00,CYCLE3_DAY1,0 H,149.8805478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1741,90RSYC,11-May-22
C1071013,10051001,145,PF-06863135,T,6217930298,6.21793E+11,20220225,10:00,CYCLE4_DAY1,0 H,99.45435316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1742,90RSYC,11-May-22
C1071013,10051001,145,PF-06863135,T,6216725182,6.21673E+11,20220812,10:00,CYCLE10_DAY1,0 H,893.4224083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2046,132RSYC,10-Nov-22
C1071013,10051001,145,PF-06863135,T,6217309165,6.21731E+11,20221028,10:30,CYCLE13_DAY1,0 H,672.1509818,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2155,140RSYC,22-Mar-23
C1071013,10051001,145,PF-06863135,T,6218988074,6.21899E+11,20220603,12:00,UNPL,9001 H,981.8160302,NG/ML,,Received as 6217930299-09,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2017,115RSYC,25-Jul-22
C1071013,10051001,145,PF-06863135,T,6216725177,6.21673E+11,20211201,11:40,CYCLE1_DAY1,24 H,817.5586637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1351,50RSYC,29-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725179,6.21673E+11,20211203,10:30,CYCLE1_DAY4,0 H,414.8103946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1353,50RSYC,29-Apr-22
C1071013,10051001,145,PF-06863135,T,6216725180,6.21673E+11,20211204,11:10,CYCLE1_DAY4,24 H,305.0147215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1354,50RSYC,29-Apr-22
C1071013,10461007,146,PF-06863135,T,6217283542,6.21728E+11,20211130,11:10,CYCLE1_DAY1,0 H,153.4796339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1562,58RSYC,1-May-22
C1071013,10461007,146,PF-06863135,T,6217283542,6.21728E+11,20211130,17:45,CYCLE1_DAY1,6 H,742.8588121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1561,58RSYC,1-May-22
C1071013,10461007,146,PF-06863135,T,6217283543,6.21728E+11,20211206,8:00,CYCLE1_DAY8,0 H,72.33254612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1564,58RSYC,1-May-22
C1071013,10461007,146,PF-06863135,T,6217283543,6.21728E+11,20211206,18:14,CYCLE1_DAY8,6 H,688.4954461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1563,58RSYC,1-May-22
C1071013,10461007,146,PF-06863135,T,6217368115,6.21737E+11,20211213,10:50,CYCLE1_DAY15,0 H,514.8974746,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1829,92RSYC,12-May-22
C1071013,10461007,146,PF-06863135,T,6217340171,6.21734E+11,20211227,14:05,CYCLE2_DAY1,0 H,553.5375955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1828,92RSYC,12-May-22
C1071013,10461007,146,PF-06863135,T,6217142649,6.21714E+11,20220112,16:45,END_OF_TRT,,635.1773452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1827,86RSYC,13-May-22
C1071013,10461007,146,PF-06863135,T,6217233438,6.21723E+11,20211201,12:18,CYCLE1_DAY1,24 H,892.5603596,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1539,58RSYC,1-May-22
C1071013,10461007,146,PF-06863135,T,6217133173,6.21713E+11,20211202,11:15,CYCLE1_DAY4,0 H,904.1843857,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1462,54RSYC,30-Apr-22
C1071013,10461007,146,PF-06863135,T,6217133177,6.21713E+11,20211203,11:35,CYCLE1_DAY4,24 H,550.7956105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1463,54RSYC,30-Apr-22
C1071013,11001005,147,PF-06863135,T,6217163736,6.21716E+11,20211130,11:00,CYCLE1_DAY1,0 H,144.0024344,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1471,54RSYC,30-Apr-22
C1071013,11001005,147,PF-06863135,T,6217163736,6.21716E+11,20211130,17:00,CYCLE1_DAY1,6 H,848.9770897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1470,54RSYC,30-Apr-22
C1071013,11001005,147,PF-06863135,T,6217163741,6.21716E+11,20211206,10:15,CYCLE1_DAY8,0 H,715.7012325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1475,105RSYC,22-May-22
C1071013,11001005,147,PF-06863135,T,6217163741,6.21716E+11,20211206,18:20,CYCLE1_DAY8,6 H,344.8988989,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1474,54RSYC,30-Apr-22
C1071013,11001005,147,PF-06863135,T,6216170950,6.21617E+11,20211213,9:30,CYCLE1_DAY15,0 H,98.5198938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1282,89RSYC,11-May-22
C1071013,11001005,147,PF-06863135,T,6216170953,6.21617E+11,20211220,9:35,CYCLE1_DAY22,0 H,428.7306452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1789,71RSYC,7-May-22
C1071013,11001005,147,PF-06863135,T,6217163753,6.21716E+11,20211227,9:30,CYCLE2_DAY1,0 H,641.816916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1790,71RSYC,7-May-22
C1071013,11001005,147,PF-06863135,T,6217468785,6.21747E+11,20220124,10:30,CYCLE3_DAY1,0 H,660.0984831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1792,71RSYC,7-May-22
C1071013,11001005,147,PF-06863135,T,6217366245,6.21737E+11,20220222,11:20,CYCLE4_DAY1,0 H,916.4651302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1791,71RSYC,7-May-22
C1071013,11001005,147,PF-06863135,T,6216170961,6.21617E+11,20220516,11:15,CYCLE7_DAY1,0 H,399.4406042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2054,132RSYC,10-Nov-22
C1071013,11001005,147,PF-06863135,T,6217183911,6.21718E+11,20220808,11:00,CYCLE10_DAY1,0 H,90.00094964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2055,132RSYC,10-Nov-22
C1071013,11001005,147,PF-06863135,T,6219556971,6.21956E+11,20221031,13:35,CYCLE13_DAY1,0 H,708.4798869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2164,140RSYC,22-Mar-23
C1071013,11001005,147,PF-06863135,T,6216170951,6.21617E+11,20211201,11:00,CYCLE1_DAY1,24 H,196.0504341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1283,89RSYC,11-May-22
C1071013,11001005,147,PF-06863135,T,6216170967,6.21617E+11,20211202,15:00,CYCLE1_DAY4,0 H,350.1177399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1288,84RSYC,10-May-22
C1071013,11001005,147,PF-06863135,T,6217163749,6.21716E+11,20211203,11:00,CYCLE1_DAY4,24 H,540.505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1481,55RSYC,30-Apr-22
C1071013,10901004,148,PF-06863135,T,6519266723,6.51927E+11,20211130,12:00,CYCLE1_DAY1,0 H,209.8305273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2096,141RSYC,17-May-23
C1071013,10901004,148,PF-06863135,T,6519266723,6.51927E+11,20211130,19:20,CYCLE1_DAY1,6 H,426.3624593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1902,81RSYC,4-May-22
C1071013,10901004,148,PF-06863135,T,6517433524,6.51743E+11,20211209,11:00,CYCLE1_DAY8,0 H,993.2539013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 981,66RSYC,3-May-22
C1071013,10901004,148,PF-06863135,T,6517433524,6.51743E+11,20211209,16:30,CYCLE1_DAY8,6 H,986.0239236,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 980,66RSYC,3-May-22
C1071013,10901004,148,PF-06863135,T,6518828367,6.51883E+11,20211214,11:20,CYCLE1_DAY15,0 H,740.1382995,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1162,108RSYC,24-May-22
C1071013,10901004,148,PF-06863135,T,6517433527,6.51743E+11,20211221,12:50,CYCLE1_DAY22,0 H,614.269318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 983,66RSYC,3-May-22
C1071013,10901004,148,PF-06863135,T,6517433530,6.51743E+11,20211228,16:40,CYCLE2_DAY1,0 H,487.1857747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1678,101RSYC,13-May-22
C1071013,10901004,148,PF-06863135,T,6517433532,6.51743E+11,20220125,11:30,CYCLE3_DAY1,0 H,842.8613522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1677,101RSYC,13-May-22
C1071013,10901004,148,PF-06863135,T,6519231707,6.51923E+11,20220222,13:25,CYCLE4_DAY1,0 H,553.8761644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1679,101RSYC,13-May-22
C1071013,10901004,148,PF-06863135,T,6517433535,6.51743E+11,20220517,11:33,CYCLE7_DAY1,0 H,670.2374204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1964,114RSYC,25-Jul-22
C1071013,10901004,148,PF-06863135,T,6518807251,6.51881E+11,20220809,12:22,CYCLE10_DAY1,0 H,68.02185946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2087,127RSYC,19-Oct-22
C1071013,10901004,148,PF-06863135,T,6518807252,6.51881E+11,20221101,15:00,CYCLE13_DAY1,0 H,275.0025522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2146,139RSYC,22-Mar-23
C1071013,10901004,148,PF-06863135,T,6522393540,6.52239E+11,20230124,15:45,CYCLE16_DAY1,0 H,64.62170227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2249,143RSYC,27-Nov-23
C1071013,10901004,148,PF-06863135,T,6522242183,6.52224E+11,20230418,14:00,CYCLE19_DAY1,0 H,897.7606837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2220,142RSYC,18-May-23
C1071013,10901004,148,PF-06863135,T,6522242179,6.52224E+11,20230711,13:05,CYCLE22_DAY1,0 H,593.2304077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2285,145RSYC,4-Jan-24
C1071013,10901004,148,PF-06863135,T,6525460187,6.52546E+11,20240228,13:41,END_OF_TRT,,586.2155935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2365,152RSYC,9-Apr-24
C1071013,10901004,148,PF-06863135,T,6517433548,6.51743E+11,20211210,11:22,UNPL,9002 H,265.5675298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 986,86RSYC,13-May-22
C1071013,10901004,148,PF-06863135,T,6515447313,6.51545E+11,20211201,13:10,CYCLE1_DAY1,24 H,814.4466276,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1676,109RSYC,25-May-22
C1071013,10901004,148,PF-06863135,T,6517433540,6.51743E+11,20211203,14:55,CYCLE1_DAY4,0 H,549.7072679,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 984,88RSYC,11-May-22
C1071013,10901004,148,PF-06863135,T,6517433542,6.51743E+11,20211204,14:20,CYCLE1_DAY4,24 H,465.5693735,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 985,66RSYC,3-May-22
C1071013,10041001,149,PF-06863135,T,6216725194,6.21673E+11,20211201,8:00,CYCLE1_DAY1,0 H,41.37502338,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1357,76RSYC,4-May-22
C1071013,10041001,149,PF-06863135,T,6216725194,6.21673E+11,20211201,18:25,CYCLE1_DAY1,6 H,525.8117562,NG/ML,11,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1356,84RSYC,10-May-22
C1071013,10041001,149,PF-06863135,T,6216725196,6.21673E+11,20211209,7:45,CYCLE1_DAY8,0 H,91.05304907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1359,84RSYC,10-May-22
C1071013,10041001,149,PF-06863135,T,6216725196,6.21673E+11,20211209,19:40,CYCLE1_DAY8,6 H,108.2870267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1358,84RSYC,10-May-22
C1071013,10041001,149,PF-06863135,T,6216725199,6.21673E+11,20211216,8:00,CYCLE1_DAY15,0 H,635.1959792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1360,84RSYC,10-May-22
C1071013,10041001,149,PF-06863135,T,6216725200,6.21673E+11,20211223,7:30,CYCLE1_DAY22,0 H,994.3429042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1361,84RSYC,10-May-22
C1071013,10041001,149,PF-06863135,T,6216725203,6.21673E+11,20211230,9:30,CYCLE2_DAY1,0 H,938.7968218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1737,72RSYC,7-May-22
C1071013,10041001,149,PF-06863135,T,6216725204,6.21673E+11,20220127,9:00,CYCLE3_DAY1,0 H,168.0759628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1738,90RSYC,11-May-22
C1071013,10041001,149,PF-06863135,T,6216725207,6.21673E+11,20220224,9:35,CYCLE4_DAY1,0 H,764.1775876,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1739,90RSYC,11-May-22
C1071013,10041001,149,PF-06863135,T,6216725208,6.21673E+11,20220519,9:30,CYCLE7_DAY1,0 H,92.29438641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1993,115RSYC,25-Jul-22
C1071013,10041001,149,PF-06863135,T,6217233005,6.21723E+11,20220811,9:10,CYCLE10_DAY1,0 H,410.6249301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2045,132RSYC,10-Nov-22
C1071013,10041001,149,PF-06863135,T,6216725210,6.21673E+11,20211202,13:30,CYCLE1_DAY1,24 H,926.170021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1362,84RSYC,10-May-22
C1071013,10041001,149,PF-06863135,T,6216725213,6.21673E+11,20211206,7:05,CYCLE1_DAY4,0 H,746.5701734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1363,84RSYC,10-May-22
C1071013,10161006,150,PF-06863135,T,6518935552,6.51894E+11,20211201,9:14,CYCLE1_DAY1,0 H,361.1290308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1220,87RSYC,13-May-22
C1071013,10161006,150,PF-06863135,T,6518935552,6.51894E+11,20211201,17:42,CYCLE1_DAY1,6 H,40.57138495,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1219,87RSYC,13-May-22
C1071013,10161006,150,PF-06863135,T,6518935560,6.51894E+11,20211208,9:35,CYCLE1_DAY8,0 H,966.0479209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1232,46RSYC,28-Apr-22
C1071013,10161006,150,PF-06863135,T,6518935560,6.51894E+11,20211208,16:52,CYCLE1_DAY8,6 H,379.0760523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1231,46RSYC,28-Apr-22
C1071013,10161006,150,PF-06863135,T,6518935562,6.51894E+11,20211215,10:07,CYCLE1_DAY15,0 H,635.1797917,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1233,46RSYC,28-Apr-22
C1071013,10161006,150,PF-06863135,T,6518935569,6.51894E+11,20211222,10:15,CYCLE1_DAY22,0 H,643.5174962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1235,46RSYC,28-Apr-22
C1071013,10161006,150,PF-06863135,T,6518972840,6.51897E+11,20211230,10:15,CYCLE2_DAY1,0 H,237.9006543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1604,97RSYC,12-May-22
C1071013,10161006,150,PF-06863135,T,6518935573,6.51894E+11,20211202,11:50,CYCLE1_DAY1,24 H,871.1031521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1237,47RSYC,28-Apr-22
C1071013,10161006,150,PF-06863135,T,6518981610,6.51898E+11,20211204,10:16,CYCLE1_DAY4,0 H,771.0537003,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1258,47RSYC,28-Apr-22
C1071013,10161006,150,PF-06863135,T,6518935581,6.51894E+11,20211205,11:40,CYCLE1_DAY4,24 H,195.6760522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1242,47RSYC,28-Apr-22
C1071013,10901005,151,PF-06863135,T,6518772457,6.51877E+11,20211202,16:35,CYCLE1_DAY1,0 H,437.3233389,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1141,95RSYC,13-May-22
C1071013,10901005,151,PF-06863135,T,6518772457,6.51877E+11,20211202,23:45,CYCLE1_DAY1,6 H,325.7898595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1140,95RSYC,13-May-22
C1071013,10901005,151,PF-06863135,T,6518877869,6.51888E+11,20211203,17:30,CYCLE1_DAY1,24 H,871.3776626,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1177,104RSYC,22-May-22
C1071013,10461008,152,PF-06863135,T,6217133144,6.21713E+11,20211202,10:55,CYCLE1_DAY1,0 H,6.68814237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1456,54RSYC,30-Apr-22
C1071013,10461008,152,PF-06863135,T,6217133144,6.21713E+11,20211202,18:32,CYCLE1_DAY1,6 H,373.3227758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1455,54RSYC,30-Apr-22
C1071013,10461008,152,PF-06863135,T,6217368118,6.21737E+11,20211214,6:00,CYCLE1_DAY15,0 H,421.5684076,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1833,93RSYC,12-May-22
C1071013,10461008,152,PF-06863135,T,6217233424,6.21723E+11,20211221,6:00,CYCLE1_DAY22,0 H,544.7370894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1831,92RSYC,12-May-22
C1071013,10461008,152,PF-06863135,T,6217233428,6.21723E+11,20211228,10:20,CYCLE2_DAY1,0 H,964.2896751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1832,93RSYC,12-May-22
C1071013,10461008,152,PF-06863135,T,6217142648,6.21714E+11,20220111,12:10,END_OF_TRT,,857.9867229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1830,86RSYC,13-May-22
C1071013,10461008,152,PF-06863135,T,6217133170,6.21713E+11,20211203,11:15,CYCLE1_DAY1,24 H,68.10718283,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1461,54RSYC,30-Apr-22
C1071013,10461008,152,PF-06863135,T,6217368128,6.21737E+11,20211206,10:54,CYCLE1_DAY4,0 H,941.089078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1579,59RSYC,1-May-22
C1071013,10461008,152,PF-06863135,T,6217283552,6.21728E+11,20211207,11:20,CYCLE1_DAY4,24 H,410.7145963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1567,97RSYC,12-May-22
C1071013,10921005,153,PF-06863135,T,6216725229,6.21673E+11,20211202,11:35,CYCLE1_DAY1,0 H,905.0490211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1367,76RSYC,4-May-22
C1071013,10921005,153,PF-06863135,T,6216725229,6.21673E+11,20211202,21:55,CYCLE1_DAY1,6 H,42.31605203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1366,84RSYC,10-May-22
C1071013,10921005,153,PF-06863135,T,6216725231,6.21673E+11,20211210,11:31,CYCLE1_DAY8,0 H,505.636963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1369,84RSYC,10-May-22
C1071013,10921005,153,PF-06863135,T,6216725231,6.21673E+11,20211210,17:53,CYCLE1_DAY8,6 H,95.25178254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1368,84RSYC,10-May-22
C1071013,10921005,153,PF-06863135,T,6217039333,6.21704E+11,20211217,12:46,CYCLE1_DAY15,0 H,710.5722087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1447,54RSYC,30-Apr-22
C1071013,10921005,153,PF-06863135,T,6216725235,6.21673E+11,20211223,16:30,CYCLE1_DAY22,0 H,687.2171972,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1371,84RSYC,10-May-22
C1071013,10921005,153,PF-06863135,T,6216725236,6.21673E+11,20211230,12:23,CYCLE2_DAY1,0 H,200.6048697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1753,91RSYC,11-May-22
C1071013,10921005,153,PF-06863135,T,6216725239,6.21673E+11,20220127,12:59,CYCLE3_DAY1,0 H,219.7912113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1754,91RSYC,11-May-22
C1071013,10921005,153,PF-06863135,T,6217039355,6.21704E+11,20220224,15:50,CYCLE4_DAY1,0 H,517.34986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1755,91RSYC,11-May-22
C1071013,10921005,153,PF-06863135,T,6217142484,6.21714E+11,20220818,14:30,CYCLE10_DAY1,0 H,332.6353428,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2048,132RSYC,10-Nov-22
C1071013,10921005,153,PF-06863135,T,6219074084,6.21907E+11,20221110,11:05,CYCLE13_DAY1,0 H,736.7242962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2156,140RSYC,22-Mar-23
C1071013,10921005,153,PF-06863135,T,6219074083,6.21907E+11,20230427,13:10,END_OF_TRT,,499.9939699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2238,143RSYC,27-Nov-23
C1071013,10921005,153,PF-06863135,T,6216725253,6.21673E+11,20211203,12:00,UNPL,9001 H,44.69245814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1374,108RSYC,24-May-22
C1071013,10921005,153,PF-06863135,T,6216725244,6.21673E+11,20211203,15:20,CYCLE1_DAY1,24 H,102.0338904,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1372,84RSYC,10-May-22
C1071013,10921005,153,PF-06863135,T,6216725247,6.21673E+11,20211207,10:35,CYCLE1_DAY4,0 H,662.9243114,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1373,84RSYC,10-May-22
C1071013,10921005,153,PF-06863135,T,6217039367,6.21704E+11,20211208,15:10,CYCLE1_DAY4,24 H,746.8364326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1450,54RSYC,30-Apr-22
C1071013,11021013,154,PF-06863135,T,6217233476,6.21723E+11,20211202,16:30,CYCLE1_DAY1,0 H,826.980991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1542,58RSYC,1-May-22
C1071013,11021013,154,PF-06863135,T,6217233476,6.21723E+11,20211202,23:25,CYCLE1_DAY1,6 H,646.8552731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1541,58RSYC,1-May-22
C1071013,11021013,154,PF-06863135,T,6217280311,6.21728E+11,20211213,15:00,CYCLE1_DAY8,0 H,425.1417716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1555,58RSYC,1-May-22
C1071013,11021013,154,PF-06863135,T,6217280311,6.21728E+11,20211213,21:35,CYCLE1_DAY8,6 H,151.480009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1554,58RSYC,1-May-22
C1071013,11021013,154,PF-06863135,T,6217170437,6.21717E+11,20211220,16:05,CYCLE1_DAY15,0 H,221.5806361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1497,55RSYC,30-Apr-22
C1071013,11021013,154,PF-06863135,T,6217170451,6.21717E+11,20211227,14:40,CYCLE1_DAY22,0 H,490.4363041,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1854,93RSYC,12-May-22
C1071013,11021013,154,PF-06863135,T,6217023834,6.21702E+11,20220103,14:00,CYCLE2_DAY1,0 H,529.0067166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1853,93RSYC,12-May-22
C1071013,11021013,154,PF-06863135,T,6217170474,6.21717E+11,20220131,13:50,CYCLE3_DAY1,0 H,171.4122779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1855,93RSYC,12-May-22
C1071013,11021013,154,PF-06863135,T,6217170489,6.21717E+11,20220228,14:30,CYCLE4_DAY1,0 H,668.3191733,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1883,80RSYC,4-May-22
C1071013,11021013,154,PF-06863135,T,6217656228,6.21766E+11,20220628,13:00,END_OF_TRT,,154.7250386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2043,128RSYC,21-Oct-22
C1071013,11021013,154,PF-06863135,T,6217170507,6.21717E+11,20211203,16:25,CYCLE1_DAY1,24 H,939.7515558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1512,56RSYC,30-Apr-22
C1071013,11021013,154,PF-06863135,T,6217184365,6.21718E+11,20211208,11:30,CYCLE1_DAY4,24 H,362.3923845,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1522,56RSYC,30-Apr-22
C1071013,10151008,155,PF-06863135,T,6518957152,6.51896E+11,20211207,16:37,CYCLE1_DAY1,0 H,729.4807566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1246,87RSYC,13-May-22
C1071013,10151008,155,PF-06863135,T,6518911699,6.51891E+11,20211215,10:06,CYCLE1_DAY8,0 H,791.3665459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1183,104RSYC,22-May-22
C1071013,10151008,155,PF-06863135,T,6518911699,6.51891E+11,20211215,16:20,CYCLE1_DAY8,6 H,482.285946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1182,104RSYC,22-May-22
C1071013,10151008,155,PF-06863135,T,6518957154,6.51896E+11,20211221,10:40,CYCLE1_DAY15,0 H,267.9119868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1248,47RSYC,28-Apr-22
C1071013,10151008,155,PF-06863135,T,6518957156,6.51896E+11,20211228,9:57,CYCLE1_DAY22,0 H,951.5451543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1250,47RSYC,28-Apr-22
C1071013,10151008,155,PF-06863135,T,6518842178,6.51884E+11,20220104,10:40,CYCLE2_DAY1,0 H,175.3631114,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1662,101RSYC,13-May-22
C1071013,10151008,155,PF-06863135,T,6518911726,6.51891E+11,20220201,11:56,CYCLE3_DAY1,0 H,758.0608564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1663,101RSYC,13-May-22
C1071013,10151008,155,PF-06863135,T,6517560134,6.51756E+11,20220301,9:55,CYCLE4_DAY1,0 H,344.5985472,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1898,81RSYC,4-May-22
C1071013,10151008,155,PF-06863135,T,6518957177,6.51896E+11,20220525,9:02,CYCLE7_DAY1,0 H,812.9688279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1986,114RSYC,25-Jul-22
C1071013,10151008,155,PF-06863135,T,6518957179,6.51896E+11,20211208,16:00,CYCLE1_DAY1,24 H,785.3463001,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1254,47RSYC,28-Apr-22
C1071013,10151008,155,PF-06863135,T,6518957181,6.51896E+11,20211210,12:43,CYCLE1_DAY4,0 H,321.9840237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1256,47RSYC,28-Apr-22
C1071013,10021004,156,PF-06863135,T,6603529934,6.60353E+11,20211203,9:00,CYCLE1_DAY1,0 H,319.2163941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 946,65RSYC,3-May-22
C1071013,10021004,156,PF-06863135,T,6603529934,6.60353E+11,20211203,17:15,CYCLE1_DAY1,6 H,997.1718976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 947,65RSYC,3-May-22
C1071013,10021004,156,PF-06863135,T,6603324912,6.60332E+11,20211213,9:15,CYCLE1_DAY8,0 H,67.4165775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 945,65RSYC,3-May-22
C1071013,10021004,156,PF-06863135,T,6603529937,6.60353E+11,20211220,12:10,CYCLE1_DAY15,0 H,845.4793656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 948,65RSYC,3-May-22
C1071013,10021004,156,PF-06863135,T,6603626210,6.60363E+11,20211229,9:38,CYCLE1_DAY22,0 H,646.1705014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1588,59RSYC,1-May-22
C1071013,10021004,156,PF-06863135,T,6603578696,6.60358E+11,20211204,11:43,CYCLE1_DAY1,24 H,910.8425789,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 949,,
C1071013,10021004,156,PF-06863135,T,6603529964,6.60353E+11,20211206,9:40,CYCLE1_DAY4,0 H,988.8948016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1586,59RSYC,1-May-22
C1071013,10021004,156,PF-06863135,T,6603529965,6.60353E+11,20211207,11:45,CYCLE1_DAY4,24 H,808.2823764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1587,59RSYC,1-May-22
C1071013,10971001,157,PF-06863135,T,6216725127,6.21673E+11,20211203,14:30,CYCLE1_DAY1,0 H,30.07569342,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1334,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725127,6.21673E+11,20211203,21:45,CYCLE1_DAY1,6 H,323.6946745,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1333,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725129,6.21673E+11,20211210,9:30,CYCLE1_DAY8,0 H,688.5149243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1336,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725129,6.21673E+11,20211210,17:00,CYCLE1_DAY8,6 H,265.0855013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1335,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725133,6.21673E+11,20211223,11:30,CYCLE1_DAY22,0 H,884.8553959,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1337,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725135,6.21673E+11,20211230,13:40,CYCLE2_DAY1,0 H,771.5550452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1809,92RSYC,12-May-22
C1071013,10971001,157,PF-06863135,T,6216725137,6.21673E+11,20220127,13:45,CYCLE3_DAY1,0 H,182.7036878,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1810,92RSYC,12-May-22
C1071013,10971001,157,PF-06863135,T,6216725142,6.21673E+11,20211204,16:30,CYCLE1_DAY1,24 H,185.4843586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1338,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725144,6.21673E+11,20211206,13:00,CYCLE1_DAY4,0 H,312.9899442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1339,50RSYC,29-Apr-22
C1071013,10971001,157,PF-06863135,T,6216725146,6.21673E+11,20211207,15:00,CYCLE1_DAY4,24 H,532.1143314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1340,50RSYC,29-Apr-22
C1071013,11041006,158,PF-06863135,T,6217133142,6.21713E+11,20211206,9:00,CYCLE1_DAY1,0 H,876.1772359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1454,54RSYC,30-Apr-22
C1071013,11041006,158,PF-06863135,T,6217133142,6.21713E+11,20211206,22:15,CYCLE1_DAY1,6 H,693.9066364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1453,54RSYC,30-Apr-22
C1071013,11041006,158,PF-06863135,T,6217133145,6.21713E+11,20211213,9:00,CYCLE1_DAY8,0 H,897.7606315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1458,54RSYC,30-Apr-22
C1071013,11041006,158,PF-06863135,T,6217133145,6.21713E+11,20211213,19:00,CYCLE1_DAY8,6 H,537.8268427,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1457,54RSYC,30-Apr-22
C1071013,11041006,158,PF-06863135,T,6216725278,6.21673E+11,20211220,12:00,CYCLE1_DAY15,0 H,845.9723632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1375,84RSYC,10-May-22
C1071013,11041006,158,PF-06863135,T,6216725281,6.21673E+11,20211227,9:35,CYCLE1_DAY22,0 H,609.6497593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1762,91RSYC,11-May-22
C1071013,11041006,158,PF-06863135,T,6217133155,6.21713E+11,20220103,11:45,CYCLE2_DAY1,0 H,418.1991494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1764,91RSYC,11-May-22
C1071013,11041006,158,PF-06863135,T,6217133161,6.21713E+11,20220131,12:10,CYCLE3_DAY1,0 H,358.4826264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1765,91RSYC,11-May-22
C1071013,11041006,158,PF-06863135,T,6216725305,6.21673E+11,20220207,11:29,END_OF_TRT,,126.7760008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1763,109RSYC,25-May-22
C1071013,11041006,158,PF-06863135,T,6217133169,6.21713E+11,20211207,16:15,CYCLE1_DAY1,24 H,28.15637068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1460,54RSYC,30-Apr-22
C1071013,11041006,158,PF-06863135,T,6216924030,6.21692E+11,20211208,8:15,CYCLE1_DAY4,0 H,242.7548366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1423,57RSYC,30-Apr-22
C1071013,11041006,158,PF-06863135,T,6216924035,6.21692E+11,20211209,17:05,CYCLE1_DAY4,24 H,729.3029779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1424,57RSYC,30-Apr-22
C1071013,10921004,159,PF-06863135,T,6216725228,6.21673E+11,20211206,11:55,CYCLE1_DAY1,0 H,773.371566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1365,76RSYC,4-May-22
C1071013,10921004,159,PF-06863135,T,6216725228,6.21673E+11,20211206,18:49,CYCLE1_DAY1,6 H,17.55254521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1364,84RSYC,10-May-22
C1071013,10921004,159,PF-06863135,T,6217039329,6.21704E+11,20211213,13:16,CYCLE1_DAY8,0 H,220.501582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1445,96RSYC,12-May-22
C1071013,10921004,159,PF-06863135,T,6217039329,6.21704E+11,20211213,20:33,CYCLE1_DAY8,6 H,691.1742722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1444,96RSYC,12-May-22
C1071013,10921004,159,PF-06863135,T,6217039332,6.21704E+11,20211220,16:07,CYCLE1_DAY15,0 H,477.4564536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1446,54RSYC,30-Apr-22
C1071013,10921004,159,PF-06863135,T,6217039339,6.21704E+11,20211227,15:56,CYCLE1_DAY22,0 H,167.3234022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1448,54RSYC,30-Apr-22
C1071013,10921004,159,PF-06863135,T,6217039345,6.21704E+11,20220103,16:06,CYCLE2_DAY1,0 H,953.4438911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1751,91RSYC,11-May-22
C1071013,10921004,159,PF-06863135,T,6217039353,6.21704E+11,20220131,14:55,CYCLE3_DAY1,0 H,697.1864581,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1752,91RSYC,11-May-22
C1071013,10921004,159,PF-06863135,T,6216725259,6.21673E+11,20220216,14:30,END_OF_TRT,,667.0342964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1750,109RSYC,25-May-22
C1071013,10921004,159,PF-06863135,T,6217039371,6.21704E+11,20211207,17:00,UNPL,9001 H,354.3915912,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1451,105RSYC,22-May-22
C1071013,10921004,159,PF-06863135,T,6217039357,6.21704E+11,20211207,12:05,CYCLE1_DAY1,24 H,734.2003734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1449,54RSYC,30-Apr-22
C1071013,11301001,160,PF-06863135,T,6216756836,6.21676E+11,20211213,12:53,CYCLE1_DAY1,0 H,691.7424536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1387,95RSYC,13-May-22
C1071013,11301001,160,PF-06863135,T,6216756836,6.21676E+11,20211213,20:19,CYCLE1_DAY1,6 H,194.9997388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1386,95RSYC,13-May-22
C1071013,11301001,160,PF-06863135,T,6216756838,6.21676E+11,20211220,17:12,CYCLE1_DAY8,0 H,555.0038499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1391,95RSYC,13-May-22
C1071013,11301001,160,PF-06863135,T,6216756838,6.21676E+11,20211221,1:00,CYCLE1_DAY8,6 H,393.7179617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1390,95RSYC,13-May-22
C1071013,11301001,160,PF-06863135,T,6216756840,6.21676E+11,20211228,15:45,CYCLE1_DAY15,0 H,457.6061295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1864,80RSYC,4-May-22
C1071013,11301001,160,PF-06863135,T,6217347400,6.21735E+11,20220104,14:30,CYCLE1_DAY22,0 H,727.7141213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1865,80RSYC,4-May-22
C1071013,11301001,160,PF-06863135,T,6216756848,6.21676E+11,20211214,14:30,CYCLE1_DAY1,24 H,625.0863245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1394,95RSYC,13-May-22
C1071013,11301001,160,PF-06863135,T,6217347402,6.21735E+11,20211216,13:00,CYCLE1_DAY4,0 H,794.057019,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1575,59RSYC,1-May-22
C1071013,11301001,160,PF-06863135,T,6217347403,6.21735E+11,20211217,12:57,CYCLE1_DAY4,24 H,868.0707968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1576,97RSYC,12-May-22
C1071013,11001006,161,PF-06863135,T,6217163737,6.21716E+11,20211206,12:00,CYCLE1_DAY1,0 H,315.4617683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1473,54RSYC,30-Apr-22
C1071013,11001006,161,PF-06863135,T,6217163737,6.21716E+11,20211206,19:00,CYCLE1_DAY1,6 H,183.3373267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1472,54RSYC,30-Apr-22
C1071013,11001006,161,PF-06863135,T,6217163747,6.21716E+11,20211228,9:30,CYCLE1_DAY22,0 H,10.69714796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1796,71RSYC,7-May-22
C1071013,11001006,161,PF-06863135,T,6216170955,6.21617E+11,20220104,10:00,CYCLE2_DAY1,0 H,122.1609119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1793,71RSYC,7-May-22
C1071013,11001006,161,PF-06863135,T,6216170956,6.21617E+11,20220201,11:45,CYCLE3_DAY1,0 H,272.5916266,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1794,71RSYC,7-May-22
C1071013,11001006,161,PF-06863135,T,6217366241,6.21737E+11,20220301,11:40,CYCLE4_DAY1,0 H,344.0697335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1878,80RSYC,4-May-22
C1071013,11001006,161,PF-06863135,T,6217366226,6.21737E+11,20220104,17:30,UNPL,9002 H,372.105392,NG/ML,,Visit revised from C1D8,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1797,71RSYC,7-May-22
C1071013,11001006,161,PF-06863135,T,6217183915,6.21718E+11,20211207,13:00,CYCLE1_DAY1,24 H,68.69700883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1518,56RSYC,30-Apr-22
C1071013,11001006,161,PF-06863135,T,6216170966,6.21617E+11,20211209,9:50,CYCLE1_DAY4,0 H,289.4282462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1795,71RSYC,7-May-22
C1071013,11001006,161,PF-06863135,T,6217183961,6.21718E+11,20211210,12:15,CYCLE1_DAY4,24 H,543.1866343,NG/ML,,Received as 6216170972-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1290,87RSYC,13-May-22
C1071013,10981005,162,PF-06863135,T,6517769655,6.51777E+11,20211206,9:10,CYCLE1_DAY1,0 H,670.3526511,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1078,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517769655,6.51777E+11,20211206,18:00,CYCLE1_DAY1,6 H,362.6740828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1077,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517769659,6.51777E+11,20211216,8:39,CYCLE1_DAY8,0 H,748.1817443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1080,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517769659,6.51777E+11,20211216,16:35,CYCLE1_DAY8,6 H,709.5764905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1079,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517769665,6.51777E+11,20211223,10:00,CYCLE1_DAY15,0 H,389.6542992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1081,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517769667,6.51777E+11,20211230,10:20,CYCLE1_DAY22,0 H,840.3336599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1720,125RSYC,31-Jul-22
C1071013,10981005,162,PF-06863135,T,6517768785,6.51777E+11,20220203,9:07,CYCLE3_DAY1,0 H,882.7299511,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1719,72RSYC,7-May-22
C1071013,10981005,162,PF-06863135,T,6517768788,6.51777E+11,20220303,13:50,CYCLE4_DAY1,0 H,522.7036532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1906,81RSYC,4-May-22
C1071013,10981005,162,PF-06863135,T,6518807320,6.51881E+11,20220817,9:05,CYCLE10_DAY1,0 H,923.3158703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2091,127RSYC,19-Oct-22
C1071013,10981005,162,PF-06863135,T,6520972523,6.52097E+11,20221108,9:25,CYCLE13_DAY1,0 H,33.19991242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2147,139RSYC,22-Mar-23
C1071013,10981005,162,PF-06863135,T,6522975588,6.52298E+11,20230404,9:28,END_OF_TRT,,609.3256954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2224,142RSYC,18-May-23
C1071013,10981005,162,PF-06863135,T,6520939738,6.52094E+11,20220531,10:20,UNPL,9001 H,968.1047362,NG/ML,,Received as 6517769687-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2015,115RSYC,25-Jul-22
C1071013,10981005,162,PF-06863135,T,6517755818,6.51776E+11,20211207,13:55,CYCLE1_DAY1,24 H,15.34949675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1070,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517755821,6.51776E+11,20211209,6:00,CYCLE1_DAY4,0 H,124.8953767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1071,41RSYC,26-Apr-22
C1071013,10981005,162,PF-06863135,T,6517755825,6.51776E+11,20211210,12:10,CYCLE1_DAY4,24 H,727.3561053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1072,41RSYC,26-Apr-22
C1071013,10931005,163,PF-06863135,T,6518934226,6.51893E+11,20211206,14:20,CYCLE1_DAY1,0 H,280.7205722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1203,105RSYC,22-May-22
C1071013,10931005,163,PF-06863135,T,6518934226,6.51893E+11,20211206,20:40,CYCLE1_DAY1,6 H,330.6922986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1202,105RSYC,22-May-22
C1071013,10931005,163,PF-06863135,T,6518934229,6.51893E+11,20211213,11:11,CYCLE1_DAY8,0 H,587.2019963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1205,105RSYC,22-May-22
C1071013,10931005,163,PF-06863135,T,6518934229,6.51893E+11,20211213,17:00,CYCLE1_DAY8,6 H,723.7114131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1204,105RSYC,22-May-22
C1071013,10931005,163,PF-06863135,T,6518934230,6.51893E+11,20211221,16:27,CYCLE1_DAY15,0 H,816.719077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1206,46RSYC,28-Apr-22
C1071013,10931005,163,PF-06863135,T,6518934234,6.51893E+11,20211229,15:00,CYCLE1_DAY22,0 H,651.63528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1716,72RSYC,7-May-22
C1071013,10931005,163,PF-06863135,T,6518934237,6.51893E+11,20220104,14:00,CYCLE2_DAY1,0 H,779.213607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1715,72RSYC,7-May-22
C1071013,10931005,163,PF-06863135,T,6518778282,6.51878E+11,20220201,15:20,CYCLE3_DAY1,0 H,119.6074091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1711,72RSYC,7-May-22
C1071013,10931005,163,PF-06863135,T,6518934247,6.51893E+11,20220301,14:35,CYCLE4_DAY1,0 H,103.4149922,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1905,81RSYC,4-May-22
C1071013,10931005,163,PF-06863135,T,6517472620,6.51747E+11,20220524,15:36,CYCLE7_DAY1,0 H,930.2279496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1970,114RSYC,25-Jul-22
C1071013,10931005,163,PF-06863135,T,6518807286,6.51881E+11,20220816,14:50,CYCLE10_DAY1,0 H,460.3096635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2090,127RSYC,19-Oct-22
C1071013,10931005,163,PF-06863135,T,6521929820,6.52193E+11,20230718,11:50,CYCLE22_DAY1,0 H,746.7992568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2286,148RSYC,27-Mar-24
C1071013,10931005,163,PF-06863135,T,6518934250,6.51893E+11,20211207,14:30,CYCLE1_DAY1,24 H,670.5335639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1212,87RSYC,13-May-22
C1071013,10931005,163,PF-06863135,T,6518934252,6.51893E+11,20211209,13:51,CYCLE1_DAY4,0 H,14.60109274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1214,46RSYC,28-Apr-22
C1071013,10931005,163,PF-06863135,T,6518934256,6.51893E+11,20211210,14:10,CYCLE1_DAY4,24 H,786.2348088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1218,46RSYC,28-Apr-22
C1071013,10251002,164,PF-06863135,T,6517559620,6.51756E+11,20211206,12:55,CYCLE1_DAY1,0 H,802.7460729,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1012,39RSYC,26-Apr-22
C1071013,10251002,164,PF-06863135,T,6517559620,6.51756E+11,20211206,19:00,CYCLE1_DAY1,6 H,718.3349887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1011,39RSYC,26-Apr-22
C1071013,10251002,164,PF-06863135,T,6517559621,6.51756E+11,20211213,11:35,CYCLE1_DAY8,0 H,290.6759275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1013,39RSYC,26-Apr-22
C1071013,10251002,164,PF-06863135,T,6515447223,6.51545E+11,20211220,8:45,CYCLE1_DAY15,0 H,422.0454202,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 961,65RSYC,3-May-22
C1071013,10251002,164,PF-06863135,T,6517559625,6.51756E+11,20211227,8:24,CYCLE1_DAY22,0 H,906.6648566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1015,39RSYC,26-Apr-22
C1071013,10251002,164,PF-06863135,T,6517559628,6.51756E+11,20220103,9:30,CYCLE2_DAY1,0 H,260.0265274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1669,101RSYC,13-May-22
C1071013,10251002,164,PF-06863135,T,6517559629,6.51756E+11,20220201,8:40,CYCLE3_DAY1,0 H,592.5241305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1670,101RSYC,13-May-22
C1071013,10251002,164,PF-06863135,T,6517559632,6.51756E+11,20220301,9:20,CYCLE4_DAY1,0 H,213.1329914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1900,81RSYC,4-May-22
C1071013,10251002,164,PF-06863135,T,6519204947,6.5192E+11,20220524,8:10,CYCLE7_DAY1,0 H,815.965021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1988,114RSYC,25-Jul-22
C1071013,10251002,164,PF-06863135,T,6517559641,6.51756E+11,20220816,7:55,CYCLE10_DAY1,0 H,921.8724573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2085,127RSYC,19-Oct-22
C1071013,10251002,164,PF-06863135,T,6521799628,6.5218E+11,20221108,8:35,CYCLE13_DAY1,0 H,463.8011593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2148,139RSYC,22-Mar-23
C1071013,10251002,164,PF-06863135,T,6521699573,6.5217E+11,20230505,13:30,CYCLE19_DAY1,0 H,738.2969013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2250,143RSYC,27-Nov-23
C1071013,10251002,164,PF-06863135,T,6521699574,6.5217E+11,20230801,10:50,CYCLE22_DAY1,0 H,305.7893843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2293,145RSYC,4-Jan-24
C1071013,10251002,164,PF-06863135,T,6517559635,6.51756E+11,20211207,13:20,CYCLE1_DAY1,24 H,782.3860864,NG/ML,12; Damaged sample tube,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1018,,
C1071013,10251002,164,PF-06863135,T,6517559638,6.51756E+11,20211209,9:15,CYCLE1_DAY4,0 H,230.6881297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1019,39RSYC,26-Apr-22
C1071013,10251002,164,PF-06863135,T,6517559640,6.51756E+11,20211210,12:10,CYCLE1_DAY4,24 H,155.5851217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1020,39RSYC,26-Apr-22
C1071013,10561008,165,PF-06863135,T,6217026117,6.21703E+11,20211207,12:00,CYCLE1_DAY1,0 H,366.2097852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1431,57RSYC,30-Apr-22
C1071013,10561008,165,PF-06863135,T,6217026117,6.21703E+11,20211207,18:45,CYCLE1_DAY1,6 H,901.8328841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1430,57RSYC,30-Apr-22
C1071013,10561008,165,PF-06863135,T,6216408041,6.21641E+11,20211213,12:20,CYCLE1_DAY8,0 H,595.1746247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1317,49RSYC,29-Apr-22
C1071013,10561008,165,PF-06863135,T,6216408041,6.21641E+11,20211213,19:15,CYCLE1_DAY8,6 H,185.5592263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1316,49RSYC,29-Apr-22
C1071013,10561008,165,PF-06863135,T,6216898574,6.2169E+11,20211220,15:35,CYCLE1_DAY15,0 H,344.2513287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1404,96RSYC,12-May-22
C1071013,10561008,165,PF-06863135,T,6217026145,6.21703E+11,20220103,16:10,CYCLE2_DAY1,0 H,479.7819328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1782,71RSYC,7-May-22
C1071013,10561008,165,PF-06863135,T,6216898586,6.2169E+11,20220201,9:50,CYCLE3_DAY1,0 H,587.8673429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1780,71RSYC,7-May-22
C1071013,10561008,165,PF-06863135,T,6216898589,6.2169E+11,20220301,10:50,CYCLE4_DAY1,0 H,114.1581848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1781,71RSYC,7-May-22
C1071013,10561008,165,PF-06863135,T,6216898590,6.2169E+11,20220524,11:30,CYCLE7_DAY1,0 H,577.1876679,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1994,122RSYC,29-Jul-22
C1071013,10561008,165,PF-06863135,T,6216898602,6.2169E+11,20220816,14:30,CYCLE10_DAY1,0 H,110.4635153,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2052,132RSYC,10-Nov-22
C1071013,10561008,165,PF-06863135,T,6218590818,6.21859E+11,20221107,13:30,CYCLE13_DAY1,0 H,384.8892609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2157,140RSYC,22-Mar-23
C1071013,10561008,165,PF-06863135,T,6219498870,6.2195E+11,20230407,11:00,END_OF_TRT,,688.5634174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2231,142RSYC,18-May-23
C1071013,10561008,165,PF-06863135,T,6216898594,6.2169E+11,20211208,12:45,CYCLE1_DAY1,24 H,4.668397613,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1409,96RSYC,12-May-22
C1071013,10561008,165,PF-06863135,T,6216898597,6.2169E+11,20211210,12:10,CYCLE1_DAY4,0 H,932.1328885,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1410,96RSYC,12-May-22
C1071013,10561008,165,PF-06863135,T,6216898599,6.2169E+11,20211211,13:30,CYCLE1_DAY4,24 H,90.45594111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1411,96RSYC,12-May-22
C1071013,10931004,166,PF-06863135,T,6518934225,6.51893E+11,20211207,16:50,CYCLE1_DAY1,0 H,198.4039111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1201,105RSYC,22-May-22
C1071013,10931004,166,PF-06863135,T,6518934225,6.51893E+11,20211207,23:04,CYCLE1_DAY1,6 H,18.45157561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1200,105RSYC,22-May-22
C1071013,10931004,166,PF-06863135,T,6518934231,6.51893E+11,20211221,13:50,CYCLE1_DAY15,0 H,890.8775412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1207,46RSYC,28-Apr-22
C1071013,10931004,166,PF-06863135,T,6517472612,6.51747E+11,20211228,13:28,CYCLE1_DAY22,0 H,59.50249408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1003,39RSYC,26-Apr-22
C1071013,10931004,166,PF-06863135,T,6518778285,6.51878E+11,20220524,10:50,CYCLE7_DAY1,0 H,428.7268915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1984,114RSYC,25-Jul-22
C1071013,10931004,166,PF-06863135,T,6518934249,6.51893E+11,20211208,16:55,CYCLE1_DAY1,24 H,517.5329691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1211,46RSYC,28-Apr-22
C1071013,10931004,166,PF-06863135,T,6518934253,6.51893E+11,20211210,13:00,CYCLE1_DAY4,0 H,99.34228381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1215,46RSYC,28-Apr-22
C1071013,10931004,166,PF-06863135,T,6518934255,6.51893E+11,20211211,12:26,CYCLE1_DAY4,24 H,479.0920331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1217,87RSYC,13-May-22
C1071013,10741003,167,PF-06863135,T,6518693889,6.51869E+11,20211207,12:50,CYCLE1_DAY1,0 H,545.3103301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1127,94RSYC,12-May-22
C1071013,10741003,167,PF-06863135,T,6519029233,6.51903E+11,20211215,10:15,CYCLE1_DAY8,0 H,36.88764042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1261,47RSYC,28-Apr-22
C1071013,10741003,167,PF-06863135,T,6519029233,6.51903E+11,20211215,17:37,CYCLE1_DAY8,6 H,94.80775177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1260,47RSYC,28-Apr-22
C1071013,10741003,167,PF-06863135,T,6519029234,6.51903E+11,20211223,8:48,CYCLE1_DAY15,0 H,792.6571226,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1262,47RSYC,28-Apr-22
C1071013,10741003,167,PF-06863135,T,6518693895,6.51869E+11,20211228,10:00,CYCLE1_DAY22,0 H,172.8486657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1129,94RSYC,12-May-22
C1071013,10741003,167,PF-06863135,T,6518988295,6.51899E+11,20220105,17:00,CYCLE2_DAY1,0 H,475.4067589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1658,109RSYC,25-May-22
C1071013,10741003,167,PF-06863135,T,6519123788,6.51912E+11,20220202,11:38,CYCLE3_DAY1,0 H,491.8033809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1659,109RSYC,25-May-22
C1071013,10741003,167,PF-06863135,T,6517472587,6.51747E+11,20220302,13:41,CYCLE4_DAY1,0 H,684.665461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1897,81RSYC,4-May-22
C1071013,10741003,167,PF-06863135,T,6517472589,6.51747E+11,20220525,13:01,CYCLE7_DAY1,0 H,575.6147223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2014,122RSYC,29-Jul-22
C1071013,10741003,167,PF-06863135,T,6520917900,6.52092E+11,20221122,12:40,CYCLE13_DAY1,0 H,221.116329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2134,139RSYC,22-Mar-23
C1071013,10741003,167,PF-06863135,T,6520917901,6.52092E+11,20230215,13:04,CYCLE16_DAY1,0 H,282.2004194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2196,141RSYC,17-May-23
C1071013,10741003,167,PF-06863135,T,6522652197,6.52265E+11,20230517,13:12,CYCLE19_DAY1,0 H,680.4277977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2251,145RSYC,4-Jan-24
C1071013,10741003,167,PF-06863135,T,6522652198,6.52265E+11,20230816,12:35,CYCLE22_DAY1,0 H,301.2066346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2302,147RSYC,29-Feb-24
C1071013,10741003,167,PF-06863135,T,6523537652,6.52354E+11,20231108,13:15,CYCLE25_DAY1,0 H,284.6300306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2333,149RSYC,27-Mar-24
C1071013,10741003,167,PF-06863135,T,6524974340,6.52497E+11,20240207,13:33,CYCLE28_DAY1,0 H,731.7935688,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2358,148RSYC,27-Mar-24
C1071013,10741003,167,PF-06863135,T,6518807209,6.51881E+11,20220824,11:10,UNPL,9001 H,240.9486713,NG/ML,,Visit revised from C10D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2084,129RSYC,21-Oct-22
C1071013,10741003,167,PF-06863135,T,6517472592,6.51747E+11,20211210,7:45,CYCLE1_DAY4,0 H,396.2896719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1000,39RSYC,26-Apr-22
C1071013,10741003,167,PF-06863135,T,6519029241,6.51903E+11,20211211,10:25,CYCLE1_DAY4,24 H,534.358562,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1266,89RSYC,11-May-22
C1071013,11041007,168,PF-06863135,T,6216923988,6.21692E+11,20211209,11:00,CYCLE1_DAY1,0 H,422.7551901,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1415,96RSYC,12-May-22
C1071013,11041007,168,PF-06863135,T,6216923988,6.21692E+11,20211209,21:15,CYCLE1_DAY1,6 H,478.6175633,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1414,96RSYC,12-May-22
C1071013,11041007,168,PF-06863135,T,6216923992,6.21692E+11,20211220,14:00,CYCLE1_DAY8,0 H,177.0791395,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1417,57RSYC,30-Apr-22
C1071013,11041007,168,PF-06863135,T,6216923992,6.21692E+11,20211220,21:20,CYCLE1_DAY8,6 H,692.9234624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1416,57RSYC,30-Apr-22
C1071013,11041007,168,PF-06863135,T,6217338965,6.21734E+11,20220106,14:50,CYCLE1_DAY22,0 H,428.676396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1769,71RSYC,7-May-22
C1071013,11041007,168,PF-06863135,T,6216725282,6.21673E+11,20220112,14:45,CYCLE2_DAY1,0 H,602.1756474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1766,91RSYC,11-May-22
C1071013,11041007,168,PF-06863135,T,6216924016,6.21692E+11,20220208,12:46,CYCLE3_DAY1,0 H,682.9544372,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1767,91RSYC,11-May-22
C1071013,11041007,168,PF-06863135,T,6216924019,6.21692E+11,20220310,14:45,CYCLE4_DAY1,0 H,220.7953798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1908,123RSYC,29-Jul-22
C1071013,11041007,168,PF-06863135,T,6217133181,6.21713E+11,20220317,15:15,END_OF_TRT,,315.9495989,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1909,120RSYC,28-Jul-22
C1071013,11041007,168,PF-06863135,T,6216924025,6.21692E+11,20211210,15:15,CYCLE1_DAY1,24 H,673.6981783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1422,57RSYC,30-Apr-22
C1071013,11041007,168,PF-06863135,T,6217133176,6.21713E+11,20211215,14:30,CYCLE1_DAY4,0 H,743.2851355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1768,71RSYC,7-May-22
C1071013,11041007,168,PF-06863135,T,6217133178,6.21713E+11,20211216,15:30,CYCLE1_DAY4,24 H,198.7748722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1464,54RSYC,30-Apr-22
C1071013,10321005,169,PF-06863135,T,6517559952,6.51756E+11,20211209,11:25,CYCLE1_DAY1,0 H,647.3895493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1035,40RSYC,26-Apr-22
C1071013,10321005,169,PF-06863135,T,6517559952,6.51756E+11,20211209,17:30,CYCLE1_DAY1,6 H,299.1620628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1034,66RSYC,3-May-22
C1071013,10321005,169,PF-06863135,T,6517559953,6.51756E+11,20211216,10:06,CYCLE1_DAY8,0 H,362.0336055,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1037,40RSYC,26-Apr-22
C1071013,10321005,169,PF-06863135,T,6517559953,6.51756E+11,20211216,17:27,CYCLE1_DAY8,6 H,703.3522962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1036,40RSYC,26-Apr-22
C1071013,10321005,169,PF-06863135,T,6517509075,6.51751E+11,20211222,14:52,CYCLE1_DAY15,0 H,311.3587153,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1009,66RSYC,3-May-22
C1071013,10321005,169,PF-06863135,T,6517509076,6.51751E+11,20211229,14:37,CYCLE1_DAY22,0 H,970.959038,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1633,85RSYC,10-May-22
C1071013,10321005,169,PF-06863135,T,6517509079,6.51751E+11,20220106,13:29,CYCLE2_DAY1,0 H,19.21708945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1634,100RSYC,23-May-22
C1071013,10321005,169,PF-06863135,T,6517509091,6.51751E+11,20220111,1:14,END_OF_TRT,,992.3883432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1635,100RSYC,23-May-22
C1071013,10321005,169,PF-06863135,T,6517559967,6.51756E+11,20211210,11:35,CYCLE1_DAY1,24 H,897.0633411,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1044,107RSYC,24-May-22
C1071013,10321005,169,PF-06863135,T,6517509085,6.51751E+11,20211212,9:05,CYCLE1_DAY4,0 H,984.8393477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1010,39RSYC,26-Apr-22
C1071013,10321005,169,PF-06863135,T,6517559972,6.51756E+11,20211213,10:04,CYCLE1_DAY4,24 H,636.4179415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1048,66RSYC,3-May-22
C1071013,10051002,170,PF-06863135,T,6216725160,6.21673E+11,20211209,13:15,CYCLE1_DAY1,0 H,667.4634409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1342,50RSYC,29-Apr-22
C1071013,10051002,170,PF-06863135,T,6216725160,6.21673E+11,20211209,19:15,CYCLE1_DAY1,6 H,627.60113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1341,50RSYC,29-Apr-22
C1071013,10051002,170,PF-06863135,T,6216725162,6.21673E+11,20211217,12:00,CYCLE1_DAY8,0 H,216.9027062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1345,50RSYC,29-Apr-22
C1071013,10051002,170,PF-06863135,T,6216725164,6.21673E+11,20211223,10:00,CYCLE1_DAY15,0 H,283.6058308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1348,50RSYC,29-Apr-22
C1071013,10051002,170,PF-06863135,T,6216725166,6.21673E+11,20211231,10:30,CYCLE1_DAY22,0 H,612.4890743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1743,90RSYC,11-May-22
C1071013,10051002,170,PF-06863135,T,6216725168,6.21673E+11,20220110,10:00,CYCLE2_DAY1,0 H,863.0056999,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1744,90RSYC,11-May-22
C1071013,10051002,170,PF-06863135,T,6216725183,6.21673E+11,20220211,7:00,CYCLE3_DAY1,0 H,625.0338956,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1745,90RSYC,11-May-22
C1071013,10051002,170,PF-06863135,T,6217930297,6.21793E+11,20220311,10:00,CYCLE4_DAY1,0 H,148.9128022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1875,80RSYC,4-May-22
C1071013,10051002,170,PF-06863135,T,6217930300,6.21793E+11,20220606,12:00,CYCLE7_DAY1,0 H,303.0619102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2018,115RSYC,25-Jul-22
C1071013,10051002,170,PF-06863135,T,6217309164,6.21731E+11,20220901,13:00,CYCLE10_DAY1,0 H,679.0223867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2047,132RSYC,10-Nov-22
C1071013,10051002,170,PF-06863135,T,6219609252,6.21961E+11,20221116,9:40,END_OF_TRT,,30.88640965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2158,140RSYC,22-Mar-23
C1071013,10051002,170,PF-06863135,T,6216725176,6.21673E+11,20211210,13:20,CYCLE1_DAY1,24 H,784.7027141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1350,50RSYC,29-Apr-22
C1071013,10051002,170,PF-06863135,T,6216725178,6.21673E+11,20211213,11:00,CYCLE1_DAY4,0 H,719.0726332,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1352,50RSYC,29-Apr-22
C1071013,10051002,170,PF-06863135,T,6216725181,6.21673E+11,20211214,12:05,CYCLE1_DAY4,24 H,335.5309595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1355,50RSYC,29-Apr-22
C1071013,11021012,171,PF-06863135,T,6217283562,6.21728E+11,20211209,10:00,CYCLE1_DAY1,0 H,354.1236117,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1571,59RSYC,1-May-22
C1071013,11021012,171,PF-06863135,T,6217283562,6.21728E+11,20211209,23:05,CYCLE1_DAY1,6 H,853.9499142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1570,59RSYC,1-May-22
C1071013,11021012,171,PF-06863135,T,6217280300,6.21728E+11,20211220,17:20,CYCLE1_DAY8,0 H,569.2691998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1551,58RSYC,1-May-22
C1071013,11021012,171,PF-06863135,T,6217280300,6.21728E+11,20211220,23:20,CYCLE1_DAY8,6 H,227.6916905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1550,58RSYC,1-May-22
C1071013,11021012,171,PF-06863135,T,6217023833,6.21702E+11,20211227,13:55,CYCLE1_DAY15,0 H,99.88229661,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1850,93RSYC,12-May-22
C1071013,11021012,171,PF-06863135,T,6217170444,6.21717E+11,20220103,14:00,CYCLE1_DAY22,0 H,651.5734457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1851,93RSYC,12-May-22
C1071013,11021012,171,PF-06863135,T,6216756808,6.21676E+11,20220110,16:05,CYCLE2_DAY1,0 H,427.8223925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1849,93RSYC,12-May-22
C1071013,11021012,171,PF-06863135,T,6217170473,6.21717E+11,20220207,13:30,CYCLE3_DAY1,0 H,296.7343447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1852,93RSYC,12-May-22
C1071013,11021012,171,PF-06863135,T,6217170483,6.21717E+11,20220307,13:45,CYCLE4_DAY1,0 H,489.3676788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1882,80RSYC,4-May-22
C1071013,11021012,171,PF-06863135,T,6217170498,6.21717E+11,20220530,13:45,CYCLE7_DAY1,0 H,469.7413081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2021,115RSYC,25-Jul-22
C1071013,11021012,171,PF-06863135,T,6217142670,6.21714E+11,20220823,14:00,CYCLE10_DAY1,0 H,886.1236462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2065,132RSYC,10-Nov-22
C1071013,11021012,171,PF-06863135,T,6218384025,6.21838E+11,20221114,14:30,CYCLE13_DAY1,0 H,412.874144,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2165,140RSYC,22-Mar-23
C1071013,11021012,171,PF-06863135,T,6219958816,6.21996E+11,20230206,14:30,CYCLE16_DAY1,0 H,828.8162449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2211,142RSYC,18-May-23
C1071013,11021012,171,PF-06863135,T,6219958823,6.21996E+11,20230406,16:00,END_OF_TRT,,256.7560783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2233,142RSYC,18-May-23
C1071013,11021012,171,PF-06863135,T,6217170503,6.21717E+11,20211210,17:00,CYCLE1_DAY1,24 H,758.5948169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1510,56RSYC,30-Apr-22
C1071013,11021012,171,PF-06863135,T,6217280324,6.21728E+11,20211214,11:00,CYCLE1_DAY4,0 H,68.83538438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1558,58RSYC,1-May-22
C1071013,11021012,171,PF-06863135,T,6217280337,6.21728E+11,20211215,17:40,CYCLE1_DAY4,24 H,845.7599083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1560,58RSYC,1-May-22
C1071013,11021015,172,PF-06863135,T,6217360199,6.21736E+11,20211209,10:00,CYCLE1_DAY1,0 H,514.8297766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1578,59RSYC,1-May-22
C1071013,11021015,172,PF-06863135,T,6217360199,6.21736E+11,20211209,23:30,CYCLE1_DAY1,6 H,229.5320027,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1577,59RSYC,1-May-22
C1071013,11021015,172,PF-06863135,T,6217280308,6.21728E+11,20211220,17:15,CYCLE1_DAY8,0 H,552.7985928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1553,58RSYC,1-May-22
C1071013,11021015,172,PF-06863135,T,6217280308,6.21728E+11,20211220,23:15,CYCLE1_DAY8,6 H,89.01680476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1552,58RSYC,1-May-22
C1071013,11021015,172,PF-06863135,T,6216756803,6.21676E+11,20211227,14:20,CYCLE1_DAY15,0 H,956.2748294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1860,80RSYC,4-May-22
C1071013,11021015,172,PF-06863135,T,6216756806,6.21676E+11,20220104,15:30,CYCLE1_DAY22,0 H,710.5636128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1861,80RSYC,4-May-22
C1071013,11021015,172,PF-06863135,T,6217170455,6.21717E+11,20220111,15:50,CYCLE2_DAY1,0 H,4.132451779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1863,80RSYC,4-May-22
C1071013,11021015,172,PF-06863135,T,6217023848,6.21702E+11,20220211,13:10,CYCLE3_DAY1,0 H,428.4489594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1862,80RSYC,4-May-22
C1071013,11021015,172,PF-06863135,T,6217170491,6.21717E+11,20220311,15:40,CYCLE4_DAY1,0 H,117.5881398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1910,123RSYC,29-Jul-22
C1071013,11021015,172,PF-06863135,T,6217170496,6.21717E+11,20220603,14:00,CYCLE7_DAY1,0 H,26.4374476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2023,115RSYC,25-Jul-22
C1071013,11021015,172,PF-06863135,T,6217142671,6.21714E+11,20220826,17:00,CYCLE10_DAY1,0 H,590.305368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2106,131RSYC,9-Nov-22
C1071013,11021015,172,PF-06863135,T,6219958815,6.21996E+11,20230210,12:50,CYCLE16_DAY1,0 H,719.4135792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2197,141RSYC,17-May-23
C1071013,11021015,172,PF-06863135,T,6219265231,6.21927E+11,20230509,15:00,CYCLE19_DAY1,0 H,224.2461896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2242,143RSYC,27-Nov-23
C1071013,11021015,172,PF-06863135,T,6221060211,6.22106E+11,20230731,14:47,CYCLE22_DAY1,0 H,282.8137251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2295,145RSYC,4-Jan-24
C1071013,11021015,172,PF-06863135,T,6221060212,6.22106E+11,20231023,15:30,CYCLE25_DAY1,0 H,350.3805876,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2319,147RSYC,29-Feb-24
C1071013,11021015,172,PF-06863135,T,6217170510,6.21717E+11,20211210,17:30,CYCLE1_DAY1,24 H,930.3522546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1514,56RSYC,30-Apr-22
C1071013,11021015,172,PF-06863135,T,6217280322,6.21728E+11,20211214,10:15,CYCLE1_DAY4,0 H,744.166398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1557,58RSYC,1-May-22
C1071013,11021015,172,PF-06863135,T,6217233482,6.21723E+11,20211215,18:00,CYCLE1_DAY4,24 H,834.834657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1546,58RSYC,1-May-22
C1071013,10151009,173,PF-06863135,T,6518957151,6.51896E+11,20211214,13:00,CYCLE1_DAY1,0 H,771.7536902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1245,87RSYC,13-May-22
C1071013,10151009,173,PF-06863135,T,6518911700,6.51891E+11,20211221,9:45,CYCLE1_DAY8,0 H,419.6290454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1185,104RSYC,22-May-22
C1071013,10151009,173,PF-06863135,T,6518911700,6.51891E+11,20211221,16:28,CYCLE1_DAY8,6 H,246.8387995,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1184,104RSYC,22-May-22
C1071013,10151009,173,PF-06863135,T,6518911704,6.51891E+11,20211228,10:33,CYCLE1_DAY15,0 H,264.4934809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1188,104RSYC,22-May-22
C1071013,10151009,173,PF-06863135,T,6518911712,6.51891E+11,20220104,10:13,CYCLE1_DAY22,0 H,620.7146541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1665,101RSYC,13-May-22
C1071013,10151009,173,PF-06863135,T,6518911713,6.51891E+11,20220111,12:40,CYCLE2_DAY1,0 H,274.3062617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1666,101RSYC,13-May-22
C1071013,10151009,173,PF-06863135,T,6518842179,6.51884E+11,20220208,11:35,CYCLE3_DAY1,0 H,286.0475629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1664,101RSYC,13-May-22
C1071013,10151009,173,PF-06863135,T,6518957171,6.51896E+11,20220308,11:45,CYCLE4_DAY1,0 H,108.081883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1899,81RSYC,4-May-22
C1071013,10151009,173,PF-06863135,T,6521544921,6.52154E+11,20230718,12:30,UNPL,9001 H,881.2940746,NG/ML,,Visit revised from C22D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2287,148RSYC,27-Mar-24
C1071013,10151009,173,PF-06863135,T,6518957178,6.51896E+11,20211215,15:02,CYCLE1_DAY1,24 H,224.4511464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1253,47RSYC,28-Apr-22
C1071013,10151009,173,PF-06863135,T,6518957180,6.51896E+11,20211217,11:35,CYCLE1_DAY4,0 H,61.01898606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1255,47RSYC,28-Apr-22
C1071013,10901007,174,PF-06863135,T,6518877855,6.51888E+11,20211210,11:00,CYCLE1_DAY1,0 H,122.2844978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1170,104RSYC,22-May-22
C1071013,10901007,174,PF-06863135,T,6518877855,6.51888E+11,20211210,17:50,CYCLE1_DAY1,6 H,680.4162616,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1169,104RSYC,22-May-22
C1071013,10901007,174,PF-06863135,T,6518877858,6.51888E+11,20211217,13:00,CYCLE1_DAY8,0 H,749.583524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1174,104RSYC,22-May-22
C1071013,10901007,174,PF-06863135,T,6518877858,6.51888E+11,20211217,19:00,CYCLE1_DAY8,6 H,728.9503595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1173,104RSYC,22-May-22
C1071013,10901007,174,PF-06863135,T,6517433525,6.51743E+11,20211223,11:28,CYCLE1_DAY15,0 H,129.2443846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 982,66RSYC,3-May-22
C1071013,10901007,174,PF-06863135,T,6518828368,6.51883E+11,20211230,14:57,CYCLE1_DAY22,0 H,186.1908683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1680,101RSYC,13-May-22
C1071013,10901007,174,PF-06863135,T,6519019919,6.51902E+11,20220203,11:21,CYCLE3_DAY1,0 H,240.6564094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1681,101RSYC,13-May-22
C1071013,10901007,174,PF-06863135,T,6517433533,6.51743E+11,20220303,12:10,CYCLE4_DAY1,0 H,671.6662547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1903,81RSYC,4-May-22
C1071013,10901007,174,PF-06863135,T,6518807250,6.51881E+11,20220818,10:16,CYCLE10_DAY1,0 H,963.9443831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2088,127RSYC,19-Oct-22
C1071013,10901007,174,PF-06863135,T,6518877868,6.51888E+11,20211211,11:50,CYCLE1_DAY1,24 H,143.3706945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1176,104RSYC,22-May-22
C1071013,10901007,174,PF-06863135,T,6518877870,6.51888E+11,20211213,15:05,CYCLE1_DAY4,0 H,997.6571074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1178,104RSYC,22-May-22
C1071013,10901007,174,PF-06863135,T,6518805056,6.51881E+11,20211214,15:10,CYCLE1_DAY4,24 H,313.6912902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1160,108RSYC,24-May-22
C1071013,11061006,175,PF-06863135,T,6217165064,6.21717E+11,20211213,14:30,CYCLE1_DAY1,0 H,826.126176,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1484,55RSYC,30-Apr-22
C1071013,11061006,175,PF-06863135,T,6217165064,6.21717E+11,20211213,20:00,CYCLE1_DAY1,6 H,597.5763444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1483,55RSYC,30-Apr-22
C1071013,11061006,175,PF-06863135,T,6217356187,6.21736E+11,20211220,9:00,CYCLE1_DAY8,0 H,426.7281127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1808,92RSYC,12-May-22
C1071013,11061006,175,PF-06863135,T,6217193491,6.21719E+11,20211227,10:00,CYCLE1_DAY15,0 H,932.4385674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1805,92RSYC,12-May-22
C1071013,11061006,175,PF-06863135,T,6217193500,6.21719E+11,20220103,10:00,CYCLE1_DAY22,0 H,64.98263315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1806,92RSYC,12-May-22
C1071013,11061006,175,PF-06863135,T,6217165067,6.21717E+11,20220124,8:00,END_OF_TRT,,552.8623141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1804,86RSYC,13-May-22
C1071013,11061006,175,PF-06863135,T,6217193534,6.21719E+11,20211214,9:00,CYCLE1_DAY1,24 H,4.622887927,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1530,56RSYC,30-Apr-22
C1071013,11061006,175,PF-06863135,T,6217266048,6.21727E+11,20211217,16:00,CYCLE1_DAY4,24 H,487.5039041,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1807,92RSYC,12-May-22
C1071013,11301002,176,PF-06863135,T,6217347397,6.21735E+11,20211213,16:30,CYCLE1_DAY1,0 H,108.3706312,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1868,80RSYC,4-May-22
C1071013,11301002,176,PF-06863135,T,6217347397,6.21735E+11,20211213,23:00,CYCLE1_DAY1,6 H,190.5110874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1867,80RSYC,4-May-22
C1071013,11301002,176,PF-06863135,T,6217347398,6.21735E+11,20211220,16:20,CYCLE1_DAY8,0 H,859.215226,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1573,59RSYC,1-May-22
C1071013,11301002,176,PF-06863135,T,6217347398,6.21735E+11,20211220,23:00,CYCLE1_DAY8,6 H,916.8044118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1572,59RSYC,1-May-22
C1071013,11301002,176,PF-06863135,T,6217347399,6.21735E+11,20211228,14:45,CYCLE1_DAY15,0 H,506.7300182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1866,80RSYC,4-May-22
C1071013,11301002,176,PF-06863135,T,6217347401,6.21735E+11,20211214,16:55,CYCLE1_DAY1,24 H,644.954344,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1574,59RSYC,1-May-22
C1071013,11301002,176,PF-06863135,T,6216756850,6.21676E+11,20211216,16:30,CYCLE1_DAY4,0 H,640.2244559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1396,95RSYC,13-May-22
C1071013,11301002,176,PF-06863135,T,6216756853,6.21676E+11,20211217,16:55,CYCLE1_DAY4,24 H,373.2893062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1399,95RSYC,13-May-22
C1071013,10161007,177,PF-06863135,T,6518935554,6.51894E+11,20211213,10:59,CYCLE1_DAY1,0 H,220.0004365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1224,87RSYC,13-May-22
C1071013,10161007,177,PF-06863135,T,6518935554,6.51894E+11,20211213,18:30,CYCLE1_DAY1,6 H,7.808827414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1223,46RSYC,28-Apr-22
C1071013,10161007,177,PF-06863135,T,6518935557,6.51894E+11,20211221,9:43,CYCLE1_DAY8,0 H,706.376802,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1228,46RSYC,28-Apr-22
C1071013,10161007,177,PF-06863135,T,6518935557,6.51894E+11,20211221,16:07,CYCLE1_DAY8,6 H,425.9333484,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1227,46RSYC,28-Apr-22
C1071013,10161007,177,PF-06863135,T,6518935564,6.51894E+11,20211228,8:58,CYCLE1_DAY15,0 H,807.0281486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1607,97RSYC,12-May-22
C1071013,10161007,177,PF-06863135,T,6518935567,6.51894E+11,20220103,10:15,CYCLE1_DAY22,0 H,97.29021218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1608,97RSYC,12-May-22
C1071013,10161007,177,PF-06863135,T,6519158770,6.51916E+11,20220110,9:30,CYCLE2_DAY1,0 H,307.3772686,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1609,97RSYC,12-May-22
C1071013,10161007,177,PF-06863135,T,6517697451,6.5177E+11,20220207,10:10,CYCLE3_DAY1,0 H,169.7218266,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1606,97RSYC,12-May-22
C1071013,10161007,177,PF-06863135,T,6518914774,6.51891E+11,20220308,15:11,END_OF_TRT,,728.6062065,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1889,87RSYC,13-May-22
C1071013,10161007,177,PF-06863135,T,6518935576,6.51894E+11,20211214,12:44,CYCLE1_DAY1,24 H,662.2701548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1239,47RSYC,28-Apr-22
C1071013,10161007,177,PF-06863135,T,6518972843,6.51897E+11,20211216,12:10,CYCLE1_DAY4,0 H,564.5579527,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1257,47RSYC,28-Apr-22
C1071013,10161007,177,PF-06863135,T,6518935577,6.51894E+11,20211217,13:06,CYCLE1_DAY4,24 H,773.8053909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1240,47RSYC,28-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559951,6.51756E+11,20211214,9:10,CYCLE1_DAY1,0 H,877.742541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1033,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559951,6.51756E+11,20211214,18:48,CYCLE1_DAY1,6 H,898.319382,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1032,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559954,6.51756E+11,20211221,9:08,CYCLE1_DAY8,0 H,784.74674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1039,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559954,6.51756E+11,20211221,18:09,CYCLE1_DAY8,6 H,104.2697741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1038,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559956,6.51756E+11,20211227,15:30,CYCLE1_DAY15,0 H,195.3041584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1041,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559958,6.51756E+11,20220103,14:48,CYCLE1_DAY22,0 H,709.903189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1636,85RSYC,10-May-22
C1071013,10321004,178,PF-06863135,T,6517559959,6.51756E+11,20220110,13:55,CYCLE2_DAY1,0 H,561.9376634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1637,85RSYC,10-May-22
C1071013,10321004,178,PF-06863135,T,6519136785,6.51914E+11,20220207,14:33,CYCLE3_DAY1,0 H,624.2541708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1638,85RSYC,10-May-22
C1071013,10321004,178,PF-06863135,T,6518150045,6.51815E+11,20220307,11:56,CYCLE4_DAY1,0 H,964.1691725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1895,81RSYC,4-May-22
C1071013,10321004,178,PF-06863135,T,6517559981,6.51756E+11,20220502,12:56,END_OF_TRT,,649.1584323,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1979,114RSYC,25-Jul-22
C1071013,10321004,178,PF-06863135,T,6517559968,6.51756E+11,20211215,12:58,CYCLE1_DAY1,24 H,333.9260294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1045,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559970,6.51756E+11,20211217,9:36,CYCLE1_DAY4,0 H,278.7890123,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1046,40RSYC,26-Apr-22
C1071013,10321004,178,PF-06863135,T,6517559971,6.51756E+11,20211218,13:08,CYCLE1_DAY4,24 H,40.78434841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1047,40RSYC,26-Apr-22
C1071013,11021014,179,PF-06863135,T,6217283561,6.21728E+11,20211214,10:00,CYCLE1_DAY1,0 H,232.2806882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1569,59RSYC,1-May-22
C1071013,11021014,179,PF-06863135,T,6217283561,6.21728E+11,20211214,23:20,CYCLE1_DAY1,6 H,985.3666432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1568,110RSYC,25-May-22
C1071013,11021014,179,PF-06863135,T,6217280306,6.21728E+11,20211223,17:00,CYCLE1_DAY8,0 H,648.7705412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2022,122RSYC,29-Jul-22
C1071013,11021014,179,PF-06863135,T,6217280306,6.21728E+11,20211223,23:30,CYCLE1_DAY8,6 H,681.5154736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1859,80RSYC,4-May-22
C1071013,11021014,179,PF-06863135,T,6217170442,6.21717E+11,20211230,13:40,CYCLE1_DAY15,0 H,876.108564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1857,93RSYC,12-May-22
C1071013,11021014,179,PF-06863135,T,6217136147,6.21714E+11,20220106,13:45,CYCLE1_DAY22,0 H,73.36198877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1856,93RSYC,12-May-22
C1071013,11021014,179,PF-06863135,T,6217170454,6.21717E+11,20220113,14:00,CYCLE2_DAY1,0 H,440.2456601,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1858,80RSYC,4-May-22
C1071013,11021014,179,PF-06863135,T,6217170497,6.21717E+11,20220602,16:30,CYCLE7_DAY1,0 H,698.9144107,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2044,128RSYC,21-Oct-22
C1071013,11021014,179,PF-06863135,T,6217004156,6.217E+11,20220825,13:44,CYCLE10_DAY1,0 H,789.9070577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2105,134RSYC,11-Nov-22
C1071013,11021014,179,PF-06863135,T,6218384028,6.21838E+11,20221124,15:40,CYCLE13_DAY1,0 H,52.88139164,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2166,140RSYC,22-Mar-23
C1071013,11021014,179,PF-06863135,T,6219958819,6.21996E+11,20230216,14:50,CYCLE16_DAY1,0 H,767.8091859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2198,141RSYC,17-May-23
C1071013,11021014,179,PF-06863135,T,6219265228,6.21927E+11,20230511,14:22,CYCLE19_DAY1,0 H,229.7693103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2241,143RSYC,27-Nov-23
C1071013,11021014,179,PF-06863135,T,6221060210,6.22106E+11,20230817,13:59,CYCLE22_DAY1,0 H,730.3519558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2296,145RSYC,4-Jan-24
C1071013,11021014,179,PF-06863135,T,6221060209,6.22106E+11,20231109,15:00,CYCLE25_DAY1,0 H,307.6266058,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2353,150RSYC,28-Mar-24
C1071013,11021014,179,PF-06863135,T,6221060215,6.22106E+11,20240201,15:15,CYCLE28_DAY1,0 H,118.0326828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2362,152RSYC,9-Apr-24
C1071013,11021014,179,PF-06863135,T,6217170508,6.21717E+11,20211215,17:20,CYCLE1_DAY1,24 H,113.717651,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1513,56RSYC,30-Apr-22
C1071013,11021014,179,PF-06863135,T,6217023852,6.21702E+11,20211220,17:25,CYCLE1_DAY4,0 H,153.9016737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1429,57RSYC,30-Apr-22
C1071013,11021014,179,PF-06863135,T,6217280336,6.21728E+11,20211221,17:25,CYCLE1_DAY4,24 H,733.023238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1559,97RSYC,12-May-22
C1071013,10901009,180,PF-06863135,T,6518805047,6.51881E+11,20211214,17:25,CYCLE1_DAY1,0 H,732.5968187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1155,107RSYC,24-May-22
C1071013,10901009,180,PF-06863135,T,6518805047,6.51881E+11,20211215,0:40,CYCLE1_DAY1,6 H,223.9502295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1154,107RSYC,24-May-22
C1071013,10901009,180,PF-06863135,T,6518805051,6.51881E+11,20211220,10:40,CYCLE1_DAY8,0 H,984.2170204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1159,108RSYC,24-May-22
C1071013,10901009,180,PF-06863135,T,6518805051,6.51881E+11,20211220,16:04,CYCLE1_DAY8,6 H,638.4857254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1158,108RSYC,24-May-22
C1071013,10901009,180,PF-06863135,T,6518883085,6.51888E+11,20211228,10:02,CYCLE1_DAY15,0 H,974.6872016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1181,104RSYC,22-May-22
C1071013,10901009,180,PF-06863135,T,6518877863,6.51888E+11,20220104,9:47,CYCLE1_DAY22,0 H,772.0633281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1693,106RSYC,23-May-22
C1071013,10901009,180,PF-06863135,T,6517433529,6.51743E+11,20220111,11:59,CYCLE2_DAY1,0 H,969.2686259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1692,106RSYC,23-May-22
C1071013,10901009,180,PF-06863135,T,6518877872,6.51888E+11,20211217,8:40,CYCLE1_DAY4,0 H,734.5441727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1179,104RSYC,22-May-22
C1071013,10901009,180,PF-06863135,T,6518805057,6.51881E+11,20211218,10:32,CYCLE1_DAY4,24 H,288.9680823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1161,108RSYC,24-May-22
C1071013,11021011,181,PF-06863135,T,6217417530,6.21742E+11,20211215,10:30,CYCLE1_DAY1,0 H,865.3010538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1581,59RSYC,1-May-22
C1071013,11021011,181,PF-06863135,T,6217417530,6.21742E+11,20211215,22:00,CYCLE1_DAY1,6 H,128.1714127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1580,59RSYC,1-May-22
C1071013,11021011,181,PF-06863135,T,6217280305,6.21728E+11,20211223,17:00,CYCLE1_DAY8,0 H,426.5756164,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2020,122RSYC,29-Jul-22
C1071013,11021011,181,PF-06863135,T,6217280305,6.21728E+11,20211224,0:00,CYCLE1_DAY8,6 H,145.2497758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1848,93RSYC,12-May-22
C1071013,11021011,181,PF-06863135,T,6216756804,6.21676E+11,20211230,15:25,CYCLE1_DAY15,0 H,126.7510291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1844,93RSYC,12-May-22
C1071013,11021011,181,PF-06863135,T,6217136145,6.21714E+11,20220106,14:20,CYCLE1_DAY22,0 H,99.00695245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1845,93RSYC,12-May-22
C1071013,11021011,181,PF-06863135,T,6217170458,6.21717E+11,20220113,11:20,CYCLE2_DAY1,0 H,12.18483303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1846,93RSYC,12-May-22
C1071013,11021011,181,PF-06863135,T,6217170475,6.21717E+11,20220210,13:30,CYCLE3_DAY1,0 H,991.6690355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1847,93RSYC,12-May-22
C1071013,11021011,181,PF-06863135,T,6217170487,6.21717E+11,20220310,15:15,CYCLE4_DAY1,0 H,652.314061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1911,123RSYC,29-Jul-22
C1071013,11021011,181,PF-06863135,T,6217170500,6.21717E+11,20220609,15:50,CYCLE7_DAY1,0 H,403.7500804,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2042,131RSYC,9-Nov-22
C1071013,11021011,181,PF-06863135,T,6218384032,6.21838E+11,20220905,15:40,CYCLE10_DAY1,0 H,286.1161937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2104,131RSYC,9-Nov-22
C1071013,11021011,181,PF-06863135,T,6219265227,6.21927E+11,20221128,14:45,CYCLE13_DAY1,0 H,193.4230965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2167,140RSYC,22-Mar-23
C1071013,11021011,181,PF-06863135,T,6219958820,6.21996E+11,20230220,14:20,CYCLE16_DAY1,0 H,984.4309954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2199,141RSYC,17-May-23
C1071013,11021011,181,PF-06863135,T,6219958822,6.21996E+11,20230515,14:00,CYCLE19_DAY1,0 H,122.8115603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2240,143RSYC,27-Nov-23
C1071013,11021011,181,PF-06863135,T,6219958826,6.21996E+11,20230829,16:10,END_OF_TRT,,731.9507245,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2312,147RSYC,29-Feb-24
C1071013,11021011,181,PF-06863135,T,6217170505,6.21717E+11,20211216,16:00,CYCLE1_DAY1,24 H,163.3022778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1511,56RSYC,30-Apr-22
C1071013,11021011,181,PF-06863135,T,6217280321,6.21728E+11,20211220,17:30,CYCLE1_DAY4,0 H,633.2843116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1556,58RSYC,1-May-22
C1071013,11021011,181,PF-06863135,T,6217233483,6.21723E+11,20211221,17:30,CYCLE1_DAY4,24 H,150.9714626,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1547,97RSYC,12-May-22
C1071013,10901010,182,PF-06863135,T,6518877856,6.51888E+11,20211217,12:10,CYCLE1_DAY1,0 H,283.4126658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1172,104RSYC,22-May-22
C1071013,10901010,182,PF-06863135,T,6518877856,6.51888E+11,20211217,18:59,CYCLE1_DAY1,6 H,353.8184652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1171,104RSYC,22-May-22
C1071013,10901010,182,PF-06863135,T,6518805050,6.51881E+11,20211223,9:46,CYCLE1_DAY8,0 H,839.2194818,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1157,107RSYC,24-May-22
C1071013,10901010,182,PF-06863135,T,6518805050,6.51881E+11,20211223,16:00,CYCLE1_DAY8,6 H,969.556222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1156,107RSYC,24-May-22
C1071013,10901010,182,PF-06863135,T,6519057380,6.51906E+11,20211230,14:55,CYCLE1_DAY15,0 H,636.6298116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1695,109RSYC,25-May-22
C1071013,10901010,182,PF-06863135,T,6519057382,6.51906E+11,20220113,14:40,CYCLE2_DAY1,0 H,830.2744122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1696,109RSYC,25-May-22
C1071013,10901010,182,PF-06863135,T,6519231708,6.51923E+11,20220310,15:10,CYCLE4_DAY1,0 H,371.46592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1904,81RSYC,4-May-22
C1071013,10901010,182,PF-06863135,T,6518807260,6.51881E+11,20220526,14:39,END_OF_TRT,,598.6385965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1985,122RSYC,29-Jul-22
C1071013,10901010,182,PF-06863135,T,6517433531,6.51743E+11,20220217,12:00,UNPL,9001 H,784.253557,NG/ML,,Visit revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1694,109RSYC,25-May-22
C1071013,10901010,182,PF-06863135,T,6518877867,6.51888E+11,20211218,13:25,CYCLE1_DAY1,24 H,823.3343362,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1175,104RSYC,22-May-22
C1071013,10901010,182,PF-06863135,T,6518828370,6.51883E+11,20211220,8:45,CYCLE1_DAY4,0 H,765.4543621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1163,108RSYC,24-May-22
C1071013,10901010,182,PF-06863135,T,6518877875,6.51888E+11,20211221,14:33,CYCLE1_DAY4,24 H,968.6569473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1180,87RSYC,13-May-22
C1071013,10031016,183,PF-06863135,T,6517473906,6.51747E+11,20211228,10:35,CYCLE1_DAY1,0 H,481.049233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1944,112RSYC,25-Jul-22
C1071013,10031016,183,PF-06863135,T,6517473906,6.51747E+11,20211228,18:22,CYCLE1_DAY1,6 H,986.7351304,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1945,118RSYC,27-Jul-22
C1071013,10031016,183,PF-06863135,T,6516580389,6.51658E+11,20220106,12:30,CYCLE1_DAY8,0 H,802.146154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1946,123RSYC,29-Jul-22
C1071013,10031016,183,PF-06863135,T,6516580389,6.51658E+11,20220106,18:30,CYCLE1_DAY8,6 H,67.37086315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1947,123RSYC,29-Jul-22
C1071013,10031016,183,PF-06863135,T,6519134602,6.51913E+11,20220112,14:34,CYCLE1_DAY15,0 H,664.178565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1948,122RSYC,29-Jul-22
C1071013,10031016,183,PF-06863135,T,6519134603,6.51913E+11,20220119,13:25,CYCLE1_DAY22,0 H,92.43461043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1626,85RSYC,10-May-22
C1071013,10031016,183,PF-06863135,T,6516580401,6.51658E+11,20220126,12:34,CYCLE2_DAY1,0 H,386.3359296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1625,85RSYC,10-May-22
C1071013,10031016,183,PF-06863135,T,6518620857,6.51862E+11,20220323,8:30,CYCLE4_DAY1,0 H,276.6291074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1949,124RSYC,29-Jul-22
C1071013,10031016,183,PF-06863135,T,6518620861,6.51862E+11,20220615,10:30,CYCLE7_DAY1,0 H,229.2970097,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2097,137RSYC,18-Nov-22
C1071013,10031016,183,PF-06863135,T,6519134615,6.51913E+11,20220907,10:44,CYCLE10_DAY1,0 H,890.0657799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2082,129RSYC,21-Oct-22
C1071013,10031016,183,PF-06863135,T,6519134617,6.51913E+11,20221109,9:05,END_OF_TRT,,86.37658434,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2149,139RSYC,22-Mar-23
C1071013,10031016,183,PF-06863135,T,6518620867,6.51862E+11,20211231,15:13,UNPL,9001 H,145.4889285,NG/ML,,Visit revised from C7D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1950,124RSYC,29-Jul-22
C1071013,10031016,183,PF-06863135,T,6517472378,6.51747E+11,20211229,11:05,CYCLE1_DAY1,24 H,946.7097522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1951,122RSYC,29-Jul-22
C1071013,10031016,183,PF-06863135,T,6517751599,6.51775E+11,20220104,16:23,CYCLE1_DAY4,24 H,795.0967417,NG/ML,9,Visit and time point revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071013,10031015,184,PF-06863135,T,6518620835,6.51862E+11,20211220,13:56,CYCLE1_DAY1,0 H,836.3951706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1952,112RSYC,25-Jul-22
C1071013,10031015,184,PF-06863135,T,6518620835,6.51862E+11,20211220,21:00,CYCLE1_DAY1,6 H,781.3661861,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1953,122RSYC,29-Jul-22
C1071013,10031015,184,PF-06863135,T,6518620840,6.51862E+11,20211228,13:38,CYCLE1_DAY8,0 H,906.8598464,NG/ML,,Visit revised from C7D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1955,124RSYC,29-Jul-22
C1071013,10031015,184,PF-06863135,T,6519134604,6.51913E+11,20220113,16:03,CYCLE1_DAY22,0 H,100.5822375,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1954,122RSYC,29-Jul-22
C1071013,10031015,184,PF-06863135,T,6519134609,6.51913E+11,20220217,13:10,CYCLE3_DAY1,0 H,723.7277101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1627,85RSYC,10-May-22
C1071013,10031015,184,PF-06863135,T,6517751589,6.51775E+11,20220316,10:45,CYCLE4_DAY1,0 H,591.2463426,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1894,81RSYC,4-May-22
C1071013,10031015,184,PF-06863135,T,6519134618,6.51913E+11,20220411,13:28,END_OF_TRT,,205.8412366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1956,124RSYC,29-Jul-22
C1071013,10031015,184,PF-06863135,T,6517473938,6.51747E+11,20211221,13:15,CYCLE1_DAY1,24 H,466.0736789,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1957,122RSYC,29-Jul-22
C1071013,10031015,184,PF-06863135,T,6517472380,6.51747E+11,20211224,14:29,CYCLE1_DAY4,0 H,504.7989509,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1958,126RSYC,1-Aug-22
C1071013,10031015,184,PF-06863135,T,6517473950,6.51747E+11,20211225,15:44,CYCLE1_DAY4,24 H,651.5983698,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1959,124RSYC,29-Jul-22
C1071013,11301003,185,PF-06863135,T,6216756837,6.21676E+11,20211220,14:48,CYCLE1_DAY1,0 H,863.9456609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1389,95RSYC,13-May-22
C1071013,11301003,185,PF-06863135,T,6216756837,6.21676E+11,20211220,22:30,CYCLE1_DAY1,6 H,4.704856377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1388,95RSYC,13-May-22
C1071013,11301003,185,PF-06863135,T,6216756839,6.21676E+11,20211227,14:27,CYCLE1_DAY8,0 H,181.5378018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1393,95RSYC,13-May-22
C1071013,11301003,185,PF-06863135,T,6216756839,6.21676E+11,20211227,20:36,CYCLE1_DAY8,6 H,963.6325119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1392,95RSYC,13-May-22
C1071013,11301003,185,PF-06863135,T,6216756841,6.21676E+11,20220103,15:21,CYCLE1_DAY15,0 H,18.14097495,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1869,80RSYC,4-May-22
C1071013,11301003,185,PF-06863135,T,6216756843,6.21676E+11,20220110,15:00,CYCLE1_DAY22,0 H,509.6605683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1870,80RSYC,4-May-22
C1071013,11301003,185,PF-06863135,T,6217542182,6.21754E+11,20220117,14:00,CYCLE2_DAY1,0 H,838.0925374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1872,80RSYC,4-May-22
C1071013,11301003,185,PF-06863135,T,6217339265,6.21734E+11,20220215,15:15,CYCLE3_DAY1,0 H,954.9254309,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1871,80RSYC,4-May-22
C1071013,11301003,185,PF-06863135,T,6217542186,6.21754E+11,20220315,11:00,CYCLE4_DAY1,0 H,461.4202218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1884,80RSYC,4-May-22
C1071013,11301003,185,PF-06863135,T,6216756849,6.21676E+11,20211221,16:32,CYCLE1_DAY1,24 H,565.7902487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1395,95RSYC,13-May-22
C1071013,11301003,185,PF-06863135,T,6216756851,6.21676E+11,20211223,11:04,CYCLE1_DAY4,0 H,941.1290764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1397,95RSYC,13-May-22
C1071013,11301003,185,PF-06863135,T,6216756852,6.21676E+11,20211224,12:22,CYCLE1_DAY4,24 H,765.5658864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1398,108RSYC,24-May-22
C1071013,10901008,186,PF-06863135,T,6518877857,6.51888E+11,20211231,11:27,CYCLE1_DAY1,0 H,799.7270211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1689,102RSYC,20-May-22
C1071013,10901008,186,PF-06863135,T,6518877857,6.51888E+11,20211231,18:45,CYCLE1_DAY1,6 H,329.7368275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1688,106RSYC,23-May-22
C1071013,10901008,186,PF-06863135,T,6518805052,6.51881E+11,20220107,10:20,CYCLE1_DAY8,0 H,141.564933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1683,101RSYC,13-May-22
C1071013,10901008,186,PF-06863135,T,6518805052,6.51881E+11,20220107,16:31,CYCLE1_DAY8,6 H,447.1870953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1684,101RSYC,13-May-22
C1071013,10901008,186,PF-06863135,T,6519019918,6.51902E+11,20220114,15:24,CYCLE1_DAY15,0 H,2.482666546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1691,106RSYC,23-May-22
C1071013,10901008,186,PF-06863135,T,6517433528,6.51743E+11,20220120,14:23,CYCLE1_DAY22,0 H,571.9436618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1682,101RSYC,13-May-22
C1071013,10901008,186,PF-06863135,T,6520346778,6.52035E+11,20220203,14:14,UNPL,9001 H,819.0901306,NG/ML,,Received as 6518828369-07,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1687,106RSYC,23-May-22
C1071013,10901008,186,PF-06863135,T,6518805053,6.51881E+11,20220101,12:40,CYCLE1_DAY1,24 H,471.5132753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1685,101RSYC,13-May-22
C1071013,10901008,186,PF-06863135,T,6518877871,6.51888E+11,20220103,11:29,CYCLE1_DAY4,0 H,399.3554057,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1690,106RSYC,23-May-22
C1071013,10901008,186,PF-06863135,T,6518805058,6.51881E+11,20220104,11:25,CYCLE1_DAY4,24 H,699.635963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1686,106RSYC,23-May-22
C1071013,10901011,187,PF-06863135,T,6517433456,6.51743E+11,20220103,13:30,CYCLE1_DAY1,0 H,10.14130639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1698,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6517433456,6.51743E+11,20220103,20:20,CYCLE1_DAY1,6 H,209.0438324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1697,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6517433458,6.51743E+11,20220111,12:02,CYCLE1_DAY8,0 H,293.5090976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1700,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6517433458,6.51743E+11,20220111,18:37,CYCLE1_DAY8,6 H,289.9773725,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1699,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6519138599,6.51914E+11,20220118,12:01,CYCLE1_DAY15,0 H,840.2224647,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1706,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6519057381,6.51906E+11,20220125,13:00,CYCLE1_DAY22,0 H,601.1683551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1704,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6519138601,6.51914E+11,20220201,14:20,CYCLE2_DAY1,0 H,754.0693872,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1707,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6517433551,6.51743E+11,20220222,11:36,END_OF_TRT,,181.1260309,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1702,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6518805055,6.51881E+11,20220104,14:20,CYCLE1_DAY1,24 H,365.3412912,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1703,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6519057385,6.51906E+11,20220106,14:25,CYCLE1_DAY4,0 H,729.7629925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1705,109RSYC,25-May-22
C1071013,10901011,187,PF-06863135,T,6517433537,6.51743E+11,20220107,15:45,CYCLE1_DAY4,24 H,272.5353326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1701,109RSYC,25-May-22
C1071013,10321006,188,PF-06863135,T,6519136767,6.51914E+11,20220106,11:26,CYCLE1_DAY1,0 H,436.2323065,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1642,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6519136767,6.51914E+11,20220106,18:31,CYCLE1_DAY1,6 H,497.710935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1641,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6519136771,6.51914E+11,20220113,7:40,CYCLE1_DAY8,0 H,68.94569858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1644,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6519136771,6.51914E+11,20220113,18:52,CYCLE1_DAY8,6 H,381.3534376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1643,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6518722091,6.51872E+11,20220120,14:51,CYCLE1_DAY15,0 H,935.6498071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1639,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6519136778,6.51914E+11,20220127,14:42,CYCLE1_DAY22,0 H,488.9584712,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1648,100RSYC,23-May-22
C1071013,10321006,188,PF-06863135,T,6518722095,6.51872E+11,20220203,13:59,CYCLE2_DAY1,0 H,770.1766448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1640,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6518150042,6.51815E+11,20220303,14:30,CYCLE3_DAY1,0 H,981.5845369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1896,81RSYC,4-May-22
C1071013,10321006,188,PF-06863135,T,6517559965,6.51756E+11,20220623,13:56,CYCLE7_DAY1,0 H,483.3773036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2031,128RSYC,21-Oct-22
C1071013,10321006,188,PF-06863135,T,6518807507,6.51881E+11,20220923,11:25,CYCLE10_DAY1,0 H,986.4846743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2109,131RSYC,9-Nov-22
C1071013,10321006,188,PF-06863135,T,6518807505,6.51881E+11,20221215,11:09,CYCLE13_DAY1,0 H,610.630359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2135,139RSYC,22-Mar-23
C1071013,10321006,188,PF-06863135,T,6519136790,6.51914E+11,20220107,13:01,CYCLE1_DAY1,24 H,290.9659126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1645,85RSYC,10-May-22
C1071013,10321006,188,PF-06863135,T,6519136793,6.51914E+11,20220109,9:45,CYCLE1_DAY4,0 H,768.0344442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1646,100RSYC,23-May-22
C1071013,10321006,188,PF-06863135,T,6519136795,6.51914E+11,20220110,11:09,CYCLE1_DAY4,24 H,802.6786827,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1647,85RSYC,10-May-22
C1071013,11281002,189,PF-06863135,T,6518343086,6.51834E+11,20220107,15:45,CYCLE1_DAY1,0 H,792.4948295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1731,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6518343086,6.51834E+11,20220107,22:18,CYCLE1_DAY1,6 H,196.4871849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1730,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6518343088,6.51834E+11,20220117,8:55,CYCLE1_DAY8,0 H,938.7834619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1735,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6518343088,6.51834E+11,20220117,17:54,CYCLE1_DAY8,6 H,324.7596571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1734,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6518343090,6.51834E+11,20220124,8:40,CYCLE1_DAY15,0 H,962.7468921,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1733,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6518343093,6.51834E+11,20220131,8:30,CYCLE1_DAY22,0 H,484.4319154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1732,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6519452615,6.51945E+11,20220307,9:45,CYCLE3_DAY1,0 H,186.8039871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1907,81RSYC,4-May-22
C1071013,11281002,189,PF-06863135,T,6520815984,6.52082E+11,20220628,7:11,CYCLE7_DAY1,0 H,407.2855664,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2095,127RSYC,19-Oct-22
C1071013,11281002,189,PF-06863135,T,6520815985,6.52082E+11,20220920,10:30,CYCLE10_DAY1,0 H,17.69730247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2101,132RSYC,10-Nov-22
C1071013,11281002,189,PF-06863135,T,6520815987,6.52082E+11,20221213,7:35,CYCLE13_DAY1,0 H,448.1058047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2136,139RSYC,22-Mar-23
C1071013,11281002,189,PF-06863135,T,6522253824,6.52225E+11,20230307,7:54,CYCLE16_DAY1,0 H,644.4552392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2207,142RSYC,18-May-23
C1071013,11281002,189,PF-06863135,T,6522253826,6.52225E+11,20230530,7:25,CYCLE19_DAY1,0 H,235.5590868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2269,144RSYC,27-Nov-23
C1071013,11281002,189,PF-06863135,T,6522253825,6.52225E+11,20230825,7:26,CYCLE22_DAY1,0 H,760.5545074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2306,147RSYC,29-Feb-24
C1071013,11281002,189,PF-06863135,T,6522253827,6.52225E+11,20231201,8:08,CYCLE25_DAY1,0 H,170.0877061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2334,149RSYC,27-Mar-24
C1071013,11281002,189,PF-06863135,T,6525647210,6.52565E+11,,,CYCLE28_DAY1,0 H,43.05500531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2375,152RSYC,9-Apr-24
C1071013,11281002,189,PF-06863135,T,6518343098,6.51834E+11,20220108,16:25,CYCLE1_DAY1,24 H,736.5615797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1728,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6518343101,6.51834E+11,20220110,14:10,CYCLE1_DAY4,0 H,88.33479067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1729,72RSYC,7-May-22
C1071013,11281002,189,PF-06863135,T,6519452620,6.51945E+11,20220111,14:53,CYCLE1_DAY4,24 H,164.3868087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1736,72RSYC,7-May-22
